Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1, DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 64.7;Spermatogonia: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	4.8	4.3	6.0	9.6	11.3	15.3	5.1	12.9	10.6	5.4	9.2	3.4	6.8	4.3	5.4	5.5	9.1	5.5	3.3	6.5	6.6	5.3	4.2	7.7	4.9	13.0	7.5	5.9	5.1	4.7	4.2	11.0	5.3	10.5	4.1	10.4	3.7	5.4	7.4	7.3	8.3	6.7	5.5	9.2	5.9	5.1	17.6	7.0	10.9	15.6	7.3	14.6	5.5	5.6	2.0	9.1	9.7	12.7	1.4	1.3	10.7	15.7	25.6	14.1	11.2	2.3	5.2	13.8	18.6	8.0	15.6	14.9	15.5	12.3	36.4	3.4	7.1	18.5	18.3	19.1	10.4	26.2	16.6	14.0	17.1	20.1	13.4	0.5	30.5	14.9	1.4	1.7	23.5	7.5	4.0	8.1	17.0	25.8	15.6	14.7	10.5	25.5	10.1	7.7	10.6	6.8	17.6	29.7	14.9	5.8	15.3	9.7	10.4	14.3	4.7	7.0	10.0	12.6	14.1	5.2	14.0	11.4	18.1	19.3	7.3	17.8	28.0	11.3	18.1	14.6	4.6	12.7	1.8	1.3	4.0	1.3	1.1	1.3	1.0	9.1	2.0	1.2	1.3	9.7	1.4	1.5	1.4	0.4	10.7	6.0	11.3	12.9	10.6	6.6	5.3	7.5	5.9	10.5	7.0	0.0	3.2	5.2	3.8	2.6	8.3	10.4	7.6	13.4	5.7	1.8	21.6	7.0	0.0	2.6	11.1	2.9	1.0	0.0	1.0	17.5	2.9	2.4	8.1	16.1	8.6	11.1	0.0	5.5	4.0	5.2	2.3	5.3	0.0	3.6	3.7	2.8	1.6	3.1	1.4	0.8	21.1	6.5	1.4	64.7	61.1	1.9	3.3	2.5	3.5	2.5
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133345-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease mutation, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 329.4;Spermatocytes: 249.6;Syncytiotrophoblasts: 270.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	12.1	7.6	9.8	20.2	10.8	31.9	11.5	27.1	14.4	12.0	8.6	10.0	4.3	8.1	12.1	8.0	12.0	11.5	7.8	8.0	9.3	8.1	6.9	9.2	11.8	29.7	12.5	7.9	11.1	6.2	10.2	8.8	32.5	8.7	8.3	10.7	7.8	9.3	6.5	6.8	10.8	11.3	11.2	9.1	11.0	9.0	19.9	12.6	31.4	9.5	8.8	28.8	11.4	9.7	12.6	19.0	10.2	13.4	25.0	18.2	6.8	24.3	15.4	19.7	16.7	7.3	7.5	42.3	16.5	13.1	23.8	23.9	14.9	13.3	40.8	10.4	10.1	12.0	16.1	21.7	12.9	24.4	16.0	32.3	59.1	13.8	7.7	3.2	24.0	24.0	5.0	2.5	20.8	8.2	7.2	12.9	12.6	23.4	25.2	17.7	16.2	35.1	32.8	25.9	11.0	22.5	35.6	20.7	22.4	7.5	15.4	21.0	16.3	20.0	9.0	6.4	12.6	9.4	12.2	9.7	40.0	13.7	24.2	24.4	20.6	21.5	48.3	11.6	22.4	31.0	10.2	13.4	3.3	18.2	13.2	15.9	7.9	14.6	12.5	11.3	12.6	16.6	12.3	3.1	25.0	7.9	19.0	12.9	6.8	9.8	10.8	27.1	14.4	9.3	8.1	12.5	7.9	8.7	12.6	6.0	24.5	38.8	19.1	26.3	66.8	11.9	7.6	48.2	29.6	21.0	53.0	329.4	11.6	20.3	42.9	33.0	4.7	93.5	12.4	56.3	25.7	12.5	34.8	12.1	68.9	62.0	15.1	24.5	28.2	38.6	25.9	51.5	13.5	45.1	16.3	39.9	15.7	11.5	26.9	7.6	50.4	12.9	22.0	249.6	179.2	19.6	270.7	54.2	37.6	14.1
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 400.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		39000	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.9	15.5	43.2	30.6	11.3	9.4	24.6	19.2	17.1	26.1	21.5	24.7	14.2	84.4	28.7	11.6	11.5	21.8	59.4	18.8	23.1	35.4	82.9	32.6	20.7	16.1	6.8	54.2	15.8	9.2	7.5	21.0	14.9	7.3	20.3	19.6	51.9	43.1	13.5	13.8	17.3	19.6	79.5	40.9	30.8	52.5	74.0	78.0	12.2	20.7	43.5	38.1	25.0	28.0	15.7	31.8	23.5	34.0	15.4	13.9	23.0	18.7	35.9	17.6	29.4	72.5	11.6	18.3	31.1	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8	50.6	68.3	130.2	75.6	64.2	94.4	106.4	43.3	75.0	97.8	54.1	133.5	400.4	61.3	77.0	28.3	54.0	16.8	23.3	91.9	75.6	55.5	70.8	116.9	65.7	117.1	85.8	72.1	31.9	42.2	16.3	37.2	45.7	59.1	93.8	46.5	78.6	54.3	24.6	32.9	36.1	102.8	45.3	47.4	92.8	211.4	42.0	115.1	74.0	57.9	42.9
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm		Yes	No		98000	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	43.9	52.8	30.6	33.2	32.5	55.6	43.6	24.1	44.9	38.5	41.9	37.3	28.4	44.1	53.2	30.1	40.7	42.9	46.4	34.4	28.0	27.4	44.4	61.3	31.8	44.5	30.2	31.1	64.7	48.4	31.8	21.7	29.4	34.4	36.1	39.8	36.0	35.5	38.9	53.2	41.2	37.6	40.9	30.1	51.0	41.7	20.9	28.3	73.2	51.2	38.5	48.4	41.8	32.7	35.0	53.0	1.5	23.7	20.6	32.5	38.4	44.6	54.9	49.3	45.4	34.7	50.1	42.5	42.0	45.2	62.6	54.3	40.0	44.4	86.3	37.5	32.0	33.5	47.9	58.6	44.4	58.2	38.5	25.0	34.9	32.5	66.7	36.5	110.9	36.3	51.7	49.0	40.7	40.4	50.2	52.2	35.7	40.5	28.4	50.1	43.5	71.0	46.7	48.5	50.7	49.7	79.0	55.4	36.2	52.5	60.3	59.5	37.8	45.5	56.8	45.1	36.3	34.5	50.2	33.7	33.0	55.4	33.2	39.1	38.2	66.1	58.2	14.8	70.5	41.7	0.1	23.7	1.5	19.0	20.5	25.9	35.0	23.8	22.6	46.8	31.4	32.5	28.3	1.5	20.6	12.4	53.0	14.1	38.4	30.6	32.5	24.1	44.9	28.0	27.4	30.2	31.1	34.4	28.3	59.6	45.2	101.2	74.7	94.4	52.3	42.8	86.6	72.3	79.6	64.6	39.3	161.9	127.6	119.2	16.8	57.5	33.9	0.0	91.3	165.4	86.9	49.2	78.7	65.2	158.8	27.0	115.1	39.3	80.7	4.0	74.5	109.4	60.8	100.0	78.8	68.5	83.2	73.7	60.5	126.7	45.4	51.8	136.6	6.3	43.7	84.8	84.9	76.1	136.8	42.5
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965804-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	12.3	16.6	7.0	17.9	11.1	15.9	12.8	10.7	13.4	17.7	14.7	10.0	11.3	11.0	15.8	17.8	23.8	12.4	12.8	12.0	7.7	6.9	13.4	17.4	13.7	19.7	8.7	7.9	14.4	13.2	11.0	21.0	27.9	10.8	13.0	16.8	10.9	13.2	11.3	11.1	16.3	18.7	17.8	8.8	19.8	13.1	5.8	8.1	33.4	12.4	15.3	19.6	13.3	14.7	18.9	41.4	18.8	24.3	14.2	13.6	7.2	13.3	6.8	21.5	12.5	5.3	4.8	21.7	10.1	4.2	14.2	8.0	11.6	6.1	31.6	6.2	8.4	2.3	9.0	25.6	11.9	11.2	12.9	20.7	24.8	10.3	5.2	5.0	30.7	18.8	5.6	15.9	10.5	8.5	8.7	13.9	18.7	27.7	5.3	6.8	14.0	34.3	17.3	26.0	9.9	10.9	35.4	11.1	11.2	15.5	19.8	28.3	19.6	12.3	14.5	9.0	13.2	23.2	16.6	8.4	4.4	7.3	4.7	12.0	11.6	15.3	27.1	4.9	16.6	8.5	18.5	24.3	18.8	13.6	16.3	10.3	17.7	13.0	11.2	14.9	18.9	13.5	12.1	16.0	14.2	15.9	41.4	12.6	7.2	7.0	11.1	10.7	13.4	7.7	6.9	8.7	7.9	10.8	8.1	35.7	18.4	41.0	33.6	70.2	45.5	23.0	35.7	40.2	40.9	31.4	25.5	58.2	31.5	66.4	3.9	43.9	26.9	23.3	46.9	70.7	38.1	38.3	38.3	30.1	39.3	33.4	78.4	36.2	38.6	2.1	25.3	39.1	15.1	39.7	39.8	23.0	64.5	34.5	28.3	18.0	37.1	45.3	30.7	9.9	25.0	89.8	131.0	39.9	38.9	48.0
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 119.8;Horizontal cells: 90.6;Rod photoreceptor cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.7;REH: 25.4;SH-SY5Y: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	7.8	12.4	13.7	12.7	15.5	10.8	8.6	21.6	20.1	9.0	12.7	14.5	7.6	9.1	13.0	12.2	8.0	9.6	8.9	8.2	12.3	6.7	9.4	6.9	9.5	13.6	15.3	10.1	18.3	12.1	6.3	12.6	20.8	10.7	9.3	9.2	12.0	8.5	9.2	29.1	6.6	11.4	11.3	7.9	17.5	11.6	6.6	15.2	20.8	9.1	10.5	11.8	9.8	8.4	3.0	4.1	4.9	4.1	8.7	8.3	2.3	1.1	3.5	14.9	3.6	1.6	1.2	19.5	1.0	0.9	2.0	1.6	8.8	5.7	0.0	2.2	1.9	1.6	1.0	1.6	2.2	1.2	3.7	2.6	6.4	5.3	10.5	3.9	1.3	4.1	3.6	1.1	2.6	0.9	3.9	8.3	14.5	7.3	1.4	1.5	8.5	13.9	15.1	25.7	5.9	1.9	25.4	16.4	2.1	1.2	1.5	8.8	31.3	1.2	8.4	2.6	13.4	1.0	6.7	2.8	2.5	3.3	0.6	1.3	3.2	2.2	8.6	0.9	3.8	2.6	4.7	1.8	3.1	5.2	3.0	7.0	2.3	3.4	4.9	2.0	3.0	8.3	6.6	4.9	8.7	4.1	4.1	2.8	2.3	13.7	15.5	21.6	20.1	12.3	6.7	15.3	10.1	10.7	15.2	6.0	13.3	10.0	8.3	4.6	74.9	13.7	5.1	9.4	12.5	19.2	119.8	30.2	5.0	13.8	1.5	14.6	5.3	0.0	8.5	9.4	14.7	11.7	36.9	5.5	19.8	90.6	12.6	6.2	10.5	1.1	17.8	11.9	6.8	4.6	11.5	22.7	9.2	10.5	14.5	5.6	144.9	19.4	8.2	2.3	13.4	2.3	26.9	18.7	11.0	6.7
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"kidney: 7.8;liver: 20.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 17.3;Proximal tubular cells: 13.5"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Group enriched"	"Detected in some"	16	"memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.2;dendritic cells: 1.1"	"Cell line enriched"	"Detected in some"	7	"BEWO: 31.2"									"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.1	0.0	0.1	0.2	0.1	0.3	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	7.8	20.5	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	4.6	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA057999			Supported	Nucleoli		NA	NA			Nucleoli		"HPA057999: AB_2683574"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	14.1	6.2	7.3	7.2	9.2	3.7	14.2	6.9	8.5	12.5	6.5	6.2	5.2	4.3	19.4	7.6	7.2	12.5	8.2	6.3	6.6	4.3	10.1	5.3	5.1	6.5	9.1	8.7	19.4	9.8	5.7	7.4	5.6	6.5	13.9	6.9	5.7	11.9	10.0	7.7	7.3	5.7	16.8	7.2	5.0	6.0	7.3	10.8	13.1	11.5	8.3	4.4	11.3	13.3	3.8	1.6	1.9	3.3	0.5	5.3	1.5	3.0	2.7	8.2	1.7	19.7	6.5	8.3	3.3	1.0	3.3	3.1	2.8	2.3	8.0	3.5	1.8	6.0	2.6	7.2	5.0	3.6	5.4	6.2	10.0	4.9	4.5	2.3	4.7	4.2	7.7	3.9	2.4	0.8	3.0	4.8	9.1	6.6	3.0	5.1	4.1	7.0	3.0	8.0	1.9	4.7	8.3	8.1	3.3	3.1	4.2	6.5	9.6	4.0	5.0	4.3	5.4	4.8	2.7	3.1	4.9	6.9	4.1	4.3	4.0	9.5	19.8	1.8	5.4	4.1	1.9	1.1	1.3	2.3	3.3	2.0	2.9	2.7	2.9	1.0	3.8	4.5	5.3	0.2	0.5	1.9	1.6	1.7	1.5	7.3	9.2	6.9	8.5	6.6	4.3	9.1	8.7	6.5	10.8	0.0	5.3	2.7	7.6	2.2	5.2	5.9	5.1	9.4	13.6	0.0	0.0	20.4	11.6	10.1	0.6	6.8	2.3	0.0	11.6	12.2	7.4	3.2	1.1	2.5	5.2	0.0	3.5	3.7	1.0	0.9	8.9	1.8	0.0	4.6	2.6	4.1	6.6	5.1	12.4	4.3	2.8	6.5	5.7	4.6	5.1	0.5	13.6	1.3	5.6	3.1
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX, chromatin remodeler"	P46100	X	77504878-77786269	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321"	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	16.4	16.6	24.5	18.9	29.3	24.3	16.3	48.2	26.4	20.6	15.4	7.1	18.9	10.2	20.2	17.1	13.5	13.8	13.4	15.1	22.9	15.8	16.6	12.2	15.9	18.6	21.1	21.3	25.4	18.3	35.7	28.1	15.9	20.2	18.4	12.6	7.1	15.8	16.5	20.1	14.1	13.5	22.3	15.3	20.1	15.6	6.5	22.4	23.7	19.8	12.7	16.5	19.9	21.1	21.9	12.8	21.5	11.5	14.6	17.7	5.7	15.3	24.7	25.4	17.1	12.7	17.1	9.0	13.3	12.3	9.9	11.7	8.4	13.5	21.4	13.7	14.1	18.6	13.7	20.4	7.9	16.8	12.0	13.3	12.9	29.4	6.2	6.9	16.7	4.4	11.2	7.8	14.5	13.9	12.3	17.4	13.5	15.1	24.6	12.3	12.1	12.9	8.7	18.4	7.1	19.2	21.0	35.2	10.9	9.6	20.6	14.5	25.1	26.8	10.5	8.8	17.2	8.5	8.6	24.0	14.0	21.6	15.6	9.3	7.3	22.7	19.2	10.2	13.3	12.3	21.3	6.9	13.8	17.7	8.7	17.1	19.2	16.3	13.7	5.1	21.9	16.8	13.5	21.5	14.6	11.5	12.8	12.8	5.7	24.5	29.3	48.2	26.4	22.9	15.8	21.1	21.3	20.2	22.4	148.9	213.6	88.0	96.7	82.1	217.2	263.3	58.6	120.5	117.2	68.0	200.3	58.0	19.9	72.8	3.1	123.5	43.3	23.3	72.0	39.7	90.3	99.7	106.6	45.6	60.7	149.4	121.7	91.4	84.5	4.9	150.4	86.3	59.1	120.0	68.3	114.7	80.3	40.3	195.6	28.6	231.4	90.5	113.3	13.6	49.5	73.8	50.0	94.4	62.6	104.6
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7;testis: 23.3"	"Cell type enhanced"	"Detected in some"	7	"Cytotrophoblasts: 3.7;Extravillous trophoblasts: 3.8;Horizontal cells: 4.8;Sertoli cells: 6.5;Syncytiotrophoblasts: 4.0"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 55.3;CACO-2: 20.8;HEL: 21.7;K-562: 20.8;NTERA-2: 74.7;SuSa: 41.2"					"Low region specificity"	"Detected in some"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	1.1	0.8	0.9	2.5	0.9	4.7	2.4	4.5	1.4	1.6	2.1	0.7	0.5	0.9	1.3	4.7	1.6	1.1	1.6	1.8	0.8	0.7	2.7	1.2	1.2	1.9	0.9	0.5	1.2	7.5	2.5	1.1	2.8	0.8	1.1	0.8	1.2	3.5	1.6	0.5	5.5	0.8	1.0	0.5	1.3	1.1	23.3	0.8	17.7	2.6	1.7	2.5	2.7	2.2	0.7	1.0	0.0	0.2	0.9	1.3	0.1	0.8	1.1	6.0	1.4	0.1	0.5	55.3	0.7	0.5	0.8	0.8	20.8	0.9	2.1	2.2	0.3	0.9	0.5	3.9	0.3	0.6	0.2	3.1	21.7	0.7	3.9	0.2	0.9	2.2	0.5	0.4	1.2	0.2	0.4	1.4	1.3	20.8	0.6	0.3	3.3	3.3	18.4	74.7	1.9	0.7	3.3	1.0	0.5	2.0	0.9	1.9	1.2	1.3	1.9	0.5	41.2	1.2	1.1	0.3	1.2	2.8	0.6	0.5	1.3	0.6	0.8	0.5	5.9	0.5	0.0	0.2	0.0	0.1	0.1	0.1	0.7	0.2	0.0	1.0	0.0	1.3	0.0	0.0	0.9	0.1	0.9	0.0	0.1	0.9	0.9	4.5	1.4	0.8	0.7	0.9	0.5	0.8	0.8	0.0	1.0	0.0	0.1	0.8	1.4	1.1	0.0	0.0	1.2	0.0	2.0	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.5	3.8	0.9	0.6	0.0	0.0	0.6	4.8	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.8	1.1	0.0	0.4	0.6	2.1	6.5	0.4	0.0	2.5	1.1	4.0	0.0	0.8	0.0
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	12.1	5.6	15.2	11.4	9.3	11.1	4.5	5.5	8.0	5.8	6.7	11.3	8.8	15.0	11.3	8.0	10.3	10.6	16.1	6.1	11.6	16.5	6.2	29.4	5.2	6.1	5.2	17.5	5.7	5.3	6.2	12.7	17.0	7.3	9.0	9.8	19.1	12.8	7.3	9.5	11.6	10.3	9.2	5.0	8.4	8.8	14.6	5.0	8.5	9.2	12.5	8.1	13.8	4.5	2.9	8.3	7.8	5.9	13.2	9.9	9.0	7.2	9.8	3.7	2.9	10.1	3.7	12.9	5.9	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4	65.5	59.8	31.5	64.8	77.2	147.8	34.4	38.2	53.5	35.2	36.6	143.3	12.2	3.3	26.8	6.6	70.1	19.7	0.0	22.3	8.1	43.5	71.4	26.7	23.1	14.2	184.3	63.8	45.4	32.6	4.7	61.9	26.1	40.5	33.3	29.3	117.0	23.2	14.4	73.9	6.9	144.6	64.7	59.7	11.1	14.9	70.4	5.0	50.7	27.3	49.9
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 10.3;NTERA-2: 15.8;U-266/84: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	9.4	12.2	13.1	9.6	21.4	7.6	6.3	17.1	17.5	8.0	7.7	12.3	8.4	14.6	15.0	11.7	18.0	7.6	8.1	7.6	12.3	12.4	5.3	4.4	8.5	6.9	12.6	10.6	10.6	13.2	2.2	8.1	6.0	10.3	10.4	4.3	7.2	5.6	9.6	5.2	5.5	10.1	9.6	8.4	9.1	9.8	7.6	14.9	14.6	9.5	4.8	7.2	8.7	7.6	0.3	0.6	0.0	0.7	0.1	1.1	1.3	0.0	3.6	6.4	0.0	2.8	1.5	4.1	2.8	2.3	3.2	2.6	0.0	0.0	0.0	6.3	4.5	3.3	0.0	0.0	6.9	1.5	4.2	9.6	0.0	0.0	0.0	0.0	10.3	0.0	3.9	1.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	7.3	0.0	15.8	0.0	0.0	6.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	5.3	2.7	0.0	0.0	3.0	3.4	2.6	5.7	0.0	9.1	12.4	3.0	3.9	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.1	0.8	0.6	0.3	0.3	1.1	1.1	0.0	0.1	0.7	0.6	0.2	1.3	13.1	21.4	17.1	16.5	12.3	12.4	12.6	10.6	10.3	14.9	14.9	11.8	22.3	5.6	7.4	59.2	4.5	22.9	9.4	19.4	24.4	39.3	19.7	6.6	12.9	33.8	11.9	8.9	0.0	10.6	12.5	13.2	5.8	13.9	6.4	14.1	36.5	21.7	20.3	9.1	44.9	25.3	9.9	18.6	16.2	15.5	28.2	11.0	5.8	21.5	7.8	48.2	25.8	8.5	6.1	30.6	9.7	4.7	14.9	15.0	2.6
MGMT		ENSG00000170430	"O-6-methylguanine-DNA methyltransferase"	P16455	10	129467184-129768007	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 419.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002786, HPA032135, HPA032136, HPA069497, CAB069881"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134"	"unprognostic (1.10e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.81e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.32e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	11.7	11.3	7.4	15.5	7.6	7.1	11.3	3.5	9.1	8.3	12.2	10.0	19.6	10.8	15.3	17.1	9.9	15.2	14.1	10.5	7.1	7.1	12.6	45.6	7.5	11.6	8.6	6.6	12.3	16.5	5.7	5.8	4.5	9.2	11.2	3.4	11.8	14.9	24.5	14.4	9.2	9.6	10.9	8.1	8.6	9.9	11.7	3.9	16.0	10.2	14.9	14.7	12.6	13.0	20.3	17.7	6.5	15.3	18.2	21.2	16.6	0.0	2.5	2.7	13.0	5.7	11.8	10.2	5.7	6.4	4.2	4.1	15.8	16.9	11.8	9.2	7.4	0.0	7.7	1.7	6.1	1.9	0.0	1.0	2.3	5.8	10.1	8.8	0.2	6.8	7.5	0.0	2.4	0.0	0.0	0.0	20.0	0.0	8.3	5.1	21.3	9.3	12.1	0.6	10.9	10.2	10.8	0.0	4.6	7.8	5.8	2.7	6.8	6.9	2.8	0.0	2.2	11.2	9.2	0.0	5.5	2.8	0.0	0.0	0.0	0.0	6.0	0.0	3.8	0.0	2.6	15.3	6.5	19.1	14.8	18.6	20.3	17.5	17.8	15.8	19.9	17.6	18.9	1.8	18.2	13.7	17.7	21.2	16.6	7.4	7.6	3.5	9.1	7.1	7.1	8.6	6.6	9.2	3.9	11.9	14.7	57.0	56.4	45.4	15.7	37.8	86.6	57.6	15.9	97.7	7.9	41.1	107.8	40.8	70.9	48.0	68.8	23.3	51.1	53.2	48.9	49.8	64.5	419.1	76.3	14.3	52.4	98.2	75.3	90.6	62.5	39.9	62.4	45.9	56.4	33.9	74.4	47.0	51.9	227.8	39.0	45.3	55.7	43.1	97.3	37.3	22.4	67.1	59.6	48.8
CTCF		ENSG00000102974	"CCCTC-binding factor"	P49711	16	67562407-67639185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Chromosome partition, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004122, CAB062550, CAB068181, CAB068182"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139"	"unprognostic (2.70e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (3.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-2)"	19.1	17.5	22.3	35.0	24.3	32.2	20.2	31.6	26.6	23.0	19.4	20.5	21.0	16.5	24.2	15.4	23.1	21.7	20.3	17.6	21.8	16.7	19.5	19.5	17.2	27.9	22.3	21.0	24.6	21.2	42.4	21.8	23.5	17.9	19.4	23.2	14.3	19.9	24.9	29.4	25.2	21.4	22.0	20.2	26.1	18.5	14.8	22.9	68.8	20.7	16.2	35.5	22.6	26.7	10.1	7.9	9.6	6.2	4.9	7.2	1.9	11.0	17.1	22.8	9.0	10.4	8.9	18.5	10.6	11.3	15.7	15.0	14.0	11.5	34.7	8.6	9.2	8.9	14.4	21.9	11.9	17.7	12.3	14.4	21.1	9.7	16.0	7.1	23.8	20.2	7.2	14.5	11.7	13.1	9.4	11.9	27.9	18.4	14.5	13.0	21.7	50.0	9.1	19.8	12.7	11.5	36.6	18.7	19.1	9.6	16.1	19.5	13.5	19.2	11.2	9.3	12.5	13.8	14.8	11.3	13.6	14.1	10.3	11.6	12.7	15.9	50.6	7.8	14.3	14.5	9.4	3.4	4.9	6.7	3.4	6.3	7.9	7.2	5.4	3.1	10.1	5.9	6.7	9.6	4.9	6.2	7.9	5.4	1.9	22.3	24.3	31.6	26.6	21.8	16.7	22.3	21.0	17.9	22.9	20.8	28.0	26.8	21.6	19.8	33.6	32.3	38.2	17.4	38.7	22.7	7.9	20.9	16.6	25.5	0.9	30.1	18.7	46.7	29.1	27.5	18.8	26.1	18.5	21.3	20.8	42.9	30.0	20.3	23.2	2.0	23.0	23.7	11.8	24.4	25.6	30.4	26.6	14.0	26.9	19.5	27.1	19.4	21.7	15.8	25.6	21.7	24.7	32.3	21.2	29.4
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 72.2;Spermatocytes: 126.7;Spermatogonia: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	17.0	8.0	27.3	18.2	0.8	1.4	14.9	13.3	5.4	11.0	11.1	12.0	19.7	30.2	6.5	5.0	10.0	10.5	14.0	4.6	14.0	43.2	14.0	12.9	9.9	9.3	2.2	28.6	10.6	1.2	2.6	8.2	4.4	3.3	6.4	29.3	27.3	20.1	9.8	19.3	55.6	23.9	21.7	15.0	10.8	34.4	15.3	18.7	5.1	8.2	26.1	16.6	16.7	12.7	4.4	7.3	9.3	12.3	3.9	11.7	5.4	23.3	23.8	18.0	19.6	30.4	10.7	19.6	22.9	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3	0.0	7.9	6.7	5.7	23.6	4.8	6.5	2.5	14.7	7.9	7.0	33.4	13.6	3.3	9.1	72.2	7.1	6.7	23.3	7.4	29.5	10.8	4.4	21.8	1.3	10.4	14.3	8.6	4.3	8.9	19.2	2.8	10.9	13.5	19.0	10.2	2.0	10.1	9.3	0.7	1.0	21.1	6.5	9.9	126.7	62.4	25.3	25.5	18.7	18.6	4.0
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151601-54224788	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 8.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872"	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favorable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	29.8	11.9	8.5	27.9	9.8	15.3	24.0	9.9	9.0	17.5	22.5	7.4	20.1	10.5	12.5	14.8	33.1	11.3	18.7	17.9	7.9	8.1	23.3	23.2	21.3	33.7	10.0	5.3	15.3	19.3	13.1	12.5	38.1	8.6	18.3	15.0	12.1	23.3	17.3	13.9	24.1	26.7	15.7	11.7	36.9	12.5	26.1	9.4	31.0	31.0	25.4	32.2	22.8	27.1	2.0	1.5	2.2	8.2	0.4	2.6	0.8	12.7	5.8	10.8	5.3	12.7	10.8	10.6	12.1	15.2	14.0	12.3	3.7	7.1	30.2	6.2	18.6	6.2	20.5	9.1	16.3	15.4	22.5	5.0	4.4	9.1	8.0	13.2	14.1	8.2	9.4	18.4	10.7	15.7	9.3	16.1	9.3	3.4	28.1	12.6	6.1	14.2	7.9	11.3	5.0	7.8	9.6	6.3	12.2	20.1	13.2	11.8	5.0	9.4	9.5	6.3	14.9	4.9	7.2	13.9	14.3	6.6	4.9	10.7	30.5	16.6	23.3	12.6	12.0	8.5	0.1	2.6	1.2	1.2	4.6	1.6	1.4	1.3	1.9	1.5	2.0	0.7	1.2	2.2	0.4	8.2	1.2	2.6	0.8	8.5	9.8	9.9	9.0	7.9	8.1	10.0	5.3	8.6	9.4	26.8	16.0	24.2	25.1	43.8	17.7	28.8	20.4	24.1	20.5	31.4	15.7	11.3	6.6	23.6	1.7	25.3	29.7	23.3	49.8	45.1	20.5	42.9	8.1	17.9	28.1	20.6	15.6	24.5	111.1	3.3	23.3	44.3	25.3	33.3	38.0	36.6	44.0	20.1	24.8	19.0	23.2	25.8	18.1	5.2	4.3	54.6	15.3	17.5	33.1	78.0
CTCFL	"BORIS, CT27, dJ579F20.2"	ENSG00000124092	"CCCTC-binding factor like"	Q8NI51	20	57495966-57525652	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 35.4"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 114.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"HMC-1: 33.3;K-562: 45.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001472	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001472: AB_1078583"	"unprognostic (2.50e-1)"	"unprognostic (4.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.85e-5)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.00e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.75e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.84e-2)"		0.2	0.1	0.1	0.1	0.4	1.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.3	0.1	0.1	0.1	0.4	0.0	0.5	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.1	35.4	0.1	0.1	0.4	0.1	0.1	0.1	0.1	2.1	1.0	4.3	0.8	0.8	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.3	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	1.2	0.1	0.1	0.2	1.8	0.7	1.2	0.6	0.7	0.5	1.3	0.4	0.5	0.3	2.1	0.7	0.8	4.3	0.8	0.8	1.0	0.5	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.5	0.4	18.5	114.6	0.0	0.0	0.0	0.0	0.1
FOS	"AP-1, c-fos"	ENSG00000170345	"Fos proto-oncogene, AP-1 transcription factor subunit"	P01100	14	75278774-75282230	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 84.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 84.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 98.8;OE19: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA018531	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA018531: AB_1846576"	"unprognostic (1.18e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.55e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-2)"	104.8	58.4	17.0	143.7	30.0	157.6	40.7	24.0	21.3	132.3	48.7	52.3	22.1	17.4	79.7	50.5	93.6	239.5	271.8	56.8	17.5	21.4	22.7	47.9	70.7	31.0	23.9	10.6	94.5	32.7	40.9	52.9	130.2	44.6	60.6	49.3	64.4	42.8	255.8	37.5	156.2	44.1	98.1	43.7	18.5	60.7	33.2	26.8	10.1	77.5	226.7	28.1	60.8	54.0	0.0	11.6	84.5	12.3	0.7	0.1	3.3	0.4	0.3	1.5	2.2	13.2	4.0	9.1	1.3	0.5	0.9	0.7	0.9	2.6	0.1	0.4	9.2	9.2	0.6	0.7	15.9	0.2	0.2	0.2	0.2	3.8	0.3	6.1	0.5	9.3	9.9	98.8	0.8	6.0	1.3	0.5	1.9	0.4	4.2	0.2	5.4	0.1	2.6	1.6	35.5	0.5	0.4	0.3	4.8	4.1	4.3	11.4	0.7	2.0	18.3	7.8	4.9	0.3	1.9	1.3	0.1	1.2	0.8	0.4	11.4	11.9	2.0	0.6	1.6	1.2	6.0	12.3	14.6	0.0	3.5	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.0	84.5	0.7	0.4	0.2	0.0	3.3	17.0	30.0	24.0	21.3	17.5	21.4	23.9	10.6	44.6	26.8	1024.3	2295.6	355.2	364.1	763.7	85.4	943.0	545.2	294.5	662.0	181.5	121.7	1104.1	14.9	389.9	11.8	1089.3	1251.6	70.0	471.9	2288.8	1942.6	1138.8	1518.7	136.0	1546.5	33.4	1566.3	439.5	1852.6	21.7	873.9	1719.6	811.4	159.7	1650.2	515.9	381.7	1444.9	167.6	15.8	410.8	1190.0	1600.6	4.1	8.0	954.8	1909.4	705.6	1252.5	275.6
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884669-67918390	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	17.2	32.3	12.6	21.1	17.8	17.0	18.1	22.6	14.5	24.2	20.5	15.7	14.0	9.2	19.0	12.7	12.7	15.1	15.2	14.7	14.1	10.4	13.9	17.3	12.6	16.1	17.0	10.1	26.6	14.4	16.4	13.3	14.7	12.1	21.7	12.5	12.1	12.3	16.1	19.9	12.9	15.0	21.0	17.7	13.5	13.2	25.4	16.3	28.1	15.2	9.3	14.7	21.6	37.5	4.9	3.9	3.8	3.5	3.6	7.1	1.8	8.3	9.6	15.2	16.9	14.5	11.2	9.5	11.6	12.0	16.0	14.3	10.5	7.2	17.6	6.3	7.7	10.0	6.7	18.8	3.9	17.2	9.4	10.9	9.3	7.2	8.2	13.3	10.0	7.2	10.3	9.4	9.6	16.6	17.2	6.4	10.1	11.8	9.6	11.6	6.7	9.3	13.9	18.8	5.4	15.3	16.9	12.0	6.9	7.5	5.2	9.8	13.5	21.3	14.1	14.7	13.7	10.2	9.3	5.3	12.5	11.6	11.0	11.2	8.1	9.6	34.9	6.4	15.2	5.1	3.8	2.4	3.2	3.4	3.0	4.9	4.9	3.7	4.7	3.9	3.3	7.1	4.2	3.1	3.6	3.5	3.5	2.9	1.8	12.6	17.8	22.6	14.5	14.1	10.4	17.0	10.1	12.1	16.3	17.9	6.1	10.4	16.4	34.8	11.7	27.0	15.3	1.4	9.1	5.2	25.5	5.7	5.0	3.9	171.4	12.8	17.4	23.3	4.7	4.3	17.6	23.9	11.5	14.8	7.8	11.1	41.1	14.1	20.9	29.0	16.4	13.5	15.1	1.8	16.9	7.0	6.4	10.5	18.4	6.3	13.4	0.0	38.2	20.6	15.4	41.5	10.4	13.8	12.4	14.9
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708020	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: AB_2678803, HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	8.2	8.5	6.2	6.7	8.6	2.7	9.7	9.6	8.8	9.7	9.1	8.2	4.5	6.5	7.0	5.9	7.1	8.0	5.8	11.1	5.4	5.7	7.9	9.4	5.9	8.3	6.5	3.7	8.3	7.9	8.4	11.2	10.2	6.4	9.3	9.1	9.9	7.2	8.7	16.5	8.2	6.7	7.8	5.5	8.3	7.8	9.9	6.6	12.7	8.8	6.5	10.3	8.5	9.4	5.4	4.9	11.4	5.7	5.2	5.3	3.2	5.3	8.0	6.5	4.4	7.0	7.7	8.2	5.6	7.3	12.4	14.0	8.1	3.3	8.3	3.2	5.1	5.8	4.9	14.2	6.1	14.7	5.6	5.6	4.4	4.7	6.8	9.9	4.6	2.9	6.5	10.1	7.3	11.6	5.5	10.1	6.5	6.8	4.8	6.6	8.5	6.2	6.0	7.2	8.1	10.3	6.2	6.6	5.5	7.1	4.8	8.4	6.3	4.6	4.8	6.1	5.6	11.8	4.8	4.6	5.2	5.3	5.7	4.5	6.0	9.5	8.1	3.5	6.7	5.1	11.4	5.0	2.2	5.0	5.7	4.3	5.4	4.7	5.0	4.9	4.9	5.0	3.9	1.4	5.2	3.8	2.6	5.3	3.2	6.2	8.6	9.6	8.8	5.4	5.7	6.5	3.7	6.4	6.6	0.0	4.6	3.7	4.9	7.4	4.0	6.5	0.0	5.3	3.4	1.8	2.0	8.9	8.3	5.3	3.3	4.1	4.2	0.0	6.1	6.7	6.0	3.8	9.2	3.0	6.5	0.0	2.4	3.1	4.6	3.1	6.1	5.6	5.0	5.4	4.6	7.3	5.7	0.0	4.9	5.1	4.9	6.5	5.2	15.8	14.9	4.6	10.2	4.4	4.2	3.0
MECP2	"MRX16, MRX79, RTT"	ENSG00000169057	"Methyl-CpG binding protein 2"	P51608	X	154021573-154137103	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 194.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000593, HPA001341, CAB037264"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347"	"unprognostic (1.27e-3)"	"unprognostic (2.60e-3)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.22e-1)"	"prognostic favorable (7.32e-9)"	"unprognostic (7.63e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.05e-2)"	18.6	21.4	29.2	17.0	27.1	33.8	17.6	39.1	33.5	20.2	19.2	17.6	15.9	13.9	20.0	15.1	18.8	21.1	19.5	23.1	22.5	14.0	17.1	16.4	22.8	19.7	22.5	26.7	29.0	21.2	24.3	22.9	13.9	25.4	23.0	8.0	20.8	18.7	23.7	31.6	14.1	15.3	16.2	21.1	23.3	15.0	9.7	24.4	13.8	19.1	8.7	14.3	18.7	28.6	5.6	4.2	22.4	4.9	2.9	6.8	1.8	19.4	11.6	9.8	12.2	8.4	6.0	8.3	9.8	11.0	12.0	19.6	8.9	9.5	23.4	23.2	8.6	19.0	9.3	14.7	11.5	6.1	17.7	17.7	9.0	10.6	5.6	10.3	11.3	18.9	6.1	6.5	11.2	13.2	9.5	9.3	11.5	9.7	20.0	7.2	11.6	13.6	13.0	7.6	14.7	13.0	11.8	10.7	7.7	8.5	8.9	13.8	8.0	7.6	8.9	18.7	5.5	5.8	14.7	9.7	9.1	18.1	18.5	19.7	24.0	17.8	26.6	13.2	22.3	15.6	22.4	3.5	13.3	6.8	3.2	4.8	5.6	4.8	5.5	2.4	4.9	4.6	4.4	16.9	2.9	4.9	4.2	5.0	1.8	29.2	27.1	39.1	33.5	22.5	14.0	22.5	26.7	25.4	24.4	6.0	33.8	38.3	36.3	27.4	82.7	40.4	30.6	17.4	33.0	43.6	194.4	13.1	56.3	31.6	0.5	36.8	24.4	0.0	27.0	13.6	26.3	29.6	50.8	30.8	23.4	93.8	35.1	60.8	37.0	2.1	49.5	41.8	28.7	60.5	17.4	46.1	29.3	28.1	69.3	21.9	81.7	32.3	40.0	7.7	36.0	25.3	15.4	82.9	16.4	29.4
TRIM28	"KAP1, PPP1R157, RNF96, TF1B, TIF1B"	ENSG00000130726	"Tripartite motif containing 28"	Q13263	19	58544091-58550722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010066, HPA064033"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		140000	Nucleoplasm		"CAB010066: AB_2209905, HPA064033: AB_2685179"	"unprognostic (2.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (1.20e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.28e-2)"	24.2	26.4	17.9	40.1	20.6	52.2	30.6	34.5	26.3	46.7	36.5	26.2	26.2	26.8	43.3	30.0	34.1	34.5	38.5	28.4	18.5	16.4	27.3	42.3	29.5	38.1	29.2	22.7	69.3	47.0	30.7	25.7	45.6	22.8	37.6	18.5	21.5	31.8	32.4	56.5	41.2	27.5	38.4	17.9	34.9	32.9	48.1	23.1	119.9	50.6	33.5	33.5	34.0	46.4	13.7	14.6	5.0	7.6	16.0	16.9	6.3	36.5	78.7	42.3	31.2	18.5	14.2	47.2	24.0	21.8	23.5	18.0	54.8	30.8	40.2	15.9	20.7	43.6	25.1	47.8	34.6	15.4	20.6	221.1	69.2	35.7	43.6	19.7	43.9	44.5	19.2	19.3	30.0	23.5	19.8	21.9	47.6	33.6	22.7	21.6	54.1	61.3	54.1	29.6	37.7	50.7	58.2	25.6	43.2	21.0	60.7	42.4	33.2	25.1	32.7	13.4	13.1	22.4	42.7	20.2	55.3	21.9	12.0	43.0	29.3	47.7	45.0	25.0	32.8	35.0	1.3	7.1	5.0	8.9	7.6	11.6	11.5	12.8	12.3	9.0	13.7	16.9	15.1	3.8	16.0	4.9	14.6	8.2	6.3	17.9	20.6	34.5	26.3	18.5	16.4	29.2	22.7	22.8	23.1	11.9	15.2	37.3	46.8	57.1	60.0	8.4	40.8	8.1	17.0	31.4	25.5	50.7	19.9	38.6	75.8	40.5	45.0	0.0	47.9	51.6	41.1	44.2	21.8	31.0	40.2	52.4	62.0	26.4	32.9	81.1	60.9	36.2	27.0	29.7	61.8	50.0	49.3	45.6	38.9	32.1	31.8	58.2	46.4	124.7	74.6	53.1	46.9	30.5	58.1	39.7
H2AFY	macroH2A1.2	ENSG00000113648	"H2A histone family member Y"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm		NA	NA		4700000	Nucleoplasm		"HPA041189: AB_2677357, HPA050962: AB_2681292"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	34.9	26.0	24.8	32.2	27.2	75.1	21.7	37.6	27.6	22.5	40.0	19.7	14.0	40.2	22.0	21.8	60.7	22.4	38.8	41.9	21.4	28.8	23.8	24.1	36.7	39.4	24.1	26.5	21.8	16.6	24.2	25.8	30.0	21.0	20.2	43.2	24.4	28.3	14.0	34.9	33.4	52.0	21.9	21.8	33.8	28.5	21.4	16.9	76.9	22.2	40.7	47.2	28.7	29.6	16.0	51.8	23.8	45.6	21.5	15.9	30.1	45.6	32.2	49.7	34.0	23.3	13.9	44.7	19.2	20.7	34.2	24.2	50.6	45.9	54.2	32.8	15.5	29.0	31.2	37.2	81.4	25.7	29.3	37.1	64.7	38.0	34.0	17.1	30.7	28.5	14.7	22.1	28.5	30.7	21.0	21.9	37.1	22.4	22.3	19.4	39.9	88.2	58.5	19.4	54.7	17.2	79.8	28.3	38.3	42.4	52.2	70.0	44.1	37.4	36.4	30.8	27.2	43.2	85.1	17.6	30.0	25.3	22.0	39.1	10.7	43.5	50.8	25.0	69.3	21.1	4.1	45.6	20.5	10.8	30.1	9.1	11.7	14.0	13.4	51.8	16.0	13.6	11.2	23.8	21.5	19.0	37.3	15.9	30.1	24.8	27.2	37.6	27.6	21.4	28.8	24.1	26.5	21.0	16.9	89.3	73.9	95.3	103.9	115.3	133.0	49.8	99.3	112.4	113.7	75.0	90.3	125.6	61.3	217.9	39.7	83.0	188.9	46.7	110.7	116.9	69.9	135.3	50.8	51.0	384.3	322.6	171.4	63.8	399.4	18.3	56.7	337.9	86.0	166.9	190.1	115.6	179.5	156.5	77.4	76.7	166.8	71.1	91.4	52.4	75.0	139.4	153.4	97.8	202.7	196.4
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378576	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 100.3;lymphoid tissue: 70.2"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 391.4;Kupffer cells: 374.7;Macrophages: 436.5;monocytes: 317.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 45.4;neutrophil: 24.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 45.4"	"Cell line enhanced"	"Detected in some"		"HEL: 19.2;HL-60: 33.6;HMC-1: 62.7;NB-4: 56.7;THP-1: 44.2;U-698: 17.9;U-937: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	24.4	8.1	6.7	35.7	15.2	100.3	9.0	1.5	6.6	3.6	5.2	8.6	0.0	7.6	3.2	6.2	4.0	8.5	7.7	15.7	5.6	5.1	5.8	11.9	37.2	51.1	12.6	1.6	6.1	3.5	0.9	3.6	10.1	9.6	4.5	3.9	3.9	6.4	2.6	3.3	5.0	10.5	7.6	12.1	70.2	5.8	5.4	10.5	9.6	3.7	2.7	16.8	9.1	5.7	1.0	4.6	45.4	9.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	33.6	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	56.7	0.0	0.0	0.0	10.3	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	17.9	0.0	25.0	0.0	3.6	5.4	45.4	0.0	7.8	0.0	1.0	0.0	0.0	4.6	0.8	0.0	0.0	24.8	0.0	9.1	0.2	0.0	1.5	6.7	15.2	1.5	6.6	5.6	5.1	12.6	1.6	9.6	10.5	3.0	0.6	71.3	0.5	9.3	1.5	2.0	7.6	1.4	1.2	5.2	0.0	1.9	16.6	0.0	5.9	2.2	0.3	0.0	0.3	2.5	5.9	0.4	34.5	1.3	391.4	0.0	4.1	11.1	374.7	20.0	1.7	436.5	10.1	317.4	0.1	4.0	0.0	0.0	0.0	1.3	1.0	12.9	2.1	5.5	2.5	8.7	3.5	2.5	0.4	0.4
HINFP	"DKFZP434F162, HiNF-P, MIZF, ZNF743"	ENSG00000172273	"Histone H4 transcription factor"	Q9BQA5	11	119121587-119136044	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061008	Uncertain					NA	NA					"HPA061008: AB_2684414"	"unprognostic (2.79e-1)"	"unprognostic (2.63e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.44e-2)"	"prognostic unfavorable (4.44e-8)"	"unprognostic (4.17e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.95e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.25e-2)"	7.3	7.3	13.1	9.5	17.4	7.6	8.7	28.5	18.2	8.6	10.6	9.9	10.7	13.0	10.9	9.2	9.3	13.8	7.4	8.5	11.5	9.4	9.1	7.3	8.2	11.4	11.6	12.5	13.3	10.4	12.2	15.0	7.7	11.8	10.3	13.5	11.5	11.9	10.2	12.6	12.9	10.1	11.1	8.6	10.7	9.4	11.4	11.1	13.0	10.3	4.8	12.7	9.8	8.1	12.5	16.9	10.3	13.5	17.6	18.1	10.4	4.2	6.8	7.8	7.4	6.5	4.5	7.1	3.2	5.3	7.7	8.5	12.6	9.6	5.5	12.0	4.6	8.6	10.2	13.5	3.3	5.1	12.3	6.7	28.6	4.8	4.1	7.7	8.3	6.9	6.2	12.3	8.1	7.1	8.9	6.1	10.5	11.2	9.8	4.3	8.4	10.5	7.9	6.8	7.9	6.5	10.6	8.7	6.3	5.2	4.1	11.1	5.5	5.8	8.6	4.9	8.0	11.6	9.7	4.5	6.8	2.7	4.4	4.0	4.6	4.8	6.1	2.5	7.4	5.1	10.3	13.5	9.2	11.1	10.5	12.1	11.2	13.5	12.9	16.9	12.5	18.1	11.2	8.9	17.6	6.7	8.1	16.0	10.4	13.1	17.4	28.5	18.2	11.5	9.4	11.6	12.5	11.8	11.1	0.0	9.1	9.3	6.2	12.8	20.9	4.8	10.2	9.4	9.1	8.7	33.4	6.2	5.0	8.0	7.4	9.2	12.8	0.0	9.6	6.5	7.1	7.5	4.7	3.4	4.8	14.3	8.1	12.3	6.3	2.6	7.8	6.0	8.5	20.8	9.0	9.5	8.2	8.6	6.0	4.4	26.6	0.0	9.2	19.2	23.0	14.3	7.0	11.4	10.1	5.4
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391739-411447	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.7"	"Group enriched"	"Detected in some"	6	"Melanocytes: 42.2;monocytes: 92.8"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8"	"Group enriched"	"Detected in many"	5	"B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 50.2;Karpas-707: 46.7;RPMI-8226: 45.1;U-266/70: 42.2;U-266/84: 31.4;WM-115: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favorable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	7.1	0.5	0.4	36.6	0.4	18.4	4.0	0.4	0.4	17.4	13.9	0.1	0.4	5.0	2.2	0.7	6.4	1.2	4.1	1.6	0.4	0.5	1.4	5.6	4.2	31.5	0.5	0.0	1.9	0.7	0.0	0.7	0.5	0.1	1.5	4.8	15.8	21.3	1.9	0.7	4.5	11.1	0.3	0.6	33.8	4.6	1.7	0.1	15.2	1.3	2.4	48.7	8.4	4.2	9.7	10.4	0.0	1.6	0.2	4.8	1.3	0.1	0.0	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.9	0.0	45.1	0.0	0.0	0.1	0.0	0.0	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	31.4	13.7	0.0	0.0	25.6	0.0	1.6	0.0	0.6	1.2	0.0	9.5	0.9	0.9	9.0	9.7	1.6	0.7	0.0	0.2	1.2	10.4	4.8	1.3	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.0	0.1	0.1	0.0	4.0	12.0	0.1	7.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.0	1.8	0.0	0.0	3.1	6.9	42.2	92.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	3.8	0.1	6.2	0.0	0.0
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: AB_2682220"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	15.1	19.0	19.7	16.8	23.2	24.9	19.3	28.0	26.6	20.0	20.6	15.1	21.0	16.2	28.9	30.6	20.9	22.0	15.7	18.6	16.4	18.9	15.9	14.8	15.1	19.5	13.8	25.4	27.4	21.4	24.6	28.7	19.3	20.3	20.9	21.6	16.4	21.3	19.9	24.8	23.3	16.9	19.1	10.7	16.2	17.1	78.4	12.1	48.1	20.9	19.1	22.1	18.7	21.9	9.1	9.7	5.7	6.9	3.8	7.4	1.9	30.3	15.7	44.9	39.6	11.9	15.2	32.0	12.9	16.3	26.4	23.6	14.7	29.5	22.6	18.6	21.2	13.4	34.1	41.6	24.6	33.6	20.5	25.2	31.7	26.2	35.7	15.2	24.4	14.0	14.1	17.7	28.0	19.8	23.3	32.9	42.0	34.7	10.7	18.7	18.0	53.2	18.7	29.2	16.9	22.9	51.1	29.6	15.3	22.1	19.6	56.2	42.5	58.3	15.4	19.2	32.9	15.4	18.3	26.6	11.8	19.9	21.8	17.6	13.9	10.9	26.3	12.3	29.0	16.7	2.8	3.7	5.7	5.9	5.9	5.2	9.1	5.4	5.7	4.4	3.3	7.1	7.4	0.3	3.8	6.9	9.7	5.8	1.9	19.7	23.2	28.0	26.6	16.4	18.9	13.8	25.4	20.3	12.1	17.9	26.1	9.0	22.9	16.6	27.5	21.6	15.3	26.8	17.0	22.7	25.5	25.8	14.9	30.7	32.2	12.8	14.4	0.0	21.5	47.0	17.4	18.6	11.5	13.9	13.3	14.3	21.9	14.1	13.9	16.3	19.8	15.0	11.8	28.9	20.5	19.3	25.4	14.0	21.5	12.6	20.0	0.0	15.9	100.4	63.4	11.2	13.8	8.7	24.7	17.5
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056679-107059294	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	6.6	16.1	14.4	10.5	13.4	4.6	10.8	12.6	13.9	8.9	10.3	11.5	10.4	8.1	9.7	11.3	10.9	12.2	9.8	5.0	11.8	16.2	16.7	16.3	5.9	11.5	12.2	14.1	12.3	16.8	15.0	13.8	9.6	13.2	11.8	9.7	12.6	8.3	11.4	2.1	7.6	9.3	8.0	13.6	11.5	9.5	9.4	10.6	18.2	9.5	3.4	11.1	10.1	7.3	9.7	14.7	1.8	10.1	14.6	10.9	7.6	3.6	0.0	7.3	3.2	4.8	5.4	2.0	4.9	3.7	4.8	4.9	4.7	2.5	9.0	6.8	4.5	2.6	5.2	6.6	7.2	3.8	0.0	7.1	5.4	10.2	6.7	4.8	11.2	3.4	5.0	4.0	4.3	4.4	3.2	4.1	5.2	7.2	1.4	4.3	83.6	6.5	3.9	3.1	2.9	6.9	8.3	15.9	3.4	11.5	7.4	13.6	16.6	6.7	9.7	3.2	4.6	6.7	8.4	4.7	3.5	7.3	7.4	7.3	1.5	1.0	1.5	5.3	5.3	2.8	1.8	8.9	1.6	7.5	10.1	8.4	6.9	7.6	6.8	11.9	9.7	10.9	10.9	0.5	14.6	9.2	14.7	7.8	7.6	14.4	13.4	12.6	13.9	11.8	16.2	12.2	14.1	13.2	10.6	0.0	4.1	8.2	6.2	3.9	12.5	2.2	0.0	8.1	2.3	14.0	0.0	16.1	23.2	9.0	0.9	4.2	3.5	0.0	6.5	11.9	3.9	3.6	1.1	0.0	8.5	14.3	16.8	4.9	7.0	2.3	8.1	3.6	1.7	1.8	8.7	6.9	4.9	7.0	8.5	15.2	4.3	12.9	8.4	8.4	8.8	5.4	5.9	5.4	9.5	5.8
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358563	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	14.8	14.4	15.6	12.7	22.0	11.1	12.9	29.4	20.5	11.4	11.7	20.2	13.9	7.0	18.9	11.9	12.7	18.1	9.3	23.1	14.4	13.1	9.5	12.2	9.7	17.0	11.2	18.7	21.9	14.8	12.0	14.0	11.4	13.3	12.8	7.6	20.8	17.3	16.2	34.0	16.9	9.9	18.5	11.6	12.4	9.9	17.0	13.1	24.4	11.1	12.0	14.9	13.3	10.4	10.8	26.2	9.9	8.5	18.6	18.1	11.5	10.2	16.7	8.0	20.0	7.6	7.2	26.7	10.3	5.6	13.1	10.9	42.3	10.3	21.9	17.4	8.7	4.8	13.4	11.3	10.4	7.3	7.8	16.9	6.5	18.8	19.1	5.5	11.9	10.2	8.0	4.5	10.8	10.2	8.1	7.8	11.4	15.4	1.2	7.1	17.2	14.7	18.5	13.1	10.3	11.4	19.8	11.7	14.8	6.1	9.4	10.9	8.5	34.5	8.7	7.0	6.8	14.5	11.9	9.3	9.3	8.3	11.1	9.2	6.7	12.4	22.5	11.8	12.8	9.6	9.9	7.0	5.9	15.8	8.5	18.1	10.1	10.6	13.9	10.2	10.8	16.1	14.1	0.8	18.6	7.7	26.2	11.7	11.5	15.6	22.0	29.4	20.5	14.4	13.1	11.2	18.7	13.3	13.1	17.9	11.7	10.4	7.4	6.2	20.5	11.8	15.3	14.7	9.1	8.7	51.1	21.8	5.0	11.0	3.4	6.8	24.9	0.0	14.4	6.5	8.0	6.2	6.9	7.5	10.2	28.6	12.7	6.7	5.9	3.2	10.9	8.3	8.5	4.6	27.0	9.4	15.1	26.9	12.4	6.8	16.4	12.9	5.7	6.3	20.0	5.3	9.7	15.2	23.3	9.3
SMARCB1	"BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5L1, Snr1"	ENSG00000099956	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	Q12824	22	23786931-23838008	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009196, HPA018248, HPA019127"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165"	"unprognostic (2.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.63e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.43e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.04e-2)"	11.0	15.2	14.6	33.2	15.4	16.9	12.1	30.4	21.9	13.4	25.1	16.4	11.4	41.1	17.2	11.0	15.6	12.3	15.0	12.6	13.2	14.2	14.6	11.7	14.0	32.8	13.0	13.8	21.3	16.1	7.9	15.7	20.8	12.8	11.0	9.4	16.7	40.9	13.1	28.1	14.7	27.4	10.6	12.8	19.8	24.1	37.7	12.9	29.4	15.7	12.0	16.0	21.1	12.2	19.5	9.9	4.8	11.6	7.0	7.5	5.9	1.5	1.0	19.2	1.8	1.8	0.5	3.9	6.1	1.8	1.8	2.9	2.2	1.8	15.7	5.3	0.8	2.0	2.9	4.6	3.0	3.0	2.6	6.7	13.0	1.8	1.3	2.1	13.8	3.8	1.1	2.2	2.1	4.7	0.9	0.9	1.9	3.5	8.7	1.1	3.9	11.2	3.2	5.7	4.7	3.8	7.0	15.5	7.0	1.6	3.0	9.1	6.9	1.4	0.4	10.3	10.4	1.5	2.1	1.6	1.6	6.7	2.6	1.7	9.6	8.8	10.4	1.3	7.6	4.6	4.0	10.0	4.8	3.8	10.2	5.2	19.5	4.6	4.6	9.3	6.4	3.8	2.5	0.8	7.0	11.6	9.9	7.5	5.9	14.6	15.4	30.4	21.9	13.2	14.2	13.0	13.8	12.8	12.9	6.0	10.4	102.1	57.3	44.6	51.7	3.7	38.2	18.7	6.8	45.4	19.6	106.2	71.3	80.0	26.9	31.5	31.9	23.3	67.3	185.0	45.7	53.3	33.5	17.7	66.6	63.5	68.9	36.8	19.7	12.4	33.1	35.4	54.0	63.1	50.5	72.3	62.0	51.8	30.1	65.4	36.9	19.4	58.2	125.7	116.1	46.3	133.9	35.0	61.6	56.7
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 63.9;REH: 145.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.9	11.6	17.5	12.4	0.5	2.0	2.8	13.0	6.2	13.6	13.2	13.8	8.1	9.1	3.2	5.7	4.9	8.0	12.0	7.0	9.6	14.7	13.7	7.8	10.8	14.7	0.2	19.3	11.9	1.0	0.5	7.3	1.9	2.1	4.0	14.4	11.2	10.5	8.1	12.5	63.9	11.8	7.8	5.8	12.5	145.0	39.1	6.6	3.7	11.7	13.0	10.3	10.2	5.6	1.8	2.9	10.1	18.4	5.0	14.4	11.7	18.6	15.7	4.5	4.6	26.8	8.3	18.8	18.3	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9											0.0	0.0	1.5	0.6	0.0	2.6	1.6	2.5	1.4	1.2	0.0	0.0	1.7	0.0	1.7	2.5	0.0	0.9	0.0	0.3	5.8	0.5	0.5	0.0	0.6	7.5	3.2	0.0	0.0	2.1	0.9	0.6	0.7	0.0	2.8	1.5	0.5	2.6	1.9	0.4	0.0	0.8	0.0	1.5	4.2	6.9	0.0	1.1	0.0	4.7	0.7
ALKBH2	"ABH2, MGC90512"	ENSG00000189046	"AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase"	Q6NS38	12	109088188-109093631	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011198, HPA045392, HPA051976"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680"	"prognostic favorable (6.67e-5)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (8.67e-4)"	16.1	12.3	13.6	16.9	13.4	8.2	22.3	12.7	20.5	12.9	11.7	15.2	14.6	9.0	18.0	14.2	14.1	18.3	12.2	12.3	13.5	12.3	12.0	25.6	9.8	17.0	14.3	8.9	23.1	18.5	7.1	7.8	8.1	15.7	15.0	10.7	10.8	18.9	18.5	20.0	25.0	10.7	15.9	15.4	12.3	12.6	14.3	13.5	11.3	13.9	19.7	16.5	15.5	13.8	16.9	13.1	1.1	6.7	9.0	18.2	6.9	13.0	22.4	12.8	28.6	9.0	12.3	20.4	8.7	5.8	9.2	10.3	23.5	9.4	20.1	8.7	5.0	4.3	9.5	21.5	8.7	5.4	17.9	19.2	10.0	12.7	21.4	12.0	13.8	9.4	12.6	19.0	8.7	22.4	11.4	3.5	19.4	14.8	12.0	6.1	23.0	12.7	27.8	17.7	13.8	22.8	11.3	12.5	21.6	12.2	18.2	13.2	22.8	9.2	30.0	18.2	5.0	18.4	8.5	3.6	10.3	11.2	9.7	12.8	16.9	19.6	43.8	8.8	12.0	16.4	1.1	5.1	0.7	8.0	6.7	14.1	16.2	12.1	11.2	5.1	16.9	18.2	10.7	0.9	9.0	4.3	13.1	9.0	6.9	13.6	13.4	12.7	20.5	13.5	12.3	14.3	8.9	15.7	13.5	8.9	4.6	11.9	40.0	45.2	4.3	5.9	10.2	13.4	18.2	8.7	2.0	14.2	13.3	16.1	10.1	14.7	2.6	0.0	20.7	22.0	18.8	11.8	5.8	19.2	9.1	4.8	8.1	4.9	7.1	4.9	24.7	7.4	25.3	3.6	10.2	10.0	18.9	2.9	16.3	14.6	6.4	0.0	27.8	8.8	28.1	52.4	4.2	11.5	14.5	23.5
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871513-10923070	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 64.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073, HPA069313"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (8.37e-4)"	12.2	8.8	12.3	12.6	16.1	13.2	9.6	12.5	17.7	15.8	14.0	9.3	9.0	11.5	19.6	9.1	20.5	14.8	12.4	14.7	11.2	7.2	9.3	14.5	8.9	12.4	7.8	10.2	13.0	16.9	8.2	6.9	15.3	9.5	12.6	10.2	12.0	11.4	13.2	64.3	12.5	12.0	15.6	6.6	9.8	11.1	17.5	8.6	9.4	10.0	12.7	15.6	15.8	15.9	1.3	1.6	0.3	1.4	0.1	2.6	0.4	22.6	16.9	24.2	32.8	20.2	27.7	23.2	16.3	28.3	24.2	23.3	26.0	8.3	31.2	19.6	28.4	12.2	21.7	24.7	24.5	15.3	34.9	20.1	9.6	11.0	31.5	17.3	14.4	12.5	18.9	16.0	16.5	20.0	13.8	30.6	24.9	22.9	28.1	14.2	40.9	25.1	12.4	29.9	15.2	28.1	35.1	12.4	36.3	14.6	11.7	17.6	16.9	11.6	14.1	15.7	12.6	14.1	12.4	18.3	29.2	16.5	27.7	19.0	27.4	21.6	27.3	19.2	23.2	12.6	0.0	1.4	0.2	1.2	1.4	0.5	1.3	0.9	2.6	1.3	1.3	1.0	0.9	0.3	0.1	0.7	1.6	0.8	0.4	12.3	16.1	12.5	17.7	11.2	7.2	7.8	10.2	9.5	8.6	8.9	13.5	11.5	4.9	6.9	31.0	0.8	17.8	8.1	6.8	8.7	49.1	16.3	6.6	11.8	25.6	5.7	28.0	46.7	16.9	26.3	10.3	10.9	1.1	23.7	22.3	42.9	26.5	11.1	17.8	13.0	26.2	7.5	5.0	28.9	25.6	10.2	20.3	25.9	18.0	7.3	19.9	6.5	9.2	25.8	16.4	6.0	10.1	4.1	21.2	9.0
FTO	"ALKBH9, KIAA1752, MGC5149"	ENSG00000140718	"FTO, alpha-ketoglutarate dependent dioxygenase"	Q9C0B1	16	53701692-54158512	"Disease related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 315.8;Club cells: 92.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017123, HPA041086, HPA068695"	Enhanced		Supported	Vesicles,Cytosol		No	No		130000	Cytosol	Vesicles	"CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117"	"unprognostic (9.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.11e-3)"	17.5	25.4	19.7	8.7	37.4	5.6	27.1	29.7	37.5	20.2	13.5	30.1	11.4	5.8	22.7	16.8	13.2	19.5	16.2	19.5	19.9	25.9	19.0	13.0	27.3	10.1	21.8	19.6	21.2	15.2	42.0	31.6	14.7	28.9	15.8	10.9	18.9	13.4	19.1	19.9	13.6	8.1	22.6	23.8	11.5	10.1	6.2	22.2	10.0	20.7	7.8	10.6	16.1	12.5	12.3	15.3	8.1	14.8	16.3	22.1	14.0	6.7	12.2	16.2	16.6	32.0	24.2	5.3	16.2	14.8	13.7	4.0	7.6	8.9	15.4	17.9	20.9	7.8	10.0	15.0	16.0	20.1	7.1	11.7	6.9	16.5	14.1	22.1	5.5	7.9	26.6	16.9	12.4	15.3	17.2	20.2	11.5	6.7	3.9	22.0	5.2	12.2	8.4	8.4	7.0	8.0	18.8	24.6	14.4	20.7	5.7	20.0	13.9	18.4	10.9	5.0	16.4	14.4	13.2	19.2	17.2	11.4	9.2	9.9	7.4	5.9	15.8	15.9	10.3	13.1	8.1	11.6	6.0	17.7	14.8	22.1	12.3	17.0	17.7	15.3	11.7	16.0	17.2	2.0	16.3	10.0	6.1	16.5	14.0	19.7	37.4	29.7	37.5	19.9	25.9	21.8	19.6	28.9	22.2	74.5	43.6	3.7	8.0	11.0	22.7	19.6	17.8	315.8	92.1	7.0	11.8	7.9	6.6	7.4	35.1	11.7	4.2	0.0	4.9	6.2	13.6	6.4	24.4	12.1	7.9	15.9	6.3	11.1	6.3	45.9	13.3	9.3	10.1	2.8	6.0	17.6	5.5	6.8	14.2	12.4	14.2	12.9	11.9	2.5	3.8	8.0	4.2	5.1	6.0	7.1
KIN	"KIN17, Rts2"	ENSG00000151657	"Kin17 DNA and RNA binding protein"	O60870	10	7750962-7787981	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016339, HPA038700"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016339: AB_627860, HPA038700: AB_2676159"	"unprognostic (4.33e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (3.23e-5)"	8.5	8.6	9.0	8.2	9.7	9.4	9.0	19.8	11.9	9.5	7.0	10.2	9.1	7.8	11.3	9.9	6.5	8.1	7.2	8.6	7.5	7.8	10.1	12.9	7.4	10.4	9.7	8.2	10.8	10.2	7.7	15.5	10.0	10.6	10.0	7.7	8.4	8.4	8.6	9.1	11.5	10.0	9.1	9.0	10.8	8.1	6.9	9.7	13.6	11.1	7.7	9.7	8.8	8.3	7.0	6.9	13.8	5.1	5.9	5.0	1.8	6.9	4.4	6.8	4.3	5.6	6.8	5.5	6.2	2.8	7.5	8.1	8.5	7.0	5.4	3.3	3.8	2.3	6.7	5.7	3.8	8.7	6.1	6.6	8.5	4.5	8.1	8.0	3.0	6.9	5.6	4.3	5.7	3.8	6.3	5.6	6.9	8.4	5.2	5.8	6.2	6.0	4.7	6.6	7.2	2.7	7.7	4.9	4.9	6.3	3.9	3.0	6.4	4.9	5.0	9.9	6.8	9.1	6.1	4.0	4.9	5.5	8.6	5.0	6.8	7.3	6.7	6.2	4.7	3.3	13.8	4.8	8.0	4.7	5.1	4.7	6.5	4.2	3.9	3.6	7.0	4.8	5.0	10.8	5.9	4.6	6.9	3.4	1.8	9.0	9.7	19.8	11.9	7.5	7.8	9.7	8.2	10.6	9.7	32.8	25.6	13.0	13.7	15.3	52.4	11.1	22.9	30.8	18.2	17.4	37.3	31.0	11.6	26.4	4.2	24.1	15.8	23.3	18.7	21.8	20.6	11.9	15.1	12.4	27.3	60.4	22.3	24.5	18.0	4.3	25.6	22.4	15.1	19.0	17.1	29.5	18.4	20.1	29.0	14.6	53.1	12.9	17.6	28.6	16.7	12.5	32.2	25.4	13.3	13.3
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492432-101669726	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 47.9;seminal vesicle: 42.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 29.8;Ciliated cells: 40.2;Club cells: 27.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"A-431: 15.6;CACO-2: 11.4;HaCaT: 19.1;hTCEpi: 14.9;MCF7: 13.1;OE19: 15.3;RT4: 28.1;T-47d: 33.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.4	0.3	0.4	3.3	0.4	0.0	11.3	0.3	0.4	6.0	9.9	0.0	34.7	2.1	1.6	16.4	18.7	5.2	10.3	0.4	0.4	0.4	6.4	0.7	11.3	0.0	0.4	0.0	1.5	22.1	7.1	1.5	47.9	0.1	15.2	5.6	0.1	15.0	42.4	0.4	18.0	8.6	1.6	0.4	0.4	5.9	0.6	0.0	1.7	12.7	14.3	12.2	7.4	8.4	0.0	0.0	0.0	0.0	1.2	0.2	0.0	15.6	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	11.4	7.8	0.0	0.0	0.0	0.0	19.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	28.1	0.5	0.0	0.0	6.2	0.0	1.9	33.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.0	0.1	0.0	29.8	8.8	0.0	9.3	21.6	0.0	0.4	10.2	40.2	27.3	10.4	0.0	12.4	5.0	6.5	2.2	0.4	5.9	0.0	4.8	5.9	0.8	10.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	4.1	0.0	0.0	1.7	1.0	10.0	0.0	7.4	7.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	22.7	16.6	0.0	7.6	5.1
MEN1		ENSG00000133895	"Menin 1"	O00255	11	64803510-64811294	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030342	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030342: AB_10610138"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (1.40e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	12.1	20.6	13.2	15.6	17.7	11.8	12.5	25.8	26.9	15.5	14.9	16.4	22.2	16.9	14.8	18.4	18.9	17.6	14.7	9.0	12.4	11.5	15.9	23.0	12.8	22.1	12.5	15.6	19.7	25.9	16.8	18.0	16.1	16.0	15.9	11.6	16.6	23.3	19.9	8.4	21.6	15.8	11.0	9.8	20.6	15.3	21.2	12.3	33.2	23.9	6.2	20.3	13.7	15.5	5.2	2.9	3.4	1.5	1.8	4.8	1.0	16.3	22.0	14.1	22.1	15.8	10.2	16.6	11.8	11.7	18.4	12.4	12.7	16.2	23.3	19.3	9.1	15.4	23.4	19.1	16.3	11.1	19.9	28.2	19.3	17.7	16.9	14.0	12.4	13.1	11.7	12.3	15.5	12.8	11.1	17.0	30.0	28.0	8.9	10.2	30.6	31.3	25.1	18.4	13.8	33.1	24.3	16.0	22.3	11.9	15.2	19.9	17.5	13.9	19.7	14.3	10.5	29.3	13.8	10.7	17.4	16.7	20.8	9.9	14.0	16.2	11.8	13.8	9.7	11.0	0.9	1.3	3.4	3.7	1.5	4.8	3.7	2.6	4.6	1.3	5.2	4.5	2.6	0.2	1.8	0.5	2.9	1.9	1.0	13.2	17.7	25.8	26.9	12.4	11.5	12.5	15.6	16.0	12.3	3.0	4.8	19.3	3.8	5.0	8.3	3.7	2.5	1.4	1.2	3.5	5.9	15.7	3.3	7.3	0.9	4.4	8.4	0.0	6.2	18.5	4.6	4.9	1.1	9.4	7.9	3.2	4.1	8.0	0.3	0.6	11.2	2.6	8.5	6.4	8.7	8.4	7.1	10.1	3.5	6.2	5.7	12.9	2.7	16.6	15.5	6.0	13.6	6.7	9.5	3.0
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601840	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	26.3	20.4	16.6	28.0	17.9	28.7	20.5	21.6	24.8	23.9	22.0	31.5	15.6	17.1	23.8	16.9	45.1	19.9	23.7	18.8	15.8	12.4	19.0	23.6	21.8	35.5	19.7	12.7	35.0	13.7	22.5	19.8	22.3	20.9	21.9	27.3	21.2	22.3	22.1	12.7	41.1	23.5	25.0	23.8	39.4	19.9	25.7	18.9	64.6	19.3	20.3	49.1	21.7	27.8	12.9	12.0	8.4	13.2	10.4	17.3	4.4	24.8	21.8	34.8	45.5	15.6	14.7	24.0	21.1	29.7	42.4	31.1	20.6	21.8	35.5	22.8	27.7	22.7	33.6	46.9	58.4	36.1	35.1	23.5	37.8	23.6	20.7	24.3	42.6	48.7	16.4	32.9	29.8	44.6	20.2	39.2	37.1	41.7	28.3	30.3	48.3	54.0	54.4	30.0	23.7	25.5	51.9	24.8	41.5	30.0	37.4	27.8	25.5	22.0	31.5	17.8	28.8	36.9	29.3	27.4	23.9	22.0	26.9	24.3	21.2	27.4	50.2	17.4	31.2	23.0	5.6	6.4	8.4	17.3	11.0	14.6	12.9	14.4	12.5	10.2	9.8	13.7	13.5	2.9	10.4	13.2	12.0	11.6	4.4	16.6	17.9	21.6	24.8	15.8	12.4	19.7	12.7	20.9	18.9	3.0	3.8	13.4	3.6	11.8	0.0	3.4	2.5	0.0	5.7	1.8	0.0	11.3	5.0	4.9	0.4	6.2	7.9	23.3	8.1	8.8	6.6	3.3	10.4	8.2	7.3	0.0	11.5	14.1	16.4	0.4	4.6	5.3	1.7	7.2	10.5	0.0	6.9	5.8	3.9	2.1	0.0	0.0	5.7	5.1	5.3	9.8	15.8	7.5	11.5	3.9
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 57.4;Late spermatids: 22.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"eosinophil: 9.1;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"U-266/84: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: AB_2681472"	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	5.0	5.9	3.5	3.6	3.9	4.6	5.4	1.9	5.4	9.3	5.2	2.7	6.3	1.9	8.6	7.0	3.3	7.7	6.1	5.0	3.2	3.1	3.1	0.8	7.4	2.7	3.4	4.2	15.2	10.3	19.3	12.5	5.0	6.1	7.7	4.4	9.4	3.3	6.8	2.2	2.7	3.2	9.5	6.2	3.3	4.1	5.0	3.3	0.5	8.4	5.1	2.3	5.8	14.1	0.0	0.0	9.1	0.0	0.0	0.3	0.0	1.8	2.9	6.6	0.1	4.0	8.3	7.8	3.9	8.6	4.0	3.5	3.7	1.1	0.4	1.1	5.2	3.8	0.0	0.0	0.8	5.3	0.0	1.1	2.4	2.6	0.2	4.3	8.1	0.1	5.8	2.6	2.8	3.6	3.7	2.9	1.0	0.0	12.1	4.9	0.3	1.2	0.0	4.9	0.6	2.2	0.0	7.7	5.0	1.4	0.0	1.2	5.3	0.0	0.1	0.8	3.6	5.5	3.4	1.1	0.2	2.4	4.1	3.8	11.2	15.6	0.0	3.0	0.0	3.0	0.1	0.0	9.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	6.7	0.0	0.0	0.0	0.0	0.0	3.5	3.9	1.9	5.4	3.2	3.1	3.4	4.2	6.1	3.3	11.9	3.5	0.5	2.5	1.4	9.5	7.3	0.0	2.7	5.7	1.8	7.9	0.8	1.7	1.8	57.4	4.9	0.0	0.0	2.1	2.1	4.4	2.0	2.3	0.0	0.7	0.0	3.5	3.7	0.3	22.0	8.1	0.8	1.7	0.0	2.7	8.2	1.9	0.0	8.9	0.0	8.0	6.5	3.6	5.0	3.3	1.5	0.5	0.0	2.4	0.6
SMAD4	"DPC4, MADH4"	ENSG00000141646	"SMAD family member 4"	Q13485	18	51028394-51085045	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019154	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA019154: AB_1853480"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.00e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (4.40e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	25.6	17.5	16.0	14.0	16.7	11.4	24.9	29.7	16.0	27.9	22.6	17.9	21.3	15.1	28.2	18.8	21.7	20.5	17.5	19.6	15.3	11.5	21.0	22.0	20.1	16.0	17.2	13.3	30.5	25.0	30.0	28.9	30.6	14.2	27.8	17.4	18.4	23.1	22.8	39.7	18.2	23.4	27.6	13.9	21.7	19.3	17.6	18.4	38.8	35.0	13.9	18.1	29.0	24.1	3.6	3.6	3.4	1.8	2.9	4.7	1.3	8.5	11.4	30.9	8.9	12.8	19.8	17.4	15.1	16.6	20.3	25.5	7.0	2.0	14.3	4.5	13.0	10.4	14.2	17.3	6.8	21.6	12.4	9.8	9.9	11.4	8.0	12.7	17.2	7.8	8.9	11.5	10.0	14.7	19.6	14.7	7.3	11.1	13.2	12.0	4.5	10.2	5.0	16.1	4.6	7.1	13.3	15.7	14.0	9.7	3.7	19.1	11.3	14.1	2.6	9.4	13.7	7.0	10.0	11.0	17.2	8.0	4.3	10.0	19.9	13.8	12.4	11.2	6.7	11.3	0.8	1.8	1.8	3.2	1.1	3.7	2.2	3.3	2.6	3.6	3.6	4.0	4.7	3.4	2.9	1.3	2.9	4.3	1.3	16.0	16.7	29.7	16.0	15.3	11.5	17.2	13.3	14.2	18.4	20.8	23.2	11.8	18.4	22.8	13.2	33.5	40.8	16.0	19.4	21.0	19.6	15.5	10.0	16.2	7.3	23.2	15.6	0.0	10.8	16.8	23.8	31.7	4.6	40.0	13.2	14.3	38.1	23.9	26.1	11.4	30.8	16.7	27.0	5.4	33.8	18.9	18.1	24.3	28.7	18.5	20.8	25.8	29.2	13.9	16.2	23.8	10.5	13.8	26.2	22.5
MBD3		ENSG00000071655	"Methyl-CpG binding domain protein 3"	O95983	19	1573596-1592801	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 101.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013265	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013265: "	"unprognostic (1.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.44e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	19.4	14.8	27.3	18.2	21.0	19.9	19.7	18.9	25.1	11.8	14.9	12.7	18.8	17.1	14.4	12.0	14.8	13.4	18.3	21.5	26.5	16.5	17.2	19.1	13.1	18.2	18.2	16.9	17.2	25.4	17.7	18.1	27.3	13.1	19.5	7.5	12.5	28.0	17.1	41.4	28.5	14.5	11.4	14.9	18.3	14.1	21.1	11.0	23.9	17.2	14.3	15.4	12.3	26.8	3.1	7.0	2.3	3.7	1.2	3.7	2.0	27.5	31.3	13.1	22.5	10.8	9.4	19.5	17.0	10.3	18.2	17.0	29.2	12.6	27.8	13.4	12.4	6.3	22.9	14.6	16.4	4.9	37.2	30.2	16.3	33.8	21.6	15.6	20.8	23.2	13.4	14.0	17.6	8.0	9.1	16.6	20.4	30.0	23.8	8.9	31.3	25.0	28.9	21.9	8.4	20.7	29.8	16.3	20.8	9.2	26.8	36.8	29.9	17.0	14.9	12.7	4.7	16.7	25.7	16.5	25.6	18.7	37.9	40.1	23.2	19.3	25.4	20.7	29.1	26.2	1.2	3.7	2.3	3.7	2.0	3.3	1.6	3.0	2.0	3.4	3.1	3.3	2.8	1.5	1.2	1.7	7.0	0.7	2.0	27.3	21.0	18.9	25.1	26.5	16.5	18.2	16.9	13.1	11.0	11.9	28.2	15.2	7.7	9.6	22.9	17.3	7.6	2.7	10.3	10.4	13.7	42.8	5.0	14.0	2.5	16.5	27.6	46.7	22.3	36.6	14.2	12.7	3.5	37.6	23.2	17.5	14.3	28.8	26.1	4.7	20.8	11.9	5.0	10.0	22.7	30.6	17.9	14.7	24.1	15.8	10.7	38.8	11.6	5.7	11.0	11.2	101.6	7.5	25.3	7.4
NR1H4	"FXR, HRR-1, HRR1, RIP14"	ENSG00000012504	"Nuclear receptor subfamily 1 group H member 4"	Q96RI1	12	100473708-100564413	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease mutation, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 109.4"	"Cell type enhanced"	"Detected in some"	15	"Cholangiocytes: 79.0;Distal tubular cells: 36.5;Hepatocytes: 90.4;Proximal tubular cells: 116.5"	"Group enriched"	"Detected in some"	11	"liver cancer: 18.7;renal cancer: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"Hep G2: 18.4;HHSteC: 11.1;RPTEC TERT1: 29.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047699			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047699: AB_10965320"			"unprognostic (1.78e-1)"		"unprognostic (1.81e-1)"		"unprognostic (6.68e-2)"	"unprognostic (2.49e-1)"		"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"		"unprognostic (3.77e-3)"	0.1	11.3	0.1	1.4	0.4	0.0	0.2	0.1	0.2	0.2	5.8	0.4	0.1	11.3	0.1	0.4	0.1	0.1	7.0	0.1	0.1	0.0	25.0	109.4	0.6	2.4	0.1	0.1	7.7	2.7	0.0	2.9	0.2	0.3	0.5	0.4	0.6	0.1	0.1	0.1	0.0	19.5	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	79.0	0.0	0.0	21.0	0.0	0.0	36.5	6.3	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	90.4	0.0	0.0	0.0	14.7	1.9	1.3	0.9	0.0	0.0	0.0	0.1	0.0	0.6	2.9	0.0	116.5	0.0	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.3	0.9
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920511-22929585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330"	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (1.82e-4)"	"prognostic unfavorable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.04e-4)"	17.0	21.6	18.3	17.8	22.8	12.0	21.2	18.4	24.9	20.3	25.0	18.1	24.9	16.1	24.9	19.6	33.1	28.0	16.6	22.3	15.3	13.2	25.7	22.2	15.8	15.6	17.2	15.2	30.2	30.9	30.8	17.4	24.3	15.9	21.1	22.6	16.9	19.0	21.7	42.0	21.7	14.5	22.2	13.4	17.9	19.5	22.1	17.3	22.7	30.9	19.6	22.1	20.8	22.0	17.6	23.8	4.3	17.6	9.8	15.6	15.5	40.7	39.4	28.5	28.2	13.6	15.5	31.1	28.1	20.9	43.6	37.0	36.0	37.9	39.8	23.0	20.7	25.9	32.6	56.4	47.2	50.5	25.5	27.2	24.7	26.6	55.3	26.1	51.8	21.6	15.2	25.2	33.7	61.6	17.8	20.6	31.8	35.0	21.8	22.5	36.8	37.1	23.2	25.5	35.5	49.8	43.8	34.5	28.9	21.2	28.0	30.7	20.1	30.7	32.9	14.3	25.5	22.2	19.6	19.3	18.5	26.4	26.3	35.8	29.9	63.7	52.9	11.7	25.2	28.9	1.7	16.8	0.2	8.2	17.6	13.4	17.6	11.3	13.5	23.8	15.5	15.6	12.5	4.3	9.8	13.2	14.1	9.4	15.5	18.3	22.8	18.4	24.9	15.3	13.2	17.2	15.2	15.9	17.3	17.9	10.8	4.5	23.8	23.6	9.5	0.8	28.1	26.8	11.4	7.0	7.9	33.6	19.9	25.6	1.9	11.2	6.3	0.0	23.3	26.7	18.6	11.3	6.9	15.5	17.4	15.9	5.8	11.1	4.9	2.7	15.3	10.4	25.3	11.8	15.7	19.1	60.5	8.6	19.8	18.4	7.5	6.5	27.8	34.9	54.7	24.3	27.9	10.1	19.0	16.8
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 113.5;bone marrow: 42.7;lymphoid tissue: 31.5"	"Cell type enriched"	"Detected in many"	5	"Urothelial cells: 223.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 113.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 113.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.5"									"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	4.3	0.2	0.3	11.0	0.4	42.7	0.5	0.2	0.7	1.7	0.8	0.2	0.0	0.6	1.3	1.4	7.2	3.3	3.4	0.9	0.2	0.3	0.7	1.3	16.0	15.8	1.9	0.5	0.7	0.7	0.1	0.3	4.9	0.7	0.3	0.2	2.0	5.9	0.0	1.2	0.3	0.8	0.8	1.7	31.5	0.8	0.4	0.2	1.4	0.7	22.3	29.0	2.7	6.4	0.2	1.2	15.3	113.5	0.1	0.1	15.2	0.7	0.3	0.5	2.5	0.2	0.4	1.1	0.3	0.0	0.0	0.1	0.2	1.6	0.6	1.7	0.2	0.3	2.1	0.6	0.4	0.0	0.8	0.2	0.2	1.7	0.2	0.2	0.3	1.1	0.2	0.9	0.3	0.2	0.3	0.1	0.5	0.3	3.5	0.1	1.3	0.5	0.5	1.1	0.5	0.2	0.9	0.5	0.7	0.6	1.3	1.2	0.6	0.4	1.4	0.2	0.3	1.1	0.1	1.5	1.1	0.9	0.4	0.4	0.5	0.8	1.0	1.4	2.5	1.2	3.5	26.8	0.9	0.0	113.5	0.1	0.2	0.0	0.0	1.2	0.1	0.0	0.0	15.3	0.1	31.1	0.1	0.1	15.2	0.3	0.4	0.2	0.7	0.2	0.3	1.9	0.5	0.7	0.2	26.8	47.2	0.0	9.0	1.1	0.5	0.0	0.0	14.7	33.0	1.8	3.9	0.2	0.0	0.0	0.5	0.1	4.3	23.3	0.2	0.2	0.5	4.8	24.4	0.0	15.6	0.0	0.0	0.6	18.0	0.0	0.3	11.3	15.1	0.0	0.0	0.8	0.8	0.0	0.4	0.0	0.8	0.0	0.9	0.1	0.5	5.9	0.2	1.0	0.0	223.8
HDAC1	"GON-10, HD1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292086-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	13.8	22.8	12.8	33.5	14.8	15.0	21.1	5.1	13.0	21.9	35.7	16.0	34.8	22.2	24.6	17.5	40.6	21.0	43.8	12.4	12.5	8.5	21.1	21.5	17.2	33.3	14.7	8.6	27.7	20.5	17.2	27.1	24.4	12.2	25.2	33.9	18.0	27.8	31.3	6.6	16.9	32.7	22.1	13.3	32.6	27.8	20.0	16.7	59.4	36.8	21.2	51.1	26.0	25.1	47.7	32.1	59.8	44.6	42.4	49.2	54.7	29.4	18.0	11.6	23.0	6.8	8.1	24.1	20.9	23.4	28.0	25.9	32.9	53.1	45.4	38.8	23.0	28.5	34.4	35.5	28.4	31.1	42.4	35.3	31.3	21.6	25.2	16.0	55.4	45.4	14.6	15.6	21.7	14.4	22.0	21.2	59.5	41.0	18.1	12.3	22.4	63.1	31.2	26.8	35.2	46.1	43.6	27.5	20.2	30.3	42.6	9.1	11.5	34.8	23.5	43.8	47.7	27.7	43.1	24.5	18.7	21.9	5.7	50.8	11.0	23.7	62.3	15.4	46.0	24.2	37.0	27.7	59.8	43.2	35.5	35.4	47.7	42.4	46.1	32.1	44.3	49.2	45.7	19.9	42.4	44.6	20.1	42.5	54.7	12.8	14.8	5.1	13.0	12.5	8.5	14.7	8.6	12.2	16.7	23.8	38.4	50.1	48.1	22.0	15.5	18.2	56.0	80.3	48.9	64.6	15.7	81.3	81.2	57.2	10.0	40.9	97.1	0.0	65.1	93.0	21.5	29.1	29.0	28.2	38.0	11.1	82.9	63.8	40.8	5.9	38.0	31.0	27.0	42.3	101.3	32.1	65.7	108.7	41.8	25.9	13.9	58.2	37.7	45.1	76.2	22.2	78.1	50.7	115.8	49.8
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300215	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	11.8	13.2	11.9	25.4	15.7	23.9	14.0	28.9	16.7	15.6	14.2	18.5	17.0	10.6	19.0	13.9	17.8	13.6	15.8	11.7	12.8	11.5	14.4	10.5	12.3	19.4	12.9	11.7	16.6	27.1	24.6	19.3	16.0	13.4	14.2	14.3	13.8	13.5	18.7	20.6	16.1	14.5	15.6	13.2	16.1	13.1	28.1	16.1	27.3	20.1	10.6	22.7	13.4	20.2	10.2	8.9	18.7	10.8	10.9	7.8	2.9	9.9	12.8	13.3	11.5	6.6	8.5	0.4	9.0	9.0	12.7	11.8	2.8	8.3	20.5	10.2	12.4	11.7	8.5	21.2	20.0	15.4	34.7	12.8	9.1	14.5	0.1	10.9	19.6	10.8	8.0	12.1	15.0	14.1	9.0	18.4	13.0	12.4	7.2	12.7	20.8	13.6	6.3	14.5	6.7	11.3	15.1	1.7	6.3	8.2	12.1	16.3	11.2	23.4	10.2	7.0	12.9	10.2	16.3	13.5	8.8	12.9	5.6	11.1	8.5	7.4	14.7	5.1	9.6	9.4	10.7	9.1	9.4	7.5	6.1	6.3	8.5	6.3	5.0	6.7	10.2	7.8	6.3	18.7	10.9	10.8	8.9	5.7	2.9	11.9	15.7	28.9	16.7	12.8	11.5	12.9	11.7	13.4	16.1	20.8	26.1	42.4	26.2	15.0	91.7	37.5	33.1	13.4	36.4	52.4	141.4	34.8	14.9	22.8	25.5	31.5	21.9	0.0	18.5	20.4	23.3	24.0	39.4	16.3	24.2	84.2	40.3	31.3	29.2	33.9	47.2	39.1	15.1	50.5	19.4	35.7	20.1	24.6	31.1	13.9	100.0	51.8	19.6	63.2	47.7	18.1	29.6	51.1	21.5	23.5
PRMT8	"HRMT1L3, HRMT1L4"	ENSG00000111218	"Protein arginine methyltransferase 8"	Q9NR22	12	3381349-3593973	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 24.8"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 6.0;Bipolar cells: 18.4;Ciliated cells: 13.4;Club cells: 9.1;Cone photoreceptor cells: 15.7;Early spermatids: 11.0;Horizontal cells: 4.8;Late spermatids: 11.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"hTERT-HME1: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039747, HPA069769"	Enhanced					NA	NA					"HPA039747: AB_2732482, HPA069769: AB_2686193"	"unprognostic (3.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (5.59e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.80e-3)"	"unprognostic (9.41e-2)"		"unprognostic (3.41e-5)"	"unprognostic (5.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.49e-2)"	0.6	0.6	4.6	0.6	18.3	0.6	0.7	8.7	24.8	0.8	0.7	0.2	0.1	0.7	0.7	0.6	0.6	3.1	0.6	2.3	4.0	2.1	1.2	0.6	2.2	0.6	3.5	10.0	0.7	1.8	0.6	0.0	0.6	1.4	0.6	0.7	0.0	0.6	0.7	0.6	0.6	0.6	0.6	0.4	0.6	0.7	3.0	1.8	1.0	0.6	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	18.3	8.7	14.6	4.0	2.1	3.5	10.0	1.4	1.8	6.0	1.7	0.0	0.0	0.0	18.4	1.2	0.0	13.4	9.1	0.0	15.7	0.0	0.0	0.0	11.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	11.4	0.6	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.6	1.1	0.0	0.0	1.8	1.2	0.0	0.0	0.0	0.0	0.1
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345387-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"lymphoid tissue: 331.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 37.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 18.6;T-cells: 37.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 91.1;JURKAT: 44.0;REH: 25.4;THP-1: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144, HPA070534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favorable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	6.7	5.3	11.8	11.7	11.0	16.4	5.9	10.1	22.7	5.6	15.1	3.6	16.1	6.8	5.9	11.1	5.3	8.0	7.7	10.9	10.8	8.1	5.4	7.2	7.6	25.9	10.0	15.6	6.2	14.8	22.4	12.9	1.8	6.6	10.1	8.2	5.9	17.9	26.2	35.7	9.2	11.3	12.1	8.1	11.5	10.4	2.9	4.5	331.6	11.3	4.6	11.8	18.7	11.0	4.7	1.2	4.7	0.6	18.6	37.9	7.9	0.4	0.0	2.6	0.0	3.6	3.6	0.2	0.7	2.5	0.6	2.0	0.1	4.7	0.9	0.0	0.8	0.2	0.0	9.5	1.1	1.2	91.1	5.8	0.0	0.2	0.0	0.5	5.3	0.8	1.5	0.8	0.0	0.1	7.4	0.6	44.0	0.1	5.0	0.4	0.0	21.2	6.8	3.8	0.3	0.3	25.4	1.3	0.9	1.0	3.1	1.2	7.2	0.0	0.8	0.0	2.2	20.4	38.9	0.3	2.6	1.7	1.2	0.7	0.2	0.0	2.0	2.1	20.5	1.1	4.7	0.5	1.3	14.3	0.6	25.8	0.5	9.7	7.4	1.0	4.7	37.9	22.6	1.2	18.6	0.3	1.2	1.7	7.9	11.8	11.0	10.1	22.7	10.8	8.1	10.0	15.6	6.6	4.5	23.8	26.4	13.7	11.8	12.7	10.1	57.9	22.9	46.8	14.8	29.6	82.5	0.4	1.7	10.0	4.8	11.7	11.0	23.3	10.8	0.1	8.7	29.4	22.0	18.8	9.1	0.0	31.2	31.3	44.9	3.5	7.8	19.2	10.1	1.0	32.6	14.2	11.1	28.1	7.8	7.3	62.2	6.5	9.5	0.7	2.5	19.3	0.2	62.3	25.2	14.4
PAXIP1	"CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2"	ENSG00000157212	"PAX interacting protein 1"	Q6ZW49	7	154943687-155003084	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 32.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006694, HPA016950"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA006694: AB_1855011, HPA016950: AB_2669489"	"unprognostic (2.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.30e-1)"	6.0	5.4	5.7	6.2	5.0	9.7	6.3	32.3	5.7	7.8	5.5	5.8	4.5	5.2	6.5	6.7	7.1	5.7	5.0	4.7	6.0	3.4	5.7	6.9	4.7	9.4	5.7	1.4	7.1	8.4	7.2	8.7	7.9	5.6	7.7	5.7	6.9	6.6	5.4	7.1	7.4	6.9	9.3	4.2	6.4	5.9	10.4	6.2	31.2	6.4	4.7	6.9	6.1	5.9	2.2	3.3	1.4	3.1	2.9	6.5	2.5	9.9	8.2	10.9	18.4	4.8	4.0	9.7	4.4	4.7	6.1	7.2	9.0	7.9	13.1	5.6	5.3	12.7	7.9	13.9	7.0	7.6	13.1	10.9	9.9	5.9	7.7	3.4	13.5	13.3	3.8	5.3	6.1	2.5	3.5	5.8	13.3	13.6	8.8	6.1	13.9	28.7	11.3	17.6	9.8	5.6	16.4	11.1	14.2	6.3	8.4	8.7	5.6	11.8	8.8	5.5	10.3	6.7	11.6	2.9	5.1	0.9	7.3	10.6	9.0	5.2	18.0	12.6	16.0	13.8	0.7	2.3	1.4	2.5	2.6	3.8	1.3	4.0	2.9	2.6	2.2	6.5	1.7	1.0	2.9	3.1	3.3	3.2	2.5	5.7	5.0	32.3	5.7	6.0	3.4	5.7	1.4	5.6	6.2	6.0	7.5	6.5	4.7	5.7	18.0	6.1	7.6	4.0	9.1	8.7	9.8	7.4	5.0	3.5	1.5	5.0	4.7	0.0	2.9	6.4	6.0	6.1	2.3	8.9	3.9	3.2	2.4	3.1	4.0	2.7	8.1	3.6	3.3	3.6	8.7	9.3	4.0	2.9	8.9	3.1	12.8	0.0	2.5	15.2	19.9	6.0	5.1	3.9	9.9	3.5
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.5	0.0	0.0	0.2	0.0	0.0	0.8	0.3	0.6	0.0	0.0	0.1	7.2	0.3	2.7	0.0	0.1	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.2	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.2	0.3	0.1	0.6	0.0	0.0	0.1	0.0	1.9	0.5	0.1	0.1	5.3	0.0	0.9	9.7	0.4	0.8	0.0	0.2	0.4	0.1	0.1	0.1	0.0	1.1	0.2	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	5.1	0.0	9.0	18.5	0.0	0.8	0.0	1.4	2.3	10.4	0.0	1.2	0.0	3.6	1.7	0.0	0.3	0.0	1.2	0.2	0.2	5.0	0.0	0.4	0.1	0.0	2.9	0.0	0.0	3.8	0.0	0.0	5.0	0.0	0.0	0.2	12.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	33.0	6.6	0.0	0.5	10.1
PRMT1	"ANM1, HCP1, HRMT1L2"	ENSG00000126457	"Protein arginine methyltransferase 1"	Q99873	19	49675786-49689029	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022550, HPA069769, HPA072136"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490"	"unprognostic (1.88e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.04e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.10e-2)"	21.3	31.5	27.4	28.1	29.7	21.8	22.0	29.4	35.9	31.8	25.5	26.9	27.8	21.4	36.0	22.5	28.9	45.4	24.5	56.4	25.2	28.6	23.4	20.8	22.0	34.9	32.0	23.8	43.4	35.0	20.0	31.7	27.9	25.6	33.3	18.4	34.1	20.9	31.5	83.8	21.9	19.8	38.3	20.9	33.3	20.3	24.9	28.0	25.0	32.9	31.3	32.0	29.8	23.8	51.9	41.2	9.2	23.6	38.7	35.5	31.8	38.2	87.7	60.8	73.3	16.5	18.8	32.0	24.6	43.0	71.2	61.3	65.3	30.6	63.0	18.4	28.8	28.0	28.3	51.2	52.0	31.2	48.9	87.9	45.9	24.1	70.8	40.5	55.2	33.0	26.2	25.9	39.8	57.3	24.0	42.1	51.1	48.3	44.8	27.6	57.9	71.3	68.4	64.1	48.1	57.1	50.7	49.1	57.5	40.1	80.8	67.8	52.8	28.4	29.5	15.1	20.5	22.3	32.6	26.1	41.9	40.8	19.2	58.6	43.1	64.9	62.2	25.7	40.0	43.9	5.8	20.2	9.2	28.6	23.6	35.5	51.9	26.6	30.5	34.2	41.9	29.9	29.1	3.9	38.7	17.1	41.2	24.2	31.8	27.4	29.7	29.4	35.9	25.2	28.6	32.0	23.8	25.6	28.0	3.0	15.9	80.4	187.9	183.9	238.6	13.0	28.1	1.4	7.9	41.8	100.1	170.7	107.8	159.3	3.5	104.4	27.5	0.0	117.3	137.0	110.0	82.0	55.2	18.3	92.0	122.3	110.5	96.3	30.9	13.2	96.4	65.7	106.3	237.2	61.8	106.4	105.3	52.0	83.8	63.8	130.7	90.5	132.8	70.0	132.2	138.9	196.7	52.4	83.7	157.1
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2"	Q9BYW2	3	47016429-47163967	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	13.2	10.5	12.2	15.2	15.4	20.0	11.7	22.4	16.4	13.4	14.0	9.1	12.9	9.5	15.8	7.5	10.8	11.4	8.7	8.8	10.6	6.8	11.4	10.3	10.4	11.8	11.7	9.5	16.0	13.4	21.4	16.3	10.7	11.3	12.4	10.9	7.7	12.7	14.8	27.6	12.5	11.5	11.9	9.8	13.8	10.4	12.8	12.8	23.2	15.8	5.5	12.8	16.1	15.5	4.8	2.6	6.0	2.3	7.1	3.9	1.0	11.6	9.2	15.4	7.9	9.3	10.7	6.5	10.7	10.4	12.6	11.5	9.7	7.6	25.7	6.7	14.8	12.3	7.1	16.7	10.2	17.1	14.7	6.6	26.4	15.3	7.5	7.0	19.7	15.3	9.2	9.9	12.4	15.4	10.2	11.6	13.3	16.9	9.7	10.3	6.1	14.5	2.6	11.7	5.6	7.7	9.6	15.0	13.3	6.4	15.3	6.7	10.6	18.1	7.1	6.7	11.5	7.5	14.7	14.8	13.9	10.4	11.8	17.1	12.5	13.9	26.0	8.0	11.3	8.1	2.4	2.2	5.2	3.9	2.3	2.4	3.7	2.4	3.0	2.5	4.8	3.5	3.0	6.0	7.1	1.9	2.6	1.0	1.0	12.2	15.4	22.4	16.4	10.6	6.8	11.7	9.5	11.3	12.8	44.7	53.3	20.6	20.5	29.7	33.4	58.5	22.9	66.9	80.8	10.4	39.3	16.3	10.0	17.4	24.0	29.3	26.5	0.0	19.3	10.1	20.8	25.9	55.6	26.7	14.3	25.4	21.2	23.4	27.2	20.8	28.1	21.6	16.9	20.8	27.8	21.7	20.0	17.5	31.1	9.3	37.0	12.9	21.7	78.1	18.9	31.1	15.4	27.7	24.8	34.2
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560656-68694482	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 59.1;Horizontal cells: 33.4;Leydig cells: 23.9"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.3;HAP1: 17.4;K-562: 9.7;NTERA-2: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	4.4	1.6	3.3	4.3	2.6	1.6	3.1	4.4	4.3	5.1	2.4	5.8	3.2	1.2	6.0	3.4	2.4	2.9	3.5	2.4	3.5	2.3	1.8	1.5	1.6	1.7	2.5	2.6	6.1	1.6	7.4	2.2	5.8	2.9	3.2	2.0	8.1	15.9	4.8	4.0	2.2	1.8	6.5	3.6	1.7	2.2	1.4	5.9	1.2	3.2	3.2	1.8	5.1	5.4	1.3	1.1	1.0	0.0	0.9	2.3	0.2	0.6	0.7	6.9	7.8	0.7	0.6	15.3	0.4	0.8	0.6	1.1	4.6	0.2	0.0	0.2	0.7	0.1	0.0	17.4	0.0	0.7	0.2	2.8	1.8	0.0	4.1	1.0	1.6	0.9	0.9	0.1	0.4	0.0	1.4	0.1	2.9	9.7	1.2	0.6	0.5	2.7	1.2	10.2	0.0	0.9	2.7	2.2	0.2	0.3	0.7	1.9	3.1	0.3	0.4	1.4	7.2	0.9	1.2	0.2	0.6	1.4	0.0	0.5	0.5	0.5	2.7	0.1	0.0	0.1	0.0	0.0	1.0	1.5	0.0	2.0	1.3	0.8	1.3	0.2	0.5	1.4	1.1	0.0	0.9	0.0	1.1	2.3	0.2	3.3	2.6	4.4	2.6	3.5	2.3	2.5	2.6	2.9	5.9	3.0	3.8	0.0	1.9	1.0	2.2	4.5	2.5	1.4	4.5	0.0	9.8	16.6	0.0	1.4	0.4	3.3	0.0	0.0	0.3	59.1	11.8	2.1	0.0	2.1	3.3	33.4	13.2	7.4	0.0	0.6	23.9	0.1	1.7	0.0	0.0	17.3	0.9	0.0	19.4	0.8	10.8	6.5	3.8	0.5	0.7	1.0	23.3	1.7	0.4	0.3
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: AB_2672597"	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	12.7	31.7	21.5	17.6	22.4	12.5	12.6	21.3	31.5	12.8	13.8	20.4	15.6	13.5	14.0	14.9	12.9	19.8	11.7	20.3	20.7	18.3	14.9	16.1	12.9	17.2	18.0	19.4	23.3	19.9	25.3	15.7	14.3	17.9	13.9	11.9	19.2	21.1	15.2	30.5	18.0	12.7	17.0	15.8	16.7	13.8	13.8	17.0	15.2	18.1	14.3	13.6	12.7	11.4	18.6	15.4	23.2	14.8	26.5	23.1	15.0	12.4	13.2	18.7	9.8	9.7	9.2	21.6	11.0	14.8	26.7	23.1	21.6	15.6	18.7	15.0	17.7	10.5	10.2	16.6	14.2	14.2	14.9	26.9	17.1	23.6	21.3	17.6	16.8	13.1	14.4	15.8	22.0	12.7	17.2	17.2	17.9	11.9	17.2	15.5	14.4	23.4	21.1	26.6	6.4	16.9	23.8	18.9	20.3	14.0	15.8	17.4	14.4	20.7	14.9	21.0	18.9	12.3	19.4	16.5	7.6	22.9	17.4	22.2	20.9	12.5	14.9	14.3	16.7	12.4	23.2	14.8	14.1	21.2	13.1	21.6	18.6	21.4	21.8	15.4	18.6	19.6	19.3	6.4	26.5	10.5	12.4	23.1	15.0	21.5	22.4	21.3	31.5	20.7	18.3	18.0	19.4	17.9	17.0	29.8	27.9	19.5	20.8	17.1	38.2	20.9	20.4	26.8	14.8	10.4	23.6	62.4	24.9	28.1	32.9	20.7	35.1	46.7	36.4	27.8	20.5	10.0	26.5	17.4	28.6	22.3	52.2	18.4	21.5	52.0	16.7	14.0	16.9	27.1	25.6	36.1	20.7	25.9	16.6	28.1	52.1	6.5	19.6	25.4	33.4	15.6	43.8	20.0	24.0	11.9
EBF3	"COE3, DKFZp667B0210"	ENSG00000108001	"Early B cell factor 3"	Q9H4W6	10	129835283-129963841	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 25.8;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in some"	24	"Cardiomyocytes: 2.4;Endothelial cells: 3.5;Smooth muscle cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.1;HAP1: 11.8;LHCN-M2: 18.9;NB-4: 23.8;RH-30: 10.3;SCLC-21H: 24.4;THP-1: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (2.96e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.50e-3)"	"unprognostic (8.53e-6)"	"unprognostic (2.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.58e-2)"	20.0	0.9	0.3	3.4	0.4	0.1	25.8	0.7	0.5	7.3	3.6	0.2	2.5	0.2	5.4	4.9	4.3	3.8	4.3	10.5	0.3	2.5	0.6	0.4	1.0	29.9	5.0	0.3	1.0	1.2	3.6	0.9	3.8	4.8	4.6	0.8	2.0	3.6	2.2	10.9	2.8	1.0	6.3	9.3	0.2	1.6	4.6	0.1	0.5	6.7	6.3	2.4	4.7	16.9	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	10.1	7.8	0.1	0.7	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	11.8	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.0	0.7	0.0	0.0	18.9	0.1	0.0	23.8	0.1	0.0	0.0	0.3	10.3	0.0	0.0	0.1	24.4	0.3	0.0	0.0	0.0	0.2	0.0	10.0	0.0	0.0	1.2	6.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.5	0.3	2.5	5.0	0.3	4.8	0.1	0.0	0.0	0.0	0.0	1.6	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.6	0.0	11.8	0.0	0.9	0.6	0.0	0.0	0.0	0.0
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618963-137870016	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	16.6	18.3	16.4	23.2	22.3	24.9	17.1	23.7	20.4	16.3	20.7	21.6	20.4	17.1	22.0	13.0	17.9	18.5	20.0	12.1	12.8	9.6	12.7	14.9	14.9	25.0	27.8	12.1	21.4	13.6	15.1	16.2	17.9	18.6	16.9	12.4	19.1	16.5	18.0	23.1	17.3	17.9	21.5	12.5	22.1	16.4	30.8	21.5	22.3	18.9	11.0	22.2	19.2	15.7	20.0	19.0	25.0	13.7	13.1	15.6	6.9	11.1	22.4	25.1	23.3	10.7	11.1	21.1	14.8	9.4	10.8	8.9	14.6	14.0	34.3	14.4	11.2	13.1	24.1	15.0	16.2	8.6	19.2	10.6	14.5	22.4	9.3	9.3	22.0	17.4	9.9	11.4	13.1	12.8	8.0	17.8	13.0	21.7	11.9	7.7	25.8	25.8	10.9	24.5	17.7	14.9	33.2	21.6	19.8	9.1	20.6	22.3	18.1	28.1	19.8	6.4	18.8	22.2	17.8	16.7	12.8	13.3	19.6	14.0	7.6	21.1	28.3	9.5	11.8	13.8	13.6	13.7	16.3	15.6	11.7	10.0	13.3	13.5	13.3	10.4	20.0	13.3	11.8	25.0	13.1	12.0	19.0	11.1	6.9	16.4	22.3	23.7	20.4	12.8	9.6	27.8	12.1	18.6	21.5	17.9	16.3	36.9	20.3	15.5	38.3	24.3	17.8	21.4	22.7	21.0	49.1	18.6	3.3	20.9	68.8	24.8	19.8	0.0	18.3	18.0	18.4	25.8	17.4	28.8	17.0	47.7	27.0	17.8	23.4	119.3	33.1	16.5	11.8	23.4	20.2	23.1	20.1	25.9	35.3	11.9	48.0	12.9	15.3	58.1	54.9	17.7	22.2	23.3	20.5	22.0
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 97.8;skin 1: 61.7"	"Cell type enhanced"	"Detected in many"	19	"Cytotrophoblasts: 243.8;Extravillous trophoblasts: 651.3;Syncytiotrophoblasts: 949.1"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	42	"gdT-cell: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9"	"Group enriched"	"Detected in many"	54	"NK-cells: 16.6;T-cells: 18.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 33.3;MCF7: 79.6;RT4: 32.6;SH-SY5Y: 28.0;T-47d: 103.7"	"Region enriched"	"Detected in single"	6	"midbrain: 7.3"	"Group enriched"	"Detected in some"	38	"midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016217: AB_2108591, HPA029730: AB_10601907"	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	2.0	2.0	0.3	3.4	0.3	0.9	17.8	0.3	0.3	1.8	0.5	0.1	44.4	0.1	0.4	13.5	0.8	0.4	0.4	0.9	0.3	0.4	12.9	0.7	1.6	2.7	0.8	0.0	0.3	0.4	55.0	3.8	53.4	1.4	8.1	0.0	1.8	8.9	97.8	0.8	61.7	1.2	3.4	0.4	2.7	0.5	0.8	0.1	42.4	3.3	0.6	3.4	26.9	16.4	0.2	0.0	0.3	0.0	16.6	18.9	3.0	5.5	1.3	0.0	0.0	0.0	0.0	33.3	0.1	0.0	0.0	0.0	2.0	5.0	0.0	0.0	0.0	0.0	4.9	0.5	0.1	0.0	16.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.3	0.1	2.6	7.8	0.0	0.0	0.0	79.6	8.7	0.0	0.6	1.0	0.7	0.4	0.4	0.1	0.0	32.6	1.6	28.0	0.0	4.5	0.0	6.1	103.7	0.0	0.0	0.4	1.0	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	9.7	0.0	13.3	0.2	18.2	14.1	0.0	0.0	10.0	9.0	0.3	16.6	0.0	0.0	18.9	3.0	0.3	0.3	0.3	0.3	0.3	0.4	0.8	0.0	1.4	0.1	0.0	8.9	0.5	60.9	84.1	0.0	1.2	0.0	0.0	1.2	169.3	0.0	243.8	0.0	0.2	0.0	4.9	0.0	0.0	0.3	651.3	6.9	27.0	2.3	0.5	27.7	0.0	0.0	9.8	4.0	0.0	0.0	2.2	8.5	1.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	173.9	949.1	56.1	0.0	68.0
HIC1	"ZBTB29, ZNF901"	ENSG00000177374	"HIC ZBTB transcriptional repressor 1"	Q14526	17	2054154-2063241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 16.5;Fibroblasts: 13.6;Ito cells: 20.3;Leydig cells: 53.2;Peritubular cells: 45.3;Sertoli cells: 45.3;Smooth muscle cells: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 4.9;intermediate monocyte: 1.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 4.9;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.4;BJ: 12.1;HSkMC: 7.5;TIME: 12.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043372	Uncertain					NA	NA					"HPA043372: AB_10795614"	"unprognostic (1.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (2.20e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-2)"	21.9	7.1	2.6	12.7	4.8	2.4	37.5	2.8	4.9	22.2	11.4	2.1	6.5	11.2	25.0	21.5	9.5	13.3	14.8	19.1	2.8	2.2	9.8	5.4	9.4	10.5	4.8	2.6	29.1	3.0	3.0	12.9	2.9	4.5	12.3	3.5	15.2	5.6	13.7	19.3	3.4	10.2	16.7	2.0	6.5	10.8	8.0	3.0	5.1	10.5	12.1	3.1	16.8	12.4	0.1	0.0	4.9	1.8	0.0	0.3	0.0	0.6	0.7	0.9	0.6	4.9	7.4	1.5	12.1	6.6	1.7	2.4	0.6	0.3	0.1	0.2	6.3	0.7	1.1	0.7	0.2	0.5	0.4	1.5	0.3	0.7	0.3	4.2	0.2	0.5	7.5	0.8	2.5	0.1	3.4	6.4	0.7	1.7	2.9	0.4	0.0	0.0	0.4	0.2	0.0	0.4	0.6	0.3	0.3	0.2	0.4	0.4	0.7	0.2	0.1	0.0	0.2	0.0	0.1	12.5	4.5	0.1	4.4	6.2	0.4	0.4	0.2	0.4	0.4	1.1	0.0	0.1	4.9	0.2	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	4.8	2.8	4.9	2.8	2.2	4.8	2.6	4.5	3.0	0.0	2.6	0.9	1.6	3.5	2.2	2.0	0.0	1.4	0.0	1.8	0.0	0.1	0.0	0.3	0.4	16.5	0.0	0.0	1.0	0.6	13.6	0.8	2.3	0.0	0.5	0.0	1.7	20.3	6.7	1.3	53.2	5.0	3.3	0.0	0.0	0.2	0.2	0.0	45.3	0.0	1.8	45.3	28.1	0.7	3.6	3.6	0.1	1.9	0.0	1.0
HOXA5	"HOX1, HOX1C"	ENSG00000106004	"Homeobox A5"	P20719	7	27141052-27143668	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 42.0"	"Cell type enhanced"	"Detected in many"	7	"Ito cells: 16.0;Paneth cells: 15.9;Proximal tubular cells: 21.3;Undifferentiated cells: 18.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	46	"pons and medulla: 16.3"	"Group enriched"	"Detected in some"	4	"basophil: 3.0;neutrophil: 1.6;NK-cell: 2.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.0;NK-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.1;HEK 293: 56.5;RPTEC TERT1: 12.8"	"Region enriched"	"Detected in single"	88	"pons and medulla: 23.0"	"Region enriched"	"Detected in single"	22	"pons and medulla: 5.5"							NA	NA						"unprognostic (2.43e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.80e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.00e-1)"	6.8	42.0	0.2	2.1	0.2	1.2	10.9	0.2	0.3	1.9	6.6	1.0	16.0	1.1	6.0	25.0	12.3	22.1	2.5	1.4	0.2	0.0	16.8	1.8	23.9	1.5	0.2	0.2	9.3	1.3	2.0	0.5	0.3	16.3	3.9	3.3	0.2	0.2	7.1	5.6	3.4	6.8	3.0	19.4	4.4	5.6	2.6	0.2	0.2	1.3	0.2	0.2	6.6	3.3	0.2	0.4	3.0	0.5	2.5	0.2	0.1	1.9	1.0	0.0	33.1	0.0	0.0	0.1	0.5	0.4	0.6	0.5	0.6	3.4	1.0	4.9	1.0	0.7	2.6	1.8	0.1	0.6	0.4	56.5	0.7	0.4	1.9	0.3	1.2	0.8	3.7	0.2	1.1	1.9	0.0	7.3	1.9	0.1	0.0	1.1	0.6	0.0	0.3	0.0	0.7	1.0	4.5	0.1	0.0	12.8	2.6	3.9	0.0	2.5	0.0	1.1	0.1	0.4	0.4	2.9	0.1	0.4	2.0	1.3	0.0	0.0	1.1	0.2	3.6	3.6	3.0	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.2	0.1	1.6	2.5	0.5	0.4	0.1	0.1	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	16.3	0.2	0.0	0.6	0.0	3.8	3.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	5.1	9.3	0.0	0.0	0.0	1.3	2.2	0.0	0.0	0.6	0.0	8.6	16.0	4.1	0.0	0.3	0.9	1.7	1.0	8.4	0.0	0.0	15.9	0.0	21.3	0.0	0.0	3.3	0.2	0.7	2.5	0.1	0.0	18.1	5.0
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 44.2;granulocytes: 25.4;Intestinal endocrine cells: 16.9;Mucus-secreting cells: 26.5;Undifferentiated cells: 37.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 39.5;MOLT-4: 72.0;NB-4: 37.5;REH: 44.5;THP-1: 62.8;U-937: 34.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	25.2	0.1	0.0	0.0	39.5	20.0	0.0	0.0	0.1	0.0	0.0	0.0	24.8	20.4	3.8	0.2	2.0	72.0	37.5	0.2	3.5	0.3	44.5	1.0	6.1	0.0	0.2	1.9	1.2	0.0	2.0	0.0	0.1	1.5	62.8	0.0	0.0	0.3	1.5	0.4	4.8	1.2	12.2	0.0	34.2	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6	0.0	2.2	2.9	1.1	2.4	0.6	0.4	2.5	44.2	10.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	2.9	0.0	0.7	0.6	0.4	2.7	25.4	0.0	0.9	0.0	16.9	0.0	1.2	0.0	0.0	1.5	8.5	0.0	26.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	6.0	0.2	1.9	37.5	2.0
SALL3	ZNF796	ENSG00000256463	"Spalt like transcription factor 3"	Q9BXA9	18	78980275-79002677	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.6;vagina: 6.6"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 45.2;Horizontal cells: 23.8"	"Cancer enriched"	"Detected in some"	6	"glioma: 6.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 4.0;NTERA-2: 13.8;SuSa: 2.5"	"Region enriched"	"Detected in many"	4	"olfactory region: 15.4"	"Low region specificity"	"Detected in many"			HPA016656	Uncertain					NA	NA					"HPA016656: AB_1856546"	"unprognostic (3.96e-2)"	"unprognostic (3.41e-3)"			"unprognostic (8.16e-2)"	"unprognostic (1.87e-2)"		"unprognostic (2.37e-1)"	"unprognostic (4.23e-1)"			"unprognostic (2.12e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.86e-3)"		0.7	0.7	7.3	0.7	7.6	0.7	0.7	0.3	11.6	0.9	0.7	8.3	0.0	0.7	0.7	2.1	0.7	0.7	0.7	1.2	7.1	5.4	4.4	0.7	0.7	0.7	5.7	3.3	0.7	0.7	0.7	1.1	0.8	6.8	6.0	0.7	0.2	0.7	1.2	0.7	0.7	0.7	0.7	8.8	0.7	0.7	2.4	4.6	0.0	0.9	0.0	0.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.8	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	7.6	0.3	6.6	7.1	5.4	5.7	3.3	6.8	4.6	0.0	0.0	0.0	7.0	0.0	0.5	1.4	0.0	0.0	0.0	1.8	45.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.3	23.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	6.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.2
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase"	Q96Q83	11	43880811-43920266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 78.8;Late spermatids: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	17.6	14.2	14.3	13.2	16.7	8.6	26.5	21.2	22.7	19.1	15.7	19.5	12.8	13.2	22.6	31.2	16.2	20.0	16.4	12.5	14.3	13.4	15.6	25.8	15.1	17.3	15.0	14.4	21.8	23.5	22.1	16.6	9.1	15.6	19.1	16.6	19.5	25.5	19.1	29.1	20.2	15.0	18.3	14.8	17.8	17.0	17.3	12.1	14.5	16.4	21.4	22.2	15.2	17.4	14.9	18.5	21.2	21.0	17.1	21.3	13.8	7.4	13.0	5.2	0.0	10.1	13.0	0.0	9.1	20.2	18.3	18.0	6.1	5.8	1.1	5.8	13.7	9.9	10.2	7.1	15.7	17.0	0.0	24.9	10.9	8.8	12.8	25.1	20.0	14.6	13.7	27.3	8.1	39.4	7.6	13.1	21.5	15.4	11.9	9.0	8.9	17.9	10.3	9.5	7.9	19.1	5.2	11.2	14.0	11.0	11.7	9.7	7.8	7.0	11.1	16.7	4.8	16.1	12.3	9.2	10.4	5.8	17.0	13.0	10.8	11.3	12.1	15.5	8.5	8.5	21.2	12.9	7.1	17.0	14.1	16.2	14.4	17.4	15.1	18.5	14.9	21.3	18.9	2.3	17.1	21.0	16.3	16.2	13.8	14.3	16.7	21.2	22.7	14.3	13.4	15.0	14.4	15.6	12.1	14.9	10.4	11.1	9.1	9.2	10.0	5.6	12.7	16.0	10.3	15.7	3.9	3.1	26.6	17.0	78.8	13.7	9.2	0.0	28.4	4.0	9.7	6.6	7.0	11.3	16.7	9.5	9.1	14.7	10.7	69.5	15.0	13.1	16.9	15.4	12.7	17.2	23.0	7.0	9.9	14.1	10.5	6.5	19.6	18.7	9.5	6.1	1.8	14.9	13.1	5.0
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901300-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.6"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 860.1;Smooth muscle cells: 627.3;Syncytiotrophoblasts: 769.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	43.3	5.6	7.8	13.8	9.9	4.2	22.6	3.3	11.5	27.5	14.0	9.5	4.4	6.8	29.4	10.4	14.0	15.6	27.2	16.0	5.9	5.1	14.6	5.7	14.6	14.4	11.8	6.5	18.6	4.3	14.7	11.4	22.4	9.4	16.6	8.2	6.9	14.5	7.3	88.6	15.0	12.1	29.4	10.4	12.7	9.4	7.7	10.5	8.6	7.5	11.7	18.0	22.5	17.1	21.2	1.0	4.3	3.6	5.7	14.7	2.6	0.8	0.3	2.3	5.9	5.2	14.0	0.4	16.9	45.7	12.1	9.5	20.5	0.9	1.4	4.1	16.2	1.7	5.6	8.1	2.5	14.6	5.3	2.4	0.8	4.1	5.1	9.7	0.2	10.1	17.6	1.3	7.1	8.1	10.4	1.4	2.9	0.7	2.3	3.9	2.9	5.5	0.4	0.4	3.9	5.4	6.7	3.9	0.4	7.9	9.2	1.3	1.7	7.5	4.1	4.9	5.5	3.5	0.2	1.3	6.7	9.1	10.1	4.2	0.1	0.0	4.4	5.8	0.3	2.1	4.3	0.6	0.4	7.3	1.4	0.9	19.0	10.5	6.3	1.0	21.2	6.9	4.5	1.2	5.7	3.6	0.5	14.7	2.6	7.8	9.9	3.3	11.5	5.9	5.1	11.8	6.5	9.4	10.5	122.1	57.7	77.2	286.1	860.1	43.7	59.7	12.7	50.9	120.6	48.8	0.0	138.5	84.6	43.9	23.9	62.4	4.7	23.3	12.8	104.6	292.5	224.3	23.2	5.1	46.6	69.9	34.9	106.8	33.2	10.0	140.4	39.6	131.6	60.5	13.2	19.3	30.6	20.9	57.0	145.5	2.8	129.4	627.3	5.7	0.5	417.5	769.7	77.6	30.2	122.9
KDM5A	"JARID1A, RBBP2"	ENSG00000073614	"Lysine demethylase 5A"	P29375	12	280129-389454	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006201			Supported	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"HPA006201: AB_1079160"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.81e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.69e-2)"	13.6	14.4	10.6	13.7	13.0	41.6	13.1	21.8	13.2	11.8	10.3	14.8	11.3	7.8	14.2	8.1	13.6	11.2	10.0	10.1	11.5	5.7	9.0	10.7	13.1	14.9	15.1	9.1	15.2	11.5	16.8	13.8	12.4	11.3	10.6	10.9	10.6	12.9	8.6	9.7	20.3	13.0	10.4	10.1	15.5	10.6	21.2	14.8	28.8	11.4	7.1	16.1	13.1	18.8	17.2	16.8	33.7	14.1	18.6	18.1	10.1	7.7	14.0	10.3	7.9	9.3	8.8	11.5	6.9	9.2	10.4	11.3	8.3	9.4	13.0	2.2	11.5	9.1	7.4	10.7	7.8	12.5	20.5	8.9	15.9	14.6	4.9	7.5	20.7	12.6	9.6	7.4	12.8	17.1	10.7	10.5	11.7	9.5	18.3	8.8	5.2	14.8	5.9	16.0	6.7	4.4	13.9	26.9	6.1	5.0	17.9	4.0	11.6	13.6	6.2	7.3	14.9	6.7	13.1	14.3	6.9	9.9	7.6	11.5	6.5	7.1	29.9	8.8	9.1	10.1	30.2	11.3	22.2	17.7	13.1	18.1	14.1	13.8	14.2	11.8	17.2	15.1	12.9	33.7	18.6	14.1	16.8	10.5	10.1	10.6	13.0	21.8	13.2	11.5	5.7	15.1	9.1	11.3	14.8	59.6	53.6	57.8	19.7	29.3	64.2	35.8	35.7	40.2	39.8	33.2	110.0	38.1	3.3	31.6	79.2	46.6	34.3	0.0	27.4	28.3	35.7	25.6	52.1	23.6	26.7	82.6	66.8	42.4	53.2	21.3	44.8	47.2	25.3	60.5	35.6	48.0	31.1	37.9	52.3	10.5	68.8	58.2	30.9	105.6	111.6	41.7	59.5	62.5	36.0	33.9
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	106086320-106109939	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 49.1;T-cells: 100.2;Urothelial cells: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;T-cells: 19.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 68.5;RPMI-8226: 12.8;U-266/70: 25.7;U-266/84: 16.6"	"Region enriched"	"Detected in single"	6	"olfactory region: 4.4"	"Low region specificity"	"Detected in all"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	11.6	1.5	1.6	26.3	3.2	10.4	7.0	5.3	1.6	14.0	16.5	1.9	1.4	5.4	11.6	2.2	33.4	3.8	8.1	2.3	1.9	2.0	3.1	2.4	18.8	33.3	2.1	0.5	4.2	1.8	1.2	2.1	9.0	4.9	3.6	11.0	4.3	10.6	3.0	2.0	8.9	18.2	3.4	7.4	24.2	8.6	3.0	1.5	3.1	7.7	35.7	49.9	12.8	18.0	1.5	0.2	6.8	0.6	2.5	19.3	1.3	0.4	0.1	0.3	0.0	0.5	0.7	0.0	2.3	7.2	0.7	1.3	0.4	2.8	0.6	0.1	4.6	0.1	0.1	0.0	1.1	0.8	6.4	0.0	0.1	1.4	0.0	1.1	0.2	0.5	0.7	3.6	1.0	3.0	0.2	0.9	0.3	0.4	68.5	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.0	12.8	0.6	0.1	0.0	0.0	0.3	0.3	0.0	0.5	0.3	0.7	0.4	1.1	0.6	0.6	2.1	25.7	16.6	1.5	1.6	0.4	0.6	1.2	0.4	5.6	12.6	0.6	19.3	1.5	12.0	11.6	0.2	0.5	1.1	6.8	6.8	2.5	0.1	0.2	15.4	1.3	1.6	3.2	5.3	1.6	1.9	2.0	2.1	0.5	4.9	1.5	0.0	9.0	19.7	8.0	17.3	0.8	1.4	0.0	2.7	7.9	3.5	49.1	0.4	0.0	0.3	0.8	20.4	7.3	23.3	0.2	0.5	5.1	3.1	3.5	1.5	19.3	0.0	1.7	8.0	24.7	0.0	0.0	38.5	35.4	47.7	3.1	0.5	4.8	4.3	1.1	0.1	0.4	0.0	16.4	0.3	1.3	36.3	0.6	100.2	2.5	77.0
PRDM14		ENSG00000147596	"PR/SET domain 14"	Q9GZV8	8	70051651-70071693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	658	"testis cancer: 34.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	57	"NTERA-2: 33.7;SuSa: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019094, HPA057070"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019094: AB_1855686, HPA057070: AB_2683327"					"unprognostic (5.86e-2)"					"unprognostic (9.32e-2)"			"unprognostic (6.14e-3)"	"unprognostic (1.37e-2)"	"unprognostic (8.62e-2)"			0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.4	1.1	0.2	0.3	0.2	1.1	0.2	0.2	0.5	0.2	0.5	0.2	0.2	0.2	0.5	0.2	0.3	0.3	0.2	0.2	0.2	0.1	1.7	0.3	0.2	0.4	1.2	0.2	0.2	0.2	0.6	0.3	5.4	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.6	1.0	1.4	1.6	1.0	2.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	9.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.6	1.0	0.4	0.8	1.4	1.1	0.7	0.3	1.6	2.5	1.9	1.4	1.0	1.6	1.0	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"	15.2	14.5	26.0	17.2	28.1	64.1	17.2	32.3	44.9	16.2	18.1	19.8	12.6	12.4	18.8	16.4	19.6	14.4	16.4	14.3	19.8	14.5	10.8	9.3	15.6	23.4	18.9	27.8	30.7	12.8	16.0	26.7	15.7	18.0	17.7	13.6	10.3	15.8	18.9	45.2	21.6	16.8	16.8	21.6	16.9	14.2	17.1	17.8	14.4	23.3	11.7	22.7	19.8	19.3	16.0	5.4	9.7	5.1	5.7	5.7	2.5	6.9	4.0	14.4	5.5	11.4	8.8	6.9	9.0	5.5	6.2	7.0	6.2	7.9	21.2	8.0	8.7	5.2	8.6	10.7	5.3	6.9	13.1	7.6	14.2	4.6	2.9	6.3	4.7	12.3	9.3	9.4	6.5	5.5	5.9	6.1	8.4	12.6	24.6	7.7	3.5	7.6	7.5	4.3	5.5	5.3	10.6	7.8	6.3	3.5	7.8	12.5	8.1	7.2	4.6	9.9	9.0	6.5	7.7	10.8	7.9	8.7	7.2	4.9	36.1	24.4	30.4	7.1	11.1	10.2	3.9	4.8	6.8	5.7	3.1	3.8	16.0	4.5	5.2	2.9	12.5	5.2	4.5	9.7	5.7	5.1	5.4	4.1	2.5	26.0	28.1	32.3	44.9	19.8	14.5	18.9	27.8	18.0	17.8	35.7	37.8	66.5	49.3	55.2	46.9	34.7	25.5	53.5	40.9	22.7	43.2	19.3	14.9	15.3	8.6	29.3	23.6	46.7	11.9	11.9	42.7	46.2	39.3	16.4	14.7	66.7	36.4	25.2	38.9	11.6	40.9	37.0	28.7	28.9	18.8	23.0	13.7	14.4	42.5	6.6	36.8	25.8	27.0	41.2	51.7	45.7	15.3	50.4	15.2	52.5
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 75.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 109.6;Cytotrophoblasts: 142.7;Early spermatids: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	"Intermediate filaments,Mitochondria,Cytosol"		NA	NA			Cytosol	"Intermediate filaments, Mitochondria"	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	5.9	5.7	8.8	5.6	7.3	2.7	10.0	5.0	23.9	4.9	4.7	2.1	3.1	4.8	3.8	6.7	7.3	10.4	4.5	75.7	7.0	8.4	7.7	9.7	8.1	8.0	5.3	10.0	4.7	7.8	2.9	7.5	10.6	6.9	4.6	5.8	3.1	6.2	3.0	29.5	4.3	4.7	3.8	4.7	6.2	6.2	8.9	2.2	8.0	7.8	5.1	5.6	5.2	4.0	9.3	5.5	8.1	5.9	17.6	14.5	7.3	24.5	7.1	9.7	6.8	10.0	17.5	41.3	13.9	11.5	17.6	20.0	28.0	21.0	12.7	14.3	15.7	9.6	11.6	9.2	25.8	17.1	10.6	10.7	4.1	12.0	22.3	9.0	17.8	2.9	18.7	14.6	12.2	9.7	12.2	12.7	12.2	12.9	3.2	15.7	12.8	12.4	11.2	8.7	14.4	9.7	7.7	23.5	10.8	17.4	18.0	9.6	22.4	10.8	38.9	28.6	23.3	30.3	11.9	14.6	13.7	20.2	7.5	21.5	13.1	4.9	14.6	17.8	14.2	15.6	6.7	5.9	8.1	9.5	3.2	11.2	9.3	14.5	12.7	5.5	4.8	12.7	11.6	0.6	17.6	1.2	3.8	14.5	7.3	8.8	7.3	5.0	23.9	7.0	8.4	5.3	10.0	6.9	2.2	17.9	11.9	11.2	14.0	18.3	3.8	109.6	22.9	48.2	12.5	3.5	0.0	142.7	26.6	32.4	113.6	10.8	12.7	0.0	17.4	93.2	12.2	8.9	3.5	15.5	33.9	14.3	4.1	22.1	17.4	93.5	10.9	9.9	15.1	10.8	15.2	15.2	22.5	10.5	3.5	27.8	4.6	12.9	15.7	15.2	43.7	15.7	71.9	12.8	20.8	7.6
TRDMT1	"DNMT2, RNMT1"	ENSG00000107614	"TRNA aspartic acid methyltransferase 1"	O14717	10	17142254-17202054	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009468, HPA036945, HPA036946"	Approved					NA	NA					"CAB009468: AB_2208432, HPA036945: AB_2675398, HPA036946: AB_2675399"	"unprognostic (4.55e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.49e-6)"	"unprognostic (7.07e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-2)"	6.1	4.4	4.4	8.5	7.7	4.0	6.3	14.0	6.2	5.3	3.8	4.2	4.7	4.1	7.5	14.4	3.9	6.8	5.1	5.0	4.9	4.5	6.7	2.7	5.3	5.3	4.3	2.9	9.6	5.0	12.8	12.6	5.1	6.2	5.0	3.6	8.0	5.6	3.8	4.3	4.4	5.0	5.4	5.1	5.9	4.2	4.2	6.1	19.9	11.5	3.3	5.7	4.0	5.2	6.1	10.5	5.2	4.4	3.5	8.0	3.6	5.0	2.5	10.0	2.5	3.8	2.2	0.0	4.4	3.2	4.6	5.5	4.2	4.2	3.5	0.6	4.9	8.8	2.6	6.7	4.2	5.4	7.3	4.3	5.2	3.8	2.5	3.3	3.4	3.9	3.0	2.6	3.1	2.2	4.3	6.1	9.5	6.4	3.9	7.7	1.6	16.9	0.8	6.2	1.4	2.8	3.7	7.8	2.2	2.5	2.8	2.6	3.3	0.0	1.9	3.3	5.0	4.8	3.1	3.5	3.4	7.2	6.3	5.1	5.0	4.7	8.8	4.3	4.8	3.3	5.2	4.4	2.4	3.9	2.5	7.2	5.4	6.6	4.9	5.5	6.1	8.0	5.8	2.8	3.5	1.4	10.5	2.2	3.6	4.4	7.7	14.0	6.2	4.9	4.5	4.3	2.9	6.2	6.1	6.0	3.7	0.9	1.6	3.0	12.4	3.6	2.5	6.7	7.9	3.5	3.9	1.9	5.0	3.6	5.0	5.0	1.7	23.3	4.2	2.0	4.0	1.3	12.7	0.5	4.5	15.9	0.0	3.1	4.8	4.7	6.1	4.2	0.0	1.8	1.2	16.5	2.2	1.4	6.0	3.7	18.5	0.0	2.9	12.6	3.6	2.8	1.5	5.0	2.9	0.7
CEBPZ	"CBF2, CTF2"	ENSG00000115816	"CCAAT/enhancer binding protein zeta"	Q03701	2	37201612-37231713	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052065	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052065: AB_2681715"	"unprognostic (1.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.13e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.01e-2)"	21.3	23.0	13.1	23.7	14.4	20.0	21.7	17.0	16.4	22.4	17.8	8.4	17.2	12.8	17.2	16.6	18.6	17.4	12.6	19.4	12.0	12.9	30.5	22.6	15.4	16.7	13.2	12.9	24.2	17.2	18.8	27.3	18.2	16.5	20.4	15.5	8.2	15.5	17.9	88.0	14.0	19.1	19.5	15.4	23.1	15.5	27.3	14.1	19.5	22.5	18.7	17.5	30.1	41.0	20.8	17.4	17.2	14.7	17.0	23.1	9.2	19.8	15.5	16.0	8.8	15.8	17.1	13.6	19.0	13.2	16.1	17.5	24.5	15.1	36.6	17.0	11.2	22.1	17.1	41.3	19.5	20.8	23.3	18.2	34.0	16.0	19.9	12.5	34.1	15.4	13.0	19.3	21.4	21.9	10.7	14.5	9.3	37.0	16.9	16.4	10.3	19.8	26.8	52.1	26.6	14.6	15.9	26.0	27.6	15.5	18.8	17.1	27.7	15.8	19.5	21.4	24.2	14.1	15.0	11.8	15.8	18.0	14.0	26.0	19.0	19.9	29.7	14.1	31.6	17.3	17.2	11.7	10.6	17.2	14.7	21.7	20.3	18.2	16.6	11.8	20.8	23.1	19.1	4.2	17.0	14.3	17.4	14.0	9.2	13.1	14.4	17.0	16.4	12.0	12.9	13.2	12.9	16.5	14.1	80.4	74.1	56.7	60.0	95.1	42.9	29.1	56.0	68.3	106.9	47.1	41.2	45.8	91.2	46.1	195.9	50.1	23.4	46.7	53.9	30.2	41.0	51.4	70.6	63.1	30.5	41.3	42.4	44.8	35.3	23.2	56.4	35.5	20.3	47.7	48.2	52.7	48.9	24.6	47.7	55.4	87.8	51.8	44.3	132.2	95.3	88.3	37.6	59.7	48.5	54.3
CGGBP1	"CGGBP, p20-CGGBP"	ENSG00000163320	"CGG triplet repeat binding protein 1"	Q9UFW8	3	88051944-88149885	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 111.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035568, HPA037017"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035568: AB_10670022, HPA037017: AB_2675433"	"unprognostic (2.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.79e-4)"	29.6	23.9	26.1	27.5	28.6	38.5	80.0	33.3	36.9	28.7	28.3	19.4	23.7	23.1	30.7	23.6	23.5	24.2	23.6	33.8	23.1	21.6	28.4	30.8	29.1	39.4	24.4	26.4	37.1	25.9	40.6	33.2	26.4	21.2	27.3	26.0	23.7	25.2	24.9	30.8	19.2	30.0	29.7	28.9	33.9	25.1	22.4	22.0	76.0	32.7	16.7	37.4	27.7	30.9	24.8	19.9	41.6	23.0	20.8	25.1	19.8	8.0	13.8	23.0	16.4	20.3	18.1	7.4	16.1	14.6	17.0	20.2	10.1	11.9	17.6	10.9	14.4	13.3	6.4	18.1	12.2	21.0	26.6	10.0	26.9	12.1	9.0	18.1	17.8	19.2	16.3	12.7	18.7	24.2	21.0	17.3	20.1	12.7	18.4	19.2	12.8	26.7	12.7	12.6	13.5	11.6	17.3	21.6	12.6	12.7	12.3	4.5	15.1	13.6	7.8	38.0	16.9	11.8	21.6	16.7	20.6	15.2	111.3	16.8	13.5	16.3	19.3	15.7	17.4	17.6	41.6	21.2	39.4	23.3	21.7	22.7	22.5	20.7	23.9	19.9	24.8	25.1	20.5	39.8	20.8	23.0	17.9	23.0	19.8	26.1	28.6	33.3	36.9	23.1	21.6	24.4	26.4	21.2	22.0	47.6	40.0	45.5	57.2	47.3	33.0	39.5	35.7	16.0	46.6	38.4	15.7	48.1	56.3	34.4	15.7	65.2	42.3	23.3	36.4	51.7	55.0	57.7	45.1	49.4	36.3	63.5	40.2	61.4	45.7	28.6	64.5	53.4	38.8	34.3	30.1	61.7	41.1	34.9	47.0	52.9	30.4	64.7	68.9	82.4	49.4	43.7	70.1	69.0	31.8	57.8
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223853	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;granulocytes: 7.6;monocytes: 9.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	7.3	10.5	19.1	12.2	17.8	27.9	13.4	13.5	14.6	8.6	15.6	10.6	7.2	9.8	7.5	8.2	11.7	17.5	7.5	8.1	13.8	9.6	10.0	8.9	12.1	11.4	15.1	12.0	8.8	7.8	3.9	9.8	5.5	13.5	7.0	15.9	7.1	7.6	6.4	19.1	13.3	10.3	10.0	13.0	10.5	7.1	18.7	13.8	16.0	33.5	7.6	11.5	9.2	10.0	1.6	4.2	7.6	9.6	0.3	0.8	1.2	8.4	5.1	7.2	14.9	9.5	15.3	14.2	7.9	8.4	5.2	7.4	8.7	4.9	21.4	19.3	13.1	16.3	10.3	12.1	14.4	11.6	17.9	9.6	10.4	5.6	9.0	4.8	14.5	11.5	7.5	16.8	13.2	12.5	8.5	5.5	10.7	24.7	3.0	9.0	7.7	8.3	6.2	2.2	21.6	8.4	16.6	14.0	15.5	7.5	11.2	19.8	7.6	6.4	15.6	14.8	8.7	15.4	11.8	4.2	10.5	5.5	7.6	9.2	3.0	8.4	12.0	4.2	11.0	24.3	1.3	5.3	7.6	0.6	9.6	0.4	1.3	0.6	0.6	4.2	1.6	0.6	0.2	5.6	0.3	7.5	1.8	0.8	1.2	19.1	17.8	13.5	14.6	13.8	9.6	15.1	12.0	13.5	13.8	0.0	8.0	4.7	3.6	11.3	4.6	9.4	5.1	17.4	14.8	1.8	9.8	2.3	1.7	4.9	0.6	2.4	14.4	0.0	3.8	4.4	3.8	5.9	2.3	6.0	6.8	4.8	6.4	4.9	30.8	0.2	3.4	16.9	6.8	7.2	9.9	6.6	4.9	15.6	6.3	9.1	14.4	0.0	4.7	0.4	12.4	13.9	1.1	4.5	9.7	5.2
KDM3A	"JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA"	ENSG00000115548	"Lysine demethylase 3A"	Q9Y4C1	2	86440647-86492716	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055543, HPA065162"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055543: AB_2682842, HPA065162: AB_2685424"	"unprognostic (1.97e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.32e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.15e-6)"	"unprognostic (2.01e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.50e-3)"	"unprognostic (4.44e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-2)"	21.5	12.5	21.5	14.6	27.2	52.9	18.5	17.2	18.7	18.9	25.9	19.6	17.3	17.0	21.2	24.8	20.3	16.8	14.7	21.3	22.7	11.4	13.2	11.9	17.2	14.8	17.8	15.2	20.6	15.7	16.3	20.3	19.5	17.8	19.7	14.9	14.6	19.2	19.1	20.7	34.7	19.1	21.0	22.1	15.7	14.5	42.9	23.6	30.1	18.6	12.8	17.3	29.0	22.1	4.8	4.9	14.4	3.4	4.9	9.1	4.1	18.4	7.4	17.6	4.6	9.1	9.3	16.5	9.0	8.9	8.5	10.5	9.4	7.9	10.8	17.1	7.5	17.5	11.8	13.1	9.0	16.6	14.5	10.9	17.4	6.8	13.3	6.8	13.8	11.1	10.2	13.7	7.6	14.1	29.3	10.4	10.2	11.1	17.8	8.9	4.7	19.2	19.4	15.8	11.1	11.3	13.1	23.8	23.3	7.6	10.5	13.7	14.5	11.9	8.6	16.4	16.2	5.0	9.1	11.6	17.3	7.2	17.8	10.2	18.6	17.5	16.1	21.9	14.4	21.1	11.9	3.2	5.9	7.6	3.4	8.0	4.8	8.4	7.3	4.9	4.1	9.1	7.8	14.4	4.9	2.3	4.4	8.6	4.1	21.5	27.2	17.2	18.7	22.7	11.4	17.8	15.2	17.8	23.6	32.8	13.4	6.9	20.9	27.1	22.7	22.6	10.2	36.1	23.9	5.2	49.1	3.7	0.0	12.1	58.0	19.8	15.9	23.3	8.6	5.9	16.9	16.0	37.0	6.8	9.0	52.4	15.0	14.7	11.3	20.1	16.1	15.1	20.3	5.4	11.4	35.1	10.0	9.7	16.3	4.2	33.6	6.5	14.4	32.1	10.2	35.0	9.7	17.0	9.3	11.7
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35718019-35738878	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 61.2;Rod photoreceptor cells: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006487			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	10.2	9.3	11.4	14.2	13.1	18.4	10.4	23.9	11.4	10.0	12.0	14.2	12.9	13.8	13.0	7.1	11.4	11.6	12.6	7.5	11.0	5.3	9.9	8.9	10.6	14.7	14.7	6.8	15.3	19.6	10.8	13.3	9.3	11.2	12.1	5.6	13.8	14.7	10.0	13.3	19.9	12.3	12.2	12.4	15.8	12.1	21.5	14.9	14.1	14.9	7.0	14.2	12.4	14.2	0.4	0.7	3.2	0.7	2.1	0.7	0.2	11.5	19.5	9.0	9.9	4.7	4.6	9.4	5.6	4.1	5.7	4.4	13.0	5.9	10.3	8.8	4.6	6.1	7.6	8.1	4.8	2.5	15.2	9.0	18.5	9.1	6.5	4.6	11.2	21.2	6.2	6.5	5.8	6.4	5.1	5.5	10.7	15.4	12.9	3.7	11.8	9.5	9.7	8.3	10.0	6.9	15.0	5.9	5.6	3.1	10.3	10.2	8.2	8.5	13.8	5.9	5.0	8.4	12.0	7.7	11.4	12.4	7.6	11.8	17.8	10.9	8.2	6.2	10.4	7.9	1.0	0.7	0.6	0.7	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.4	3.2	2.1	0.3	0.7	0.2	0.2	11.4	13.1	23.9	11.4	11.0	5.3	14.7	6.8	11.2	14.9	8.9	19.1	13.3	8.5	11.3	61.2	7.7	10.2	4.0	5.7	8.7	49.1	5.2	0.0	5.5	2.1	11.7	14.0	0.0	6.7	4.9	8.1	13.1	4.7	9.7	7.3	33.4	19.4	11.6	8.7	4.1	7.5	6.4	5.0	6.4	10.4	27.2	7.1	11.4	11.7	4.2	74.2	0.0	8.2	28.1	36.4	11.3	7.9	10.2	11.3	12.8
MAEL	"CT128, FLJ14904, SPATA35"	ENSG00000143194	"Maelstrom spermatogenic transposon silencer"	Q96JY0	1	166975582-167022214	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 90.7"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 1028.7;Late spermatids: 292.6;Spermatocytes: 368.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.9"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Cell line enriched"	"Detected in some"	8	"NTERA-2: 8.8"	"Region enriched"	"Detected in single"	5	"thalamus: 1.2"	"Not detected"	"Not detected"			HPA078602	Approved					NA	NA					"HPA078602: AB_2732386"	"unprognostic (1.36e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	0.1	0.0	0.8	0.1	0.2	0.0	0.1	0.6	1.3	0.1	0.3	0.1	0.1	0.0	0.1	0.7	0.2	0.0	0.2	2.1	0.7	0.5	0.6	0.3	0.1	0.1	0.4	0.1	0.1	0.6	0.0	0.2	3.5	0.2	0.2	0.0	0.2	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.1	0.0	90.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	8.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.8	0.2	0.6	1.3	0.7	0.5	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.4	0.1	1.3	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1028.7	0.1	0.0	0.0	0.2	0.4	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	292.6	10.0	0.0	0.0	0.0	0.0	42.7	0.0	0.0	9.6	4.3	1.3	0.0	0.3	368.4	143.2	0.0	0.2	0.0	0.0	0.1
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833275-37034185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 21.6;lymphoid tissue: 33.4"	"Cell type enriched"	"Detected in some"	27	"B-cells: 57.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 1.6"	"Group enriched"	"Detected in some"	209	"memory B-cell: 20.1;naive B-cell: 21.6"	"Lineage enriched"	"Detected in single"	216	"B-cells: 21.6"	"Group enriched"	"Detected in some"	8	"Daudi: 21.5;REH: 62.5;U-698: 28.2"	"Region enriched"	"Detected in single"	11	"midbrain: 4.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2"	"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.4	0.2	0.2	33.4	0.2	5.5	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.4	0.2	0.2	0.3	0.5	0.3	0.3	23.2	1.6	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.3	0.3	0.4	2.5	0.0	0.6	0.2	8.7	0.0	0.3	16.5	0.7	0.9	0.0	2.3	0.4	0.2	30.1	1.3	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.1	62.5	0.1	0.1	0.0	0.0	4.4	1.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	0.0	0.2	0.0	0.0	0.0	57.6	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing lysine methyltransferase 7"	Q8WTS6	4	139495941-139606699	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	26.1	13.2	12.0	9.6	12.3	5.7	26.3	10.2	16.2	27.9	17.7	17.9	11.0	4.8	23.8	12.0	18.3	13.8	16.9	25.2	13.0	10.0	7.2	30.7	12.1	6.9	18.0	10.1	13.3	13.8	26.8	9.3	12.0	15.4	22.8	10.2	12.4	13.7	13.9	56.4	14.2	9.9	33.3	19.0	11.8	17.7	10.6	16.5	2.9	10.3	15.2	9.9	24.2	30.1	2.3	6.8	1.8	5.6	0.5	5.6	1.6	9.0	11.7	4.5	2.6	26.5	22.9	9.9	21.5	22.4	11.0	9.3	6.9	12.4	21.1	8.5	36.2	7.6	4.6	14.9	17.0	17.9	10.4	10.5	2.9	15.3	0.2	13.1	10.1	4.5	19.8	19.9	17.5	18.7	14.0	13.9	9.0	1.7	32.9	14.0	15.1	6.6	1.5	2.2	13.3	7.7	6.2	15.5	12.1	10.7	8.3	17.4	5.8	14.3	21.3	5.1	4.5	8.4	9.2	22.5	19.5	13.9	23.2	17.8	28.4	27.2	13.4	22.5	10.2	9.3	1.0	5.6	0.5	0.6	3.2	4.1	1.8	1.8	1.8	6.8	2.3	0.8	0.5	1.8	0.5	4.8	3.5	5.6	1.6	12.0	12.3	10.2	16.2	13.0	10.0	18.0	10.1	15.4	16.5	6.0	13.1	3.4	10.9	15.2	6.6	35.4	17.8	4.0	6.8	8.7	11.8	21.9	0.0	20.5	0.9	24.7	1.8	23.3	18.1	14.4	19.2	35.1	2.3	64.4	18.3	7.9	1.2	36.8	29.7	3.5	21.3	18.3	10.1	7.2	11.2	13.3	21.5	0.0	26.5	3.9	12.6	19.4	21.0	3.2	1.9	19.3	38.6	5.0	9.9	14.2
SUV39H1	"KMT1A, SUV39H"	ENSG00000101945	"Suppressor of variegation 3-9 homolog 1"	O43463	X	48695554-48709012	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Host-virus interaction, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.92e-2)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.51e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.91e-7)"	"unprognostic (2.29e-3)"	"unprognostic (6.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.67e-2)"	5.7	3.3	6.5	6.4	7.6	18.0	4.9	8.7	12.5	7.0	5.1	9.3	6.0	5.1	5.7	20.7	7.3	5.3	3.4	6.0	6.0	8.3	5.0	9.2	4.6	10.8	8.8	6.9	6.5	4.4	3.6	4.7	9.3	6.7	4.5	5.4	8.3	6.5	5.4	6.9	7.0	6.0	4.7	6.2	9.5	5.2	6.7	5.9	21.2	3.9	6.4	10.7	4.8	3.5	5.8	2.8	7.1	6.4	10.7	11.7	6.8	14.8	18.2	7.2	7.6	1.8	2.2	14.7	7.2	5.5	14.1	11.5	11.1	10.0	16.5	4.4	5.2	14.3	10.5	17.8	10.2	8.5	12.5	18.2	6.5	16.9	9.0	1.1	15.9	3.6	2.0	2.0	12.4	6.4	2.3	10.0	10.8	16.3	11.6	7.6	17.2	13.6	16.6	8.5	7.3	17.7	10.0	13.3	17.4	4.6	8.3	9.5	6.2	9.8	9.5	5.2	8.4	14.1	13.3	5.3	8.7	15.0	12.0	12.1	8.0	12.0	13.9	6.5	22.9	9.5	4.5	3.0	7.1	9.8	4.4	7.2	5.3	6.5	10.3	2.4	5.8	8.1	7.7	2.1	10.7	6.4	2.8	11.7	6.8	6.5	7.6	8.7	12.5	6.0	8.3	8.8	6.9	6.7	5.9	6.0	0.0	7.7	0.8	1.5	4.9	2.2	0.0	4.0	1.2	1.8	0.0	4.4	3.3	1.8	0.1	0.9	1.6	0.0	2.5	24.4	1.4	0.4	1.1	5.6	4.5	0.0	2.9	1.8	1.9	0.0	1.1	2.5	5.0	3.6	1.5	0.6	1.8	1.7	1.4	1.4	3.5	0.0	1.2	1.5	0.8	1.0	5.1	4.5	1.6	0.3
BEND3	KIAA1553	ENSG00000178409	"BEN domain containing 3"	Q5T5X7	6	107065182-107115269	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 12.6"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 5.9;Late spermatids: 5.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 12.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017891, HPA062067"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017891: AB_2064595, HPA062067: AB_2684675"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.37e-8)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-1)"	1.8	1.9	1.4	1.8	2.5	1.8	5.6	4.0	2.2	1.6	3.6	1.3	0.8	3.0	2.4	4.2	2.5	2.3	3.6	3.8	1.1	1.3	3.1	4.4	2.0	1.5	1.8	0.8	1.9	12.6	1.8	2.3	1.5	3.3	2.6	3.9	1.3	3.4	1.0	5.0	1.4	4.1	2.5	1.8	2.8	5.0	4.6	1.5	2.4	1.9	3.9	3.6	2.2	1.2	1.5	1.3	2.0	1.0	0.8	1.7	0.4	2.8	4.1	11.3	6.4	1.3	1.0	9.3	1.1	1.5	1.5	1.8	4.6	2.1	8.4	2.9	2.9	2.6	2.8	12.2	6.3	2.5	3.3	6.1	2.3	3.0	5.1	1.1	6.0	3.0	2.5	2.6	2.2	3.2	1.2	1.9	4.0	6.3	3.5	1.9	5.7	5.1	4.6	15.8	7.1	2.6	7.0	3.3	5.5	2.4	8.4	11.5	5.6	3.6	6.1	2.3	6.0	3.6	4.8	2.2	4.1	3.9	1.9	5.4	2.4	3.2	8.6	1.4	4.7	3.2	2.0	0.8	1.5	1.2	1.0	0.9	1.5	1.1	1.1	0.5	1.1	0.8	1.7	1.6	0.8	1.0	1.3	1.2	0.4	1.4	2.5	4.0	1.8	1.1	1.3	1.8	0.8	3.3	1.5	3.0	2.4	0.0	0.8	2.6	1.4	2.8	0.0	1.4	2.3	0.0	5.9	0.8	0.0	0.8	4.2	0.8	0.4	0.0	1.5	1.2	0.6	1.0	0.0	0.6	0.6	0.0	1.2	0.0	1.0	5.2	0.9	0.5	0.0	0.0	2.2	0.2	0.9	0.0	0.0	0.8	1.4	0.0	2.1	0.6	2.5	2.6	0.7	0.0	3.0	0.7
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Developmental protein, Helicase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.4"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 69.2;Spermatogonia: 174.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	Yes			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.4	2.0	1.2	28.8	1.5	14.8	3.0	11.9	3.2	4.2	5.0	0.7	3.3	3.5	5.8	6.0	8.6	2.5	3.6	2.1	1.3	2.0	3.9	2.0	2.5	11.9	1.4	1.7	4.3	1.9	2.7	4.7	9.0	1.3	3.4	5.5	3.3	2.8	2.0	0.6	5.2	5.3	2.1	1.7	8.3	3.6	18.7	0.7	46.4	1.7	8.1	15.1	3.6	4.4	13.6	22.0	0.7	0.8	5.6	10.9	1.5	19.9	19.7	25.5	32.3	1.0	2.4	13.8	15.3	9.9	12.8	20.2	26.0	16.2	24.7	6.1	5.1	10.8	20.2	14.6	12.2	18.3	23.9	16.8	13.1	20.0	20.8	0.6	24.7	11.9	1.3	0.7	15.3	7.3	3.5	8.8	16.7	7.1	15.8	15.1	20.1	26.0	12.3	26.4	14.6	8.8	24.3	22.7	5.7	8.7	25.8	10.2	8.3	18.1	5.2	2.7	22.2	22.1	8.0	6.2	14.0	7.1	12.8	18.3	8.2	15.6	26.4	7.0	15.3	6.4	0.1	0.5	0.0	4.4	0.8	1.5	10.9	7.2	6.2	1.3	13.6	3.5	5.0	0.7	5.6	0.6	22.0	10.9	1.5	1.2	1.5	11.9	3.2	1.3	2.0	1.4	1.7	1.3	0.7	8.9	3.8	23.8	8.2	19.2	13.6	0.8	7.6	8.1	17.0	21.0	0.0	25.8	3.3	5.8	0.8	4.9	2.1	23.3	5.5	31.3	11.0	3.1	5.7	2.6	12.8	6.4	10.4	8.0	1.3	3.6	8.3	6.2	1.7	9.0	6.5	5.0	3.9	0.0	5.3	1.4	9.4	19.4	6.2	69.2	174.0	8.7	9.3	12.5	23.7	4.4
HSF4	CTM	ENSG00000102878	"Heat shock transcription factor 4"	Q9ULV5	16	67164681-67169945	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 41.3;Leydig cells: 30.5;Peritubular cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 14.9;T-47d: 11.2;U-266/70: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048584			Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA048584: AB_2680452"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (9.20e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (8.74e-3)"	6.9	16.8	11.8	2.5	14.7	2.6	5.5	16.4	20.2	7.1	4.6	2.6	16.0	6.4	6.5	13.7	7.5	7.9	5.3	8.7	11.6	5.5	6.4	8.3	6.0	2.6	19.3	16.9	7.1	17.4	10.2	12.3	5.0	11.5	12.2	3.4	19.1	16.4	4.3	36.8	13.2	6.3	26.8	11.7	3.4	16.1	3.4	15.1	0.3	7.4	10.6	1.9	10.9	8.4	0.0	0.5	0.0	0.9	0.0	0.4	0.2	1.4	0.9	0.0	1.0	0.5	2.7	4.9	0.6	0.5	0.2	0.0	2.0	2.5	0.0	2.2	0.9	0.6	4.8	0.4	0.6	0.2	1.6	1.9	0.7	1.9	2.9	2.0	0.3	3.5	1.5	4.1	0.3	2.2	14.9	0.7	2.3	1.4	4.7	1.9	1.2	0.6	1.3	0.1	2.8	1.7	2.3	1.7	5.7	3.7	2.1	2.7	5.7	4.0	2.6	6.0	2.3	11.2	3.9	1.2	1.4	1.6	5.4	1.5	20.4	2.9	1.3	3.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	11.8	14.7	16.4	20.2	11.6	5.5	19.3	16.9	11.5	15.1	3.0	7.7	0.0	3.3	2.7	7.9	5.5	2.5	2.7	2.3	3.5	2.0	0.8	0.0	0.5	0.4	1.0	0.5	0.0	1.2	0.5	4.4	4.1	1.1	4.7	16.6	41.3	1.2	3.1	1.5	0.0	30.5	1.3	10.1	1.8	2.0	6.9	1.6	3.2	20.8	2.1	11.6	0.0	2.1	0.2	1.0	3.0	0.6	0.0	2.6	1.1
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 32.2;SuSa: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	5.2	3.6	15.0	8.6	1.8	1.8	14.9	1.5	3.6	2.0	2.5	3.8	4.1	2.8	5.4	3.0	3.0	2.7	3.5	8.7	1.8	5.4	5.3	9.8	4.3	4.8	2.0	9.9	11.5	2.6	5.5	2.9	11.7	6.0	2.1	32.2	12.7	4.7	1.1	5.2	19.7	18.7	16.0	2.6	1.6	8.8	4.6	7.8	1.8	5.5	11.6	6.6	3.1	10.9	13.7	36.6	3.8	10.7	3.6	9.2	5.1	5.0	5.2	3.0	7.2	4.9	3.1	9.3	11.5	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5	6.0	10.9	22.2	9.5	71.4	71.0	8.9	10.2	4.0	11.4	5.2	82.5	23.3	1.7	6.8	59.2	24.1	12.3	0.0	3.9	19.3	18.6	5.7	24.3	12.9	21.4	146.2	25.7	14.1	48.4	29.9	8.1	37.2	25.3	20.8	16.0	167.6	11.0	11.5	8.1	2.6	91.1	6.5	25.0	7.0	67.9	132.5	21.1	30.5	13.4	13.6
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724491-202809470	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.0"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 181.0;Spermatocytes: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	7.7	7.1	5.9	8.2	7.8	14.8	12.3	12.7	9.0	12.9	9.6	5.1	9.7	5.0	13.6	9.4	17.6	8.6	8.4	5.7	6.1	4.5	6.0	4.6	9.0	5.4	3.7	7.3	13.3	9.0	9.8	8.6	23.1	5.0	11.3	9.0	16.0	11.1	8.8	4.3	19.5	7.3	10.1	4.9	6.9	8.2	74.0	5.2	25.8	9.1	6.2	10.4	12.2	12.6	4.1	3.0	16.0	5.2	7.3	4.4	2.6	10.6	4.3	28.9	13.9	13.7	12.4	24.4	7.3	11.3	7.7	8.2	3.6	11.3	0.0	5.0	11.4	5.7	16.4	13.6	12.0	9.9	0.1	5.2	5.8	4.1	5.8	11.7	18.0	7.7	12.9	20.0	11.0	14.5	20.8	17.1	7.2	18.0	0.0	7.7	10.8	5.0	21.5	19.6	7.4	7.6	21.2	0.0	0.0	11.1	18.4	8.8	19.5	15.5	9.5	12.9	39.6	19.5	12.9	12.6	6.8	5.1	0.8	4.2	1.1	0.7	4.5	6.0	6.7	2.8	16.0	2.9	6.4	3.7	3.4	3.1	2.8	3.3	2.7	3.0	4.1	4.2	1.8	9.5	7.3	5.2	2.1	4.4	2.6	5.9	7.8	12.7	9.0	6.1	4.5	3.7	7.3	5.0	5.2	83.4	33.4	5.4	32.8	57.2	30.9	7.3	10.2	54.9	40.9	15.7	58.9	35.8	5.0	41.9	155.3	25.3	16.1	0.0	19.5	25.5	34.2	40.2	25.5	9.6	7.0	14.3	41.9	19.0	17.8	181.0	33.6	10.8	25.3	10.0	31.3	68.3	38.0	17.3	30.8	5.9	133.9	32.3	21.7	261.1	71.6	101.6	68.9	12.5	27.0	45.7
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871424-1982207	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 17.3;Ciliated cells: 13.4;Club cells: 14.8;Collecting duct cells: 12.2;Hofbauer cells: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	8.7	7.6	17.6	11.5	16.2	35.1	8.5	20.6	18.2	7.0	14.8	12.4	6.3	14.0	9.5	7.4	12.7	6.8	6.9	11.9	15.1	10.9	8.4	7.5	11.1	18.8	14.7	16.1	7.0	11.7	10.7	11.8	9.8	14.6	8.7	17.7	9.4	10.2	7.4	11.8	12.1	14.6	10.5	15.3	13.5	11.0	26.3	13.4	46.7	13.8	5.5	17.7	8.6	9.4	4.9	3.9	4.1	1.8	2.7	4.3	0.6	27.7	14.0	42.3	18.5	4.6	6.8	12.3	22.4	19.9	27.5	30.8	12.4	33.0	29.9	7.7	18.5	36.0	12.1	27.3	18.5	47.3	14.3	11.3	35.6	19.4	7.3	5.8	21.8	18.7	2.6	4.7	24.1	23.2	15.2	21.6	30.2	19.3	31.4	22.5	10.9	58.1	22.9	17.8	14.1	16.2	33.2	27.6	10.3	11.3	13.2	26.3	21.0	18.4	6.9	8.4	19.2	16.3	14.6	16.7	27.5	20.5	17.4	45.1	14.7	15.5	27.1	16.5	21.6	25.5	2.1	1.7	1.7	2.9	1.8	3.2	1.8	3.2	3.2	1.5	4.9	2.8	2.3	4.1	2.7	1.4	3.9	4.3	0.6	17.6	16.2	20.6	18.2	15.1	10.9	14.7	16.1	14.6	13.4	11.9	17.3	0.0	0.0	0.0	0.0	0.0	0.0	13.4	14.8	12.2	0.0	10.0	3.3	10.2	0.0	0.0	0.0	0.0	6.1	7.3	0.0	0.0	2.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	10.0	0.0	0.0	10.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
PAX1		ENSG00000125813	"Paired box 1"	P15863	20	21705659-21718486	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"lymphoid tissue: 70.7;parathyroid gland: 56.0"	"Cell type enhanced"	"Detected in single"	30	"Melanocytes: 1.7"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (9.74e-2)"				"unprognostic (3.45e-2)"	"unprognostic (3.01e-1)"		"unprognostic (2.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.12e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.08e-2)"		0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	56.0	4.2	0.9	70.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
PAX7	Hup1	ENSG00000009709	"Paired box 7"	P23759	1	18631006-18748866	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.9;tongue: 12.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 3.4;CAPAN-2: 3.8;U-2 OS: 8.2"	"Region enriched"	"Detected in single"	17	"midbrain: 5.5"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.41e-4)"	"unprognostic (2.07e-1)"			"unprognostic (5.35e-2)"	"unprognostic (3.96e-2)"		"unprognostic (4.21e-1)"						"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"			0.4	0.1	0.6	0.0	0.6	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.5	0.1	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.4	0.0	3.4	0.3	0.0	0.0	0.1	0.1	12.9	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	3.4	0.8	0.8	2.4	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRDM4	PFM1	ENSG00000110851	"PR/SET domain 4"	Q9UKN5	12	107732866-107761272	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024322, HPA067437"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024322: AB_1855691, HPA067437: AB_2685839"	"unprognostic (4.64e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (9.64e-2)"	"unprognostic (9.06e-3)"	"unprognostic (5.31e-2)"	"prognostic favorable (3.15e-7)"	"unprognostic (9.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.62e-3)"	13.5	9.6	14.6	10.4	18.0	13.5	12.3	21.2	20.6	12.1	15.2	12.7	13.3	12.1	15.4	13.1	16.3	11.4	10.6	9.1	11.5	11.3	19.5	6.8	11.9	10.5	13.3	15.4	14.6	11.4	53.6	9.5	12.8	15.8	11.3	15.5	12.4	12.9	12.1	12.9	13.1	14.8	13.1	9.3	12.1	11.6	10.3	14.6	10.4	13.2	7.4	13.5	12.8	28.1	5.1	4.5	2.6	7.5	2.1	4.2	1.4	11.4	12.7	13.9	14.4	15.1	15.6	10.7	15.6	20.4	15.9	12.1	8.9	5.0	14.8	6.6	16.5	14.8	8.2	14.5	11.4	17.3	10.8	14.8	11.7	9.3	9.4	19.5	16.6	12.1	19.0	22.1	17.9	30.9	17.4	20.6	13.9	14.1	18.0	18.9	12.0	9.3	14.8	7.3	7.4	17.4	7.6	13.9	14.5	16.4	17.6	17.3	16.2	11.8	8.4	14.1	9.9	10.2	8.5	20.8	12.2	8.9	16.2	13.0	12.7	12.5	10.5	8.9	7.9	9.0	2.2	1.7	2.6	4.0	5.8	2.8	5.1	2.1	3.6	4.5	4.5	3.5	4.2	0.7	2.1	7.5	2.4	4.0	1.4	14.6	18.0	21.2	20.6	11.5	11.3	13.3	15.4	15.8	14.6	8.9	5.4	9.9	7.4	12.9	12.4	5.6	2.5	8.1	6.8	12.2	13.7	5.6	8.3	13.0	18.9	9.2	10.8	0.0	9.9	6.4	9.7	9.1	3.5	3.9	10.0	31.8	12.1	9.2	11.0	19.5	5.8	8.7	8.5	14.4	9.3	7.2	13.0	5.8	4.6	7.1	10.1	6.5	10.3	5.9	10.3	14.8	4.0	10.2	10.9	9.1
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155562807	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	20.1	10.1	12.1	17.7	14.5	12.3	14.5	23.6	15.5	15.4	17.7	15.5	20.4	8.2	18.7	12.5	12.5	12.2	10.0	11.0	11.8	10.6	13.0	8.9	10.6	9.4	16.6	11.5	23.5	10.0	24.4	22.6	12.9	13.2	18.9	10.7	10.7	11.8	22.2	21.8	12.8	12.8	17.4	14.5	8.6	10.4	7.8	14.3	15.6	16.8	7.1	10.6	17.8	19.9	11.0	5.7	16.5	5.3	8.6	10.7	1.7	13.6	11.7	7.7	6.6	17.4	18.7	8.7	11.1	11.6	7.6	6.4	8.7	9.1	6.1	11.2	14.5	5.8	14.2	12.1	9.7	12.0	6.0	7.8	7.5	11.6	4.7	8.4	8.3	5.9	11.5	10.8	12.7	12.5	11.5	9.0	6.0	10.7	9.2	12.6	10.7	5.6	4.5	7.3	17.0	11.4	5.2	15.9	7.0	8.4	15.1	7.9	11.7	17.5	15.8	8.6	8.4	12.7	18.2	13.8	11.7	12.6	11.1	13.6	8.6	4.9	9.7	9.1	6.3	10.1	16.5	5.3	11.0	8.3	3.2	7.9	10.0	7.8	6.3	2.5	11.0	10.7	5.5	12.8	8.6	3.5	5.7	8.6	1.7	12.1	14.5	23.6	15.2	11.8	10.6	16.6	11.5	13.2	14.3	56.6	88.1	42.2	92.1	92.3	138.8	87.3	43.3	45.5	96.7	48.8	190.5	40.3	14.9	37.0	14.5	82.3	61.6	23.3	34.5	22.1	98.4	94.0	78.6	28.8	21.6	108.1	64.8	59.5	40.8	12.1	94.6	55.1	50.6	62.3	49.5	77.4	31.8	59.1	111.7	23.9	119.9	97.0	97.6	85.7	46.2	97.9	63.7	68.9	46.6	109.1
DMRTC2		ENSG00000142025	"DMRT like family C2"	Q8IXT2	19	41844743-41852333	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 53.5"	"Cell type enriched"	"Detected in some"	7	"Spermatocytes: 176.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.3;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.6"	"Not detected"	"Not detected"							HPA045016	Uncertain					NA	NA					"HPA045016: AB_10960404"	"unprognostic (6.80e-3)"			"unprognostic (4.38e-2)"								"unprognostic (5.36e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.3	1.1	0.2	0.2	0.0	0.2	0.0	0.5	1.0	0.0	0.0	0.3	0.4	0.0	0.5	0.0	0.7	1.1	0.1	0.1	0.2	0.2	0.6	0.0	0.0	0.0	1.2	0.6	0.0	0.8	0.2	0.0	0.6	1.6	0.3	0.0	0.2	0.0	1.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	1.1	0.0	0.5	1.1	0.7	1.3	0.9	0.1	0.3	0.3	0.4	0.2	0.2	0.9	0.1	1.0	1.2	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	1.3	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	176.3	24.5	0.0	0.0	0.0	0.0	0.0
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436005	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	13.9	12.6	11.7	16.7	18.6	29.7	14.5	24.8	14.1	18.4	12.6	15.5	21.4	9.7	20.2	20.6	14.4	12.8	12.7	10.8	13.4	9.5	10.3	11.4	13.0	12.1	17.7	9.4	18.8	18.4	18.8	18.9	38.0	12.6	14.0	11.8	12.6	15.8	22.9	30.3	25.2	13.1	13.6	16.0	14.6	14.9	13.6	19.6	22.6	16.9	9.3	16.8	17.8	31.6	5.6	3.5	16.1	3.9	5.5	2.9	0.6	9.7	4.9	9.1	9.7	16.5	10.0	10.7	5.1	3.9	4.1	5.0	9.3	5.9	15.5	7.4	9.2	5.6	5.6	9.8	7.4	6.9	9.8	5.0	9.2	7.4	6.4	8.0	15.5	11.3	8.4	10.3	5.8	7.8	6.6	5.8	8.1	14.8	13.4	8.9	13.6	11.2	14.1	5.5	7.6	4.9	7.6	8.3	8.1	7.0	10.0	13.3	10.5	8.4	15.0	5.5	9.9	4.9	12.8	7.3	6.8	3.6	7.3	7.2	14.1	6.9	16.7	8.9	12.8	7.0	8.8	3.5	4.3	2.1	2.2	2.9	5.6	1.7	1.7	1.7	3.8	2.7	1.8	16.1	5.5	3.9	3.5	1.3	0.6	11.7	18.6	24.8	14.1	13.4	9.5	17.7	9.4	12.6	19.6	71.5	66.6	54.7	36.1	79.1	82.8	58.2	45.9	44.2	92.1	43.6	163.0	29.7	5.0	30.2	18.6	49.2	41.0	23.3	28.7	45.7	47.0	48.1	62.5	36.6	29.6	76.3	65.1	41.7	48.8	11.0	62.5	61.0	40.5	25.2	44.5	62.2	33.0	43.8	56.6	15.7	75.2	25.8	50.1	33.5	31.5	84.2	106.4	50.4	30.3	55.0
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937018-32001045	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	10.1	10.8	13.4	15.4	10.4	25.5	33.5	16.0	13.8	11.2	11.4	7.5	13.6	10.1	12.5	8.1	12.3	9.8	7.7	9.7	9.1	7.6	10.9	11.5	10.6	19.9	9.3	9.9	10.0	10.1	15.5	10.4	15.3	9.5	10.7	10.9	6.9	10.1	9.6	8.7	9.9	12.2	9.6	7.7	15.2	10.7	17.1	12.5	31.8	12.0	6.5	18.9	10.8	19.5	5.5	4.6	4.1	2.6	4.4	5.5	1.2	14.3	12.7	12.0	13.7	6.9	8.9	12.3	14.0	12.4	17.2	20.8	9.6	8.1	31.3	10.8	8.7	14.7	12.7	17.8	8.0	28.0	11.0	17.3	21.7	10.8	6.9	8.2	34.1	22.3	6.2	9.1	17.1	13.2	10.4	10.5	15.0	20.9	43.6	14.7	5.0	40.5	19.8	6.8	10.1	7.8	24.2	30.8	25.4	10.1	14.0	15.4	12.0	22.5	7.3	13.5	8.7	21.1	28.5	7.7	13.7	12.5	16.3	21.5	23.8	29.6	38.8	10.0	21.1	12.3	1.4	1.9	3.8	3.8	2.6	3.0	5.5	4.1	4.0	1.4	4.4	3.9	5.5	4.1	4.4	1.8	4.6	4.2	1.2	13.4	10.4	16.0	13.8	9.1	7.6	9.3	9.9	9.5	12.5	38.7	37.9	23.1	41.1	52.0	74.2	24.8	35.7	28.1	37.5	33.2	102.1	49.4	14.9	23.6	8.9	34.9	15.6	23.3	19.1	45.9	33.8	46.2	15.1	37.5	27.9	58.8	28.3	38.6	41.9	10.7	24.7	37.6	23.6	86.6	31.9	41.7	22.6	10.5	24.1	24.5	76.3	12.9	32.5	100.7	141.1	62.7	58.1	39.9	33.0	48.2
TET3	"hCG_40738, MGC22014"	ENSG00000187605	"Tet methylcytosine dioxygenase 3"	O43151	2	73986404-74108176	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 44.0;Suprabasal keratinocytes: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050845	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA050845: AB_2681256"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.05e-1)"	"unprognostic (5.30e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.10e-1)"	2.9	2.3	7.2	6.1	10.8	20.9	3.9	26.0	17.1	3.2	5.1	20.6	0.5	6.7	2.9	1.9	10.2	3.0	3.3	1.6	7.1	3.3	2.6	5.1	5.6	4.3	12.0	9.5	2.9	3.6	3.5	4.2	5.7	12.4	3.6	5.5	5.9	5.9	1.8	1.8	18.9	7.2	2.7	5.3	5.5	5.3	2.1	11.7	0.6	3.4	1.7	5.1	4.0	5.0	1.1	1.4	2.5	2.2	0.4	0.9	0.9	6.2	5.5	10.5	6.4	0.9	1.0	19.4	1.3	1.7	2.5	2.0	11.8	5.8	10.5	2.6	1.7	1.1	6.7	9.3	3.7	2.6	4.5	3.7	13.4	4.6	4.0	3.9	14.0	8.3	1.5	9.8	3.1	7.3	3.1	3.8	7.4	9.1	3.5	1.4	10.3	6.9	9.2	5.9	5.4	1.9	10.5	6.6	3.6	2.8	11.7	13.2	11.3	2.8	7.5	3.6	4.4	4.8	11.4	4.8	2.7	11.4	1.3	4.7	3.1	1.3	9.1	1.8	9.8	3.5	0.5	2.0	1.0	0.4	2.2	0.9	1.1	0.5	0.5	1.4	0.9	0.7	0.6	2.5	0.4	0.7	1.4	0.0	0.9	7.2	10.8	26.0	17.1	7.1	3.3	12.0	9.5	12.4	11.7	6.0	7.0	0.0	3.0	44.0	14.5	2.8	5.1	10.7	9.1	1.8	19.6	5.5	0.0	3.0	2.9	5.6	9.5	23.3	3.8	27.5	6.6	4.8	2.3	4.4	8.9	9.5	5.8	3.7	27.8	0.6	0.6	13.8	10.1	9.0	8.4	1.5	5.1	10.5	2.8	1.2	5.8	0.0	5.3	0.5	3.1	59.6	2.1	4.3	6.4	4.8
USP7	HAUSP	ENSG00000187555	"Ubiquitin specific peptidase 7"	Q93009	16	8892094-8964514	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	"Developmental protein, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 217.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008108, HPA015641, CAB079904"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700"	"unprognostic (6.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.94e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.56e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.69e-1)"	17.8	16.8	23.9	25.8	22.9	37.6	21.3	28.7	24.5	21.2	26.3	16.2	18.4	17.7	23.5	16.4	24.4	20.3	18.7	23.7	22.8	20.8	16.5	21.3	21.0	30.5	19.6	22.6	22.5	24.0	44.4	19.7	19.3	16.2	18.5	27.4	16.0	18.4	20.3	42.2	25.2	21.5	22.7	15.3	22.9	22.6	43.3	16.5	68.8	19.5	22.3	35.1	23.9	31.7	7.5	9.8	5.5	7.8	3.9	8.7	1.8	12.4	23.3	20.6	15.4	11.7	15.0	14.2	17.2	14.8	16.1	13.7	20.8	15.3	30.1	11.0	19.9	9.2	15.6	31.5	20.6	27.0	19.7	12.5	25.0	15.7	42.9	16.9	27.5	16.2	12.9	13.1	17.5	20.7	12.4	22.8	45.5	24.1	33.4	16.4	23.8	40.3	5.3	14.4	15.8	13.5	35.9	23.1	27.5	11.3	24.5	19.5	12.0	19.3	18.2	9.5	22.0	18.1	12.3	19.5	17.5	17.9	26.8	12.9	16.2	39.6	46.0	16.3	16.0	14.0	5.5	3.3	3.8	7.1	3.2	8.7	5.9	6.6	8.2	3.3	7.5	8.0	6.8	5.2	3.9	7.8	9.8	7.0	1.8	23.9	22.9	28.7	24.5	22.8	20.8	19.6	22.6	16.2	16.5	32.8	46.2	23.4	19.2	41.3	47.4	61.8	20.4	46.8	46.6	27.9	23.6	18.4	5.0	21.1	217.0	25.9	29.6	46.7	28.3	12.6	24.0	27.0	25.5	34.2	17.5	41.3	40.6	25.2	28.0	84.4	23.6	28.5	18.6	16.2	46.7	25.0	27.8	28.8	32.5	11.8	41.6	6.5	29.2	29.9	31.9	43.7	17.6	26.6	47.0	32.7
ZNF335	"bA465L10.2, NIF-1"	ENSG00000198026	"Zinc finger protein 335"	Q9H4Z2	20	45948653-45972172	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063999, HPA071230"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063999: AB_2685170, HPA071230: AB_2686369"	"unprognostic (1.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (4.48e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (7.04e-4)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (4.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.88e-3)"	10.5	8.3	12.0	12.2	13.6	28.8	10.7	17.9	15.7	10.5	10.3	9.7	4.0	11.5	14.2	5.2	11.2	12.3	8.2	7.0	10.7	5.0	8.6	7.8	10.4	15.0	8.1	11.6	15.2	10.5	13.2	10.4	13.7	8.2	10.7	6.7	8.4	12.0	9.2	12.3	22.9	13.5	7.9	7.6	13.9	10.6	16.5	10.1	19.4	14.9	8.8	12.0	11.4	9.5	3.7	3.6	5.0	4.5	8.9	7.3	3.5	9.1	9.3	8.3	9.0	4.4	5.6	17.7	8.2	5.7	8.2	5.9	20.1	10.3	11.0	12.2	8.0	7.5	13.2	8.0	12.3	3.7	7.5	10.9	9.1	13.6	10.6	6.9	11.8	15.6	9.0	10.5	10.7	7.7	5.9	7.0	11.6	8.6	14.8	5.6	18.6	13.9	11.5	5.7	6.2	15.4	11.5	5.5	9.2	7.2	14.4	8.4	7.4	12.2	17.2	8.6	5.2	13.0	9.8	7.3	17.7	7.7	11.2	11.1	17.3	8.8	11.4	14.3	7.4	9.7	2.4	3.5	5.0	7.3	4.5	3.7	3.3	3.6	4.9	3.6	3.7	3.1	3.4	3.6	8.9	3.6	2.5	3.6	3.5	12.0	13.6	17.9	15.7	10.7	5.0	8.1	11.6	8.2	10.1	11.9	15.9	11.8	11.4	16.7	17.4	2.8	2.5	1.4	4.5	1.8	25.5	7.2	0.0	3.9	22.2	8.3	13.7	0.0	5.1	7.0	7.8	9.9	6.9	5.7	5.3	12.7	20.6	7.4	6.4	17.7	6.9	10.2	8.5	2.8	9.2	5.8	6.6	10.5	4.9	1.9	11.1	0.0	8.6	3.7	8.3	19.6	10.0	16.2	9.1	11.4
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298385-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	15.1	8.5	17.3	15.1	22.2	34.5	13.4	45.9	27.0	12.8	12.0	7.9	12.7	10.2	11.6	9.7	10.1	10.7	10.7	10.0	13.3	11.5	11.3	21.7	12.0	15.8	9.6	18.7	15.3	11.4	17.2	22.9	11.3	17.3	10.8	10.6	6.4	10.8	13.5	10.6	13.2	12.3	12.5	11.0	15.3	10.2	7.9	15.0	15.0	12.6	4.5	12.8	13.8	11.9	15.1	7.5	42.7	14.1	10.7	11.1	3.6	6.7	5.7	16.0	7.9	7.9	9.6	8.1	8.1	6.9	5.5	8.7	6.7	10.7	16.3	8.6	6.8	5.3	7.8	7.0	3.9	8.1	11.4	4.5	7.4	6.4	6.4	4.8	15.5	10.7	7.2	4.3	5.3	5.5	8.8	8.7	9.5	8.3	13.5	5.8	9.1	11.2	14.0	3.1	6.6	6.9	11.6	13.8	4.8	5.9	12.0	13.8	11.9	13.7	6.9	9.6	8.2	11.8	14.3	12.3	9.4	7.4	7.5	3.7	4.4	3.3	15.0	5.6	9.9	4.7	19.3	7.6	21.7	8.5	7.8	9.5	11.6	10.3	8.8	5.6	15.1	11.1	10.8	42.7	10.7	14.1	7.5	7.2	3.6	17.3	22.2	45.9	27.0	13.3	11.5	9.6	18.7	17.3	15.0	77.4	85.3	20.4	20.9	34.1	91.9	45.6	15.3	8.1	40.9	26.2	49.1	16.0	16.6	19.0	13.5	41.6	29.5	23.3	19.0	18.3	27.2	20.2	63.6	37.6	29.9	106.5	21.9	33.2	40.4	5.3	33.6	50.9	25.3	68.5	30.9	64.2	20.9	36.8	33.9	11.9	63.2	19.4	25.5	37.6	24.7	29.2	17.0	54.9	29.8	15.5
BAZ2A	"KIAA0314, TIP5, WALp3"	ENSG00000076108	"Bromodomain adjacent to zinc finger domain 2A"	Q9UIF9	12	56595596-56636816	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005782, HPA063806"			Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005782: AB_10601089, HPA063806: AB_2685128"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.43e-1)"	25.5	22.8	18.2	25.5	22.4	45.5	25.5	39.0	26.0	25.6	23.2	24.6	23.2	20.1	25.2	21.8	28.0	21.5	24.1	19.1	18.7	11.6	19.9	19.7	31.5	25.0	23.1	13.5	32.6	26.2	33.8	36.1	29.0	19.4	21.9	22.1	27.6	24.0	34.5	24.7	26.0	27.6	19.4	19.2	32.9	20.9	34.1	24.4	46.1	26.4	19.6	30.3	27.3	30.5	5.1	8.6	20.1	9.0	12.6	3.6	1.7	20.4	20.9	27.0	22.5	15.7	16.0	27.2	14.3	19.6	20.2	14.9	24.5	24.9	30.3	21.1	16.6	17.3	17.8	31.9	18.8	18.7	19.5	17.1	34.3	12.8	12.4	17.4	19.8	25.9	14.1	19.5	17.5	25.6	22.9	20.2	12.5	36.4	36.7	11.6	13.1	16.4	13.2	24.6	14.0	15.9	13.9	20.0	20.6	14.6	20.2	18.3	15.2	23.9	25.1	13.2	31.5	27.6	18.1	27.8	10.3	20.4	13.3	10.0	20.5	19.2	28.2	9.8	14.3	15.3	6.5	5.1	3.7	3.6	4.5	3.0	4.3	2.8	2.7	1.8	5.1	2.4	2.1	20.1	12.6	9.0	8.6	2.5	1.7	18.2	22.4	39.0	26.0	18.7	11.6	23.1	13.5	19.4	24.4	62.5	60.7	48.0	38.2	45.2	69.5	21.4	25.5	20.1	27.3	24.4	129.6	38.6	6.6	27.8	52.5	40.9	47.2	0.0	25.1	27.9	32.9	50.8	40.6	25.1	20.9	30.2	42.9	52.2	50.1	51.1	56.1	40.8	37.1	57.7	40.9	27.3	28.7	38.6	54.1	9.6	68.6	84.1	49.5	82.5	133.9	54.1	80.0	43.6	29.6	49.2
BTG2	"APRO1, MGC126063, MGC126064, PC3, TIS21"	ENSG00000159388	"BTG anti-proliferation factor 2"	P78543	1	203305491-203309602	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 927.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.5;HMC-1: 39.2;RT4: 30.5;U-266/70: 60.7;U-266/84: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002355	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA002355: AB_1078304"	"prognostic favorable (8.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.86e-3)"	61.6	45.9	10.1	61.4	20.6	46.9	27.8	13.0	10.4	23.0	53.3	27.8	27.0	15.2	27.1	24.6	55.7	103.7	76.1	65.3	10.4	10.0	22.3	4.3	40.7	20.0	12.2	5.5	102.0	117.6	7.0	52.2	42.7	28.3	61.0	38.5	30.4	18.1	104.1	98.9	30.5	36.6	50.8	22.7	32.7	67.1	11.5	9.9	82.9	36.7	45.2	49.0	64.7	21.5	14.1	17.3	34.5	14.2	5.7	8.5	7.1	0.9	1.4	2.6	1.0	3.3	2.4	22.1	2.6	5.1	0.7	2.5	1.9	0.4	37.5	1.8	0.8	0.4	16.5	9.5	10.0	1.3	2.4	4.6	19.6	2.7	4.3	7.3	0.1	39.2	2.5	18.6	2.5	4.6	2.3	13.7	1.9	9.1	26.0	6.8	0.8	4.1	1.2	1.1	0.4	0.2	2.6	8.9	18.8	1.3	30.5	0.4	2.7	2.0	0.8	0.3	20.6	2.2	2.3	3.4	0.0	4.4	0.6	0.1	60.7	30.6	24.0	0.5	0.9	1.5	3.2	8.1	9.9	4.7	12.1	7.1	14.1	5.3	4.8	5.1	13.1	8.5	5.9	34.5	5.7	14.2	17.3	4.9	7.1	10.1	20.6	13.0	10.4	10.4	10.0	12.2	5.5	28.3	9.9	145.9	242.1	142.2	203.8	204.5	25.9	219.9	10.2	57.6	52.4	177.9	27.5	38.6	13.3	59.7	0.8	123.6	335.6	23.3	145.5	16.4	143.3	218.8	358.2	1.6	99.0	3.2	927.5	46.6	65.9	1.7	67.3	167.7	114.7	31.5	370.7	221.0	58.8	329.8	51.9	10.8	21.5	122.9	223.5	0.9	0.6	391.6	115.4	202.7	212.8	200.1
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2164149-2232578	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.7"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	7.3	8.8	7.0	10.7	11.7	20.1	5.1	20.6	11.7	4.5	7.9	9.8	6.0	13.5	6.4	4.9	8.3	5.4	6.9	5.7	7.0	3.6	9.5	8.5	10.0	8.4	11.9	5.3	6.5	10.8	3.6	8.3	11.6	7.1	5.7	4.9	9.5	6.1	7.4	9.8	9.9	13.0	4.2	6.7	10.4	13.3	64.7	9.7	10.5	9.2	7.0	9.1	4.8	5.3	0.7	1.0	3.0	0.9	2.8	1.4	0.6	12.2	6.6	22.4	12.2	1.7	2.5	29.5	7.0	1.5	3.8	3.1	8.4	4.6	14.4	3.4	4.5	3.3	11.0	7.4	3.9	1.8	7.3	9.3	13.2	10.8	8.2	2.7	18.9	24.4	2.4	2.9	7.4	3.8	3.1	3.1	8.2	16.0	15.1	3.0	7.0	15.1	20.9	17.3	7.8	11.8	15.6	6.3	9.9	2.1	5.8	15.0	11.6	4.9	14.6	9.2	6.2	6.7	14.5	4.4	10.7	9.8	15.8	13.4	14.0	18.3	10.0	10.6	13.1	6.2	0.5	0.7	3.0	0.9	0.3	1.4	0.7	0.8	0.2	0.9	0.7	0.5	0.3	0.3	2.8	0.9	1.0	0.1	0.6	7.0	11.7	20.6	11.7	7.0	3.6	11.9	5.3	7.1	9.7	29.8	18.9	9.9	9.3	15.8	25.0	5.2	20.4	6.7	6.8	8.7	62.8	5.3	3.3	10.1	25.8	7.1	25.4	0.0	10.4	11.3	11.0	12.4	5.8	13.1	9.3	12.7	20.0	6.7	11.9	11.9	2.8	14.6	11.8	5.4	10.8	7.3	14.1	14.0	3.2	2.2	26.6	0.0	8.1	28.3	23.5	17.3	13.6	4.9	11.7	14.2
H1FOO		ENSG00000178804	"H1 histone family member O oocyte specific"	Q8IZA3	3	129543214-129551467	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	80	"testis: 10.8"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 20.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.1;SCLC-21H: 1.5"					"Low region specificity"	"Detected in many"			HPA037992	Enhanced					NA	NA					"HPA037992: AB_10671517"															"unprognostic (5.43e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
HIST1H1E	"H1.4, H1e, H1F4, H1s-4"	ENSG00000168298	"Histone cluster 1 H1 family member e"	P10412	6	26156354-26157107	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 56.4;bone marrow: 102.3;lymphoid tissue: 123.9"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 46.7;Muller glia cells: 63.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 9.8;U-266/70: 12.1;U-266/84: 13.5;U-87 MG: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"		NA	Yes			"Nuclear speckles"		"CAB011506: AB_470256, HPA055907: AB_2682966"	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	6.7	3.6	3.1	14.3	3.5	102.3	10.3	8.1	9.0	10.7	7.7	4.7	4.2	4.1	6.8	7.5	13.7	4.0	11.3	7.4	4.0	3.5	6.6	6.7	13.1	18.4	3.4	2.4	19.3	17.1	3.7	9.0	7.3	3.5	10.2	4.4	9.8	10.0	4.0	4.1	14.4	9.0	7.4	6.8	14.6	5.3	5.9	0.7	123.9	4.6	10.0	18.4	14.3	10.7	39.6	14.6	56.4	12.9	19.2	24.4	9.4	2.4	0.3	0.5	5.3	0.1	0.0	6.4	0.0	0.4	1.2	0.8	0.1	1.5	1.2	0.7	0.1	0.5	1.2	0.3	0.7	0.5	1.7	1.5	0.8	0.5	0.4	0.1	0.7	1.1	0.1	0.3	0.3	0.5	0.1	0.5	1.4	3.9	6.8	0.1	0.5	7.9	7.2	1.9	0.7	0.8	3.6	1.2	9.8	0.3	0.0	3.9	0.9	3.1	0.8	1.1	0.6	1.0	2.6	0.4	2.4	3.7	1.5	2.4	12.1	13.5	5.4	12.3	2.1	1.1	56.4	12.7	30.0	21.1	12.9	24.4	21.4	16.7	19.2	14.3	39.6	12.7	11.6	18.6	19.2	10.9	14.6	16.4	9.4	3.1	3.5	8.1	9.0	4.0	3.5	3.4	2.4	3.5	0.7	32.8	16.3	10.4	23.8	0.6	26.5	9.8	5.1	34.8	45.5	1.8	7.9	5.2	3.3	11.4	0.5	6.7	5.1	46.7	7.4	9.1	1.9	6.7	4.7	8.7	6.9	15.9	0.0	10.4	10.0	1.1	4.4	14.0	1.7	8.2	2.5	63.4	7.0	3.5	1.8	4.1	26.6	6.5	6.4	2.8	6.3	0.0	6.1	26.1	2.5	10.2
HR	"ALUNC, AU"	ENSG00000168453	"HR, lysine demethylase and nuclear receptor corepressor"	O43593	8	22114415-22133384	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Oxidoreductase"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 50.5;tongue: 23.8"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 93.6;Cone photoreceptor cells: 31.4;Paneth cells: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.9;HaCaT: 38.1;OE19: 18.4;SiHa: 13.2;T-47d: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054888			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054888: AB_2682630"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.68e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	2.6	1.8	3.8	3.2	6.1	0.8	4.7	19.8	17.0	2.1	7.5	9.6	0.1	5.5	1.5	0.9	12.1	1.9	6.7	1.9	5.3	4.0	0.9	0.8	1.2	1.0	6.1	6.8	0.8	1.3	0.7	1.7	0.9	4.9	2.3	4.0	6.7	3.4	5.4	1.1	50.5	5.3	2.3	3.8	1.1	8.4	5.2	6.6	0.0	2.6	23.8	4.4	3.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	9.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	9.8	0.7	0.5	38.1	0.0	0.9	0.0	0.0	0.0	0.0	8.0	0.0	2.2	0.0	0.0	1.9	6.2	0.0	0.6	0.6	0.0	1.0	0.0	0.1	0.0	5.7	0.6	0.1	0.0	18.4	7.6	0.8	0.0	0.2	0.1	2.6	0.4	2.2	13.2	3.0	3.0	0.1	14.1	0.0	0.0	0.2	8.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	6.1	19.8	17.0	5.3	4.0	6.1	6.8	4.9	6.6	0.0	0.0	0.0	4.2	10.6	93.6	2.4	0.0	0.0	0.0	1.8	31.4	0.0	0.0	0.1	0.1	0.4	16.7	0.0	0.6	0.1	1.3	2.3	0.0	0.0	0.0	9.5	7.5	0.6	0.0	1.1	3.1	0.0	20.3	0.0	10.4	3.9	0.2	28.1	6.7	0.0	6.6	0.0	5.1	0.0	0.3	15.6	0.7	0.0	12.0	3.9
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018975-49059774	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	12.1	7.6	4.9	6.7	10.8	26.1	6.8	11.7	10.5	9.5	6.5	5.8	13.0	5.5	15.7	7.4	8.8	8.9	5.8	9.1	6.1	3.5	6.2	6.5	22.9	9.6	6.7	3.3	9.7	11.6	13.3	9.2	12.9	13.7	6.7	6.6	9.8	7.6	8.0	16.1	13.6	9.4	7.1	9.1	13.6	8.3	7.3	5.7	6.2	11.0	6.1	7.6	7.0	6.3	2.0	2.2	5.9	0.5	1.5	0.8	0.6	17.1	16.3	16.5	13.3	17.1	11.5	17.7	9.1	9.5	11.8	6.3	28.6	7.3	17.8	11.8	12.7	8.5	11.6	21.7	10.0	9.8	10.4	17.4	22.6	17.1	15.3	11.7	26.8	22.7	9.7	14.4	16.5	17.1	14.1	17.5	18.5	28.3	9.9	13.3	18.9	13.3	25.0	15.6	23.7	14.1	20.0	10.2	6.4	9.9	19.0	13.8	11.7	14.0	13.8	9.5	15.0	13.7	23.5	23.3	9.3	16.6	8.1	15.2	14.1	9.1	17.3	10.7	13.9	6.9	0.6	0.5	3.0	0.8	0.2	0.4	0.3	0.3	0.5	0.3	2.0	0.3	0.8	5.9	1.5	0.1	2.2	0.0	0.6	4.9	10.8	11.7	10.5	6.1	3.5	6.7	3.3	13.7	5.7	8.9	18.4	11.1	6.5	12.5	25.2	4.7	12.7	5.3	9.1	17.4	49.1	6.6	1.7	5.8	2.5	12.6	11.1	0.0	5.2	4.6	8.5	8.3	8.1	12.3	8.3	20.6	12.6	17.2	19.7	1.1	8.9	9.6	10.1	4.6	10.5	5.2	7.2	8.6	10.3	4.3	38.9	6.5	3.3	3.7	3.2	15.4	9.5	10.4	10.1	8.4
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409358	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA064495: AB_2685273"	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	7.6	5.4	8.9	14.0	7.5	20.2	7.9	9.8	14.1	13.9	9.1	9.9	21.4	7.3	15.7	9.5	22.3	12.3	8.3	10.9	8.1	5.5	6.7	7.4	8.7	8.4	7.8	10.6	7.2	13.1	6.8	7.4	9.9	12.8	18.6	9.1	7.9	19.3	12.5	13.6	15.6	9.1	11.0	10.3	13.3	9.0	5.2	8.6	42.2	17.2	8.9	19.7	12.3	14.2	3.5	3.8	7.8	3.8	4.1	5.4	0.6	12.4	7.9	9.5	14.6	6.1	10.9	13.0	18.6	8.9	10.8	9.5	9.0	7.3	28.7	10.8	12.3	4.0	11.6	13.6	6.8	11.6	12.1	14.1	24.1	8.3	4.5	9.1	18.7	6.1	4.6	8.6	11.7	10.9	10.4	8.8	12.3	43.6	13.4	8.8	9.0	18.9	27.9	4.4	11.3	9.0	22.5	8.1	7.8	7.5	15.2	13.0	10.2	18.5	9.4	8.5	8.8	13.1	23.9	11.2	12.2	8.9	14.5	13.3	7.5	7.8	26.3	8.4	9.8	10.2	4.1	2.5	7.8	2.8	3.8	5.4	3.5	3.3	4.3	2.0	2.3	1.8	2.3	3.4	4.1	3.6	3.8	2.7	0.6	8.9	7.5	9.8	14.1	8.1	5.5	7.8	10.6	12.8	8.6	11.9	12.6	0.0	14.2	0.0	19.6	0.0	5.1	21.4	12.5	26.2	5.9	10.7	6.6	8.0	7.4	11.3	8.5	0.0	8.1	13.9	8.7	20.1	2.3	13.4	15.1	3.2	4.7	28.8	17.1	2.1	15.0	10.3	0.0	1.0	28.5	22.4	11.3	10.5	40.3	8.3	16.8	6.5	0.0	8.9	11.7	0.0	11.9	8.2	12.4	19.3
METTL3	"M6A, MT-A70, Spo8"	ENSG00000165819	"Methyltransferase like 3"	Q86U44	14	21498133-21511375	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Spermatogenesis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.78e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.22e-1)"	13.1	21.0	15.7	18.3	20.4	6.8	17.4	27.1	16.4	13.5	12.8	16.3	20.4	7.7	17.1	19.8	14.3	20.9	11.2	17.3	16.3	8.6	14.6	14.0	14.2	18.4	21.7	15.2	18.2	14.2	25.8	21.3	16.0	16.3	19.3	13.9	12.2	17.0	19.3	18.8	17.0	11.9	17.6	13.8	17.5	12.9	21.6	20.6	15.4	19.2	13.3	21.8	15.1	14.8	13.0	12.6	7.7	10.3	15.3	14.3	8.1	16.6	24.9	23.7	9.5	18.4	15.2	11.9	15.3	11.3	18.4	21.6	9.4	19.7	17.4	9.9	9.5	24.1	17.7	29.0	15.1	29.2	16.4	17.1	10.8	13.8	37.2	7.5	14.5	12.3	11.4	13.3	11.4	13.4	8.1	24.0	9.0	13.2	10.0	24.3	12.2	12.9	11.6	20.2	28.2	30.8	12.9	18.8	15.4	16.8	11.2	14.7	15.9	16.7	22.0	15.6	19.7	17.4	9.6	15.6	6.5	11.0	12.0	10.4	10.6	13.2	12.1	8.0	11.7	13.8	5.1	8.1	7.7	8.7	10.3	12.7	13.0	10.5	9.6	10.5	10.3	11.0	9.7	0.9	15.3	8.4	12.6	14.3	8.1	15.7	20.4	27.1	16.4	16.3	8.6	21.7	15.2	16.3	20.6	11.9	15.3	14.3	20.7	13.3	23.6	30.5	12.7	16.0	12.5	12.2	13.7	26.1	3.3	12.6	132.7	11.7	4.2	23.3	8.6	12.2	16.4	16.1	8.1	9.5	14.4	20.6	10.4	10.4	7.1	15.9	15.8	12.9	15.1	19.8	7.6	16.2	9.0	3.5	18.7	7.2	18.7	32.3	14.2	32.6	17.9	10.8	21.2	13.8	11.1	17.6
N6AMT1	"C21orf127, HEMK2, MTQ2, N6AMT, PRED28"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome		Yes	No			Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957"	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	5.4	10.9	10.1	6.0	18.6	2.0	10.5	7.4	14.8	9.9	7.0	17.0	6.0	6.7	13.8	13.7	5.6	9.3	6.2	10.8	10.8	9.2	9.0	6.3	5.5	6.7	21.3	8.4	18.3	6.6	14.6	15.6	13.1	14.1	10.1	7.4	8.4	6.5	9.0	11.3	8.0	6.2	7.8	14.5	7.9	6.7	7.6	19.3	3.9	12.1	4.0	6.9	8.7	9.2	2.2	2.0	1.6	2.1	4.1	4.8	1.8	3.4	3.1	7.8	10.8	6.5	7.2	6.0	7.4	3.1	4.4	2.6	3.8	6.2	3.8	3.8	4.0	7.8	4.1	6.6	3.7	5.4	4.8	5.1	8.0	4.7	4.8	5.8	4.8	3.1	3.7	8.0	4.4	3.1	8.2	3.2	4.7	9.9	6.8	9.0	3.4	2.3	3.9	9.8	7.2	4.3	3.4	7.4	2.9	8.0	5.0	5.9	8.3	6.7	2.4	2.7	7.3	3.3	4.2	7.5	3.7	6.6	6.7	4.5	4.1	4.6	2.1	5.8	12.6	6.8	1.1	1.5	1.6	1.8	2.1	2.0	2.2	3.4	2.3	2.0	2.2	4.8	3.4	0.5	4.1	1.6	1.7	1.4	1.8	10.1	18.6	7.4	14.8	10.8	9.2	21.3	8.4	14.1	19.3	3.0	4.8	1.4	5.3	1.6	11.1	14.0	7.6	21.4	6.8	12.2	7.9	15.0	6.6	9.7	2.5	4.9	0.9	23.3	5.5	9.8	6.1	3.4	1.1	2.8	6.2	9.5	0.0	4.9	1.2	3.4	8.9	2.6	1.7	2.8	2.6	10.3	6.4	4.8	9.6	7.3	10.0	0.0	8.2	2.6	8.1	3.1	12.5	2.5	3.3	4.8
PAXBP1	"C21orf66, fSAP105, GCFC, GCFC1"	ENSG00000159086	"PAX3 and PAX7 binding protein 1"	Q9Y5B6	21	32733899-32771858	"Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003757	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003757: AB_10600796"	"unprognostic (8.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.38e-3)"	"unprognostic (2.54e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.43e-4)"	"prognostic unfavorable (1.50e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	8.9	10.6	11.9	16.6	19.6	42.0	11.6	25.7	20.0	13.5	14.1	11.3	10.1	15.8	16.3	12.4	10.3	11.6	10.1	8.3	11.2	9.7	11.3	10.3	10.1	13.7	22.7	10.0	19.8	12.3	11.6	19.3	13.2	14.7	11.2	12.6	6.9	10.2	10.5	15.2	12.6	12.8	10.8	19.0	11.2	9.5	12.9	19.7	18.5	11.3	5.0	12.3	11.2	18.9	2.2	1.6	0.3	1.3	0.7	3.1	0.4	7.5	6.2	12.5	9.8	4.9	3.9	17.9	5.6	3.6	7.4	5.4	13.0	6.8	9.0	4.4	3.1	5.7	7.7	12.5	5.2	7.7	7.3	10.4	15.5	10.2	9.4	2.4	17.3	9.2	2.1	7.9	8.6	3.8	4.8	4.8	9.5	18.0	8.3	5.4	6.6	11.8	10.1	35.4	8.4	6.3	11.0	11.9	13.1	5.8	7.0	10.3	5.9	8.0	9.3	6.3	8.1	5.9	9.7	4.2	5.5	7.6	6.4	8.7	8.2	10.2	16.7	4.0	15.8	5.5	0.0	1.3	0.3	2.2	0.6	3.1	1.6	2.5	1.9	1.6	2.2	2.7	2.6	0.0	0.7	0.8	1.1	1.4	0.4	11.9	19.6	25.7	20.0	11.2	9.7	22.7	10.0	14.7	19.7	11.9	16.3	9.8	17.0	22.7	51.8	11.5	15.3	28.1	20.5	19.2	58.9	13.9	5.0	6.5	28.6	16.1	13.2	0.0	6.8	10.2	16.4	18.1	11.5	9.9	9.0	20.6	21.2	12.9	11.8	25.3	13.6	15.8	20.3	2.8	15.4	37.6	6.3	12.2	15.9	5.7	78.8	32.3	15.1	24.2	15.5	22.2	14.9	13.1	18.8	22.8
PHF1	"MTF2L2, PCL1, TDRD19C"	ENSG00000112511	"PHD finger protein 1"	O43189	6	33410399-33416453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031038	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031038: AB_10671365"	"unprognostic (1.96e-3)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.43e-3)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (1.72e-4)"	10.7	10.2	12.0	15.5	15.2	23.5	29.0	14.2	12.5	29.7	14.6	9.4	26.4	11.0	18.2	30.7	10.0	16.3	18.3	15.4	13.2	13.3	13.0	10.5	19.7	16.7	16.9	12.0	31.5	24.9	21.1	26.6	7.7	14.6	16.9	6.2	14.6	17.6	28.5	12.9	7.7	12.1	18.9	12.3	18.8	12.7	26.7	12.8	5.0	22.4	9.3	21.3	20.7	29.2	1.5	0.5	3.2	0.4	1.1	4.6	0.9	1.5	2.1	4.8	3.1	2.1	1.2	9.6	3.3	5.2	2.5	2.8	2.9	1.4	0.6	2.0	7.8	16.8	0.5	1.0	1.7	0.6	1.9	1.0	4.5	3.5	1.3	0.4	2.6	11.2	2.5	2.2	4.9	4.4	3.7	1.6	1.6	1.7	3.9	2.0	1.2	0.8	1.6	1.7	0.4	1.5	1.9	0.6	1.6	0.3	2.0	3.2	3.4	1.7	1.8	2.7	0.9	1.3	3.2	3.1	5.0	1.4	2.9	3.5	2.6	4.3	5.2	3.6	2.8	2.9	0.2	0.3	0.7	1.4	0.4	4.6	1.2	2.8	3.5	0.5	1.5	3.3	1.7	3.2	1.1	0.4	0.3	0.9	0.9	12.0	15.2	14.2	12.5	13.2	13.3	16.9	12.0	14.6	12.8	17.9	22.7	25.1	75.0	30.1	69.3	17.0	2.5	12.0	10.3	22.7	35.3	14.3	29.9	11.6	144.2	27.0	13.3	0.0	15.8	11.3	18.6	51.5	69.1	6.2	10.6	42.9	11.5	27.6	8.6	57.2	40.0	15.1	35.4	13.6	13.8	32.4	13.9	11.2	38.5	20.3	62.8	77.6	51.5	61.1	42.1	21.0	31.4	46.8	9.6	66.3
PRDM12		ENSG00000130711	"PR/SET domain 12"	Q9H4Q4	9	130664594-130682981	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"brain: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"RH-30: 19.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 11.2"	"Group enriched"	"Detected in some"	33	"basal ganglia: 6.1;hypothalamus: 2.0"	HPA043143	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA043143: AB_10806379"	"unprognostic (3.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.81e-4)"	"unprognostic (7.90e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.01e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.30e-4)"	"unprognostic (1.40e-1)"	0.1	0.7	1.0	0.3	1.5	0.0	0.1	1.1	2.2	0.0	0.1			0.3	0.0	0.9	0.0	0.0	0.0	0.0	1.0	3.7	0.0	0.2	0.0	0.0	0.5		0.0	0.8	0.1	0.2	0.0		0.0	0.3		0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.7			0.0		0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.3	0.2	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.9	0.0	0.8	0.0	0.1	0.1	0.0	19.4	0.5	0.0	0.0	0.9	0.3	0.4	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"Rearranged L-myc fusion"	Q13129	1	40161373-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	14.8	8.1	12.6	11.3	12.6	44.5	13.9	20.8	17.1	12.4	11.1	11.6	7.1	8.6	14.1	8.6	12.4	9.9	11.2	12.3	11.0	8.3	8.7	12.7	12.8	11.8	12.8	11.8	14.6	9.4	12.5	15.1	11.9	15.4	13.2	9.2	10.2	9.4	9.9	13.4	17.7	9.9	14.3	14.1	10.1	9.3	15.9	11.8	14.9	10.0	8.4	13.5	18.1	14.8	4.1	3.5	10.1	4.1	4.1	4.9	2.4	12.4	4.8	9.5	9.9	8.5	6.9	11.3	4.7	7.0	8.1	10.8	9.7	6.6	12.4	6.2	6.0	6.1	11.8	11.9	8.2	14.8	5.8	8.1	10.2	5.9	5.9	6.7	8.4	6.2	6.8	8.7	8.6	9.8	9.7	5.5	6.9	15.5	7.7	7.4	3.9	7.1	5.1	12.6	4.6	5.6	5.6	15.6	7.2	5.2	12.6	6.8	9.5	8.7	11.7	8.3	15.4	5.5	30.8	4.7	9.6	10.2	7.8	8.7	7.0	6.6	11.7	8.3	7.9	5.9	10.1	2.8	5.5	3.7	3.9	4.9	4.1	3.7	3.8	3.5	4.1	4.8	4.0	6.3	4.1	4.1	1.6	3.3	2.4	12.6	12.6	20.8	17.1	11.0	8.3	12.8	11.8	15.4	11.8	29.8	10.8	22.4	42.2	58.3	17.2	13.4	5.1	30.8	30.7	3.5	15.7	6.9	5.0	10.9	32.9	23.3	8.4	0.0	5.9	8.0	34.2	25.7	26.5	8.3	8.5	25.4	19.4	16.0	13.9	4.9	8.3	16.8	16.9	10.0	7.8	17.0	9.3	14.0	7.4	5.7	15.8	12.9	27.8	26.5	20.0	53.3	14.4	14.1	6.7	27.2
ALX3	FND	ENSG00000156150	"ALX homeobox 3"	O95076	1	110059994-110070700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 19.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 2.4;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"olfactory region: 14.8"	"Low region specificity"	"Detected in single"			HPA074290			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA074290: "	"unprognostic (4.28e-1)"				"unprognostic (4.41e-2)"			"unprognostic (2.91e-1)"		"unprognostic (2.48e-2)"					"unprognostic (1.31e-1)"			0.5	1.8	1.2	1.0	2.7	0.8	2.6	0.9	4.1	0.7	0.4	1.2	0.3	1.6	2.7	0.9	2.6	2.6	1.7	0.7	1.3	1.5	0.8	0.4	1.0	2.3	0.5	1.9	3.1	1.0	0.2	5.3	0.7	0.5	0.8	0.0	19.3	2.0	0.3	2.8	8.0	2.7	0.3	0.4	2.4	0.8	1.8	0.6	0.3	2.1	1.8	0.3	1.4	2.4	0.4	0.0	1.4	0.1	0.0	2.0	0.2	3.3	1.7	4.3	6.3	0.0	0.0	8.1	8.5	11.2	0.0	0.0	3.4	1.5	1.8	3.5	0.1	1.3	5.1	0.0	0.0	0.0	4.5	6.2	1.1	3.9	2.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	4.4	0.0	3.5	2.9	0.5	0.0	3.9	1.4	1.6	4.5	2.4	4.8	3.1	5.4	1.5	0.0	4.5	5.3	7.4	3.9	6.0	5.7	4.8	2.7	3.2	3.3	5.1	4.4	6.4	2.1	3.3	1.2	2.0	5.4	4.8	3.5	0.8	0.1	1.4	0.1	0.0	0.3	0.2	1.1	0.4	0.0	0.4	0.1	2.0	0.0	0.0	0.1	0.0	0.1	0.2	1.2	2.7	0.9	4.1	1.3	1.5	0.5	1.9	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0
BCOR	"FLJ20285, KIAA1575"	ENSG00000183337	"BCL6 corepressor"	Q6W2J9	X	40049815-40177329	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA056308, HPA073591"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056308: AB_2683095, HPA073591: AB_2732227"	"unprognostic (2.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (3.82e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.83e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.55e-1)"	9.1	12.8	8.7	8.7	10.5	20.6	13.3	11.5	12.0	10.0	12.6	22.7	11.9	7.8	11.1	13.9	13.6	10.4	8.6	13.0	7.1	5.4	11.2	13.3	11.4	15.2	12.9	8.4	19.8	13.6	19.7	11.9	12.5	10.7	13.2	8.2	13.7	11.1	16.5	28.8	13.6	10.3	12.9	8.6	11.4	11.5	9.8	15.8	18.4	16.0	11.4	13.5	13.8	25.5	6.5	7.3	7.6	7.1	8.2	6.8	11.8	13.1	8.7	17.8	21.7	2.0	1.6	3.1	4.5	7.1	5.7	4.7	3.7	5.3	12.0	5.3	8.3	3.7	12.4	29.0	3.8	5.1	20.9	26.4	13.4	13.4	14.4	3.4	10.8	7.7	2.6	5.6	6.3	3.6	8.4	7.7	7.9	34.3	29.0	7.0	8.4	24.4	22.6	17.5	6.2	13.6	11.9	18.4	13.5	10.5	8.3	12.8	23.1	9.4	8.3	7.0	9.1	8.9	23.8	6.4	6.2	7.8	9.1	5.0	17.2	13.3	12.5	5.4	9.9	9.5	7.6	5.0	4.5	6.8	6.1	4.3	6.5	4.7	3.9	7.3	5.5	4.7	4.8	1.1	8.2	7.1	3.1	5.5	11.8	8.7	10.5	11.5	12.0	7.1	5.4	12.9	8.4	10.7	15.8	20.8	23.2	12.3	3.2	13.1	34.2	7.6	10.2	6.7	5.7	10.4	11.8	3.7	1.7	4.5	2.1	17.4	4.9	0.0	9.1	5.5	13.6	7.9	23.2	9.5	6.4	14.3	15.6	19.0	11.0	2.1	9.8	8.6	5.0	7.2	11.7	7.7	6.6	0.0	7.4	4.0	22.0	0.0	26.4	1.1	13.5	12.2	1.7	7.5	7.6	2.6
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23, rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 144.6;Exocrine glandular cells: 122.2;Pancreatic endocrine cells: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	16.6	23.4	16.3	15.0	18.8	19.6	18.3	12.3	20.6	17.5	19.3	17.9	19.5	18.3	19.1	30.6	17.5	24.1	23.1	34.2	16.0	17.5	28.1	36.3	16.1	18.3	25.3	17.5	19.3	27.9	14.3	21.8	22.1	16.4	16.5	19.8	20.3	25.1	25.6	52.2	19.3	21.6	21.2	18.7	18.7	18.9	97.0	16.5	22.1	25.8	22.6	22.7	18.7	14.8	43.9	49.0	14.4	18.3	30.1	37.6	31.4	22.2	24.6	9.0	71.4	12.4	11.1	15.0	15.4	13.9	19.9	16.3	34.0	30.1	26.0	8.1	16.5	34.3	16.0	20.7	14.9	18.4	18.2	24.0	11.3	28.7	13.7	15.7	31.7	16.6	10.0	17.2	17.5	15.9	10.1	12.8	21.5	44.7	48.2	17.2	35.1	19.9	43.6	21.5	51.7	28.3	17.8	17.6	113.3	22.0	16.1	27.3	20.5	20.6	55.0	22.8	9.3	34.6	25.4	13.7	17.2	21.9	21.7	32.9	16.7	29.2	43.7	39.4	24.2	35.9	11.5	17.1	14.4	30.7	18.3	34.3	43.9	35.5	33.6	31.5	38.0	37.6	34.4	3.2	30.1	16.2	49.0	37.3	31.4	16.3	18.8	12.3	20.6	16.0	17.5	25.3	17.5	16.4	16.5	41.7	53.9	0.0	0.0	0.0	0.0	0.0	0.0	144.6	78.5	43.6	0.0	64.0	82.9	81.2	0.0	0.0	0.0	0.0	122.2	66.3	0.0	0.0	43.0	0.0	62.2	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	36.9	0.0	0.0	97.5	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	0.0	89.2	0.0	0.0	0.0
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 60.3;Early spermatids: 202.3;Horizontal cells: 212.9;Late spermatids: 67.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 17.0;U-2 OS: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	17.0	0.2	0.2	0.0	0.0	0.0	2.9	0.1	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8	0.0	0.0	0.0	0.0	0.1	60.3	1.7	0.0	0.0	0.0	3.5	11.8	0.0	0.0	0.0	202.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	212.9	0.0	0.0	0.0	67.4	0.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.4	0.0	48.3	0.0	0.9	3.4	17.0	0.4	0.0	0.0	0.0	0.0
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148458-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 29.5;epididymis: 9.3;fallopian tube: 8.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 1.3;Horizontal cells: 3.2;Muller glia cells: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HAP1: 11.5"	"Low region specificity"	"Detected in some"							"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.9	0.9	7.9	0.6	29.5	0.6	0.6	0.2	17.8	1.0	0.8	0.3	0.0	1.2	1.2	9.3	0.7	8.0	0.6	0.6	13.5	10.8	2.4	0.6	0.9	0.6	3.4	10.4	1.4	1.1	0.7	1.3	0.6	11.8	1.5	0.7	1.6	0.7	0.8	0.6	0.7	1.3	0.8	0.7	0.6	1.4	0.7	1.7	0.0	0.7	0.0	0.6	1.4	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	29.5	0.2	16.8	13.5	10.8	3.4	10.4	11.8	1.7	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1
EED	"HEED, WAIT-1"	ENSG00000074266	"Embryonic ectoderm development"	O75530	11	86244544-86278813	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012211, HPA060089, HPA061140"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.19e-3)"	"prognostic unfavorable (1.36e-7)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (2.27e-5)"	10.9	12.0	20.1	20.6	19.8	9.7	14.0	33.4	26.5	13.4	14.4	10.4	19.2	15.6	20.0	20.1	16.7	13.5	14.5	10.8	17.7	12.7	13.7	15.1	13.0	31.1	18.3	17.7	16.9	14.1	16.2	21.6	17.6	17.7	15.5	15.0	9.8	13.7	13.8	11.8	14.6	14.6	12.5	18.2	19.5	13.7	12.5	20.5	17.0	14.6	11.9	36.2	14.9	22.8	21.5	6.7	11.3	7.6	8.9	27.3	9.2	11.7	13.5	14.2	6.1	7.9	6.6	16.5	17.4	7.3	15.4	15.6	42.4	22.6	26.5	18.4	4.9	15.9	14.7	16.8	9.2	14.7	27.4	8.0	17.8	13.5	12.6	6.9	18.3	11.9	4.3	6.1	16.4	6.9	6.4	7.0	11.9	19.5	5.7	13.1	19.2	17.0	18.5	10.5	37.6	6.6	18.8	17.6	12.9	10.0	19.4	9.9	8.0	22.3	10.5	4.9	11.0	17.6	7.8	6.9	17.0	16.1	25.0	15.1	3.3	10.6	21.5	4.8	16.1	12.7	11.3	4.5	7.1	13.3	7.2	11.6	21.5	17.4	16.6	6.7	18.8	14.0	15.8	1.9	8.9	7.6	4.4	27.3	9.2	20.1	19.8	33.4	26.5	17.7	12.7	18.3	17.7	17.7	20.5	6.0	9.4	18.2	10.8	22.8	23.0	8.1	7.6	10.7	2.3	7.0	17.7	38.3	16.6	13.6	4.9	15.2	11.5	0.0	8.8	28.8	17.9	8.0	16.1	10.9	14.9	30.2	6.9	14.1	13.6	2.3	21.0	11.3	18.6	36.9	11.2	9.9	10.4	11.4	16.3	6.2	17.7	6.5	14.3	12.7	18.8	14.6	20.8	28.4	11.8	18.4
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	19.2	16.1	14.7	24.4	15.3	30.5	25.9	11.1	14.2	12.9	22.2	12.2	20.4	24.8	16.7	16.1	23.3	13.1	17.4	16.3	16.2	11.3	21.2	28.7	22.3	29.9	12.8	10.1	16.0	28.5	13.8	16.2	26.9	15.3	11.7	13.0	18.1	16.7	20.2	17.9	29.9	26.4	13.1	14.8	28.1	19.5	42.0	11.4	34.1	16.1	15.3	24.6	16.3	23.0	3.2	4.9	12.3	4.9	3.7	5.2	2.7	18.7	16.1	15.0	22.2	6.2	6.5	31.6	14.8	10.1	15.5	14.8	29.1	19.9	36.8	22.6	14.8	10.3	15.7	14.0	13.1	9.0	12.5	15.2	27.0	16.1	16.0	15.3	29.9	23.4	10.3	9.7	16.1	13.1	5.1	15.4	21.3	43.0	11.9	8.9	21.2	35.3	11.9	31.6	17.4	14.7	37.7	15.1	17.1	8.0	24.8	28.5	15.9	12.8	15.6	18.7	10.2	14.1	12.6	30.0	29.5	14.2	34.4	27.6	14.9	18.7	39.4	18.4	25.3	17.1	5.6	4.9	4.5	5.2	2.3	3.1	3.1	3.1	4.2	2.1	3.2	2.3	2.6	12.3	3.7	4.5	4.9	2.1	2.7	14.7	15.3	11.1	14.2	16.2	11.3	12.8	10.1	15.3	11.4	11.9	16.3	12.4	16.8	49.5	14.4	10.6	10.2	9.4	12.5	14.0	17.7	20.2	11.6	19.7	14.7	28.5	34.2	0.0	26.2	27.9	19.3	19.6	16.2	25.1	23.4	22.3	15.0	25.2	24.1	13.3	14.4	19.3	30.4	16.2	28.2	17.4	36.9	32.3	13.1	22.5	18.5	19.4	21.7	12.1	33.7	48.6	30.7	35.5	26.9	23.0
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92474762-92486876	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.9;lymphoid tissue: 56.1"	"Group enriched"	"Detected in some"	6	"Mucus-secreting cells: 10.4;T-cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 16.7;HMC-1: 13.4;NB-4: 17.3;THP-1: 34.8;U-937: 71.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain					NA	NA					"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favorable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"	1.2	0.4	0.1	3.6	0.3	31.9	0.7	0.2	0.3	1.1	3.9	0.1	0.1	3.0	0.7	0.7	1.2	1.0	2.6	0.6	0.2	0.1	1.0	0.9	3.4	5.4	0.5	0.3	0.5	12.4	0.0	0.7	0.7	0.5	1.1	3.1	0.9	1.2	1.3	0.7	0.4	6.8	0.6	0.8	8.9	1.8	1.1	0.2	56.1	1.2	0.5	5.0	1.9	0.8	0.0	1.6	0.8	0.0	0.3	4.9	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	1.4	0.0	16.7	13.4	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.1	4.3	0.0	0.5	10.5	17.3	0.0	0.0	0.0	2.1	0.7	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.4	0.0	0.0	6.2	0.4	1.1	0.0	71.9	0.0	0.0	0.0	0.8	4.9	0.0	2.2	0.0	2.1	3.0	0.0	0.0	0.8	4.5	0.1	0.3	0.0	1.6	0.7	0.5	0.1	0.3	0.2	0.3	0.2	0.1	0.5	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	13.1	0.2	0.0
JMJD1C	"DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8"	ENSG00000171988	"Jumonji domain containing 1C"	Q15652	10	63167221-63521850	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056175, HPA066195"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA056175: AB_2683057, HPA066195: AB_2685634"	"unprognostic (7.72e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.13e-1)"	31.7	10.9	8.7	26.0	10.9	25.9	16.2	43.0	11.1	21.8	16.6	5.4	11.8	12.2	18.1	17.4	16.4	13.1	18.5	11.7	10.8	8.1	14.1	16.7	29.9	20.9	9.6	6.5	19.2	12.6	27.1	18.6	10.3	14.1	14.1	9.2	13.8	15.3	15.6	13.4	11.0	22.2	11.7	17.6	29.1	12.9	10.9	13.3	27.2	15.6	20.1	15.3	21.9	11.8	4.8	4.2	15.2	2.8	1.7	3.1	1.1	11.0	5.6	13.2	10.1	7.0	13.0	4.6	7.7	16.0	7.0	9.6	9.5	11.9	15.0	4.7	7.2	6.3	9.1	3.7	7.4	12.5	4.0	4.7	5.7	5.8	6.9	8.6	12.2	2.1	12.9	7.7	12.3	36.1	15.9	12.5	10.8	10.0	11.4	16.3	3.0	9.3	6.6	14.1	2.5	19.8	16.2	28.7	7.1	7.1	8.0	7.2	11.8	11.6	7.3	11.1	10.1	7.2	22.2	14.9	6.5	9.2	5.6	9.6	10.2	8.1	14.3	7.9	7.3	5.8	0.6	2.8	3.1	2.0	1.9	3.1	4.7	2.2	2.1	2.4	4.8	3.1	2.6	15.2	1.7	1.6	4.2	1.9	1.1	8.7	10.9	43.0	11.1	10.8	8.1	9.6	6.5	14.1	13.3	104.2	81.3	88.7	263.2	135.0	89.5	52.3	45.9	113.8	121.7	52.4	143.3	28.1	11.6	51.6	31.8	129.1	72.6	0.0	41.5	23.6	115.8	122.0	90.2	30.6	51.0	111.2	82.5	89.6	79.2	32.2	96.1	141.3	72.6	41.5	51.6	62.3	60.4	56.1	84.1	23.1	170.7	71.1	102.3	135.2	137.3	117.1	27.8	76.7	33.1	223.6
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	16.9	15.4	9.5	21.2	15.9	16.9	17.7	21.6	18.2	18.6	15.4	25.2	18.6	13.0	22.8	18.9	15.6	16.8	14.0	10.9	9.6	8.5	13.3	12.7	15.6	20.7	15.3	13.2	23.9	17.6	21.0	15.4	18.4	13.7	14.9	16.8	20.6	16.1	18.5	20.0	18.0	17.1	17.9	13.7	21.9	15.0	33.5	14.2	24.5	18.6	12.0	20.7	18.6	16.3	11.2	12.8	6.9	14.9	7.6	9.1	5.3	5.9	6.9	10.0	6.6	4.8	6.4	16.7	4.9	5.7	7.1	6.1	4.6	8.2	11.6	6.8	5.4	2.8	7.4	9.3	5.3	5.6	5.6	11.5	6.6	7.1	5.3	6.8	11.6	6.3	8.4	5.9	5.8	9.5	7.2	8.3	7.5	11.0	9.5	5.0	11.4	8.0	6.8	13.7	8.3	5.5	9.3	6.5	8.6	5.4	6.8	7.3	13.3	7.5	8.8	5.9	12.6	9.5	15.7	5.6	4.1	4.3	4.5	6.8	9.9	10.6	90.6	4.3	4.1	4.0	6.8	10.7	6.9	8.3	14.9	8.7	8.7	7.4	9.1	12.8	11.2	8.3	8.3	6.5	7.6	10.6	8.6	4.7	5.3	9.5	15.9	21.6	18.2	9.6	8.5	15.3	13.2	13.7	14.2	6.0	12.3	5.3	7.2	4.8	10.9	4.1	5.1	9.4	6.8	7.0	17.7	11.4	3.3	6.6	23.5	6.9	6.2	0.0	5.0	7.2	4.9	6.2	7.0	6.2	8.8	6.4	3.5	10.4	14.2	21.8	9.5	10.4	1.7	7.2	10.3	6.3	7.3	10.7	9.2	5.4	10.1	6.5	5.9	22.4	14.5	4.4	8.4	7.0	9.3	6.4
SUV39H2	"FLJ23414, KMT1B"	ENSG00000152455	"Suppressor of variegation 3-9 homolog 2"	Q9H5I1	10	14878820-14904315	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 302.5;Late spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045901, HPA057554"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045901: AB_10960702, HPA057554: AB_2683466"	"prognostic unfavorable (5.55e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.39e-1)"	3.0	2.9	4.7	3.4	7.4	4.9	5.2	20.0	8.6	3.1	3.8	1.6	2.1	3.2	3.8	2.3	4.0	3.0	3.2	2.4	5.4	2.8	3.5	3.8	2.7	3.6	3.3	4.4	4.2	2.4	2.4	6.3	5.1	3.3	3.9	4.7	1.6	2.4	3.6	2.4	3.3	2.9	3.7	3.0	3.4	2.7	41.8	4.4	10.3	2.8	4.9	4.0	3.3	2.8	0.8	3.1	0.5	1.8	5.6	4.0	0.8	13.7	13.1	22.0	12.5	4.1	5.0	8.6	7.5	4.6	14.0	19.9	19.6	7.9	11.1	6.8	4.5	12.3	9.7	16.3	9.1	17.3	11.3	10.8	16.7	9.3	12.1	2.4	7.5	8.0	2.4	3.2	14.2	4.4	3.1	9.6	18.9	21.5	7.5	10.3	13.5	14.8	2.1	13.6	12.6	3.5	18.4	14.5	8.9	5.9	6.6	7.3	8.1	11.7	7.3	6.3	13.5	12.9	6.5	5.6	10.1	16.3	12.3	11.9	4.3	16.1	25.5	6.2	8.2	6.5	0.5	0.4	0.3	2.8	1.8	4.0	0.8	2.4	3.5	2.2	0.6	3.8	3.6	0.3	5.6	0.5	3.1	3.7	0.8	4.7	7.4	20.0	8.6	5.4	2.8	3.3	4.4	3.3	4.4	0.0	1.0	0.0	7.0	7.3	7.4	2.4	0.0	4.0	7.9	1.8	9.8	11.4	5.0	3.5	302.5	5.2	0.9	0.0	1.8	20.4	5.5	6.6	2.3	2.9	4.3	11.1	3.4	1.8	1.8	78.4	4.4	2.4	1.7	1.0	2.8	2.4	2.2	1.1	2.5	5.0	9.8	6.5	6.6	37.0	52.7	7.8	7.4	1.8	3.9	10.9
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	35.5	9.3	19.6	18.6	17.1	18.5	31.6	26.7	14.1	17.2	20.5	28.3	23.9	19.4	32.3	17.0	47.0	14.2	14.8	19.7	18.8	30.7	16.0	10.6	25.9	30.3	20.0	12.6	21.9	15.9	27.0	15.6	13.2	23.2	14.7	16.2	19.5	35.3	15.5	20.7	20.0	33.4	8.4	10.6	8.9	20.2	21.6	27.0	15.4	27.5	26.5	20.6	21.0	9.9	46.4	22.2	21.3	34.8	29.1	20.0	14.0	26.9	29.2	29.5	40.3	27.4	22.6	23.9	19.9	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7	68.5	53.6	80.6	311.1	324.0	73.3	287.9	109.5	50.9	37.5	71.5	76.6	127.7	145.9	138.0	194.0	119.9	104.0	210.2	148.2	103.0	162.4	304.2	116.3	90.1	106.8	82.6	126.4	82.3	121.3	244.2	143.5	139.6	215.9	189.4	109.5	124.2	180.7	129.8	106.4	130.7	89.5	148.8	178.2	201.6	171.6	323.2	605.1	89.5	82.7	405.3
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 39.1"					"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	9.9	7.6	5.9	8.8	7.0	8.8	15.4	16.6	6.7	7.5	9.9	11.7	14.0	6.3	10.0	12.2	11.7	9.8	14.7	12.0	5.9	4.8	7.3	14.0	12.0	12.8	12.5	5.5	16.8	8.9	20.3	10.9	7.6	9.5	10.4	5.8	14.5	8.6	11.0	11.2	11.4	10.6	10.6	8.7	10.7	8.3	19.3	7.9	6.1	15.3	8.6	10.9	11.2	12.8	16.3	6.7	23.0	8.0	14.0	18.1	8.8	9.0	6.4	10.7	4.4	6.8	10.1	10.4	7.5	4.1	8.2	7.4	3.7	6.7	3.1	4.9	4.6	8.8	2.6	5.0	10.5	11.4	6.4	39.1	14.6	6.3	6.0	11.1	10.4	24.2	8.0	13.5	10.1	19.5	8.5	6.5	5.0	10.9	14.1	6.1	5.9	5.6	9.3	10.2	5.3	6.3	12.7	2.7	13.4	6.2	3.8	7.0	3.1	10.0	4.4	8.4	8.5	10.6	19.7	6.2	4.5	6.7	5.1	8.4	6.4	6.8	10.3	2.0	11.5	9.3	13.7	4.7	23.0	9.3	5.1	14.3	13.8	12.2	13.2	6.7	16.3	18.1	13.0	17.3	14.0	8.0	3.1	15.3	8.8	5.9	7.0	16.6	6.7	5.9	4.8	12.5	5.5	9.5	7.9	14.9	18.7	18.2	36.1	9.3	30.1	14.3	12.7	10.7	10.3	17.4	41.2	9.0	1.7	10.9	14.5	11.3	11.9	0.0	4.9	9.9	6.6	25.3	28.8	6.8	6.8	19.1	6.3	4.3	10.2	8.1	11.2	13.4	6.8	10.0	8.8	20.1	9.3	17.5	11.3	9.0	60.4	19.4	11.8	17.9	12.8	10.7	14.0	25.3	7.6	21.2
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105242-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	22.3	17.0	24.2	16.7	26.7	24.0	19.7	26.1	28.2	20.9	20.0	21.9	14.7	14.5	20.8	16.1	21.6	18.2	19.6	20.6	21.0	23.4	21.0	20.6	16.0	21.4	20.3	26.8	24.1	30.1	28.3	13.9	24.3	23.1	19.4	20.9	16.0	18.1	20.0	31.8	18.8	23.0	21.8	20.1	20.3	18.8	41.7	16.0	36.2	19.5	15.3	24.1	20.1	17.4	12.6	17.0	33.9	16.6	16.6	13.2	11.4	14.1	7.5	12.6	12.6	9.1	11.4	16.2	14.4	15.2	18.2	16.1	8.0	6.4	16.0	12.3	12.1	9.1	8.5	16.2	8.1	17.3	6.2	7.3	65.0	8.0	16.9	13.2	10.5	13.2	9.8	7.7	8.4	9.4	9.2	14.2	15.0	43.5	12.4	17.7	8.2	27.7	13.1	16.4	12.6	4.8	11.5	14.0	6.9	9.4	10.7	5.8	10.4	10.7	7.0	11.6	13.1	8.5	12.3	11.1	11.3	11.4	16.0	11.4	11.8	14.8	14.2	11.5	13.7	15.5	18.2	13.9	33.9	11.1	16.6	11.8	12.5	12.5	13.1	17.0	12.6	13.2	12.1	11.8	16.6	15.0	9.7	13.0	11.4	24.2	26.7	26.1	28.2	21.0	23.4	20.3	26.8	23.1	16.0	11.9	18.6	12.7	7.9	6.2	12.1	15.3	10.2	25.4	17.0	12.2	9.8	31.2	6.6	17.1	6.6	11.3	10.6	0.0	25.1	31.4	12.7	5.3	18.5	10.2	20.4	6.4	10.4	13.5	18.9	11.2	21.6	14.8	21.9	29.7	10.5	14.8	16.9	7.0	19.4	13.2	14.9	12.9	9.5	30.1	32.2	5.9	25.9	15.0	11.4	6.5
EZH1	"KIAA0388, KMT6B"	ENSG00000108799	"Enhancer of zeste 1 polycomb repressive complex 2 subunit"	Q92800	17	42700275-42745049	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Rod photoreceptor cells: 268.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005478, HPA077684"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005478: AB_1848340, HPA077684: AB_2732356"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.74e-2)"	21.7	10.4	15.0	10.1	25.0	9.9	18.7	39.6	26.1	18.4	15.1	21.4	10.0	9.7	29.8	21.2	10.6	18.8	9.7	17.2	19.0	11.2	13.6	5.3	12.6	14.0	13.7	22.0	38.2	8.1	20.0	19.1	9.3	25.6	13.1	12.1	21.5	10.7	19.3	25.4	16.0	14.0	16.4	19.9	16.0	10.6	8.6	16.7	11.9	15.0	7.5	14.9	16.0	15.9	6.2	6.0	18.8	5.4	4.8	8.3	2.3	5.5	5.8	8.0	5.5	32.1	19.4	6.8	8.9	8.2	7.4	7.6	2.7	6.9	8.4	5.6	9.4	7.3	12.6	5.2	5.9	10.7	9.3	9.3	2.9	10.8	3.3	11.0	6.2	7.0	11.1	10.8	5.6	13.6	13.0	6.0	8.5	7.6	11.9	6.5	2.3	10.1	8.0	2.2	5.1	3.0	6.6	8.2	8.9	7.7	5.9	5.5	4.4	4.9	2.4	5.9	11.9	8.5	4.0	6.2	8.0	3.3	9.3	5.6	12.5	6.3	5.0	5.7	6.5	4.0	10.2	5.2	6.9	5.9	5.4	8.3	5.7	5.2	6.0	1.9	6.2	7.7	5.7	18.8	4.8	3.3	6.0	5.7	2.3	15.0	25.0	39.6	26.1	19.0	11.2	13.7	22.0	25.6	16.7	8.9	17.3	10.7	12.1	4.6	67.2	34.7	17.8	38.8	17.0	12.2	62.8	6.1	8.3	9.2	0.4	12.2	6.7	46.7	6.4	2.6	7.5	7.2	19.7	6.7	7.7	44.5	12.5	15.4	11.6	1.1	28.7	10.6	1.7	20.8	4.2	32.0	9.4	6.0	32.2	8.1	268.1	51.8	13.3	9.3	8.8	5.4	9.0	15.9	6.8	7.6
HEMK1	MTQ1	ENSG00000114735	"HemK methyltransferase family member 1"	Q9Y5R4	3	50569152-50596168	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 124.5;Late spermatids: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034701, HPA034702"	Uncertain					NA	NA					"HPA034701: AB_10601429, HPA034702: AB_10673101"	"unprognostic (1.27e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.95e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.44e-3)"	8.8	15.1	8.8	10.8	13.3	7.6	12.9	4.9	11.2	13.0	13.6	15.1	33.3	11.7	17.9	12.6	12.4	15.3	12.8	11.9	10.5	8.2	15.9	21.8	11.1	13.5	13.1	13.3	19.7	24.3	20.2	19.2	14.1	12.5	18.7	11.4	14.9	27.1	14.7	7.8	8.9	11.9	19.4	12.8	15.5	13.8	19.5	14.1	18.3	21.1	4.2	14.9	12.6	15.6	16.5	17.4	12.1	10.1	13.0	15.7	10.8	7.1	4.2	6.9	6.2	15.3	11.8	9.9	8.9	6.8	7.9	9.9	3.6	11.7	6.9	6.7	11.8	9.1	8.5	5.2	19.4	3.6	35.5	3.9	8.3	8.3	5.0	12.5	8.3	5.7	9.8	15.0	9.0	11.7	14.2	9.5	13.7	7.3	7.3	7.7	6.3	13.7	8.8	2.8	8.0	12.1	4.9	3.4	13.5	9.5	8.6	2.4	7.8	3.2	9.2	9.6	9.9	7.9	12.3	4.6	9.1	8.1	7.4	10.1	6.5	3.3	3.7	13.2	11.0	5.0	12.1	10.1	9.1	15.7	6.8	13.9	16.5	12.7	13.2	13.6	13.6	14.0	14.7	1.7	13.0	4.3	17.4	8.1	10.8	8.8	13.3	4.9	11.2	10.5	8.2	13.1	13.3	12.5	14.1	11.9	12.0	6.9	11.3	3.9	12.5	12.9	7.6	24.1	14.8	7.0	0.0	21.9	10.0	11.7	124.5	5.6	11.2	0.0	7.1	15.0	8.9	10.0	16.2	13.9	17.1	6.4	0.0	16.5	6.4	104.6	10.6	10.6	8.5	20.8	19.6	12.4	8.8	10.5	7.8	16.6	20.2	19.4	5.3	24.7	5.5	3.0	11.4	9.6	16.4	9.7
HIST1H1B	"H1.5, H1b, H1F5, H1s-3"	ENSG00000184357	"Histone cluster 1 H1 family member b"	P16401	6	27866849-27867529	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 342.6"	"Cell type enhanced"	"Detected in some"	10	"Extravillous trophoblasts: 3.8;Hofbauer cells: 2.6;Kupffer cells: 2.2;Macrophages: 1.8;T-cells: 1.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 14.0;NB-4: 7.7;U-698: 6.0"									"CAB012241, HPA055907, HPA060331"	Supported		Supported	Nucleoplasm		NA	NA		510000	Nucleoplasm		"CAB012241: , HPA055907: AB_2682966, HPA060331: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.4	0.4	22.9	0.5	18.2	2.1	0.5	0.4	1.7	7.3	0.0	0.0	0.3	0.5	1.0	10.2	0.3	1.9	0.6	0.5	0.5	0.4	0.6	3.9	10.7	0.5	0.0	0.4	0.4	0.3	0.4	6.4	0.0	0.4	0.5	0.0	0.8	0.3	0.4	1.4	7.0	0.3	1.7	14.4	1.3	1.7	0.0	342.6	0.6	10.5	26.0	2.0	0.7	13.0	12.7	0.7	1.1	1.8	3.4	2.1	2.2	0.0	0.8	0.0	0.0	0.0	1.7	0.7	0.6	1.0	0.6	0.7	1.5	2.7	0.4	0.8	0.7	0.8	0.0	0.0	0.1	0.8	1.0	3.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.9	1.9	2.7	1.9	0.1	0.4	14.0	7.7	2.1	2.1	0.0	4.2	0.0	0.0	0.4	0.0	1.9	1.1	2.4	0.3	0.0	0.8	1.0	2.5	0.8	1.4	0.1	1.4	1.1	2.9	0.0	6.0	2.0	0.9	1.3	0.0	0.9	0.0	3.3	0.9	1.7	4.8	3.1	3.4	5.1	13.0	1.7	1.8	0.7	1.8	1.1	12.7	3.4	2.1	0.4	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.1	0.0	0.0	2.6	0.0	0.0	0.6	2.2	0.0	0.3	1.8	0.0	0.0	0.3	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.6	1.8	0.9	0.1
HIST1H1C	"H1.2, H1c, H1F2, H1s-1"	ENSG00000187837	"Histone cluster 1 H1 family member c"	P16403	6	26055787-26056428	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 353.5"	"Cell type enhanced"	"Detected in all"	6	"Glandular cells: 442.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 79.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"K-562: 50.0;SiHa: 47.6;U-2 OS: 93.7;U-266/70: 103.9;U-266/84: 98.7"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		1800000	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	25.1	17.4	10.1	32.1	10.2	94.7	36.0	23.8	12.8	29.8	23.3	8.1	14.3	15.0	24.7	21.0	48.6	16.6	27.4	37.6	9.3	7.3	23.8	43.1	31.4	37.2	8.2	8.7	34.4	46.6	2.3	5.8	29.1	6.9	44.3	21.2	26.5	22.0	9.5	69.1	21.0	21.1	22.9	12.5	28.4	25.6	33.7	5.4	353.5	21.7	28.5	39.7	38.8	28.0	14.9	5.9	79.7	3.2	3.3	8.6	4.2	5.9	4.2	3.1	3.4	8.1	1.6	0.1	2.9	4.9	14.1	15.0	2.3	4.3	0.4	17.2	3.9	5.1	2.6	1.0	2.3	3.9	5.7	3.7	2.4	4.7	2.6	2.4	1.1	5.9	11.5	3.1	1.8	3.1	4.3	2.2	2.7	50.0	37.6	7.0	2.6	3.0	2.6	1.7	14.5	6.5	1.6	1.4	19.1	8.3	4.3	8.2	2.8	47.6	8.2	3.3	3.1	10.1	1.7	1.0	6.4	93.7	1.9	1.3	103.9	98.7	4.5	4.7	38.9	2.2	35.8	2.6	79.7	3.8	2.6	4.8	9.8	6.3	4.1	5.6	14.9	5.8	4.4	43.0	3.3	3.2	5.9	8.6	4.2	10.1	10.2	23.8	12.8	9.3	7.3	8.2	8.7	6.9	5.4	65.5	28.8	111.5	307.6	7.2	72.6	41.5	30.6	100.4	35.2	66.3	47.1	37.6	44.7	79.4	2.2	29.5	161.7	256.9	100.4	59.2	37.4	442.5	18.6	102.4	61.4	49.3	37.3	33.7	27.5	4.2	24.2	37.4	3.3	16.2	65.1	147.0	86.1	92.5	10.3	161.0	135.9	25.8	23.3	14.2	90.3	6.9	249.6	48.4	36.8	295.6
HIST1H1D	"H1.3, H1d, H1F3, H1s-2"	ENSG00000124575	"Histone cluster 1 H1 family member d"	P16402	6	26234268-26234933	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 182.1"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 15.9;Spermatogonia: 13.2;T-cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.5;MOLT-4: 13.6;NB-4: 6.2;REH: 5.6;SiHa: 5.6;U-266/70: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA055907	Supported					NA	NA					"HPA055907: AB_2682966"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.61e-8)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-2)"	3.2	1.1	0.4	14.7	0.9	37.5	5.0	2.8	0.9	4.1	5.2	0.1	2.0	1.0	3.9	4.8	10.7	1.3	3.7	2.5	0.8	0.8	1.5	1.1	9.9	21.2	0.6	0.0	3.4	0.9	0.9	0.6	2.3	0.1	3.7	2.4	1.4	1.8	1.0	0.9	6.1	4.9	1.2	4.4	14.2	1.6	4.6	0.0	182.1	1.7	4.5	17.6	8.3	9.2	26.3	17.9	8.6	3.8	12.5	21.2	8.0	1.0	0.8	0.2	0.0	0.4	0.0	8.5	0.4	0.3	1.1	0.8	0.2	1.0	0.0	0.2	0.1	0.5	1.0	0.3	0.0	0.5	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.2	0.3	0.0	0.4	1.2	2.3	2.3	0.1	0.0	13.6	6.2	0.7	0.0	2.5	5.6	0.1	3.2	0.0	0.0	2.8	0.4	5.6	2.4	0.0	0.9	1.1	1.3	0.0	0.4	0.0	0.2	0.9	7.0	3.5	0.4	1.0	1.8	0.7	8.6	3.8	3.2	17.7	2.4	12.6	16.5	16.3	12.0	9.5	26.3	21.2	16.4	1.4	12.5	3.4	17.9	12.1	8.0	0.4	0.9	2.8	0.8	0.8	0.8	0.6	0.0	0.1	0.0	0.0	3.0	9.7	7.4	0.5	0.7	0.7	0.0	9.4	6.8	0.0	0.0	1.0	0.0	0.0	0.0	1.6	2.3	0.0	0.0	15.9	0.4	2.0	7.0	0.0	6.0	0.0	1.2	4.3	4.0	0.0	1.1	7.9	0.0	1.8	2.3	7.0	0.0	0.3	0.0	0.5	0.3	0.0	0.4	0.2	13.2	0.3	3.0	30.2	1.3	2.4
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E"	Q8IZD2	7	105014179-105114361	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	22.7	11.8	18.6	24.5	23.5	44.8	20.9	41.6	22.4	26.4	20.9	18.6	21.7	14.7	25.3	15.8	16.5	18.6	18.2	16.8	20.6	15.1	14.2	11.6	22.8	20.1	22.7	17.4	33.5	15.6	20.5	20.1	18.7	18.6	21.2	20.5	17.6	19.6	19.2	21.3	25.7	18.5	26.2	23.1	21.6	17.9	12.9	27.2	24.6	21.7	15.1	22.7	26.6	21.4	38.2	24.7	72.9	20.8	20.3	30.6	14.7	15.1	10.7	22.7	19.5	14.1	16.9	5.8	11.6	17.4	9.8	12.1	8.7	13.9	12.6	11.6	13.6	13.2	11.8	12.5	11.5	16.3	20.3	7.2	12.7	14.0	7.4	13.3	17.0	16.0	11.8	10.8	13.6	14.6	17.9	17.7	14.1	17.3	36.1	13.8	11.9	27.1	14.6	7.9	8.3	8.6	23.4	14.0	14.6	9.7	15.4	13.0	15.7	16.1	13.9	8.8	15.9	6.0	10.2	21.8	23.2	16.2	26.5	11.5	27.6	21.8	29.1	15.2	13.0	15.9	48.5	18.0	39.4	30.6	13.6	30.3	35.6	28.4	26.1	12.8	38.2	28.0	26.0	72.9	20.3	20.8	24.7	23.6	14.7	18.6	23.5	41.6	22.4	20.6	15.1	22.7	17.4	18.6	27.2	131.0	136.3	133.9	100.8	130.3	219.2	86.5	76.5	84.3	142.1	109.9	237.6	33.5	29.9	70.0	19.2	197.7	91.8	93.5	59.6	38.6	151.9	115.7	236.2	33.7	53.7	174.8	96.0	86.5	76.0	18.6	130.6	138.7	133.3	110.0	88.5	114.4	63.9	84.2	123.8	28.6	269.1	122.9	222.6	98.9	71.7	117.7	54.6	186.4	107.4	119.5
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663618	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 169.5;Club cells: 93.3;Collecting duct cells: 118.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.6;HUVEC TERT2: 22.0;RPTEC TERT1: 28.2;RT4: 44.4;TIME: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046537	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA046537: AB_2679689"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	25.9	0.7	3.3	5.7	5.6	0.3	9.1	3.4	5.3	13.5	13.9	1.6	22.1	11.2	15.4	5.7	10.4	14.3	8.1	8.2	3.3	2.9	32.2	2.6	30.0	1.5	4.6	1.4	6.2	27.8	1.1	5.3	10.0	4.7	9.3	17.5	4.2	5.9	25.3	16.0	2.3	5.9	5.6	5.8	6.4	39.4	2.7	3.5	0.2	4.7	3.3	3.5	18.1	18.5	0.3	0.0	0.6	1.5	1.8	1.0	0.0	9.8	0.1	0.2	0.0	1.3	1.0	0.1	1.3	1.6	0.5	0.9	3.9	10.1	0.0	15.6	0.2	2.2	5.2	4.1	6.1	1.1	0.5	6.4	6.2	1.7	0.1	0.1	0.0	1.9	2.1	0.8	0.3	4.6	4.8	22.0	0.5	4.7	0.7	3.9	1.0	0.0	0.0	0.2	5.1	2.5	3.7	5.1	0.2	28.2	44.4	0.3	1.2	0.4	2.6	0.1	0.3	3.0	0.0	20.9	3.9	2.5	1.0	6.5	0.5	0.1	0.3	1.9	0.0	0.6	0.3	0.0	0.6	0.4	0.2	1.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	1.8	1.5	0.0	0.1	0.0	3.3	5.6	3.4	5.3	3.3	2.9	4.6	1.4	4.7	3.5	56.6	169.5	0.0	27.4	1.9	0.0	6.7	5.1	64.3	93.3	118.7	0.0	0.9	44.7	0.8	4.6	40.2	10.5	0.0	65.4	0.1	1.5	9.9	9.2	0.0	0.0	0.0	19.1	34.4	0.6	1.7	0.3	1.0	1.7	1.8	23.3	0.0	42.3	3.5	0.0	0.3	0.0	0.0	0.7	2.1	0.4	1.3	0.3	0.5	49.4	38.8
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 32.8;Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.4"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.5;HEK 293: 2.9;HHSteC: 3.4;hTERT-RPE1: 11.5;MCF7: 2.6;OE19: 5.7"	"Region enriched"	"Detected in many"	5	"basal ganglia: 16.1"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	2.7	0.7	5.3	1.4	5.6	0.5	1.6	0.5	4.7	2.1	6.2	3.3	12.8	14.1	1.5	4.5	1.1	2.0	11.7	5.1	5.2	1.9	7.0	0.6	4.2	1.4	2.9	3.1	3.6	12.7	1.2	1.1	0.6	3.3	1.1	0.9	16.1	1.3	15.0	1.2	0.9	8.0	1.5	2.5	4.2	14.8	1.4	4.8	0.0	10.7	0.0	0.9	1.1	1.5	0.3	0.1	0.0	0.0	5.4	0.4	0.0	0.0	0.0	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.5	0.0	0.4	0.0	0.4	0.0	2.2	0.0	0.0	0.2	2.9	0.0	0.0	0.5	3.4	0.0	1.2	0.0	0.0	0.0	0.0	11.5	0.0	0.2	0.0	0.0	0.0	2.6	0.2	0.0	0.3	5.7	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	5.4	0.0	0.0	0.0	0.0	5.3	5.6	0.5	4.7	5.2	1.9	2.9	3.1	3.3	4.8	32.8	8.0	0.0	0.2	0.6	0.0	4.8	17.8	2.7	9.1	7.0	0.0	0.0	5.0	7.6	0.0	0.7	0.0	0.0	4.3	2.9	0.0	0.3	0.0	0.0	0.0	1.6	5.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	1.3	5.3	0.0	1.8	0.2	0.0	0.0	5.3	0.2	1.1	0.0	0.0	0.0	1.2	0.1
RIF1	"FLJ10599, FLJ12870"	ENSG00000080345	"Replication timing regulatory factor 1"	Q5UIP0	2	151409883-151508013	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036887, HPA036888"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Plasma membrane"		No	No			"Nucleoplasm, Nuclear bodies, Plasma membrane"		"HPA036887: AB_2675361, HPA036888: AB_2675362"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.41e-2)"	13.7	9.0	12.1	11.7	18.2	31.1	16.6	23.6	17.1	12.7	10.9	12.4	8.7	7.2	15.5	7.3	10.2	11.5	9.8	8.5	11.7	8.5	9.8	11.2	10.9	13.0	15.7	11.6	19.4	12.1	16.3	17.3	13.4	13.6	10.8	10.6	9.6	12.0	9.3	18.3	13.9	10.4	13.5	11.6	10.2	10.1	17.8	15.9	18.4	15.5	9.4	12.9	11.6	11.9	6.2	2.6	7.9	4.7	10.7	7.8	2.3	9.9	8.5	13.3	10.1	5.5	7.0	12.8	12.1	9.0	11.0	13.2	13.9	8.2	19.1	11.0	8.5	9.1	10.4	20.4	8.6	18.7	13.4	9.7	30.4	10.4	9.9	5.8	30.5	10.2	5.3	5.6	19.7	15.0	6.1	10.6	11.8	24.5	16.2	11.2	6.7	18.0	10.6	21.3	5.3	11.6	18.5	21.1	12.5	5.7	12.4	12.1	9.3	15.8	7.3	8.2	9.8	6.4	11.1	13.2	16.7	11.7	10.1	12.8	8.0	13.9	27.9	7.6	12.3	11.0	7.9	3.6	4.3	6.8	2.5	7.8	6.2	5.8	4.9	2.6	5.2	7.7	5.9	4.2	10.7	4.7	2.4	4.0	2.3	12.1	18.2	23.6	17.1	11.7	8.5	15.7	11.6	13.6	15.9	89.3	38.8	22.7	37.6	43.8	43.2	30.5	30.6	22.7	51.2	14.0	29.5	33.1	1.7	31.1	9.9	38.7	14.2	0.0	18.7	32.2	38.4	39.1	32.4	17.1	19.6	44.5	24.0	27.6	27.0	9.9	40.6	34.9	28.7	29.7	28.7	37.8	25.0	23.5	32.2	9.5	42.4	84.1	40.1	87.8	126.0	36.4	34.2	27.4	28.4	37.2
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006714	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	20.4	27.8	27.6	21.6	33.8	34.3	20.4	40.5	34.5	23.7	22.5	14.3	17.6	16.9	25.7	18.4	22.4	18.5	18.4	24.8	26.5	21.4	17.6	19.6	17.2	23.0	17.0	35.1	27.7	15.2	37.0	20.3	36.9	27.2	22.0	20.6	15.4	19.5	23.2	55.2	24.8	20.7	24.7	14.9	23.5	19.0	25.4	13.5	25.3	26.7	15.6	21.6	27.8	20.2	8.0	7.4	11.6	4.3	8.6	5.7	1.4	15.3	10.1	33.4	27.1	19.0	22.6	15.8	20.6	23.2	28.3	23.7	19.7	9.8	14.6	16.7	21.5	12.6	27.4	19.3	17.1	24.3	22.2	18.0	30.7	22.9	14.7	13.3	27.3	18.0	16.2	17.4	15.1	15.3	21.1	22.7	26.8	23.3	17.0	23.1	11.7	26.1	16.9	18.0	19.2	13.9	28.4	26.1	13.9	18.4	33.1	17.2	22.8	18.5	23.7	9.3	19.0	19.4	26.5	18.6	27.8	17.7	27.6	22.5	19.7	30.3	24.3	20.0	26.1	16.9	5.9	4.3	8.4	4.8	2.8	4.4	8.0	4.7	4.1	3.0	6.5	5.7	4.7	11.6	8.6	3.3	7.4	5.4	1.4	27.6	33.8	40.5	34.5	26.5	21.4	17.0	35.1	27.2	13.5	119.1	70.9	118.3	89.5	128.8	209.3	81.2	112.1	69.6	75.1	116.9	88.4	138.6	139.3	89.0	242.0	101.3	97.3	116.8	95.9	97.3	120.4	91.4	89.0	170.3	83.7	139.8	84.2	119.7	72.1	267.8	134.3	89.8	102.9	103.6	107.1	106.0	103.7	94.8	150.3	100.0	188.1	84.1	92.0	109.4	66.6	142.4	183.4	97.8	106.5	90.9
TFB1M	"CGI-75, mtTFB"	ENSG00000029639	"Transcription factor B1, mitochondrial"	Q8WVM0	6	155257509-155314493	"Disease related genes, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029428	Approved					NA	NA					"HPA029428: AB_2673038"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.33e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.77e-2)"	6.6	24.2	9.2	10.5	11.7	3.2	10.7	15.2	13.2	7.0	10.1	12.1	7.9	8.6	12.0	10.4	12.6	9.3	6.7	16.2	8.6	8.0	10.2	19.8	6.8	13.3	8.6	7.2	10.6	11.6	11.5	26.3	5.9	12.2	8.4	13.9	12.8	12.9	8.5	21.5	10.8	8.5	10.1	10.4	11.7	9.1	13.8	10.4	16.4	11.7	6.9	17.7	9.7	8.9	18.4	15.1	9.8	9.4	16.7	20.0	8.3	6.3	4.7	4.8	11.8	6.0	14.1	7.5	9.7	9.0	9.8	13.8	6.2	5.2	13.3	5.4	4.3	8.3	13.6	5.1	10.2	17.3	6.7	7.6	5.7	4.9	38.6	20.4	10.6	4.2	14.6	4.4	15.4	13.8	12.4	12.1	11.4	14.3	4.2	12.2	4.7	5.7	10.4	8.5	9.0	10.3	5.6	2.9	13.2	10.1	6.0	5.6	11.4	2.8	9.5	9.9	9.7	6.0	10.3	5.3	3.8	5.2	11.2	11.3	7.2	8.2	9.5	17.4	13.5	8.2	9.8	7.0	8.4	11.4	9.4	16.3	17.1	16.3	14.9	15.1	18.4	20.0	16.6	3.0	16.7	7.2	12.8	18.3	8.3	9.2	11.7	15.2	13.2	8.6	8.0	8.6	7.2	12.2	10.4	20.8	11.8	9.0	11.9	5.6	13.1	19.3	2.5	9.4	9.1	12.2	21.6	16.9	26.6	17.7	196.9	5.0	4.5	0.0	15.5	16.0	7.8	6.2	26.6	21.7	13.5	28.6	5.8	3.7	7.3	7.6	4.6	8.6	3.3	17.2	7.6	12.8	11.8	7.0	8.1	15.1	21.4	12.9	12.3	24.6	14.1	9.9	6.1	14.1	14.2	7.3
APOBEC3F	"ARP8, BK150C2.4.MRNA, KA6"	ENSG00000128394	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3F"	Q8IUX4	22	39040604-39053910	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.7"									HPA073637			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA073637: "	"unprognostic (1.38e-3)"	"unprognostic (1.28e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (8.28e-4)"	6.9	9.0	1.9	7.9	2.3	2.5	3.1	0.7	2.0	9.6	5.4	3.9	14.5	3.1	8.2	5.6	5.6	8.1	3.1	6.7	2.4	1.7	5.9	4.5	5.4	13.1	1.8	1.2	14.1	5.5	3.9	4.9	1.7	2.6	6.4	2.4	6.6	6.4	16.3	3.2	1.6	5.0	3.9	3.6	14.3	4.3	11.9	1.9	7.3	4.2	2.5	15.9	5.4	4.5	23.2	4.3	5.9	9.1	9.3	6.9	4.7	4.4	3.5	1.4	5.5	4.1	6.1	2.0	3.4	6.3	8.1	12.9	3.0	8.0	10.6	3.6	7.1	6.7	5.6	1.3	5.3	3.2	10.0	4.4	14.3	0.0	1.5	8.1	1.5	6.0	8.0	2.3	4.1	1.4	4.4	7.4	2.8	1.0	17.7	4.0	3.2	3.2	1.9	0.6	0.0	0.5	5.3	0.5	2.3	6.7	5.9	0.7	1.1	4.1	1.1	2.2	3.3	4.2	1.2	1.9	1.7	4.7	0.2	1.5	3.1	1.6	0.5	4.9	1.4	2.6	1.4	3.3	5.9	6.1	6.6	6.9	16.4	4.0	6.2	4.3	23.2	2.5	3.9	1.5	9.3	9.1	3.7	5.4	4.7	1.9	2.3	0.7	2.0	2.4	1.7	1.8	1.2	2.6	1.9	0.0	0.3	5.2	4.0	0.8	0.0	4.4	10.2	2.7	0.0	0.0	0.0	1.4	1.7	7.1	2.1	1.5	0.5	0.0	3.5	1.2	2.2	3.4	2.3	0.9	5.0	0.0	1.2	4.3	2.1	3.3	4.6	1.9	5.0	6.4	2.1	2.0	4.6	2.8	6.0	2.8	0.3	0.0	1.9	0.3	0.2	0.6	1.4	5.3	1.5	6.2
CXXC1	"CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1"	ENSG00000154832	"CXXC finger protein 1"	Q9P0U4	18	50282343-50288304	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044511	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044511: AB_10963081"	"unprognostic (4.47e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-2)"	12.1	16.9	17.5	20.0	20.3	40.3	12.4	42.4	23.1	15.7	15.2	15.7	18.7	18.3	16.8	10.2	15.5	19.8	17.5	13.6	18.2	12.2	16.5	14.9	13.9	23.6	22.6	13.1	23.6	32.8	13.7	14.3	22.4	18.7	15.6	9.1	14.1	24.7	19.4	12.1	17.2	15.1	17.7	11.7	19.3	17.3	15.5	20.3	25.8	15.5	14.0	18.6	17.5	20.1	22.0	16.6	24.5	16.9	16.0	21.1	15.0	8.3	11.3	8.6	16.2	7.0	4.9	17.8	11.0	7.6	11.0	9.7	8.3	6.3	23.7	5.7	5.0	6.5	13.7	14.3	10.4	3.1	19.4	12.7	19.1	12.4	13.1	5.0	44.7	20.8	4.8	8.1	12.0	6.2	4.0	7.4	18.7	11.8	20.3	5.5	11.8	26.5	22.0	18.9	4.2	7.6	26.7	8.9	19.1	5.9	5.0	18.1	17.4	8.6	5.6	6.9	5.1	7.1	18.9	11.2	15.4	9.8	6.8	9.3	35.0	24.6	19.5	9.7	16.6	13.1	17.7	14.1	24.5	19.2	16.9	21.1	22.0	17.7	19.3	16.6	21.7	19.6	16.2	6.2	16.0	13.1	12.1	19.6	15.0	17.5	20.3	42.4	23.1	18.2	12.2	22.6	13.1	18.7	20.3	17.9	27.2	14.9	11.2	23.8	13.6	6.3	12.7	13.4	20.5	17.4	13.7	32.2	11.6	16.2	12.1	17.9	26.6	0.0	19.0	32.2	14.6	10.7	8.1	12.8	19.3	7.9	33.9	16.0	17.5	7.0	18.4	21.2	8.5	16.2	22.0	17.1	18.2	22.4	18.4	10.6	11.7	6.5	16.4	48.7	18.1	26.3	31.0	27.4	23.1	9.4
MRM2	"FJH1, FTSJ2, RRMJ2"	ENSG00000122687	"Mitochondrial rRNA methyltransferase 2"	Q9UI43	7	2234231-2242198	"Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 50.0;Extravillous trophoblasts: 29.7;Hofbauer cells: 31.2;Syncytiotrophoblasts: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019826, HPA049622"	Uncertain					NA	NA					"HPA019826: AB_2670282, HPA049622: AB_2680834"	"unprognostic (8.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (8.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.48e-1)"	10.6	18.1	14.9	11.9	13.0	5.9	18.8	14.8	17.4	9.9	11.5	12.5	11.0	11.5	11.3	10.5	15.5	12.1	7.7	18.5	12.4	10.2	13.2	18.2	11.1	17.2	12.0	10.6	13.4	18.9	13.3	10.1	15.3	14.7	14.3	11.7	12.6	12.6	14.9	24.3	13.8	11.4	10.8	10.5	17.7	11.9	21.3	11.8	15.4	15.2	10.7	18.2	12.3	11.3	25.4	33.8	15.5	26.4	20.5	18.7	17.5	25.2	16.0	12.9	9.5	8.0	9.0	10.5	14.8	15.2	18.6	17.7	21.7	11.9	23.8	7.0	11.2	15.7	20.6	20.7	19.4	19.5	9.1	17.5	15.9	14.6	12.3	10.5	20.8	14.1	7.9	13.5	14.7	14.3	7.9	8.0	13.7	24.5	13.6	14.1	28.4	6.2	23.6	38.3	15.1	16.2	14.4	18.6	18.0	12.2	18.2	12.5	19.6	11.0	31.6	12.7	18.0	28.5	29.6	6.4	10.8	27.5	21.7	22.9	12.5	19.0	24.2	12.6	21.1	32.3	5.6	23.7	15.5	14.2	26.4	17.0	25.4	14.8	15.8	33.8	22.3	18.7	16.3	1.7	20.5	20.7	17.5	16.5	17.5	14.9	13.0	14.8	17.4	12.4	10.2	12.0	10.6	14.7	11.8	20.8	13.7	0.0	0.0	0.0	0.0	0.0	0.0	17.4	14.8	10.4	0.0	50.0	26.6	20.1	0.0	0.0	0.0	0.0	17.3	29.7	0.0	0.0	10.5	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	20.8	0.0	0.0	19.2	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0
MTF2	"M96, PCL2, TDRD19A"	ENSG00000143033	"Metal response element binding transcription factor 2"	Q9Y483	1	93079235-93139081	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.4"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069047, HPA069066"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069047: AB_2686073, HPA069066: AB_2686078"	"unprognostic (1.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.88e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (1.26e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.05e-4)"	"prognostic unfavorable (2.47e-7)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	6.8	8.0	8.5	19.7	18.4	21.9	10.3	24.3	12.2	9.8	8.0	8.6	4.9	8.0	9.0	8.5	7.2	7.6	7.4	5.3	9.0	8.2	7.6	7.3	8.6	19.9	8.1	9.8	12.0	7.0	6.7	13.9	13.0	9.2	7.0	8.4	6.7	6.7	6.8	7.1	8.1	9.5	6.8	8.5	12.7	7.2	17.3	9.2	43.4	9.6	7.1	19.4	7.9	8.3	11.7	12.0	14.7	10.6	13.0	14.3	6.2	7.4	3.6	12.5	8.2	2.2	2.1	14.5	4.8	3.8	8.3	10.4	6.1	4.1	24.1	8.8	3.0	7.1	4.0	11.5	5.0	12.3	9.3	8.4	16.6	5.5	8.2	3.3	21.6	7.1	2.6	2.7	7.8	4.7	3.8	7.9	18.8	18.7	7.6	5.1	3.1	31.0	18.0	21.3	3.3	4.8	25.2	15.4	6.5	7.7	8.1	7.8	9.5	7.9	9.4	9.6	13.8	5.6	15.3	4.5	5.5	8.2	5.2	7.1	5.9	6.7	42.8	1.1	12.9	3.5	9.4	9.4	14.7	11.3	10.6	12.9	10.0	11.7	14.3	12.0	11.7	13.9	12.4	7.2	13.0	6.3	11.4	12.9	6.2	8.5	18.4	24.3	12.2	9.0	8.2	8.1	9.8	9.2	9.2	26.8	27.2	56.4	25.5	41.3	0.0	11.7	7.6	17.4	28.4	36.6	0.0	60.2	6.6	29.9	3.7	39.3	25.4	23.3	16.9	56.8	29.0	28.2	57.8	13.4	30.0	0.0	30.9	35.0	26.7	5.0	30.2	40.6	16.9	42.3	29.2	0.0	27.2	31.6	22.3	12.9	0.0	38.8	23.6	122.6	74.3	37.8	50.8	48.4	30.8	32.0
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated 2"	Q96T68	13	49444374-49495003	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"CAB012190: AB_2186195, HPA071677: AB_2686430"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favorable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	10.2	14.5	9.8	20.5	10.8	9.5	14.1	14.4	12.3	13.0	12.4	8.3	13.6	7.8	13.1	11.6	9.8	9.9	9.7	12.7	8.2	6.9	12.4	11.0	16.3	19.0	7.2	11.1	21.0	15.0	10.8	15.8	7.8	9.5	13.6	11.9	13.5	11.7	10.9	5.5	9.6	11.4	11.3	8.4	19.0	10.7	18.1	8.7	17.3	14.6	3.7	16.6	11.9	10.3	8.4	7.4	4.7	5.4	7.8	10.2	4.5	2.0	1.4	4.3	4.4	6.1	6.9	2.2	5.9	7.4	5.3	5.0	8.7	5.0	25.7	1.2	3.8	4.0	4.2	4.5	4.0	5.2	5.8	3.9	8.9	3.9	5.2	8.6	13.5	5.1	5.3	7.4	4.0	13.4	5.8	4.5	8.3	3.9	3.6	4.8	1.8	5.1	10.1	2.2	5.5	3.4	10.0	5.4	5.4	4.9	1.9	2.2	2.6	2.6	3.7	12.6	3.9	3.1	11.8	2.7	5.1	1.8	6.8	2.4	4.3	6.0	13.6	1.6	11.0	2.3	4.1	4.1	4.7	6.9	5.4	5.8	8.4	7.1	7.1	7.4	8.1	10.2	7.6	1.4	7.8	4.3	5.2	9.4	4.5	9.8	10.8	14.4	12.3	8.2	6.9	7.2	11.1	9.5	8.7	26.8	14.1	32.7	5.3	6.2	12.6	22.4	10.2	13.4	10.3	5.2	25.5	4.8	8.3	3.3	14.7	8.2	6.9	0.0	3.8	2.9	5.1	3.0	5.8	5.9	15.9	12.7	11.1	5.5	19.0	11.1	9.2	17.4	13.5	10.0	6.2	10.8	3.1	2.9	7.8	3.4	29.6	0.0	5.2	18.2	11.8	5.3	2.4	19.1	8.5	2.0
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067780-88113387	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 45.9;skeletal muscle: 103.7;tongue: 36.4"	"Cell type enriched"	"Detected in single"	1107	"Cardiomyocytes: 207.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.6"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HSkMC: 5.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA062282	Enhanced					NA	NA					"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			2.7	0.0	0.1	0.1	0.3	0.0	1.2	0.0	1.4	0.0	4.6	0.0	0.0	0.4	0.0	3.4	2.5	0.0	0.2	45.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.4	0.0	1.5	0.0	103.7	0.0	4.4	6.3	0.1	0.0	2.6	0.1	0.0	0.0	0.2	36.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone"	Q7KZ85	17	28662091-28702684	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: AB_2675094"	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	27.6	30.0	30.0	24.1	32.8	56.3	25.6	31.9	35.7	28.0	30.1	28.5	23.2	19.9	38.6	28.4	24.4	24.1	25.0	23.8	25.7	22.0	24.1	32.6	26.3	26.0	25.7	32.8	33.1	28.8	40.7	34.5	31.9	24.3	26.9	21.8	33.2	28.2	29.2	50.1	38.6	28.7	40.0	29.8	33.1	28.5	23.4	29.0	27.2	27.6	18.4	29.4	30.7	27.1	5.7	8.2	14.4	6.1	5.4	5.6	3.4	18.0	37.8	19.0	21.7	23.2	15.6	14.7	24.8	26.6	29.3	26.3	35.1	8.1	19.2	13.0	24.8	22.6	21.6	27.8	18.0	30.5	35.7	24.7	26.8	30.6	21.7	19.4	28.1	30.0	21.4	10.9	31.1	20.8	19.4	19.2	18.9	26.3	22.8	20.8	21.5	27.7	12.0	14.7	15.9	12.3	14.2	35.0	15.6	14.5	35.8	14.5	19.2	29.1	46.0	15.7	27.3	28.2	20.0	30.2	23.2	19.2	22.0	31.6	29.0	22.2	28.2	26.2	12.7	19.1	14.4	5.9	5.4	5.2	3.9	5.5	5.6	4.3	5.6	4.8	5.7	4.4	3.8	9.0	5.4	6.1	8.2	3.8	3.4	30.0	32.8	31.9	35.7	25.7	22.0	25.7	32.8	24.3	29.0	35.7	51.4	21.7	18.1	19.9	27.9	43.2	22.9	33.5	36.4	19.2	53.0	21.0	5.0	19.2	3.9	24.0	22.2	23.3	18.3	17.3	18.8	16.3	47.6	30.2	20.6	28.6	29.7	19.0	21.5	14.4	23.9	20.4	8.5	27.9	19.2	20.5	25.9	16.7	25.1	9.4	40.8	32.3	22.2	18.4	16.2	21.2	41.6	20.8	17.7	21.8
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657604-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 75.5"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 109.0;Spermatocytes: 197.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.8"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.8;T-cells: 13.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 6.7;olfactory region: 8.8"	"CAB002784, HPA074922"	Enhanced					NA	Yes					"CAB002784: , HPA074922: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	3.0	2.6	4.6	15.5	5.8	34.9	2.8	1.2	6.3	3.4	10.1	10.2	1.5	4.8	2.5	3.6	12.3	2.4	4.6	2.0	5.8	2.9	4.8	5.1	4.2	15.4	3.4	4.5	2.0	3.1	1.1	1.3	14.3	3.4	3.0	12.9	1.1	3.4	0.8	0.7	3.6	6.9	5.5	4.6	8.9	4.2	21.5	5.3	75.5	1.7	10.9	19.3	4.8	4.3	1.2	1.8	1.0	0.1	6.8	13.8	2.5	13.9	21.5	44.9	21.7	5.0	8.4	22.8	32.9	19.7	35.6	42.7	18.1	11.2	21.7	12.9	17.7	20.2	6.3	31.3	12.4	30.8	20.4	34.8	36.8	20.2	31.1	1.1	75.6	40.4	7.4	2.9	22.4	7.0	6.8	29.7	46.2	29.5	34.9	44.8	16.0	91.0	41.9	16.2	17.0	16.1	60.2	40.4	26.1	13.3	12.4	15.3	24.9	27.8	12.9	8.3	29.1	8.8	34.5	11.7	41.2	81.4	37.7	64.2	43.3	53.3	49.6	10.9	32.7	47.0	0.0	0.0	1.0	1.1	0.1	0.0	1.2	2.9	2.2	1.8	0.0	0.0	0.7	0.6	6.8	0.1	0.3	13.8	2.5	4.6	5.8	1.2	6.3	5.8	2.9	3.4	4.5	3.4	5.3	0.0	2.9	3.0	11.2	12.8	0.4	2.1	5.1	0.0	7.9	0.0	0.0	36.1	1.7	2.4	18.3	1.5	8.4	23.3	0.7	109.0	7.2	4.0	6.9	1.7	57.9	0.0	1.2	6.2	15.9	22.3	5.8	9.2	10.1	6.4	13.0	42.9	1.4	3.5	3.5	19.4	1.9	12.9	4.1	197.1	30.9	6.4	22.5	7.5	39.0	3.5
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602166-8612871	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.6;lymphoid tissue: 22.3"	"Cell type enhanced"	"Detected in single"	10	"Alveolar cells type 2: 1.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.6"	"Group enriched"	"Detected in many"	6	"B-cells: 6.6;granulocytes: 1.6"	"Group enriched"	"Detected in some"	6	"Daudi: 49.6;U-698: 41.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	1.3	0.1	0.1	22.3	0.1	0.4	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.9	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.2	0.1	0.5	15.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	1.8	0.1	1.1	0.5	3.9	0.1	0.1	1.7	0.2	0.2	0.1	0.6	0.3	0.1	12.2	0.1	0.7	6.6	0.7	1.6	0.7	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	41.4	0.0	0.1	0.0	1.0	0.7	0.4	0.4	0.3	0.2	4.3	0.4	0.2	0.4	6.6	0.4	0.4	1.6	0.5	0.4	0.7	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.3	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502726-107565746	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Oxidoreductase, RNA-binding, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547"	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	9.7	6.7	7.2	14.1	12.6	6.1	11.3	9.9	11.7	8.6	7.4	7.6	9.4	6.7	9.5	7.1	9.8	7.4	6.0	12.4	7.4	7.6	9.2	9.5	7.5	11.5	7.2	5.5	9.9	7.0	13.4	10.0	6.9	7.9	8.9	7.9	8.1	7.7	7.5	12.6	9.7	7.8	9.0	7.0	10.8	6.8	5.8	5.8	9.2	11.1	5.7	12.0	8.9	8.1	3.7	3.3	0.5	4.1	4.8	6.2	2.2	4.9	6.0	6.3	6.8	3.5	7.8	5.2	9.6	7.1	7.1	7.7	11.1	9.1	11.6	5.5	9.1	9.7	8.9	9.3	7.7	9.2	10.3	6.2	9.7	2.4	5.1	5.2	12.3	12.0	4.8	8.8	9.1	11.6	3.6	8.7	9.1	13.7	3.9	5.6	4.4	11.1	6.2	8.3	9.6	10.0	10.2	9.7	8.0	5.6	5.4	5.7	6.4	5.5	4.1	4.0	3.9	6.8	3.7	8.2	15.4	9.2	5.0	11.8	3.6	3.9	9.1	4.3	8.3	15.1	0.0	2.0	0.5	4.5	4.1	4.3	1.9	3.3	3.9	3.3	3.7	6.2	5.2	0.0	4.8	2.7	2.0	3.5	2.2	7.2	12.6	9.9	11.7	7.4	7.6	7.2	5.5	7.9	5.8	0.0	4.0	2.9	1.7	1.8	5.9	10.0	7.6	0.0	4.5	1.8	5.9	1.8	0.0	1.8	0.2	2.2	1.1	0.0	2.9	2.3	3.4	1.1	9.3	6.4	2.4	1.6	1.2	4.3	2.5	0.0	2.6	2.2	3.3	3.6	3.0	2.5	1.9	4.0	3.9	2.6	3.5	0.0	2.3	1.7	2.9	3.6	0.7	5.0	3.8	0.6
ARID4B	"BCAA, BRCAA1, RBP1L1, SAP180"	ENSG00000054267	"AT-rich interaction domain 4B"	Q4LE39	1	235131634-235328219	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027205, HPA027333"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoplasm	"HPA027205: , HPA027333: AB_1845013"	"unprognostic (2.62e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.84e-3)"	15.3	13.8	14.9	19.0	22.5	34.1	15.9	32.8	17.6	19.7	13.4	19.2	18.2	9.1	18.7	18.1	12.0	15.0	15.2	10.6	15.2	14.5	13.1	14.0	15.5	22.3	26.9	13.9	21.8	16.8	23.8	25.7	14.7	20.3	17.9	10.7	12.0	16.7	17.0	12.3	12.3	14.2	14.6	19.8	19.8	14.7	19.5	23.4	33.7	20.2	8.2	18.9	18.2	18.6	17.1	11.7	35.9	11.8	16.6	17.0	6.0	12.2	9.2	16.2	12.5	11.9	12.5	13.3	14.0	12.3	9.7	9.5	9.5	13.1	14.4	16.3	10.5	6.9	10.9	13.1	5.9	14.1	18.5	14.2	11.6	11.1	7.9	9.1	12.4	17.1	8.4	8.0	11.9	10.2	12.7	13.1	9.2	15.0	20.7	9.1	5.5	18.5	11.3	14.8	8.8	6.1	6.9	11.5	12.0	10.6	10.3	13.2	18.3	17.8	14.8	13.8	4.9	15.6	20.1	18.0	12.0	9.1	14.6	13.6	20.2	16.0	14.4	8.2	9.1	16.0	24.6	7.1	19.5	16.1	7.6	14.7	15.6	17.0	13.7	6.8	17.1	16.9	14.4	35.9	16.6	11.8	11.7	13.6	6.0	14.9	22.5	32.8	17.6	15.2	14.5	26.9	13.9	20.3	23.4	95.3	99.9	54.7	68.9	110.4	111.2	62.2	35.7	91.0	101.2	29.6	113.9	55.7	16.6	62.0	329.6	108.9	41.9	46.7	41.8	58.1	114.7	81.5	105.3	23.1	39.4	106.5	86.4	65.7	52.4	349.2	93.7	99.4	79.2	108.2	45.8	77.7	57.3	49.9	72.9	15.0	150.5	45.3	129.6	212.6	167.8	93.1	131.0	129.6	39.6	111.5
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		3200000	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	15.5	15.8	10.7	11.5	16.2	3.9	20.5	17.5	18.2	13.7	12.8	7.5	9.9	14.7	13.0	13.4	11.5	10.6	9.0	13.4	11.4	13.0	34.7	33.2	15.4	15.0	10.9	8.6	15.3	7.7	7.7	13.8	26.7	18.6	11.6	14.2	9.2	8.8	10.6	14.9	7.0	16.2	11.8	10.6	16.2	10.9	10.8	9.4	13.2	26.5	11.9	14.0	14.1	10.6	9.6	12.3	26.9	18.6	10.8	13.2	10.8	8.2	6.3	13.3	11.9	10.9	17.2	21.5	15.5	13.5	13.0	17.3	16.4	6.8	12.3	10.4	10.9	11.9	8.4	39.3	11.6	22.0	13.6	12.3	8.9	7.5	19.0	13.6	16.6	11.2	13.8	8.2	17.4	10.3	10.8	18.4	9.3	12.7	15.9	16.2	34.3	10.4	16.0	22.7	8.1	5.3	13.8	11.5	9.7	39.8	10.5	5.5	3.6	12.9	12.2	7.9	24.9	34.6	13.1	15.2	6.4	8.9	23.5	12.3	7.4	9.3	14.7	11.3	20.6	7.4	22.8	14.7	26.9	7.8	18.6	10.3	9.6	10.2	8.3	12.3	7.1	9.5	8.7	12.2	10.8	16.6	4.6	13.2	10.8	10.7	16.2	17.5	18.2	11.4	13.0	10.9	8.6	18.6	9.4	23.8	36.8	8.9	7.0	0.0	8.9	16.5	7.6	20.1	11.4	22.7	7.9	26.6	38.1	17.4	0.9	7.7	12.9	23.3	15.6	32.5	8.4	5.6	3.5	43.3	30.5	7.9	4.7	17.2	35.4	2.3	17.8	24.7	0.0	31.5	10.6	14.5	16.3	7.0	13.8	56.4	19.8	0.0	13.7	18.9	17.0	0.0	30.1	12.8	13.8	8.4
ATF7IP	"FLJ10688, p621"	ENSG00000171681	"Activating transcription factor 7 interacting protein"	Q6VMQ6	12	14365632-14502935	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016578, HPA023505"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA016578: AB_1845147, HPA023505: AB_1845148"	"unprognostic (2.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.88e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.78e-2)"	17.5	15.0	11.1	36.4	15.3	25.2	16.6	29.4	12.7	18.0	12.9	14.1	16.0	7.3	16.1	14.5	20.2	13.0	15.2	18.3	11.7	8.3	11.3	14.0	16.2	25.2	13.8	10.7	19.5	13.0	23.3	23.3	22.4	11.9	15.7	12.3	14.4	21.7	18.0	25.4	15.6	16.6	15.4	12.3	23.9	12.5	30.1	13.6	38.8	20.2	12.6	24.5	17.2	27.3	25.0	9.9	15.9	9.7	8.6	13.4	6.6	10.9	6.5	27.1	15.7	14.3	18.3	5.9	11.5	6.7	9.3	14.4	15.0	11.8	18.3	8.1	8.1	17.1	11.1	16.8	10.9	21.2	13.1	9.8	12.3	11.2	3.2	8.4	8.3	7.3	9.8	9.1	11.5	12.0	14.8	20.3	6.7	7.2	10.0	14.7	10.4	11.9	7.3	17.3	5.7	6.2	24.9	29.9	9.9	8.1	21.6	8.7	7.2	13.5	7.9	7.6	23.0	8.0	9.8	9.3	13.2	8.5	7.5	9.8	6.5	6.3	26.0	8.4	7.9	14.1	15.9	8.1	13.6	12.9	6.3	13.4	16.9	11.0	12.5	7.2	25.0	8.9	12.2	13.5	8.6	9.7	9.9	13.4	6.6	11.1	15.3	29.4	12.7	11.7	8.3	13.8	10.7	11.9	13.6	62.5	34.4	42.4	10.8	6.0	51.5	58.1	15.3	32.1	38.7	33.2	64.8	13.8	6.6	13.0	53.7	33.7	9.3	23.3	10.6	7.7	14.3	12.4	24.4	25.9	17.2	60.4	27.0	27.6	42.9	13.3	27.0	26.9	5.0	26.2	21.6	26.7	13.6	10.5	27.6	14.0	38.8	12.9	11.3	42.6	23.5	5.8	12.9	45.7	19.5	9.1
KDM6A	UTX	ENSG00000147050	"Lysine demethylase 6A"	O15550	X	44873177-45112602	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000568, HPA001165, HPA002111"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704"	"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.16e-2)"	12.3	12.1	16.5	17.6	24.5	47.9	21.4	26.1	22.0	16.9	11.8	16.7	12.0	13.1	22.6	11.3	15.4	16.9	15.2	9.1	18.2	6.5	11.6	13.5	19.7	15.1	28.8	11.3	23.8	14.9	21.3	20.2	13.3	18.3	10.3	11.3	10.3	16.1	12.6	15.1	21.3	17.6	13.5	14.9	18.1	15.0	17.7	26.1	19.1	14.5	6.9	13.6	14.9	22.8	5.5	7.1	15.7	7.5	6.2	7.9	3.5	8.7	7.6	11.3	11.4	8.1	8.4	24.2	6.8	4.8	8.2	8.6	17.9	7.5	5.7	3.7	6.3	17.0	18.8	14.5	12.0	7.6	8.3	15.5	7.1	9.6	6.7	5.7	3.8	20.2	4.5	9.9	13.5	14.1	8.8	6.3	7.0	9.8	14.2	5.1	5.7	7.8	11.2	9.4	6.7	8.8	8.7	10.9	1.0	4.7	16.3	9.7	5.2	21.7	10.9	9.2	24.8	10.6	0.1	5.3	7.8	6.0	7.8	3.5	9.0	10.8	8.6	5.4	4.0	4.5	15.7	3.8	3.5	5.3	7.5	6.0	5.5	7.2	7.9	7.1	3.8	7.0	6.3	7.3	6.2	7.2	3.8	5.6	3.5	16.5	24.5	26.1	22.0	18.2	6.5	28.8	11.3	18.3	26.1	6.0	8.8	5.2	11.3	23.2	6.5	11.4	10.2	5.3	7.9	7.0	13.7	3.8	0.0	6.5	1.0	9.4	18.8	0.0	6.6	4.9	8.9	11.4	2.3	13.9	6.1	23.8	12.6	6.2	8.9	1.1	6.1	9.7	10.1	7.2	14.2	7.4	7.7	14.4	6.7	3.3	8.4	6.5	10.3	5.6	11.7	23.1	9.2	10.1	11.0	16.3
MORC1	"CT33, MORC, ZCW6"	ENSG00000114487	"MORC family CW-type zinc finger 1"	Q86VD1	3	108958239-109118142	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 21.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 45.5;Late spermatids: 21.8;Spermatocytes: 37.7;Spermatogonia: 41.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"	"Group enriched"	"Detected in some"	10	"Karpas-707: 4.4;RPMI-8226: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036413	Enhanced					NA	NA					"HPA036413: AB_10669989"					"unprognostic (1.66e-1)"				"unprognostic (4.30e-2)"	"unprognostic (2.17e-2)"		"unprognostic (2.63e-1)"	"unprognostic (7.45e-6)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	2.2	21.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	37.7	41.6	0.0	0.0	0.0	0.0	0.1
PICK1	"dJ1039K5, MGC15204, PRKCABP"	ENSG00000100151	"Protein interacting with PRKCA 1"	Q9NRD5	22	38056311-38075701	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 106.4;Late spermatids: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA000819, HPA072674"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA000819: , HPA072674: AB_2686547"	"unprognostic (1.97e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.56e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.61e-3)"	7.7	11.9	16.9	5.7	32.7	5.3	14.9	18.4	26.2	8.9	12.5	21.3	18.6	10.8	11.3	15.5	13.0	18.1	10.0	14.7	17.2	14.8	12.4	14.5	10.8	8.1	47.4	21.5	15.6	16.1	36.6	22.7	8.7	24.7	25.5	13.4	11.4	19.1	18.9	18.0	11.5	9.8	12.5	17.6	8.1	15.0	18.6	36.5	2.5	13.4	6.8	8.5	8.9	8.6	2.5	4.6	1.9	2.7	1.4	3.2	1.7	10.3	7.4	4.2	5.5	3.0	2.4	6.3	5.8	7.0	12.5	12.7	7.9	6.5	4.6	6.5	7.0	9.5	11.3	11.5	23.4	10.8	2.8	18.4	1.6	8.9	9.0	11.0	5.3	11.3	7.6	13.8	8.2	12.2	12.8	4.8	6.1	3.3	3.4	2.6	6.6	3.1	0.5	6.6	23.7	8.1	2.7	0.2	4.1	14.5	16.8	17.5	8.9	6.5	15.9	5.9	6.4	9.2	3.9	1.3	3.6	6.7	4.7	3.4	7.6	1.8	1.3	7.7	1.8	5.1	0.0	2.7	0.0	1.8	1.5	0.6	1.1	1.8	3.2	4.6	2.5	3.1	1.8	1.9	1.4	1.5	0.9	1.7	1.7	16.9	32.7	18.4	26.2	17.2	14.8	47.4	21.5	24.7	36.5	8.9	11.7	5.1	10.6	7.1	11.8	8.9	5.1	10.7	5.7	7.0	7.9	20.7	10.0	16.8	106.4	8.0	19.0	0.0	13.6	13.0	5.4	17.5	9.2	8.5	13.1	19.1	9.9	6.7	22.6	63.9	10.3	9.9	6.8	21.6	16.2	14.5	17.0	14.8	15.9	13.3	11.7	12.9	5.1	10.9	6.0	8.4	32.2	4.4	15.7	13.1
PIH1D1	"FLJ20643, NOP17"	ENSG00000104872	"PIH1 domain containing 1"	Q9NWS0	19	49446298-49453497	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047258	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047258: AB_10964561"	"unprognostic (2.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	23.1	24.3	29.5	21.1	24.4	22.3	23.7	31.1	36.9	27.3	31.9	25.8	32.9	31.9	23.2	18.1	29.0	30.6	23.0	21.1	25.2	23.2	26.7	41.6	19.2	28.4	23.4	24.7	21.4	36.9	24.4	23.2	27.6	24.8	25.8	22.4	23.0	40.8	27.3	44.7	31.4	27.3	19.9	19.2	25.8	24.9	16.8	23.7	43.6	37.2	34.0	30.6	23.8	24.2	38.6	35.9	49.7	36.4	33.0	52.5	32.6	36.3	18.7	24.1	36.8	11.8	11.0	15.4	14.8	19.5	22.8	35.4	20.0	25.0	24.5	14.0	15.8	5.7	22.3	12.5	27.1	13.4	23.4	24.0	21.9	24.9	25.2	18.3	23.7	33.1	12.8	11.5	16.9	16.0	21.6	21.2	22.3	32.2	21.7	14.3	16.4	26.4	47.0	28.7	32.6	17.9	22.6	27.0	24.6	18.5	29.9	31.2	45.2	15.1	25.8	14.5	12.3	12.3	28.7	12.6	19.2	15.1	7.6	23.1	58.9	46.0	13.4	10.5	25.7	13.4	49.7	36.4	39.3	32.4	34.9	27.4	38.6	36.3	34.4	35.9	34.2	29.5	27.4	4.2	33.0	34.6	34.2	52.5	32.6	29.5	24.4	31.1	36.9	25.2	23.2	23.4	24.7	24.8	23.7	35.7	35.8	57.4	48.9	49.6	17.7	8.7	30.6	46.8	26.1	19.2	17.7	87.9	53.0	65.4	12.8	32.1	42.6	0.0	40.6	102.6	54.6	54.9	51.9	38.6	60.9	22.3	55.2	35.6	35.3	6.2	57.8	45.4	60.8	70.3	50.2	50.7	43.4	63.3	44.2	89.8	19.3	25.8	51.8	33.4	28.1	58.6	78.6	51.7	56.6	56.2
PRDM13		ENSG00000112238	"PR/SET domain 13"	Q9H4Q3	6	99606730-99615578	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.1"	"Cell type enhanced"	"Detected in single"	19	"Horizontal cells: 1.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070592	Uncertain					NA	NA					"HPA070592: AB_2686283"		"unprognostic (4.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"		"unprognostic (3.16e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.93e-1)"				"unprognostic (1.86e-2)"	"unprognostic (7.54e-2)"		"unprognostic (1.29e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	12.9	17.0	13.7	10.9	23.1	13.5	13.0	20.9	23.3	13.7	11.2	16.4	6.7	11.3	16.4	12.8	11.9	12.6	9.9	10.4	13.2	12.9	20.6	17.3	10.5	16.5	13.5	12.5	16.2	16.8	15.9	21.5	10.3	15.0	11.8	13.2	12.7	14.6	12.0	18.8	14.9	12.7	11.6	10.5	14.0	10.7	9.5	13.7	22.5	17.4	8.9	19.8	11.7	16.7	8.6	6.1	19.1	7.7	7.7	9.6	3.3	10.7	11.4	11.0	13.0	15.4	8.9	12.0	10.2	8.8	13.1	13.1	12.0	13.0	16.8	7.9	7.5	10.7	12.4	18.3	6.8	15.6	14.2	9.8	14.0	11.6	9.7	10.0	17.5	11.5	7.1	8.9	12.2	10.4	8.8	10.5	12.1	27.0	17.2	10.9	9.9	16.8	7.5	17.9	9.4	19.0	15.1	23.5	20.9	9.1	7.9	17.3	14.0	14.4	15.3	13.0	13.8	16.5	9.9	7.9	10.9	11.7	15.9	13.4	8.5	11.7	20.6	9.7	11.0	16.7	19.1	5.2	7.5	8.6	6.3	9.2	8.6	8.1	8.8	5.4	7.1	8.0	9.6	11.9	7.7	7.7	6.1	8.1	3.3	13.7	23.1	20.9	23.3	13.2	12.9	13.5	12.5	15.0	13.7	17.9	13.5	16.3	9.4	23.9	13.8	6.5	7.6	14.7	17.0	21.0	27.5	8.0	8.3	10.8	6.4	13.8	14.0	0.0	10.0	8.2	9.8	10.8	12.8	20.2	9.7	15.9	11.6	17.8	14.1	1.7	11.8	15.2	18.6	10.0	12.4	15.8	11.6	10.5	15.2	23.1	18.8	19.4	9.8	8.8	18.1	29.5	9.0	21.7	13.3	12.2
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 108.5;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 95.1;K-562: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	6.0	12.0	9.9	9.7	16.2	7.6	10.6	25.9	14.7	8.9	6.5	6.4	3.7	4.5	8.7	21.8	6.1	10.0	7.7	5.8	10.3	12.0	8.9	5.5	9.2	6.3	12.0	10.2	8.0	7.2	6.7	11.9	4.6	15.3	6.8	8.3	9.5	5.3	5.9	9.5	6.7	5.2	7.6	6.8	5.3	6.1	10.5	8.1	7.5	18.8	3.6	9.3	8.3	6.6	11.3	5.9	8.3	3.4	19.4	12.9	8.7	4.7	2.9	4.2	3.6	4.8	6.6	4.2	6.7	5.0	7.9	17.8	3.7	5.5	7.7	5.4	6.2	4.9	3.1	3.8	7.5	26.5	4.0	3.9	4.5	4.3	4.5	9.0	4.6	95.1	17.7	1.8	10.4	6.7	6.0	5.4	5.5	35.9	2.7	7.7	1.6	8.7	8.8	3.7	6.6	4.7	8.1	5.1	11.2	5.7	6.9	10.0	4.8	3.1	0.4	6.1	4.7	3.9	7.8	4.1	3.8	2.6	2.7	7.9	13.6	3.7	4.0	7.3	6.3	4.4	8.1	3.4	8.3	10.5	3.0	10.8	11.3	11.1	12.8	5.9	11.1	12.3	12.9	2.4	19.4	3.3	3.8	11.8	8.7	9.9	16.2	25.9	14.7	10.3	12.0	12.0	10.2	15.3	8.1	6.0	27.8	5.3	13.2	10.9	5.8	7.7	2.5	44.2	13.6	12.2	21.6	7.8	13.3	20.6	46.2	11.7	4.2	0.0	28.1	33.5	15.4	5.4	108.5	4.2	10.3	9.5	24.1	9.2	3.8	74.1	10.3	6.0	11.8	1.8	8.3	9.1	16.5	2.9	16.3	14.6	13.9	0.0	15.1	17.3	24.7	10.0	6.1	13.6	9.2	6.4
STPG4	"C2orf61, FLJ40172"	ENSG00000239605	"Sperm-tail PG-rich repeat containing 4"	Q8N801	2	47045538-47155378	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 29.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.6;RT4: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047366, HPA052691"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047366: , HPA052691: AB_2681918"	"unprognostic (6.74e-3)"	"unprognostic (5.81e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.36e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.64e-6)"	"unprognostic (5.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	29.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.1	0.0	0.3	0.4	0.1	0.2	0.8	0.5	0.5	0.4	0.4	0.5	0.0	0.2	0.0	0.7	0.5	0.5	0.6	0.0	0.1	0.0	0.0	0.6	0.0	1.1	1.0	0.1	0.8	0.3	0.2	0.1	6.6	0.9	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.1	0.4	1.8	0.4	0.1	0.0	0.4	0.1	0.3	0.0	0.2	0.6	0.3	0.9	0.1	0.2	0.8	0.2	0.0	0.0	0.6	0.2	0.0	0.1	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	2.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBN1		ENSG00000118900	"Ubinuclein 1"	Q9NPG3	16	4846665-4882360	"Predicted intracellular proteins"	"Host-virus interaction"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 15.1"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 15.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061029, HPA069036, HPA069045"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072"	"unprognostic (8.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.89e-2)"	14.1	12.4	10.5	16.6	11.5	38.2	19.8	20.2	15.4	12.6	12.4	11.0	18.1	13.4	13.1	11.8	24.5	11.7	16.6	15.5	11.2	6.5	10.4	15.3	19.1	16.5	9.4	10.8	14.4	12.9	17.6	12.3	10.4	9.1	11.7	13.4	15.9	15.9	14.5	20.9	15.1	15.2	12.8	6.6	21.2	12.5	36.7	10.1	27.1	12.0	13.8	13.7	11.6	15.8	1.2	1.7	15.1	1.2	0.9	1.6	0.9	9.2	11.5	13.3	13.2	11.9	11.0	11.0	11.7	10.9	13.4	13.0	9.5	11.1	17.3	10.9	11.1	14.6	12.5	17.1	10.4	11.4	17.0	9.0	14.1	15.3	7.5	11.4	17.0	15.6	7.5	14.0	15.6	16.8	10.2	17.5	17.1	23.3	14.7	9.9	13.3	18.6	7.9	11.5	9.6	9.0	30.0	16.7	16.3	7.1	10.6	18.3	10.1	20.0	16.4	10.1	10.4	16.1	15.3	17.8	14.4	13.9	46.5	14.3	14.3	14.9	34.5	8.5	10.9	24.2	1.4	1.2	0.9	1.6	1.2	1.1	0.9	1.2	1.4	0.8	1.2	1.3	0.8	15.1	0.9	0.9	1.7	0.8	0.9	10.5	11.5	20.2	15.4	11.2	6.5	9.4	10.8	9.1	10.1	8.9	15.7	27.8	19.9	16.0	51.1	22.6	22.9	8.1	9.1	8.7	104.1	20.7	6.6	15.5	36.6	25.1	29.2	0.0	15.6	20.6	17.1	24.2	7.0	24.6	19.9	47.7	29.6	25.2	29.7	42.8	27.0	21.1	25.3	14.4	24.1	26.6	21.6	28.8	21.2	11.3	98.8	12.9	17.8	91.9	111.7	19.4	24.4	26.7	23.3	22.9
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 452.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	44.2	17.4	42.3	40.1	43.6	30.7	24.5	19.9	39.0	37.6	26.7	22.3	26.6	27.6	27.0	43.6	19.5	21.1	54.4	13.1	20.6	20.8	40.2	25.4	21.8	53.7	37.0	18.7	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	36.9	18.5	15.9	44.5	20.2	26.1	17.9	29.5	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2	74.5	72.0	80.5	100.9	68.5	80.1	178.9	43.3	71.0	68.2	52.4	111.9	240.5	63.0	177.8	24.1	121.1	90.3	23.3	162.4	147.5	81.6	98.2	61.1	102.4	116.5	69.9	80.8	122.8	57.9	36.5	77.6	66.7	72.6	234.4	63.9	87.7	195.1	56.3	81.7	89.3	82.6	135.8	82.4	127.7	117.9	79.3	452.1	76.6	57.1	105.3
ZFP57	"bA145L22, bA145L22.2, C6orf40, ZNF698"	ENSG00000204644	"ZFP57 zinc finger protein"	Q9NU63	6	29672392-29681110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.7;heart muscle: 14.4"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 4.2;Extravillous trophoblasts: 3.1;granulocytes: 2.3;Late spermatids: 3.6;Pancreatic endocrine cells: 2.7"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 18.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"basophil: 3.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.8"	"Group enriched"	"Detected in some"	14	"BEWO: 12.0;SuSa: 3.4"					"Low region specificity"	"Detected in all"			HPA047172	Uncertain					NA	NA					"HPA047172: AB_10960886"	"unprognostic (1.35e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-4)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.29e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.11e-2)"	0.9	0.6	3.8	0.3	4.1	1.1	4.2	0.1	2.3	0.5	0.4	0.4	2.4	0.3	0.5	0.5	0.9	0.3	1.9	14.4	5.5	3.2	0.5	0.3	0.9	6.1	7.6	0.1	0.7	5.2	0.3	0.1	1.5	0.5	0.7	0.6	0.2	2.3	2.1	0.4	0.7	1.2	1.5	12.7	0.8	0.3	1.4	0.1	1.2	0.3	0.7	1.1	1.5	5.5	0.3	0.7	3.8	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.5	0.0	0.6	0.3	0.3	0.3	0.4	0.5	0.7	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.6	0.3	3.8	4.1	0.1	1.4	5.5	3.2	7.6	0.1	0.5	0.1	0.0	1.1	0.0	0.2	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.9	3.1	0.4	0.0	2.3	0.0	1.1	0.0	0.0	0.0	0.0	3.6	0.0	1.1	0.0	1.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.5	0.1	0.2	0.0	0.0	0.0
ZNF154	pHZ-92	ENSG00000179909	"Zinc finger protein 154"	Q13106	19	57697367-57709194	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 7.6;Cone photoreceptor cells: 7.9;granulocytes: 10.4;Horizontal cells: 7.9;Rod photoreceptor cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.1;HSkMC: 4.6;MOLT-4: 6.5;NTERA-2: 4.5;SuSa: 10.0"									HPA076284	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA076284: "	"unprognostic (3.32e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.35e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.11e-1)"	2.8	5.9	7.9	5.7	10.2	2.5	4.3	17.9	9.3	3.1	5.7	2.6	9.9	2.2	2.8	3.6	4.4	3.1	4.1	5.6	7.8	3.1	3.8	1.8	3.6	8.8	2.2	6.4	3.4	3.4	11.9	11.5	6.0	5.1	4.5	2.8	7.3	5.0	12.6	3.1	2.0	5.4	5.6	3.6	8.4	3.2	2.3	3.9	11.4	10.5	0.6	8.3	6.6	2.1	3.1	1.5	5.1	0.3	2.7	3.2	0.8	0.2	0.3	8.1	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.1	0.2	0.4	0.4	0.2	2.0	0.3	0.2	0.0	0.0	0.2	0.2	0.6	0.3	1.1	0.2	2.9	0.4	0.8	4.6	0.0	0.5	0.0	2.8	0.1	0.4	0.3	0.6	1.8	0.1	6.5	0.3	4.5	0.3	0.2	0.3	0.8	0.2	0.1	1.1	0.5	0.3	0.3	0.3	0.1	10.0	0.4	0.5	0.2	0.2	0.5	0.2	0.3	0.8	0.3	0.4	0.1	0.3	0.2	1.8	0.3	5.1	1.1	0.1	3.2	1.3	0.6	1.5	0.3	3.1	1.0	1.4	1.9	2.7	0.2	1.5	0.1	0.8	7.9	10.2	17.9	9.3	7.8	3.1	2.2	6.4	5.1	3.9	0.0	3.4	2.2	1.1	0.3	7.6	3.1	0.0	1.4	0.0	1.8	7.9	0.2	0.0	1.7	0.0	1.6	0.0	0.0	0.2	0.1	1.4	1.7	10.4	0.2	1.3	7.9	0.0	1.8	0.0	0.0	0.3	1.1	0.0	1.0	0.0	3.2	0.1	0.0	1.4	0.0	10.1	0.0	0.4	0.4	0.9	0.4	0.2	3.1	0.0	1.5
ZNF304		ENSG00000131845	"Zinc finger protein 304"	Q9HCX3	19	57351307-57359898	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA050531	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA050531: AB_2681160"	"unprognostic (4.44e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (1.52e-7)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.31e-1)"	"unprognostic (9.00e-3)"	8.5	11.3	8.5	7.8	13.5	6.0	10.8	20.1	12.0	7.7	8.5	7.7	7.2	4.2	9.3	12.6	8.8	8.9	7.1	10.6	7.1	7.0	7.6	5.6	8.7	11.8	8.8	11.0	11.7	5.2	16.4	9.6	9.0	8.6	9.7	5.2	7.4	8.1	10.9	8.5	9.9	7.1	8.8	6.7	11.0	6.8	6.9	8.6	11.1	11.7	9.9	11.4	9.2	6.1	5.5	3.9	5.7	5.6	5.9	6.1	3.8	5.6	2.8	6.9	8.7	5.7	5.4	4.3	5.6	8.7	6.5	14.8	0.0	2.6	4.6	3.6	6.5	3.4	2.0	3.9	7.5	9.6	1.5	18.4	7.4	7.3	3.9	4.1	4.0	4.6	6.6	10.0	6.2	8.8	6.9	4.1	10.5	2.2	0.0	6.8	1.5	8.5	2.3	4.6	0.0	8.9	5.5	11.1	5.9	4.6	12.1	5.5	5.9	5.9	4.6	4.0	6.5	5.6	5.9	4.6	9.3	5.5	2.8	6.0	7.5	6.4	6.9	5.7	0.1	4.7	5.7	2.8	2.3	3.3	2.3	6.1	5.5	5.6	4.6	3.9	4.6	4.7	4.8	0.2	5.9	5.6	2.1	4.4	3.8	8.5	13.5	20.1	12.0	7.1	7.0	8.8	11.0	8.6	8.6	0.0	0.3	2.0	0.6	5.7	6.0	4.0	7.6	6.7	5.7	0.0	0.0	1.5	1.7	1.4	0.3	3.7	0.4	0.0	0.9	0.7	1.3	1.4	0.0	2.1	1.3	3.2	0.0	9.2	1.9	0.6	1.7	1.4	3.3	0.0	1.5	1.0	0.8	0.0	2.1	1.3	2.3	0.0	2.0	1.6	4.2	4.8	0.9	2.5	0.9	1.0
FAM129B	"bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Family with sequence similarity 129 member B"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 95.6;placenta: 103.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1200000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	7.8	17.9	4.5	8.4	5.6	5.1	6.7	6.5	4.2	19.1	13.9	4.2	12.3	11.9	9.6	7.3	95.6	8.9	22.9	8.2	4.8	4.1	9.9	5.5	24.0	5.1	6.9	3.1	9.3	24.8	6.8	5.7	103.7	9.1	12.8	7.2	9.4	23.6	11.7	4.1	17.3	17.1	10.5	7.0	6.8	13.8	5.4	4.2	1.3	39.8	44.6	48.8	11.8	28.3	0.0	2.4	0.5	3.7	0.0	0.5	1.7	22.1	25.3	5.1	6.7	15.6	30.4	24.0	44.1	41.0	24.4	15.1	8.0	24.5	0.0	17.5	49.8	30.1	37.0	4.4	32.6	8.1	4.2	4.7	3.8	37.5	8.3	30.8	0.1	10.8	33.2	20.5	40.1	14.1	44.9	36.6	1.4	7.1	0.2	46.1	26.1	0.2	6.2	5.3	38.1	33.3	2.6	17.3	11.6	20.9	17.8	8.2	3.8	36.0	25.7	15.6	7.6	16.9	1.2	47.3	25.1	10.9	31.5	36.4	0.4	0.8	0.0	70.6	3.6	46.3	0.5	3.7	0.0	0.2	1.3	0.0	0.0	0.5	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.7	4.5	5.6	6.5	4.2	4.8	4.1	6.9	3.1	9.1	4.2	65.5	43.5	0.0	30.8	28.7	0.4	4.2	38.2	10.7	36.4	36.6	0.0	59.0	3.3	72.5	1.0	28.6	94.2	0.0	92.9	33.5	19.8	56.7	28.9	1.0	21.5	0.0	21.4	28.8	11.8	1.8	29.7	23.3	21.9	2.8	41.6	12.6	107.3	42.4	47.4	1.5	1.5	12.9	32.0	0.3	1.1	32.6	101.1	2.2	37.3	104.7
KDM2A	"CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA"	ENSG00000173120	"Lysine demethylase 2A"	Q9Y2K7	11	67119269-67258087	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012272, HPA044251"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012272: , HPA044251: "	"unprognostic (7.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"unprognostic (9.45e-3)"	19.6	14.6	18.6	25.3	23.9	38.1	21.0	36.5	22.8	20.0	21.9	17.8	20.7	15.3	32.0	18.6	32.7	20.2	19.3	18.8	17.4	12.7	16.8	20.3	24.3	30.1	17.9	14.9	27.4	15.3	26.1	21.1	26.0	17.5	23.3	17.1	21.0	22.2	20.5	32.8	28.7	24.1	25.0	14.6	29.0	19.8	27.6	18.6	32.2	19.9	20.3	37.3	24.9	25.9	7.2	1.9	5.0	1.9	4.6	5.2	2.8	25.5	15.4	9.4	14.6	9.3	13.6	7.1	11.2	13.0	20.1	13.8	24.1	13.4	19.7	19.7	15.7	12.4	25.0	15.5	11.1	16.3	33.0	6.9	14.5	18.4	6.0	9.9	12.3	20.1	11.2	13.6	19.7	13.8	11.1	14.6	11.5	13.4	27.8	9.7	17.0	15.9	8.9	19.0	15.9	13.2	20.3	15.8	11.0	8.4	16.1	12.8	10.2	35.9	20.7	21.3	11.6	31.1	12.6	19.5	13.5	9.1	18.5	9.5	15.5	17.0	12.5	11.9	8.9	9.3	0.6	1.9	0.5	4.8	1.5	5.2	6.4	3.6	4.2	1.2	7.2	3.8	3.5	5.0	4.6	1.0	1.9	4.3	2.8	18.6	23.9	36.5	22.8	17.4	12.7	17.9	14.9	17.5	18.6	35.7	36.8	25.7	19.5	36.6	73.1	27.1	38.2	25.4	28.4	15.7	129.6	18.9	0.0	15.1	20.3	31.6	30.8	0.0	12.5	11.7	30.7	26.1	26.5	32.7	19.2	90.6	30.5	27.0	41.3	10.2	19.8	42.0	18.6	31.5	24.9	25.1	20.3	23.0	21.5	9.1	113.7	19.4	25.9	56.1	34.8	41.8	27.0	45.7	23.2	39.3
KDM2B	"CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2"	ENSG00000089094	"Lysine demethylase 2B"	Q8NHM5	12	121429097-121581015	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071257			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071257: "	"unprognostic (7.67e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.74e-6)"	"unprognostic (1.16e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (8.64e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.82e-2)"	6.2	6.3	13.9	20.1	15.7	14.9	7.0	31.1	25.1	9.2	7.6	12.3	5.2	8.2	9.9	7.3	14.4	10.8	7.9	5.8	11.8	7.2	6.6	10.2	9.5	21.3	14.3	15.1	14.1	8.2	13.0	8.2	7.2	12.2	6.6	7.7	8.1	9.1	6.8	11.7	18.9	13.1	8.1	13.2	16.3	7.4	9.8	14.5	27.0	8.2	5.5	20.9	11.1	11.6	11.5	5.0	4.2	3.6	2.6	8.3	4.0	6.7	8.6	17.0	5.2	4.7	4.9	17.4	6.7	9.1	9.8	8.3	11.7	3.8	33.1	9.9	6.1	5.2	5.9	18.1	6.6	7.4	13.7	11.7	19.1	7.8	10.4	5.2	22.3	14.8	3.9	4.0	8.8	6.7	9.8	7.0	16.6	14.4	4.7	5.0	10.0	24.2	26.8	27.3	5.4	7.0	27.9	8.6	16.3	5.4	13.1	18.6	11.0	11.5	6.8	6.8	14.8	12.8	24.5	8.8	10.2	7.6	9.7	6.5	11.0	9.7	32.3	9.3	17.5	6.3	4.2	3.6	2.8	8.3	3.2	6.3	11.5	6.6	4.8	5.0	10.6	5.9	7.5	0.5	2.6	1.9	4.8	5.5	4.0	13.9	15.7	31.1	25.1	11.8	7.2	14.3	15.1	12.2	14.5	0.0	11.7	22.7	5.0	15.0	19.7	13.0	15.3	2.7	4.5	10.4	11.8	5.7	10.0	6.6	41.3	7.3	4.7	0.0	5.0	9.1	9.4	5.4	13.9	12.2	21.8	14.3	5.2	8.0	16.4	37.2	7.2	21.0	15.1	64.1	4.7	3.9	5.1	5.9	6.7	3.3	13.8	19.4	9.9	5.1	13.9	13.2	5.5	17.8	6.6	5.4
KDM3B	"C5orf7, JMJD1B, KIAA1082, NET22"	ENSG00000120733	"Lysine demethylase 3B"	Q7LBC6	5	138352596-138437028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016610, HPA057202"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA016610: AB_1852004, HPA057202: AB_2683367"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.60e-2)"	13.5	12.8	10.0	10.9	12.6	12.2	14.9	20.2	14.9	14.0	14.2	18.4	13.5	9.9	20.0	18.0	13.0	14.7	12.5	11.8	14.7	8.6	12.8	8.4	11.4	11.5	12.0	9.6	19.8	17.4	27.9	15.1	11.7	11.3	13.6	14.4	18.5	16.3	16.3	29.6	16.5	14.0	21.5	10.7	13.3	12.6	10.4	12.2	25.2	16.1	9.0	16.4	21.9	19.4	4.1	5.1	9.3	4.6	7.4	5.7	2.2	10.6	15.0	28.3	25.9	13.1	10.9	21.9	7.4	12.0	13.2	14.8	16.7	11.8	21.3	13.4	14.0	18.1	11.0	23.0	16.5	15.1	14.0	14.1	18.3	13.3	12.6	11.7	14.7	20.0	13.0	18.0	10.2	12.2	10.4	15.7	12.4	14.3	11.4	15.8	13.7	19.2	18.2	14.0	14.5	6.2	23.4	21.8	13.9	18.9	14.8	15.0	16.4	12.6	12.4	10.9	43.9	11.8	18.6	15.1	7.9	8.2	8.3	12.8	15.8	7.5	18.9	5.2	20.8	11.2	0.3	4.6	6.5	4.2	3.6	5.7	4.1	5.0	5.2	4.1	3.9	4.4	4.2	9.3	7.4	3.6	5.1	2.8	2.2	10.0	12.6	20.2	14.9	14.7	8.6	12.0	9.6	11.3	12.2	14.9	14.9	8.8	12.1	14.2	19.4	29.7	25.5	10.7	13.6	21.0	27.5	10.5	0.0	12.9	5.9	12.7	15.8	0.0	14.4	8.0	12.8	16.3	12.7	18.3	15.1	22.3	20.2	17.8	45.4	2.2	19.5	16.7	15.1	17.2	28.8	20.6	16.4	26.8	21.5	12.6	29.9	25.8	12.7	12.3	13.9	18.9	9.2	11.4	23.0	17.3
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	19.5	22.9	22.4	22.6	24.7	26.3	17.9	43.0	31.7	25.9	19.5	23.4	16.7	22.2	29.2	13.3	26.9	24.8	15.2	17.6	21.6	15.3	17.0	18.8	20.6	25.8	24.6	21.8	33.1	22.5	37.7	31.8	34.0	22.8	18.7	13.5	17.0	25.6	17.1	36.6	28.4	22.2	23.6	16.0	25.0	19.4	10.6	26.2	29.0	22.2	11.3	24.5	21.5	26.4	4.5	4.3	4.8	4.0	2.8	6.1	3.8	16.9	23.1	24.8	19.0	17.2	15.7	17.6	10.6	12.4	14.4	13.4	15.6	11.1	15.8	13.8	13.9	40.6	15.2	28.0	22.7	11.0	11.8	41.4	15.3	24.7	11.0	21.2	18.1	30.6	12.4	16.7	28.1	34.7	20.6	21.2	13.2	29.7	10.5	10.5	21.7	13.2	20.4	21.0	8.8	21.7	15.0	14.8	17.1	9.1	16.3	18.7	24.1	32.2	29.9	12.1	23.8	20.9	16.0	14.5	16.1	13.9	14.4	10.3	15.3	12.4	12.0	20.9	21.5	11.9	3.0	3.8	2.7	6.1	3.6	5.1	4.5	3.7	5.7	3.1	3.2	4.5	2.9	4.8	2.8	4.0	4.3	4.3	3.8	22.4	24.7	43.0	31.7	21.6	15.3	24.6	21.8	22.8	26.2	11.9	12.2	11.9	9.7	10.8	25.0	7.7	17.8	12.0	12.5	7.0	23.6	10.6	3.3	13.4	0.6	14.3	21.7	0.0	18.7	11.4	11.3	12.4	12.7	19.8	12.4	23.8	30.0	18.4	14.6	1.7	13.6	9.4	13.5	10.0	27.8	10.9	20.8	24.6	14.9	4.2	16.1	0.0	10.3	7.0	14.6	13.9	17.4	10.2	15.6	15.9
METTL4	"FLJ23017, HsT661"	ENSG00000101574	"Methyltransferase like 4"	Q8N3J2	18	2537525-2571509	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040061, HPA046734"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA040061: AB_10697713, HPA046734: AB_2732532"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.12e-5)"	"unprognostic (1.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-3)"	13.2	8.9	10.1	13.5	15.7	6.1	15.8	18.4	15.6	13.5	10.6	8.6	15.7	9.7	14.0	12.3	11.9	11.1	10.9	9.9	10.1	11.8	10.5	9.2	11.2	19.9	15.9	8.5	13.9	8.6	16.3	23.6	10.4	14.2	12.9	12.7	10.1	17.7	15.6	6.4	11.0	14.6	12.6	17.3	19.9	10.0	12.4	15.8	15.3	16.2	7.2	19.5	13.8	16.8	7.5	3.5	14.4	2.5	5.6	9.4	4.8	7.8	3.4	10.8	6.4	4.9	7.6	12.4	12.3	11.2	12.9	12.8	6.9	5.9	16.5	7.8	5.8	10.5	7.0	17.4	6.6	16.6	11.9	6.0	6.3	6.8	5.9	7.5	14.6	8.4	4.9	14.8	13.2	8.5	7.4	13.3	10.2	8.8	20.7	11.0	3.8	10.9	4.8	6.2	6.9	5.6	7.5	8.6	11.3	7.6	4.9	19.4	8.9	9.8	6.8	12.9	9.5	7.6	10.1	8.6	14.8	18.5	14.3	17.6	10.3	26.4	9.6	9.9	10.3	17.1	14.4	2.5	6.5	6.6	2.3	8.0	6.8	7.6	8.6	1.9	7.5	9.4	8.6	10.1	5.6	2.0	3.5	8.4	4.8	10.1	15.7	18.4	15.6	10.1	11.8	15.9	8.5	14.2	15.8	11.9	8.0	10.0	10.0	4.2	10.1	3.1	5.1	13.4	12.5	3.5	13.7	6.4	0.0	4.9	2.5	9.0	7.8	0.0	6.3	7.9	5.7	9.4	6.9	3.8	5.1	7.9	2.4	12.9	7.6	2.6	11.8	5.7	3.3	1.8	5.1	8.0	6.6	4.2	10.3	4.0	5.8	12.9	6.6	27.0	20.9	4.3	8.7	10.9	4.9	15.4
MPHOSPH8	"HSMPP8, mpp8"	ENSG00000196199	"M-phase phosphoprotein 8"	Q99549	13	19633681-19673459	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039701, HPA040035"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039701: AB_10805484, HPA040035: AB_10794207"	"unprognostic (4.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.90e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.02e-1)"	20.6	27.1	37.7	33.4	37.1	19.2	21.4	48.9	45.0	32.0	26.6	13.2	31.7	17.8	29.4	26.7	19.1	22.3	18.8	27.9	31.0	27.2	18.9	16.5	22.9	28.4	28.8	32.8	43.6	22.0	20.9	44.3	20.0	28.4	26.1	20.1	11.9	24.5	38.8	25.7	26.6	23.9	31.3	37.1	30.0	22.5	16.6	33.5	16.5	26.8	11.7	20.4	31.3	37.9	21.7	13.8	39.4	9.9	11.5	17.6	3.6	12.9	8.3	12.5	20.2	16.2	20.6	22.1	19.5	14.2	12.3	10.6	12.7	22.9	20.5	15.6	11.8	19.2	21.7	22.9	13.6	15.9	25.5	11.7	33.0	13.7	15.4	14.4	23.7	26.9	12.1	17.7	9.7	13.7	18.8	16.2	16.7	15.9	13.2	11.4	12.6	18.1	19.9	12.2	24.1	9.3	14.6	28.8	16.2	21.4	10.1	17.1	10.5	18.2	16.8	17.7	21.8	10.2	19.7	19.0	9.6	8.6	18.1	9.8	9.0	9.3	20.4	7.3	22.0	14.8	39.4	9.5	15.4	13.0	6.9	11.5	21.5	14.6	12.5	4.3	21.7	17.6	14.4	27.5	11.5	9.9	13.8	11.3	3.6	37.7	37.1	48.9	45.0	31.0	27.2	28.8	32.8	28.4	33.5	86.4	100.8	102.7	102.3	61.2	189.0	78.6	81.5	60.2	84.2	97.7	78.5	107.7	41.4	45.8	58.1	101.2	89.2	23.3	47.7	70.1	98.0	73.8	137.8	68.9	64.6	198.6	56.6	106.2	53.3	25.9	166.0	79.7	64.1	91.0	71.4	105.7	42.2	94.7	147.8	48.2	208.1	174.6	116.5	181.6	204.0	64.6	49.1	124.6	63.9	55.3
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	14.2	15.5	14.4	17.6	22.1	17.2	18.6	42.2	21.7	16.2	14.6	25.3	12.5	13.4	23.2	14.1	17.6	17.7	12.1	13.4	14.4	12.1	13.4	16.5	14.2	29.8	19.2	19.4	25.7	20.9	11.7	25.7	11.6	20.4	28.9	17.2	16.3	19.5	18.1	38.8	15.5	19.6	17.3	17.8	20.3	14.7	12.7	22.3	23.7	29.4	20.5	29.7	14.3	15.2	16.6	6.2	11.4	5.4	8.0	24.9	10.2	8.7	8.3	16.5	9.5	22.5	10.1	12.3	14.9	16.6	14.5	20.7	5.7	13.2	13.6	5.4	17.3	16.5	9.9	22.5	21.3	19.7	18.4	16.3	17.4	15.9	25.1	14.8	20.7	13.3	17.2	20.9	17.0	19.7	18.9	16.5	18.6	15.5	6.0	17.4	12.4	15.1	14.3	18.9	18.1	14.3	14.8	18.8	7.7	13.8	17.6	15.2	13.2	12.2	15.2	11.3	11.7	11.2	10.7	22.8	13.4	13.1	15.7	13.3	16.1	4.1	33.2	11.3	13.2	12.3	4.2	5.4	11.4	10.0	5.2	12.5	16.6	15.5	13.7	6.2	15.4	24.9	19.5	1.9	8.0	4.4	4.7	15.8	10.2	14.4	22.1	42.2	21.7	14.4	12.1	19.2	19.4	20.4	22.3	11.9	23.0	29.4	17.6	0.0	0.0	17.5	25.5	32.1	23.9	19.2	0.0	24.9	34.9	21.1	40.5	13.6	19.2	23.3	21.3	22.9	13.5	15.6	10.5	27.2	22.0	0.0	10.5	14.7	21.8	48.5	21.6	18.0	0.0	19.8	26.7	0.0	20.5	25.8	24.8	32.1	0.0	38.8	15.9	42.6	38.1	0.0	19.8	30.5	22.5	14.8
MTRR	cblE	ENSG00000124275	"5-methyltetrahydrofolate-homocysteine methyltransferase reductase"	Q9UBK8	5	7851186-7906025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 57.4;Late spermatids: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038113	Supported		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA038113: AB_10671520"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.56e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	12.2	12.3	11.2	10.5	13.8	5.4	9.7	15.6	14.3	10.8	10.4	24.1	11.5	10.3	17.3	15.9	10.5	11.3	13.3	15.8	14.2	12.9	22.0	23.9	14.9	11.4	18.1	9.6	13.6	13.6	9.4	13.1	11.6	16.6	10.8	11.9	13.6	11.3	7.4	34.6	10.5	11.5	14.2	22.1	9.3	9.2	8.4	12.5	8.1	14.7	9.9	13.5	13.6	8.8	4.6	4.8	4.6	6.8	3.4	11.4	4.2	9.4	8.9	4.7	10.5	18.2	5.9	13.5	14.7	8.7	7.3	8.4	13.4	7.6	15.9	14.1	11.8	14.0	6.1	7.3	7.2	13.9	10.1	8.2	7.6	31.0	7.1	11.1	11.6	3.3	9.5	6.6	12.4	9.1	10.4	4.7	4.1	9.9	12.1	4.3	1.8	7.4	5.9	3.6	14.0	9.9	6.1	5.1	6.7	7.9	7.4	7.4	1.0	25.8	18.8	16.2	9.7	5.8	9.0	7.3	17.1	10.8	13.1	11.5	18.0	5.9	13.1	12.4	25.6	9.1	4.6	5.1	4.1	5.5	6.8	9.5	4.6	9.2	7.9	4.8	4.1	5.4	5.1	0.1	3.4	5.4	2.7	11.4	4.2	11.2	13.8	15.6	14.3	14.2	12.9	18.1	9.6	16.6	12.5	14.9	57.4	8.2	7.5	14.4	0.0	10.1	2.5	9.4	11.4	8.7	0.0	8.3	18.3	8.0	40.0	7.0	8.5	0.0	4.9	7.5	10.2	9.9	10.3	16.6	6.7	0.0	9.2	10.4	12.5	61.7	9.8	8.7	1.7	5.4	9.6	0.0	5.8	7.0	11.0	23.3	0.0	6.5	13.3	16.9	11.9	18.1	9.4	12.9	8.9	7.0
PRDM7	ZNF910	ENSG00000126856	"PR/SET domain 7"	Q9NQW5	16	90056566-90092072	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	27	"testis: 4.8"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 1.4;Cardiomyocytes: 5.0;Ciliated cells: 2.7"	"Cancer enriched"	"Detected in single"	30	"melanoma: 3.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"REH: 9.1;SK-MEL-30: 6.7"									HPA059944	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA059944: AB_2684174"	"unprognostic (3.98e-1)"	"unprognostic (8.89e-2)"		"unprognostic (8.02e-3)"	"unprognostic (8.26e-2)"		"unprognostic (9.01e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.46e-1)"		"unprognostic (5.73e-1)"	"unprognostic (5.52e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.03e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8			0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	1.4	0.0	0.0	0.0	0.0	5.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	30.5	23.4	20.3	24.0	24.8	59.5	28.3	32.1	26.2	26.1	27.6	29.6	21.5	24.6	32.5	24.3	29.1	25.4	20.5	26.3	20.6	18.3	23.5	25.3	24.8	31.5	23.9	26.7	32.1	26.5	19.8	31.6	32.3	26.8	29.8	24.9	22.3	23.4	17.6	41.8	33.3	30.7	30.8	23.7	32.3	24.2	36.3	24.3	37.5	34.1	24.2	30.4	33.0	25.0	32.5	38.2	47.8	44.1	47.6	47.1	35.5	39.3	29.1	30.0	31.8	24.7	27.9	34.9	27.1	23.9	29.8	27.6	28.9	36.2	38.5	24.8	20.1	22.7	38.8	35.9	25.7	40.7	30.6	28.4	31.1	26.3	28.9	35.5	21.7	36.9	21.4	34.5	27.0	37.4	32.5	28.9	37.0	44.4	28.9	22.8	40.3	38.6	36.9	33.5	44.5	39.3	41.8	38.8	26.4	27.7	36.5	32.3	34.9	37.3	33.0	37.3	32.2	47.3	41.8	30.6	32.8	37.5	29.5	32.3	28.7	40.6	42.8	29.7	35.0	36.1	42.0	38.0	47.8	32.1	40.6	36.0	30.9	36.2	36.3	38.2	32.5	38.3	36.0	36.1	47.6	44.1	22.7	47.1	35.5	20.3	24.8	32.1	26.2	20.6	18.3	23.9	26.7	26.8	24.3	86.4	43.0	62.2	66.5	50.3	55.1	46.0	43.3	109.7	79.6	50.6	33.4	68.5	64.6	65.3	25.3	65.0	31.6	46.7	61.0	83.4	54.9	37.6	88.0	26.6	66.2	36.5	41.9	45.4	48.4	16.5	72.2	71.0	37.1	92.0	37.1	67.4	58.2	45.0	69.6	39.6	63.7	64.7	69.5	252.6	138.5	47.4	91.2	73.9	40.5	62.2
TARBP1	"TRM3, TRMT3, TRP-185"	ENSG00000059588	"TAR (HIV-1) RNA binding protein 1"	Q13395	1	234391313-234479103	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020810, HPA024632"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB020810: , HPA024632: AB_1857770"	"unprognostic (3.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.45e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.14e-10)"	"unprognostic (5.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.27e-2)"	7.2	6.7	10.3	10.5	19.4	12.0	11.4	22.5	22.9	6.5	7.3	10.5	3.0	7.8	7.2	9.8	10.7	10.0	11.3	6.6	7.1	6.8	7.0	4.7	7.6	11.9	6.6	18.2	5.7	12.7	12.9	12.1	10.1	13.0	9.5	11.4	8.7	12.8	5.8	11.0	10.1	8.9	5.7	8.0	8.7	10.2	5.6	6.4	8.7	10.1	6.2	13.6	5.5	7.7	1.2	4.0	0.0	0.3	0.9	1.9	0.2	11.5	8.1	5.4	6.2	8.9	12.3	11.1	4.9	3.8	6.5	4.8	3.8	7.6	10.0	5.3	3.7	5.6	7.6	6.1	6.2	6.3	9.8	9.4	5.5	8.5	5.6	2.8	24.2	4.9	5.1	5.7	4.7	2.6	5.1	6.6	13.6	6.9	6.5	4.5	2.4	10.0	11.9	11.3	12.5	3.3	17.6	3.1	9.9	4.4	6.8	5.7	6.8	6.8	8.9	7.5	3.7	5.7	24.8	4.4	6.0	0.7	6.6	9.9	17.4	11.4	4.4	3.9	11.4	8.9	0.0	0.3	0.0	0.6	0.3	0.9	1.2	0.4	0.4	0.4	0.3	1.9	1.1	0.0	0.9	0.1	4.0	0.0	0.2	10.3	19.4	22.5	22.9	7.1	6.8	6.6	18.2	13.0	6.4	38.7	17.7	11.9	3.5	5.6	29.8	5.2	10.2	30.8	14.8	7.0	35.3	16.9	1.7	4.3	12.6	9.2	4.2	0.0	5.0	12.3	8.0	4.6	3.5	7.6	7.8	54.0	11.1	11.1	5.3	1.5	5.2	9.1	10.1	2.8	11.2	8.2	7.1	3.5	5.6	3.3	17.9	0.0	7.6	3.5	5.1	7.2	10.0	11.8	17.6	4.6
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026633: AB_2732431, HPA026697: AB_2732432"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	14.1	12.9	10.6	25.4	12.2	49.1	19.0	24.8	11.8	18.6	15.6	12.7	17.6	7.9	17.5	15.1	13.3	12.0	11.9	11.3	10.2	10.6	10.1	9.8	13.5	19.3	12.3	10.5	18.9	14.5	12.7	12.7	14.6	11.4	19.3	12.0	10.7	13.0	16.4	15.7	11.0	12.0	17.1	12.2	14.1	11.6	10.6	14.8	40.3	15.2	10.2	19.8	18.7	18.2	5.1	2.5	7.5	1.4	1.2	3.6	1.2	6.7	7.7	11.1	4.7	9.1	13.2	8.1	15.6	9.6	9.8	17.2	4.9	4.9	10.3	3.4	7.7	9.1	4.4	10.2	9.1	15.0	18.7	4.7	18.0	15.0	7.8	7.5	8.4	6.1	5.9	5.9	7.6	18.8	18.8	38.2	10.6	1.7	10.1	23.1	2.3	14.1	32.7	4.3	9.9	5.7	16.0	5.1	3.6	7.3	4.6	10.0	3.9	6.7	4.5	9.7	14.1	5.6	16.9	32.2	10.5	3.8	4.3	13.0	2.7	8.0	12.1	5.1	7.4	4.1	7.5	1.1	4.3	2.3	0.9	1.7	3.5	3.6	1.8	0.7	5.1	2.3	3.0	1.3	1.2	1.4	2.5	3.5	1.2	10.6	12.2	24.8	11.8	10.2	10.6	12.3	10.5	11.4	14.8	6.0	11.8	25.0	9.7	19.2	22.6	42.0	5.1	5.3	9.1	12.2	29.5	10.8	1.7	5.1	16.0	20.4	8.1	23.3	3.4	8.5	12.4	13.9	17.3	11.3	9.2	27.0	6.8	15.4	11.7	5.9	17.8	11.0	20.3	6.4	12.4	6.7	6.0	12.9	13.8	5.1	34.9	12.9	13.7	37.2	17.2	16.7	4.9	13.8	11.3	7.1
APOBEC1	"APOBEC-1, BEDP, CDAR1, HEPR"	ENSG00000111701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 1"	P41238	12	7649400-7665903	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	51	"intestine: 56.1"	"Cell type enhanced"	"Detected in some"	23	"Cholangiocytes: 7.6;Enterocytes: 23.9;Paneth cells: 31.7"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"CAPAN-2: 6.2;OE19: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA								"unprognostic (2.35e-1)"					"unprognostic (3.80e-4)"			"unprognostic (7.96e-3)"			"unprognostic (1.79e-1)"	"unprognostic (4.38e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	56.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	2.5	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
BHMT2		ENSG00000132840	"Betaine--homocysteine S-methyltransferase 2"	Q9H2M3	5	79069717-79089466	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 87.9;liver: 122.9"	"Cell type enhanced"	"Detected in many"	25	"Distal tubular cells: 81.2;Hepatocytes: 181.0;Proximal tubular cells: 412.5"	"Group enriched"	"Detected in many"	14	"liver cancer: 79.6;renal cancer: 52.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.1;Hep G2: 38.1;hTEC/SVTERT24-B: 23.4;U-87 MG: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044573	Enhanced					NA	NA		1400000			"HPA044573: AB_10795044"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-3)"	9.3	4.4	1.7	0.9	2.0	0.2	8.2	1.1	1.0	1.7	3.4	1.1	2.9	0.6	3.2	10.5	3.5	1.4	2.9	3.3	1.5	1.5	87.9	122.9	0.6	0.4	1.6	1.0	1.9	0.5	0.5	3.2	0.3	3.5	3.0	0.8	8.2	0.8	4.0	2.2	0.4	1.3	10.5	2.2	0.3	2.4	1.4	0.9	0.0	4.6	1.9	0.4	6.4	4.4	0.9	0.5	3.2	0.4	2.4	0.7	0.3	0.0	0.0	0.0	0.0	4.4	3.2	1.5	3.8	9.1	2.1	4.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.1	38.1	3.5	0.2	0.0	3.9	0.0	23.4	0.0	4.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.8	0.2	0.0	2.5	0.4	0.7	0.4	0.3	0.5	0.5	0.6	0.4	0.2	0.9	0.6	0.7	3.2	2.4	0.2	0.5	0.4	0.3	1.7	2.0	1.1	1.0	1.5	1.5	1.6	1.0	3.5	0.9	6.0	0.3	0.5	0.4	0.7	1.5	3.5	0.0	0.0	0.0	43.6	2.0	0.2	81.2	0.1	0.3	1.6	0.0	0.0	0.0	0.3	7.3	0.4	0.0	181.0	0.3	0.0	1.2	3.1	3.3	0.0	25.3	1.1	0.0	0.0	0.0	4.8	0.0	0.0	35.0	412.5	1.1	6.5	1.7	0.5	0.4	0.9	0.2	0.0	0.0	0.9
DPPA3	"Pgc7, Stella"	ENSG00000187569	"Developmental pluripotency associated 3"	Q6W0C5	12	7711454-7717559	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.3;lung: 2.1;ovary: 1.8;testis: 3.6"	"Cell type enhanced"	"Detected in some"	14	"Extravillous trophoblasts: 1.1;Spermatocytes: 1.2;Spermatogonia: 1.6;Syncytiotrophoblasts: 1.1"	"Cancer enriched"	"Detected in single"	779	"testis cancer: 339.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	17	"dendritic cells: 2.3;granulocytes: 1.7"	"Group enriched"	"Detected in some"	5	"BEWO: 86.3;NTERA-2: 36.2"															NA	NA																			"unprognostic (2.52e-1)"	"unprognostic (9.49e-2)"			0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.4	3.6	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.0	1.1	0.0	0.0	0.0
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445773-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.9	15.5	9.2	15.7	11.1	14.8	15.5	12.9	14.1	13.6	14.1	10.4	11.9	15.6	18.7	12.8	20.0	15.0	16.2	16.9	7.8	8.6	13.0	26.3	12.5	17.5	11.0	10.3	19.3	35.5	16.5	10.3	14.7	9.5	13.8	8.0	12.0	18.6	14.4	29.1	18.3	11.5	13.3	8.2	19.4	14.7	13.1	10.9	18.6	17.3	19.0	17.3	14.1	18.0	21.1	18.4	1.4	17.8	17.4	22.6	16.5	17.0	45.1	7.7	14.4	6.3	6.2	6.6	13.3	6.4	19.2	16.1	25.3	12.7	24.4	11.6	8.3	10.8	14.6	19.1	20.6	7.6	18.2	25.8	22.2	15.3	18.0	7.3	20.9	14.3	7.4	11.4	18.1	9.2	4.3	9.5	13.4	31.0	15.4	8.0	17.7	22.0	52.6	20.9	18.2	13.2	27.4	8.6	17.5	8.0	21.1	17.3	9.6	15.0	21.3	6.6	4.8	10.5	10.6	10.1	17.9	15.1	7.8	31.6	15.7	35.9	22.8	6.0	18.9	20.8	0.1	11.0	1.4	19.6	17.8	22.6	21.1	18.1	19.5	18.4	20.4	21.3	19.7	0.8	17.4	13.5	13.6	15.6	16.5	9.2	11.1	12.9	14.1	7.8	8.6	11.0	10.3	9.5	10.9	3.0	17.4	22.9	20.9	41.1	12.6	6.5	15.3	18.7	14.8	12.2	0.0	35.6	19.9	28.0	1.7	18.0	7.3	0.0	15.7	30.6	18.6	13.5	19.6	14.7	21.5	20.6	18.4	11.6	10.7	14.6	15.8	12.4	27.0	35.1	9.0	5.3	18.5	7.0	11.7	15.3	13.0	19.4	20.2	6.1	34.7	35.5	29.3	20.0	13.4	17.6
KDM6B	"JMJD3, KIAA0346"	ENSG00000132510	"Lysine demethylase 6B"	O15054	17	7839904-7854796	"Predicted intracellular proteins"	"Inflammatory response"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 190.4;granulocytes: 180.6;Suprabasal keratinocytes: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 3.7;neutrophil: 11.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037988	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA037988: AB_10672502"	"unprognostic (3.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.89e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.85e-1)"	10.7	6.7	3.1	10.6	5.3	17.5	4.4	9.0	7.6	3.9	5.0	6.7	3.1	7.5	6.3	6.1	4.8	6.7	10.4	6.9	3.1	2.5	6.0	6.2	9.8	12.2	5.6	3.1	12.3	9.6	4.0	8.7	6.6	6.6	5.4	1.7	10.2	4.2	3.3	4.7	5.5	8.0	7.6	8.0	8.4	6.1	7.2	3.1	5.9	6.1	7.1	3.1	5.2	4.3	0.7	0.9	11.6	0.8	0.1	0.6	0.4	4.0	5.7	10.9	16.0	4.0	3.0	13.7	3.2	4.8	2.3	2.5	8.2	3.0	9.4	3.9	2.6	3.3	10.1	5.2	4.5	1.4	3.7	3.9	4.4	5.4	5.2	11.5	5.7	13.6	4.6	6.9	5.6	4.6	6.2	4.1	10.1	7.2	4.0	1.0	6.7	8.7	5.2	5.5	3.9	3.3	9.8	2.4	2.5	4.2	7.0	5.8	18.3	4.1	9.6	8.3	6.3	5.4	7.3	2.0	3.4	6.3	6.1	4.5	4.9	0.9	3.2	4.8	3.4	6.7	3.7	0.8	1.3	0.4	0.5	0.4	0.4	0.3	0.2	0.5	0.7	0.4	0.6	11.6	0.1	0.3	0.9	0.1	0.4	3.1	5.3	9.0	7.6	3.1	2.5	5.6	3.1	6.6	3.1	23.8	34.8	16.9	105.1	190.4	43.9	9.9	28.1	6.7	28.4	7.0	29.5	13.0	1.7	24.3	25.9	38.3	46.3	0.0	21.8	12.3	68.9	86.7	180.6	19.5	22.0	36.5	76.6	28.3	40.4	6.5	15.3	69.4	54.0	9.0	35.8	8.9	40.4	43.5	13.1	7.7	16.8	19.4	94.7	18.6	17.3	164.4	43.5	15.2	34.6	91.6
PRDM10	"KIAA1231, MGC131802, PFM7"	ENSG00000170325	"PR/SET domain 10"	Q9NQV6	11	129899706-130002835	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026997, HPA061749"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"HPA026997: AB_1855681, HPA061749: "	"unprognostic (4.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.88e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.51e-1)"	5.8	5.4	7.6	7.2	8.9	14.2	8.5	20.3	10.4	7.4	7.8	6.4	5.8	6.6	8.2	6.8	8.4	5.4	5.5	4.6	7.7	6.2	5.0	7.3	6.3	6.9	6.6	6.5	7.3	6.2	9.7	11.2	8.3	6.4	7.1	8.0	5.5	6.7	5.4	12.9	12.1	7.0	6.1	6.3	6.7	7.8	5.6	6.3	14.4	6.5	4.7	9.9	6.2	7.0	8.8	3.3	9.4	3.8	7.1	5.0	1.8	3.0	4.1	5.1	3.4	2.3	2.8	3.4	2.5	3.3	2.1	2.8	4.2	3.3	12.2	3.1	2.9	2.9	4.1	4.3	2.1	3.5	4.7	4.2	8.0	5.0	3.2	1.5	7.2	33.3	2.0	4.8	3.2	2.1	3.3	3.8	3.3	4.4	4.7	3.1	3.6	4.8	3.6	3.9	4.1	3.0	4.5	3.2	1.8	3.1	5.6	5.6	2.9	3.7	4.3	1.2	3.0	3.0	3.0	3.7	5.0	2.3	2.5	3.3	1.2	2.0	16.9	2.2	3.9	4.5	3.9	3.4	8.5	4.5	3.4	4.1	8.8	3.5	3.5	3.3	6.0	5.0	2.4	9.4	7.1	3.8	3.2	4.1	1.8	7.6	8.9	20.3	10.4	7.7	6.2	6.6	6.5	6.4	6.3	3.0	2.4	0.0	1.9	5.5	3.2	2.4	2.5	1.4	1.2	0.0	0.0	1.2	0.0	1.0	2.9	0.6	3.5	0.0	1.0	1.1	2.0	3.2	1.1	1.5	1.3	1.6	1.7	1.3	2.8	2.9	2.3	1.8	0.0	1.0	2.8	0.8	0.8	2.6	1.8	0.7	2.2	0.0	1.4	0.3	0.6	4.4	0.5	1.8	2.3	2.7
PRDM15	"C21orf83, ZNF298"	ENSG00000141956	"PR/SET domain 15"	P57071	21	41798225-41879482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 15.1;Club cells: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 17.9;U-266/70: 16.5;U-698: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024268, HPA029255, HPA029256"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA024268: AB_1855688, HPA029255: AB_2672970, HPA029256: AB_2672971"	"unprognostic (8.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.85e-4)"	"unprognostic (4.22e-4)"	"unprognostic (6.50e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.86e-3)"	4.8	4.7	9.0	8.1	7.0	4.6	5.5	10.4	7.5	4.8	5.4	7.3	8.4	7.9	5.4	4.5	6.7	5.9	4.9	4.4	4.3	3.4	3.9	5.1	4.7	17.0	8.0	4.8	6.7	5.9	5.6	6.4	3.3	6.0	6.3	5.0	4.3	7.6	7.3	9.3	8.3	7.7	5.1	6.6	9.4	5.4	6.2	7.8	10.8	6.1	6.9	16.8	4.8	7.7	3.0	1.5	1.2	2.5	0.1	1.3	1.3	1.3	3.0	2.6	3.3	0.7	1.3	2.7	1.2	0.9	1.3	1.0	2.0	1.7	17.9	1.2	1.4	1.2	2.9	2.3	1.5	1.3	1.7	2.3	3.2	6.8	2.1	0.7	2.8	2.1	0.7	1.8	1.5	1.3	1.4	1.8	2.2	3.0	1.1	1.6	3.7	2.7	2.0	2.8	1.8	1.9	4.6	1.7	2.1	1.4	2.4	4.2	2.6	5.4	2.2	1.0	1.0	2.2	1.6	2.3	2.0	0.7	1.4	2.1	16.5	1.9	32.6	1.6	3.4	2.8	0.0	1.4	1.2	1.3	2.5	0.1	3.0	0.2	1.1	1.5	1.0	0.8	1.2	0.0	0.1	0.6	0.7	0.8	1.3	9.0	7.0	10.4	7.5	4.3	3.4	8.0	4.8	6.0	7.8	3.0	15.1	4.5	1.9	2.6	2.9	3.8	2.5	5.3	12.5	1.8	5.9	1.2	0.0	1.2	1.4	2.0	1.3	0.0	2.2	0.7	2.2	1.8	3.5	1.8	1.7	3.2	0.0	0.6	2.2	2.5	1.1	2.1	1.7	0.0	1.4	1.0	1.3	0.0	0.4	0.6	2.4	0.0	1.4	2.1	3.0	3.0	0.6	2.2	2.0	1.1
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;prostate: 30.9;seminal vesicle: 34.0"	"Cell type enriched"	"Detected in many"	31	"Bipolar cells: 289.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.2;LHCN-M2: 18.2;NB-4: 20.4;SCLC-21H: 44.1"	"Region enhanced"	"Detected in many"		"hippocampal formation: 31.4"	"Group enriched"	"Detected in all"	4	"amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7"	HPA057253			Approved	"Nuclear bodies"		No	NA			"Nuclear bodies"		"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	3.6	3.5	17.6	6.3	10.1	4.4	3.3	3.6	31.0	9.3	8.2	10.9	1.8	2.1	8.2	3.0	2.8	3.7	2.7	1.9	30.9	6.0	1.4	0.9	2.0	6.1	12.3	18.1	5.5	1.1	0.8	4.5	5.6	7.5	30.9	2.6	4.3	1.5	34.0	3.0	2.1	4.4	8.6	15.2	2.5	4.4	1.9	9.0	0.0	1.1	0.0	3.5	9.0	8.2	2.2	0.5	2.1	0.0	0.7	2.4	0.4	0.9	0.0	0.3	0.0	0.9	3.3	0.0	2.5	9.0	1.2	1.4	0.0	0.9	0.0	0.0	3.1	0.8	0.3	0.0	1.0	5.4	3.7	0.8	0.3	0.0	0.0	1.9	3.7	1.1	2.0	0.0	4.9	1.4	12.2	0.1	1.0	0.0	1.6	18.2	0.0	1.7	20.4	0.0	0.0	7.4	0.6	0.0	0.0	0.5	0.1	44.1	6.1	0.1	0.0	0.0	0.0	0.0	1.9	3.8	3.2	0.4	2.3	0.1	0.7	0.0	0.0	7.9	1.8	0.4	0.0	0.0	0.0	1.6	0.0	2.4	0.3	2.1	2.0	0.3	2.2	1.3	0.7	2.1	0.7	0.0	0.5	0.9	0.4	17.6	10.1	3.6	31.0	30.9	6.0	12.3	18.1	7.5	9.0	0.0	0.3	3.5	3.2	0.6	289.0	1.8	0.0	6.7	9.1	1.8	2.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.2	0.1	3.0	2.3	0.0	0.0	0.5	3.2	0.0	0.0	0.0	3.3	2.8	0.7	1.7	1.0	0.0	4.1	0.4	0.0	3.2	0.0	9.2	0.0	1.7	0.4	0.5	0.1	0.1	1.0	0.0	0.6
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	9.9	6.1	8.7	11.9	11.4	26.3	8.0	4.1	10.0	9.6	7.4	10.1	5.8	8.2	10.1	7.4	16.2	9.2	6.6	6.8	9.0	4.2	6.7	5.5	9.9	9.8	13.7	5.7	8.5	7.0	7.4	29.0	12.4	9.1	6.5	8.0	4.7	13.5	8.2	9.8	16.0	10.2	7.8	15.5	12.9	6.8	3.2	14.6	9.3	7.2	6.9	8.7	9.8	12.3	2.8	5.1	29.0	7.0	2.6	2.1	1.4	4.8	3.1	10.6	10.8	1.9	4.3	4.3	3.5	4.7	5.0	4.9	3.1	6.5	0.5	4.0	4.3	2.4	4.6	10.2	6.1	5.7	6.2	2.7	6.8	6.0	1.1	5.4	15.4	11.3	3.7	8.3	4.8	6.2	8.1	6.6	3.7	7.2	12.7	4.3	3.6	2.5	4.2	2.3	6.4	1.9	7.9	5.3	1.0	4.6	10.2	7.6	6.2	3.8	9.9	0.6	6.0	4.5	11.1	8.5	7.6	6.9	2.2	5.9	8.5	6.1	6.4	4.6	3.8	7.4	10.8	7.0	7.2	2.1	5.5	0.8	2.6	1.2	1.2	5.1	2.8	1.0	1.6	29.0	2.6	6.4	4.5	1.5	1.4	8.7	11.4	4.1	10.0	9.0	4.2	13.7	5.7	9.1	14.6	23.8	26.1	5.6	9.4	12.8	21.1	21.6	7.6	21.4	20.5	8.7	15.7	16.9	6.6	5.6	0.2	12.9	15.8	0.0	6.6	4.8	7.5	10.8	26.6	6.6	13.0	33.4	22.3	9.2	49.2	0.4	7.5	43.4	5.0	11.8	15.9	5.6	6.6	17.3	6.7	2.4	23.8	12.9	8.2	0.2	0.6	31.5	28.6	17.5	12.7	22.5
TRMT2B	"CXorf34, FLJ12687"	ENSG00000188917	"TRNA methyltransferase 2 homolog B"	Q96GJ1	X	101009346-101052116	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003745, HPA035120, HPA040814"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: "	"prognostic unfavorable (1.58e-5)"	"unprognostic (6.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.30e-7)"	"unprognostic (4.58e-2)"	"unprognostic (4.82e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.60e-2)"	7.6	10.4	6.9	8.9	10.3	9.1	8.5	7.0	14.2	9.6	11.4	6.9	10.7	8.1	8.1	8.6	12.9	7.4	7.3	13.0	10.7	6.6	12.3	9.5	9.4	12.6	9.5	6.6	11.3	10.4	18.5	17.6	5.9	10.7	10.1	12.6	13.4	15.3	10.4	17.6	9.5	13.5	7.9	8.4	16.6	11.4	4.0	7.9	18.2	12.8	5.3	17.7	9.9	9.5	16.5	8.1	14.8	8.2	14.4	19.2	11.5	15.3	13.3	2.7	6.3	6.3	3.3	8.4	8.0	10.7	8.9	13.4	14.3	12.3	13.6	15.9	7.3	18.2	9.6	12.2	11.1	11.3	11.7	7.7	8.6	11.0	6.7	5.6	15.3	14.1	4.2	6.6	12.9	6.0	6.3	17.2	14.8	8.8	13.0	8.2	15.5	19.0	8.1	3.7	18.9	9.9	15.6	13.1	13.0	6.6	9.1	4.0	5.2	13.6	9.9	7.9	7.8	6.5	7.4	10.1	11.4	6.9	10.5	7.1	8.3	12.5	12.7	8.8	17.6	8.7	9.6	8.2	14.8	13.8	6.5	14.6	14.9	16.1	13.3	7.4	16.5	19.2	16.1	4.8	14.4	7.0	8.1	13.0	11.5	6.9	10.3	7.0	14.2	10.7	6.6	9.5	6.6	10.7	7.9	6.0	7.5	4.4	5.2	2.1	0.4	9.0	2.5	5.3	3.4	14.0	2.0	5.0	6.6	3.6	0.0	3.7	4.2	0.0	3.1	2.6	1.6	4.2	12.7	3.0	3.0	1.6	6.4	2.5	3.5	0.0	3.1	2.8	1.7	2.8	5.2	4.5	3.9	6.0	3.5	5.6	1.8	0.0	1.4	0.2	3.6	1.4	4.2	8.7	5.6	4.7
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 130.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavorable (5.69e-4)"	18.0	19.5	17.1	14.6	21.9	19.1	26.2	23.4	25.3	18.2	21.8	20.1	18.8	15.1	22.1	12.1	17.3	30.5	18.7	45.8	16.5	18.9	16.0	24.2	14.7	16.9	19.0	16.9	20.9	25.0	22.7	20.2	14.8	15.4	19.4	8.9	19.9	23.7	21.1	130.4	12.7	16.9	20.4	15.3	18.8	16.2	29.7	17.6	26.8	23.5	19.5	13.7	26.8	44.8	11.5	8.9	17.6	10.6	7.6	17.0	5.7	33.1	32.0	13.0	23.4	19.1	13.3	11.3	16.0	19.8	26.3	24.5	36.1	8.8	21.0	23.7	17.6	13.9	21.9	19.6	16.9	13.6	23.9	26.7	15.4	18.2	20.1	17.8	11.1	20.7	12.7	11.5	19.7	11.7	16.7	15.2	16.4	16.7	9.6	14.6	24.6	23.9	12.4	11.0	13.9	16.4	21.7	25.7	36.8	7.7	11.4	13.4	17.7	20.0	13.9	18.2	42.7	14.0	9.6	15.4	25.4	17.7	37.2	31.3	11.2	8.5	12.7	46.1	18.2	16.6	4.3	7.2	17.6	15.1	7.4	14.0	7.9	13.6	17.0	8.9	11.5	10.9	11.0	4.6	7.6	10.6	6.6	7.9	5.7	17.1	21.9	23.4	25.3	16.5	18.9	19.0	16.9	15.4	17.6	32.8	25.7	39.8	24.5	57.5	79.0	78.7	25.5	28.1	18.2	26.2	37.3	28.1	71.3	24.0	48.1	37.6	35.4	46.7	27.3	36.7	47.3	36.0	41.4	52.9	29.7	112.8	58.5	27.6	39.9	29.1	38.0	25.6	47.2	17.2	41.8	72.5	28.5	42.4	48.8	81.8	52.8	19.4	44.3	106.7	98.2	48.9	26.3	48.4	31.6	21.6
APOBEC3C	"APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI"	ENSG00000244509	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3C"	Q9NRW3	22	39014083-39020352	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 114.8"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB033048, HPA071523"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB033048: AB_2057401, HPA071523: AB_2686409"	"unprognostic (1.79e-3)"	"prognostic favorable (1.08e-5)"	"unprognostic (4.32e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (8.91e-10)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.52e-3)"	13.3	28.0	2.3	15.6	3.4	9.2	8.0	1.1	2.0	21.4	13.1	4.2	27.5	4.5	18.2	23.5	19.6	20.9	13.8	13.0	2.2	2.0	6.3	4.5	11.7	20.9	3.3	2.0	26.4	5.3	0.7	3.3	7.7	3.2	20.7	12.0	12.9	12.3	114.8	3.4	6.9	11.8	17.2	4.2	32.2	8.1	45.6	2.4	16.2	8.7	17.0	45.5	21.8	12.7	48.1	19.7	49.3	42.6	35.2	61.3	26.2	10.6	10.5	1.8	20.8	11.7	24.3	9.1	7.9	15.4	11.6	15.6	10.0	12.2	31.8	5.3	15.5	7.4	11.0	1.8	33.3	11.4	12.0	9.0	30.6	0.5	8.3	12.7	19.9	30.8	26.3	19.4	15.2	3.8	5.8	6.5	0.2	18.7	40.6	23.3	0.1	7.9	10.8	2.8	0.1	23.2	13.9	4.8	26.4	7.7	14.2	0.5	1.4	11.4	0.0	5.7	4.8	0.1	7.3	3.3	6.3	10.8	3.3	3.4	11.0	11.3	2.6	19.3	12.9	16.3	13.6	20.3	49.3	61.3	40.2	42.2	44.6	33.6	54.6	19.7	48.1	11.5	41.1	2.7	35.2	42.6	16.7	30.5	26.2	2.3	3.4	1.1	2.0	2.2	2.0	3.3	2.0	3.2	2.4	3.0	21.0	91.0	37.0	22.3	0.0	17.3	28.1	13.4	12.5	7.0	0.0	3.2	0.0	25.1	1.9	8.9	11.9	116.8	1.2	1.5	27.8	15.7	55.4	0.8	53.0	0.0	25.3	28.8	42.1	4.1	53.5	30.8	42.2	70.3	16.2	24.7	7.9	12.7	35.7	1.0	0.2	25.8	28.8	1.6	1.5	14.3	1.6	91.6	16.1	44.2
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468312-104494901	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 19.4;pituitary gland: 17.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 41.0;Cone photoreceptor cells: 29.5;Horizontal cells: 42.9;Intestinal endocrine cells: 98.1;Rod photoreceptor cells: 25.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.9;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"AF22: 7.2;AN3-CA: 10.0;Karpas-707: 9.3;RPMI-8226: 5.4;SCLC-21H: 12.5;U-266/70: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	2.2	4.3	10.3	0.9	12.0	0.6	4.3	17.5	19.4	2.4	2.5	7.4	0.8	5.4	1.9	5.3	1.0	6.7	1.5	5.3	9.9	14.4	1.7	2.7	2.3	0.7	7.9	9.9	5.6	5.8	3.2	17.2	1.4	10.2	2.1	2.9	7.9	7.5	2.1	1.3	0.8	5.5	1.8	5.3	1.4	4.3	4.9	13.3	0.0	7.1	0.1	0.7	1.6	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	7.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.6	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	9.3	0.0	0.0	2.7	0.0	2.6	0.1	0.1	0.0	0.0	5.4	0.0	0.1	12.5	2.3	0.0	0.6	0.0	3.1	0.3	0.0	0.0	0.0	1.7	0.0	0.1	10.2	2.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.1	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.0	17.5	19.4	9.9	14.4	7.9	9.9	10.2	13.3	0.0	5.4	0.0	0.8	0.2	41.0	12.8	0.0	14.7	2.3	0.0	29.5	0.1	0.0	0.1	0.2	1.6	0.9	0.0	2.9	0.0	0.4	0.5	0.0	2.4	0.1	42.9	98.1	1.3	0.3	0.4	0.3	0.0	1.7	0.0	4.3	13.3	2.1	0.0	10.3	0.7	25.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.8	0.4
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423619-30430075	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002832	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes		270000	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	15.3	15.8	14.8	25.0	13.2	12.5	20.7	15.5	19.2	12.1	37.4	10.3	11.3	20.7	14.1	14.4	19.7	18.9	28.1	23.3	12.1	12.6	27.0	25.3	11.2	27.6	13.3	16.6	16.6	25.2	16.4	7.7	16.3	11.4	15.4	40.3	10.6	20.5	21.1	28.3	16.1	22.9	13.9	11.3	22.5	16.4	9.9	7.8	21.3	22.6	26.0	25.0	13.2	13.0	47.3	30.9	19.0	24.5	23.1	26.2	25.3	26.6	32.7	14.9	19.2	4.2	5.7	13.8	12.8	7.7	19.4	19.8	24.6	22.8	36.1	27.0	8.0	12.4	21.0	30.9	25.1	24.3	19.0	48.8	21.0	15.0	32.0	5.5	37.5	32.8	6.6	14.3	21.6	12.5	5.9	19.9	19.4	26.4	12.7	13.7	46.5	44.5	42.1	19.7	27.0	26.4	63.2	16.6	47.0	22.4	17.3	31.8	18.0	8.5	30.5	12.0	10.2	26.3	16.1	10.0	15.0	13.4	19.3	23.0	8.4	25.0	46.0	9.9	31.2	17.5	19.0	12.4	11.7	18.8	22.1	26.2	47.3	24.2	21.3	28.7	40.2	21.8	21.0	1.5	23.1	24.5	30.9	24.1	25.3	14.8	13.2	15.5	19.2	12.1	12.6	13.3	16.6	11.4	7.8	17.9	14.6	32.0	37.1	80.1	23.9	33.1	61.1	20.1	19.4	41.8	7.9	81.7	107.8	107.5	10.2	47.2	79.9	0.0	108.6	68.9	31.5	41.3	31.1	18.1	68.6	14.3	37.0	25.2	16.6	36.0	18.1	35.6	45.5	108.2	103.3	19.7	78.9	105.2	18.7	54.0	16.3	19.4	35.0	2.8	33.6	70.1	23.2	25.9	124.8	43.2
DIP2B	"FLJ34278, KIAA1463"	ENSG00000066084	"Disco interacting protein 2 homolog B"	Q9P265	12	50504985-50748667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038472, HPA046133, HPA056045"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA038472: AB_2676033, HPA046133: AB_2679551, HPA056045: AB_2683019"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-3)"	8.6	12.2	20.3	11.2	33.0	14.3	14.2	37.7	25.6	10.0	12.4	35.9	5.3	8.3	8.6	5.1	17.1	6.3	9.5	7.6	24.5	17.2	8.4	14.7	9.0	11.9	35.2	17.4	13.2	10.2	21.4	8.9	13.9	24.8	9.3	14.6	9.0	11.1	6.2	6.7	22.6	8.3	9.7	35.6	18.4	9.3	9.9	34.4	11.4	11.2	6.4	15.1	9.0	10.4	3.9	2.5	7.7	5.6	0.9	3.1	1.2	13.7	8.6	13.0	9.1	7.5	7.3	18.0	7.9	9.4	7.8	5.9	15.3	7.8	9.3	9.6	8.8	8.0	14.5	20.8	15.2	9.2	10.7	7.4	14.7	7.3	19.4	11.7	17.6	9.0	8.2	13.2	8.7	12.7	13.6	14.7	8.6	20.3	9.0	6.8	11.0	13.6	8.9	7.4	8.0	15.0	15.9	12.7	4.5	8.8	11.0	12.2	8.5	19.8	11.8	12.2	15.8	16.6	12.4	14.8	6.3	7.4	5.7	6.5	6.5	10.7	11.0	8.8	8.2	8.6	1.7	2.0	4.3	0.7	2.3	1.2	2.5	1.8	0.7	2.5	3.9	3.1	2.5	7.7	0.9	5.6	0.7	1.6	1.2	20.3	33.0	37.7	23.2	24.5	17.2	35.2	17.4	24.8	34.4	6.0	8.0	14.5	21.8	48.8	26.2	8.5	15.3	4.0	4.5	8.7	60.9	11.0	0.0	8.9	1.4	14.6	15.5	0.0	14.9	15.4	8.7	29.0	10.4	16.6	16.5	11.1	30.1	14.7	25.2	2.2	9.5	12.8	15.1	7.2	20.1	15.6	16.0	14.4	9.6	4.5	31.3	0.0	6.8	11.2	18.4	58.5	31.8	6.9	10.2	19.5
KDM5D	"HY, HYA, JARID1D, KIAA0234, SMCY"	ENSG00000012817	"Lysine demethylase 5D"	Q9BY66	Y	19703865-19744939	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 27.0;U-698: 23.6"	"Low region specificity"	"Detected in all"							HPA049086			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA049086: "			"unprognostic (8.38e-2)"		"unprognostic (2.20e-1)"	"prognostic favorable (3.58e-5)"	"unprognostic (6.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.10e-2)"		"unprognostic (4.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-2)"	8.0	15.6	3.3	28.7	15.7	11.6	6.5	11.4	23.0	0.3	15.8	20.7	16.4	14.3	0.3	17.4	10.2	0.3	15.8	7.6	4.6	5.3	6.7	6.8	10.1	15.9	5.0	0.0	0.3	12.5	0.3	9.3	8.0	16.1	17.2	18.8	21.4	14.5	20.4	14.9	8.7	28.6	25.6	6.1	17.1	10.2	14.0	0.0	29.8	10.7	15.3	19.5	14.9	0.0	6.3	5.1	3.8	3.1	3.4	5.1	1.8	0.0	3.8	0.0	0.0	0.0	0.0	7.7	6.8	5.9	4.0	4.6	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	4.4	10.2	0.0	27.0	0.0	8.9	5.8	0.0	0.0	6.3	6.2	0.0	0.0	0.0	0.0	4.8	0.0	0.0	9.4	0.0	10.8	0.0	5.7	0.0	0.0	0.0	4.7	4.9	8.5	13.3	6.3	0.0	0.0	0.0	2.8	13.6	0.0	5.6	8.9	12.5	0.1	0.1	3.1	11.4	7.3	23.6	1.2	0.0	0.0	0.0	3.1	3.8	4.6	2.2	3.5	6.3	4.3	4.4	3.3	5.6	5.1	3.7	0.4	3.4	1.9	5.1	3.5	1.8	3.3	15.7	11.4	23.0	4.6	5.3	5.0	0.0	16.1	0.0	17.9	13.9	20.4	8.9	5.7	37.4	8.1	0.0	4.0	9.1	17.4	19.6	5.5	5.0	3.2	0.7	10.8	2.6	23.3	0.0	1.2	13.2	8.9	10.5	0.4	3.7	12.7	3.4	11.6	3.5	1.5	33.9	12.3	10.1	12.6	2.4	10.0	2.8	0.0	31.8	3.1	32.5	25.8	7.8	2.8	7.8	9.5	4.7	15.2	0.0	6.7
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780592-153789120	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 102.5"	"Group enriched"	"Detected in some"	15	"Basal keratinocytes: 102.6;Fibroblasts: 163.9;Melanocytes: 113.1;Smooth muscle cells: 47.4;Suprabasal keratinocytes: 92.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 53.5;ASC diff: 20.3;HSkMC: 33.5;NTERA-2: 74.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA			"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	42.9	4.0	3.4	17.6	1.7	0.2	70.0	1.3	8.0	10.9	20.6	11.3	18.2	4.4	6.4	64.4	51.5	18.5	74.9	42.2	8.5	1.2	1.9	0.2	21.3	2.6	2.8	5.6	7.9	22.5	1.6	23.2	0.3	4.6	33.4	10.8	8.4	23.9	19.5	2.5	26.1	13.7	72.3	5.4	0.3	11.4	13.2	5.0	0.3	29.1	29.4	6.8	102.5	37.4	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	53.5	0.0	20.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	1.7	1.3	5.7	8.5	1.2	2.8	5.6	4.6	5.0	3.0	1.1	0.0	0.6	102.6	0.0	0.3	0.0	5.3	3.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	163.9	0.3	1.1	0.0	3.3	0.0	0.0	0.0	0.0	0.2	3.7	2.2	113.1	1.0	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	47.4	0.0	0.2	92.6	0.1	0.0	0.0	1.0
ZNF473	"DKFZP434N043, HZFP100, KIAA1141"	ENSG00000142528	"Zinc finger protein 473"	Q8WTR7	19	50025714-50053414	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.6"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 63.5;Spermatocytes: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA004191, HPA073309"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004191: AB_2667168, HPA073309: AB_2686594"	"unprognostic (7.47e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.27e-1)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.31e-3)"	"unprognostic (6.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	3.8	3.7	4.4	3.8	6.5	3.8	4.8	9.7	5.8	4.1	3.7	4.6	3.7	2.9	5.9	4.4	3.8	10.1	3.4	3.0	5.1	4.3	3.8	4.1	4.0	3.7	5.9	3.2	4.8	4.8	4.0	7.7	3.1	7.3	5.1	3.3	2.7	3.4	5.6	4.9	3.8	3.0	5.1	5.0	6.4	3.3	38.6	7.7	2.6	5.2	3.3	4.5	3.7	18.6	12.4	5.6	5.0	7.9	2.4	11.6	4.6	9.4	6.4	10.1	8.4	3.8	4.7	5.7	8.9	5.2	12.7	11.9	12.3	6.3	14.4	3.4	5.1	4.7	7.1	12.7	5.9	16.3	10.3	12.0	14.8	5.6	5.7	4.7	10.6	8.8	4.8	11.0	13.3	17.6	5.2	4.2	8.7	20.9	13.2	6.4	4.1	8.1	5.0	7.1	14.7	9.9	10.4	14.0	6.3	4.2	10.4	8.3	9.4	12.6	6.9	6.2	7.0	6.2	9.8	2.0	17.7	9.0	3.4	8.9	6.1	14.4	12.3	4.2	8.4	14.3	2.2	5.5	2.9	7.2	7.9	7.3	12.4	7.2	8.8	5.4	10.2	9.2	11.6	5.0	2.4	3.5	5.6	3.9	4.6	4.4	6.5	9.7	5.8	5.1	4.3	5.9	3.2	7.3	7.7	0.0	1.7	2.7	2.3	4.0	0.7	2.1	0.0	13.4	1.2	0.0	0.0	2.0	3.3	2.1	63.5	2.8	1.7	0.0	2.8	2.5	2.4	2.8	0.0	1.0	1.9	0.0	1.7	8.6	2.1	16.0	3.4	1.6	1.7	2.8	2.7	1.7	3.2	2.0	3.5	1.5	3.7	12.9	2.9	38.6	20.2	4.1	1.6	3.2	1.8	1.4
ASZ1	"ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3"	ENSG00000154438	"Ankyrin repeat, SAM and basic leucine zipper domain containing 1"	Q8WWH4	7	117363222-117428123	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 15.7"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 87.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"Daudi: 4.0;U-266/70: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020558	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020558: AB_1845123"								"unprognostic (4.30e-1)"				"unprognostic (1.87e-1)"			"unprognostic (1.42e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	87.1	20.1	0.0	0.0	0.0	0.0	0.1
DDX4	VASA	ENSG00000152670	"DEAD-box helicase 4"	Q9NQI0	5	55738017-55817157	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	171	"testis: 60.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 435.1;Late spermatids: 140.2;Spermatocytes: 312.4"	"Cancer enriched"	"Detected in single"	37	"testis cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;HEK 293: 1.6;NB-4: 1.0;PC-3: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB026170, HPA037763, HPA037764"	Enhanced					NA	NA					"CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.54e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.43e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.55e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	60.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.4	0.0	0.1	0.0	0.7	0.4	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	435.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.2	5.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.0	0.0	0.0	0.0	312.4	73.7	0.0	0.0	0.0	0.0	0.0
FKBP6	"FKBP36, PPIase"	ENSG00000077800	"FK506 binding protein 6"	O75344	7	73328164-73358637	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 33.0"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 62.1;Late spermatids: 61.4;Spermatocytes: 105.5;Spermatogonia: 35.0"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;Karpas-707: 1.5;SiHa: 2.1;U-266/84: 1.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA061109	Enhanced					NA	NA					"HPA061109: AB_2684430"	"unprognostic (5.07e-2)"	"unprognostic (3.34e-2)"		"unprognostic (1.56e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.20e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	0.5	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.3	0.3	2.1	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.2	0.7	1.3	0.0	0.4	0.3	0.3	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.8	0.4	0.0	20.1	2.3	0.0	0.0	0.0	0.0	0.3	62.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	61.4	2.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	1.1	0.0	0.3	0.0	0.0	105.5	35.0	0.0	0.1	0.0	0.0	0.1
FP565260.4		ENSG00000279493			21	5011799-5017145	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	9	"kidney: 3.4;liver: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 6.0;HeLa: 2.6;Hep G2: 2.2;MCF7: 4.3;SiHa: 6.9"															NA	NA																							0.0	0.0		0.3		0.2	0.0		0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.0	0.0			3.4	10.1	0.0	0.7			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.1	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	1.9	0.0	0.0	2.9	0.0	0.0	0.0	0.0	6.0	0.0	0.9	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.2	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.6	0.0	0.0	6.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 1781.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.7	32.8	55.4	25.8	94.2	43.0	49.8	56.4	51.6	64.5	46.3	95.8	50.6	32.0	87.9	73.2	46.2	42.3	50.8	75.1	43.7	21.1	30.6	35.6	49.9	62.7	43.5	20.7	22.4	51.3	38.2	31.3	42.2	51.2	48.9	39.5	31.2	43.7	42.5	133.6	105.4	50.6	17.6	6.4	34.7	64.9	48.5	56.5	51.7	38.7	68.7	157.4	78.4	77.9	62.9	50.7	59.5	56.7	53.7	85.7	77.0	30.8	53.1	76.8	49.5	67.6	37.6	10.1	43.7	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4	205.4	224.1	189.5	151.9	115.9	363.0	884.0	242.0	250.3	255.9	247.7	53.0	672.6	376.4	220.5	577.5	343.9	323.7	303.7	196.1	292.5	221.9	260.9	133.0	165.2	333.8	1781.3	444.7	335.7	327.9	1338.6	245.7	276.8	210.9	147.9	250.3	861.2	313.5	239.3	185.3	130.9	175.1	207.0	226.4	48.2	25.4	103.0	1013.3	142.4	268.2	212.5
MIS18A	"B28, C21orf45, C21orf46, FASP1, hMis18alpha"	ENSG00000159055	"MIS18 kinetochore protein A"	Q9NYP9	21	32268219-32279069	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 118.1;Spermatogonia: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA018286, HPA020585"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA018286: AB_1845693, HPA020585: AB_1845694"	"unprognostic (1.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.28e-1)"	5.5	7.5	7.8	6.6	10.7	13.8	7.4	16.4	8.3	6.1	8.9	5.4	1.9	7.9	6.6	6.3	11.4	5.6	5.3	3.9	6.8	4.7	6.7	5.7	3.7	9.7	6.8	9.3	9.8	5.8	3.3	4.3	7.1	6.6	5.5	10.6	4.4	6.0	4.1	4.0	7.8	8.5	7.7	6.2	7.3	6.1	26.6	5.4	19.3	3.9	6.8	11.3	5.3	6.5	18.5	13.2	8.2	11.7	10.4	15.5	6.4	21.1	5.3	15.3	14.6	2.3	4.0	23.5	11.2	5.8	11.0	9.6	10.5	11.8	23.2	8.3	4.2	13.3	7.2	15.0	8.5	13.3	13.2	16.6	26.6	5.6	13.5	1.5	22.7	9.0	1.7	3.7	9.2	6.7	3.6	7.7	23.7	30.9	19.6	10.7	14.5	26.0	20.7	31.6	14.7	15.5	22.8	22.9	21.7	7.6	7.3	18.4	9.1	17.1	14.6	10.5	11.5	17.6	13.9	4.5	13.9	25.7	10.8	11.5	10.6	16.8	29.3	8.9	36.6	12.5	2.4	5.3	8.2	10.2	6.8	10.2	18.2	11.2	11.7	4.9	18.5	15.5	11.5	1.7	10.4	11.7	13.2	14.6	6.4	7.8	10.7	16.4	8.3	6.8	4.7	6.8	9.3	6.6	5.4	17.9	6.2	11.5	6.8	13.9	10.1	5.2	5.1	10.7	5.7	10.4	3.9	29.4	11.6	9.4	4.3	6.8	2.0	0.0	10.7	41.8	12.1	4.6	3.5	7.3	14.5	7.9	5.8	14.1	5.4	5.3	9.8	6.3	5.0	6.4	17.5	9.7	8.2	7.8	9.6	13.7	7.4	19.4	6.6	118.1	79.0	12.9	12.2	8.9	15.3	3.5
MOV10L1	"CHAMP, DJ402G11.8, DKFZp434B0717"	ENSG00000073146	"Mov10 RISC complex RNA helicase like 1"	Q9BXT6	22	50089879-50161690	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 27.7"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 110.5;Late spermatids: 224.1;Spermatocytes: 68.2;Spermatogonia: 38.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 3.3;HUVEC TERT2: 16.1;TIME: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019034	Approved					NA	NA					"HPA019034: AB_1854070"	"unprognostic (1.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.91e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	0.4	0.1	0.7	0.2	1.5	0.3	0.2	1.3	1.3	0.9	0.8	0.6	0.2	0.1	3.0	2.0	0.4	1.0	1.2	0.3	0.9	0.6	0.3	1.0	0.3	0.2	0.5	1.5	1.8	0.2	0.1	0.4	0.6	2.1	1.0	0.2	0.6	0.2	0.2	0.2	0.3	0.4	1.9	0.7	0.2	0.1	27.7	0.2	0.2	0.5	0.2	0.3	0.4	2.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	0.5	1.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	3.3	0.0	1.5	0.2	0.0	0.0	0.0	0.2	16.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.5	1.3	1.3	0.9	0.6	0.5	1.5	2.1	0.2	0.0	0.0	0.0	0.1	0.2	2.4	1.4	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	110.5	1.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.0	1.4	4.8	0.0	0.0	0.0	224.1	1.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.8	0.8	3.8	12.9	0.0	68.2	38.5	0.0	0.1	0.0	0.0	0.0
PIWIL2	"CT80, FLJ10351, HILI, Mili"	ENSG00000197181	"Piwi like RNA-mediated gene silencing 2"	Q8TC59	8	22275297-22357563	"Predicted intracellular proteins"	"Biological rhythms, Differentiation, Meiosis, Oogenesis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 37.3"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 40.9;Spermatogonia: 22.6"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 6.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	25	"NTERA-2: 29.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.58e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.59e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-7)"	"unprognostic (1.27e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.61e-2)"	0.9	0.2	0.3	0.6	1.3	0.1	5.7	1.5	1.0	1.1	0.7	0.5	0.2	5.7	0.8	0.5	0.3	0.9	0.2	0.9	0.5	1.0	0.2	1.0	0.2	1.0	0.6	0.7	1.9	2.2	0.0	1.4	0.5	0.9	1.6	0.9	1.2	0.8	0.5	2.2	0.5	1.7	0.6	0.8	0.2	1.4	37.3	0.2	0.4	1.3	1.6	0.8	1.0	0.7	0.3	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.2	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	1.3	1.5	1.0	0.5	1.0	0.6	0.7	0.9	0.2	6.0	4.0	0.0	0.7	0.9	6.1	1.1	0.0	4.0	0.0	1.8	7.9	0.1	0.0	0.0	3.2	0.0	6.2	0.0	1.4	0.2	1.7	0.8	1.1	3.0	0.1	0.0	0.0	0.6	0.0	4.8	2.6	0.9	1.7	1.0	4.4	0.9	1.1	1.9	2.1	0.3	3.0	0.0	2.0	40.9	22.6	1.4	0.2	0.0	4.9	0.9
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;testis: 30.9"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 10.2;Mucus-secreting cells: 7.8;Paneth cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"NB-4: 44.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036587, HPA036588, HPA057508"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	1.9	0.6	1.9	1.9	3.1	17.8	2.7	4.1	1.7	2.2	3.8	1.7	1.7	4.5	2.5	1.7	1.7	2.0	3.6	1.7	1.9	1.7	1.7	1.7	1.7	2.5	1.7	1.7	2.2	8.2	0.2	1.7	2.3	1.7	1.7	5.0	1.7	7.6	2.0	1.7	0.8	4.3	1.7	2.5	2.3	3.6	30.9	1.7	1.7	1.7	1.7	1.8	1.7	1.7	0.0	0.8	0.5	2.4	0.3	1.3	1.0	0.1	0.0	0.2	0.0	3.3	2.2	0.2	0.2	0.1	0.1	0.4	0.3	0.3	0.0	0.2	1.3	0.1	0.0	0.4	0.0	0.1	1.2	0.1	0.1	0.3	0.0	1.3	3.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.2	0.1	44.9	0.0	4.4	0.3	0.1	0.0	0.0	1.0	0.0	0.2	0.1	0.2	0.4	0.2	0.1	0.0	9.9	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.4	0.5	1.0	1.0	0.0	0.0	0.1	0.6	0.8	0.0	1.3	0.4	0.0	0.3	1.0	0.0	0.4	1.0	1.9	3.1	4.1	1.7	1.9	1.7	1.7	1.7	1.7	1.7	0.0	0.3	0.0	0.2	1.1	0.6	1.4	10.2	2.7	2.3	0.0	0.0	3.3	1.7	3.6	2.8	0.5	2.9	0.0	1.8	0.3	0.9	0.4	0.0	0.0	1.5	0.0	0.0	1.3	3.1	1.0	0.3	1.5	0.0	1.0	7.8	0.3	2.7	6.5	1.1	0.6	2.8	0.0	0.8	0.7	1.5	0.1	0.8	0.0	4.7	0.0
PLD6		ENSG00000179598	"Phospholipase D family member 6"	Q8N2A8	17	17200995-17206315	"Predicted membrane proteins"	"Differentiation, Lipid degradation, Lipid metabolism, Meiosis, Spermatogenesis"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.1"	"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 15.6;Spermatogonia: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.6;NK-cells: 5.0;T-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 25.9;REH: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA049345	Approved					NA	NA					"HPA049345: AB_2680722"	"unprognostic (1.71e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.83e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.24e-1)"	5.0	5.9	4.8	2.3	12.5	2.4	5.1	18.2	9.6	6.7	5.8	4.5	2.9	2.3	4.4	7.2	2.6	6.5	3.6	5.5	4.9	8.1	3.4	4.6	2.5	5.2	5.0	4.1	10.4	16.2	6.8	6.3	3.7	5.6	7.5	2.5	5.1	4.5	6.5	3.7	3.2	2.2	3.4	4.0	3.0	3.7	37.1	1.7	2.0	3.3	1.7	4.1	5.9	3.3	5.6	1.3	0.5	0.4	5.0	11.4	4.0	4.2	3.3	0.1	3.8	1.5	0.6	0.2	1.3	2.2	2.5	1.5	3.9	1.3	9.5	2.1	1.4	1.5	1.2	25.9	0.7	2.4	5.9	7.5	9.1	2.5	6.9	6.7	6.8	3.8	1.3	2.8	1.5	6.2	2.9	0.6	4.5	8.1	0.2	2.9	5.5	5.0	9.6	0.0	4.9	4.6	19.2	1.9	6.9	2.3	0.3	15.0	6.1	1.7	2.5	4.5	2.9	2.4	11.0	0.7	0.1	0.2	5.6	2.7	1.2	4.4	0.0	3.1	7.0	5.3	0.3	0.4	0.2	2.8	0.3	9.2	5.6	10.7	5.6	0.1	4.3	11.4	5.1	0.5	5.0	0.2	1.3	7.6	4.0	4.8	12.5	18.2	9.6	4.9	8.1	5.0	4.1	5.6	1.7	3.0	3.5	2.9	4.1	4.8	4.6	5.6	2.5	5.3	2.3	1.8	0.0	3.4	1.7	0.9	6.0	0.5	0.5	0.0	0.6	0.9	2.4	3.6	1.1	1.7	2.4	6.4	1.2	0.6	0.3	1.6	4.0	0.0	3.3	1.0	1.7	5.8	0.9	0.0	4.6	1.1	1.2	0.0	1.4	15.6	25.4	1.4	0.7	3.8	1.2	0.9
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	12.2	7.0	6.1	5.7	9.2	13.6	11.9	30.8	6.6	11.1	10.0	10.6	7.8	7.6	12.0	8.3	8.6	11.1	8.3	5.8	7.7	4.4	7.4	7.4	9.2	7.9	10.3	4.6	17.3	12.3	8.1	8.9	18.5	8.8	9.3	9.4	8.2	8.1	6.8	9.7	8.1	8.1	8.2	7.3	9.2	7.3	16.2	12.5	15.5	8.7	6.9	7.0	7.8	11.3	7.3	13.1	20.5	13.2	6.8	8.3	6.8	2.7	5.5	6.2	5.3	4.2	2.6	8.0	4.3	2.9	2.8	4.0	5.6	1.6	7.9	3.6	3.0	1.1	3.0	4.0	1.8	3.8	1.4	8.8	5.7	5.4	6.5	3.5	2.3	4.4	2.3	2.9	4.2	2.5	2.3	6.4	3.4	4.1	3.3	3.0	26.9	6.2	3.4	2.7	2.6	4.3	7.6	7.9	4.7	2.5	3.4	8.5	6.2	5.7	1.9	1.3	6.9	2.3	3.1	4.7	3.7	10.1	2.8	2.3	5.4	5.7	6.0	1.5	2.3	2.8	8.2	13.2	14.1	6.7	10.2	5.9	7.3	5.6	6.1	13.1	5.9	6.1	6.2	20.5	6.8	6.1	5.8	8.3	6.8	6.1	9.2	30.8	6.6	7.7	4.4	10.3	4.6	8.8	12.5	29.8	7.7	13.7	4.0	18.7	12.0	5.6	5.1	2.7	4.5	5.2	3.9	13.6	3.3	6.0	51.4	15.8	10.1	0.0	6.0	5.1	11.2	6.9	1.1	2.8	7.5	3.2	13.8	20.3	23.0	8.1	12.7	9.8	3.3	6.4	9.0	6.4	5.1	8.6	7.1	4.2	10.1	0.0	12.0	24.5	13.9	15.7	32.3	7.5	10.5	5.5
SMCHD1	"FSHD2, KIAA0650"	ENSG00000101596	"Structural maintenance of chromosomes flexible hinge domain containing 1"	A6NHR9	18	2655738-2805017	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Hydrolase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 30.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 30.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039441	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA039441: AB_10671042"	"unprognostic (2.99e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (1.32e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.63e-2)"	19.8	8.1	9.1	29.9	11.1	35.6	17.2	18.0	11.3	21.9	17.3	8.2	16.0	13.7	19.2	12.3	12.4	15.6	13.3	12.6	8.3	8.0	9.3	10.2	21.5	31.3	12.7	8.6	20.0	21.2	15.9	14.8	16.2	9.4	15.6	15.3	11.6	14.0	14.0	12.9	10.8	23.7	23.1	9.8	32.0	14.0	13.7	11.5	34.4	12.1	9.6	22.1	25.7	23.5	4.1	1.2	30.3	1.2	1.1	3.2	0.5	10.9	5.0	17.0	10.6	7.3	10.7	12.2	11.0	7.9	10.5	13.4	9.3	3.6	23.7	4.9	9.8	11.8	6.0	13.7	6.3	16.6	4.8	7.1	14.8	9.8	8.9	8.2	42.4	11.6	7.0	5.8	13.3	11.0	8.1	8.6	11.9	17.2	14.8	10.0	3.9	17.7	10.9	6.8	5.9	5.8	14.5	13.8	10.4	6.5	16.9	14.0	8.8	14.9	5.0	8.6	9.9	3.7	18.1	8.1	13.0	18.0	17.6	20.2	9.0	13.5	21.7	8.4	7.9	11.3	1.9	1.2	3.1	1.9	0.8	1.4	2.9	2.5	2.2	0.4	4.1	3.2	2.0	30.3	1.1	1.1	1.2	2.5	0.5	9.1	11.1	18.0	11.3	8.3	8.0	12.7	8.6	9.4	11.5	41.7	46.8	107.2	33.5	24.2	88.8	43.9	12.7	22.7	35.2	17.4	94.2	30.4	5.0	20.1	88.0	41.1	49.1	23.3	16.7	19.9	31.9	43.1	38.3	13.9	17.4	93.8	21.8	28.8	68.9	26.8	38.9	61.6	28.7	64.1	29.6	37.0	20.6	59.6	35.7	6.3	91.7	38.8	36.3	85.4	79.0	21.8	39.2	79.1	25.5	40.9
STK32C	"MGC23665, PKE, YANK3"	ENSG00000165752	"Serine/threonine kinase 32C"	Q86UX6	10	132207492-132331847	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017894	Uncertain					NA	NA					"HPA017894: AB_1857591"	"unprognostic (2.11e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.65e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.68e-6)"	"unprognostic (2.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.31e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.36e-1)"	6.8	8.2	23.5	6.4	23.5	6.1	7.1	8.3	31.6	4.1	4.9	6.3	6.0	5.0	4.6	15.5	3.4	9.4	7.8	7.0	17.9	12.8	6.3	4.2	7.3	8.5	9.2	16.1	5.8	7.0	6.2	6.7	4.8	7.7	4.6	4.7	3.2	5.6	5.5	11.3	7.1	4.7	4.9	7.7	10.7	4.8	26.1	8.1	8.7	4.9	3.0	6.1	4.6	3.6	5.5	14.5	25.0	11.2	3.2	4.9	3.6	32.1	21.1	6.5	16.3	9.1	11.6	1.3	6.8	5.3	8.6	11.1	4.7	22.5	7.1	5.1	7.8	10.9	7.4	9.4	2.7	8.4	4.2	15.1	4.1	21.6	22.3	11.5	3.7	15.5	8.7	10.3	7.8	8.9	11.0	7.5	12.1	7.2	5.0	9.2	9.7	4.7	14.2	4.2	5.9	15.4	5.7	4.1	2.2	11.2	5.6	17.0	13.3	4.8	4.5	9.5	4.0	5.2	9.0	5.0	7.1	7.1	8.9	5.3	9.3	1.7	17.7	15.5	3.6	3.4	25.0	10.7	9.2	3.5	11.2	4.5	3.6	2.9	4.0	14.5	5.5	3.6	2.9	1.4	3.2	9.5	8.3	4.9	3.6	23.5	23.5	8.3	31.6	17.9	12.8	9.2	16.1	7.7	8.1	0.0	11.1	5.2	5.5	4.6	8.8	2.9	2.5	14.7	5.7	12.2	11.8	2.8	16.6	5.0	222.3	8.3	2.6	0.0	7.5	2.0	7.3	7.5	15.1	4.9	13.1	35.0	18.4	11.1	20.5	53.0	8.3	18.4	11.8	6.4	5.5	7.3	6.0	4.0	6.3	9.7	14.6	6.5	5.3	31.4	17.2	4.4	1.3	9.2	7.9	6.2
TDRD1	CT41.1	ENSG00000095627	"Tudor domain containing 1"	Q9BXT4	10	114179270-114232304	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 35.3"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 5.9;Spermatocytes: 18.4;Spermatogonia: 21.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.1"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 2.1"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 33.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037729	Enhanced					NA	NA					"HPA037729: AB_10670527"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.15e-2)"		"unprognostic (6.13e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.60e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.68e-1)"	0.3	0.2	0.2	0.3	0.2	0.0	0.4	0.2	2.1	0.2	0.3	0.0	0.0	0.2	0.6	0.7	0.3	0.2	0.6	0.8	0.3	0.2	2.8	0.7	0.2	0.2	0.2	0.4	0.5	0.6	0.0	0.3	0.0	0.4	2.9	0.1	0.0	0.3	0.2	0.4	0.2	0.3	0.2	0.7	1.6	0.3	35.3	0.0	0.0	0.2	1.0	0.2	0.2	0.2	0.8	4.5	0.2	0.2	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.2	0.1	0.1	0.5	0.2	0.8	0.8	0.0	0.2	0.4	0.0	4.5	0.2	0.0	0.2	0.2	0.2	2.1	0.3	0.2	0.2	0.4	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	2.8	0.0	4.0	0.0	0.0	0.0	0.3	0.0	0.2	5.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.7	0.7	0.0	0.0	0.0	18.4	21.3	0.0	0.1	0.0	0.0	0.0
TDRD12	"ECAT8, FLJ13072"	ENSG00000173809	"Tudor domain containing 12"	Q587J7	19	32719753-32829580	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 36.1"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 18.5;Spermatocytes: 43.5;Spermatogonia: 44.9"	"Cancer enriched"	"Detected in many"	9	"testis cancer: 10.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.8"	"Group enriched"	"Detected in some"	30	"HDLM-2: 12.8;NTERA-2: 42.6"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (5.43e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-7)"	"unprognostic (5.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.69e-2)"	0.2	0.7	0.2	0.1	0.4	0.0	0.4	0.2	0.5	0.9	0.3	0.2	0.6	0.0	1.1	8.5	0.2	1.1	0.3	0.3	0.1	0.2	0.9	0.1	0.2	0.8	0.3	0.1	1.8	0.1	0.0	0.2	0.2	0.6	0.2	0.0	0.3	0.2	0.6	0.1	1.7	1.2	0.1	0.1	0.9	0.2	36.1	0.1	0.6	0.9	0.1	0.6	0.5	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	12.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	0.2	0.5	0.1	0.2	0.3	0.1	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.6	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	18.5	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	9.0	2.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.4	0.2	0.3	0.0	0.1	43.5	44.9	0.1	0.2	0.0	0.2	0.0
TDRD5	"FLJ34823, TUDOR3"	ENSG00000162782	"Tudor domain containing 5"	Q8NAT2	1	179591613-179691272	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 37.7"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 32.5;Late spermatids: 6.7;Spermatocytes: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 3.6;SK-BR-3: 6.0;T-47d: 10.5;U-266/70: 14.7;U-266/84: 12.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA029418	Enhanced					NA	NA					"HPA029418: AB_10603035"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.15e-4)"	"unprognostic (3.96e-1)"	"unprognostic (4.39e-3)"	"unprognostic (4.41e-4)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.31e-1)"	0.1	0.2	0.9	0.3	3.0	0.4	4.1	0.0	1.4	0.1	0.7	0.1	2.0	0.6	0.0	7.6	0.6	1.0	0.8	0.0	0.7	1.1	1.2	0.0	0.1	0.0	0.8	1.4	0.2	0.2	0.3	3.4	0.2	3.1	0.8	0.8	0.5	1.1	1.6	0.0	0.3	0.5	0.0	0.2	0.0	0.4	37.7	0.5	0.1	0.8	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.0	0.0	0.8	10.5	0.2	0.0	0.0	1.6	0.0	0.0	14.7	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.0	0.0	1.4	0.7	1.1	0.8	1.4	3.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	20.4	3.1	0.3	0.0	0.0	0.2	0.0
TDRD9	"C14orf75, DKFZp434N0820, FLJ36164, NET54"	ENSG00000156414	"Tudor domain containing 9"	Q8NDG6	14	103928462-104052667	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"parathyroid gland: 19.9;testis: 48.0"	"Group enriched"	"Detected in many"	5	"Spermatocytes: 69.1;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"classical monocyte: 4.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.1;HeLa: 9.7;HMC-1: 45.2;RPTEC TERT1: 12.3;SK-MEL-30: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.57e-3)"	"unprognostic (8.97e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.41e-2)"	0.4	0.4	0.7	0.4	1.5	1.2	0.5	1.5	1.5	0.3	0.3	0.8	0.6	0.1	0.3	0.3	0.2	0.7	2.1	0.6	0.8	0.7	1.8	0.5	1.0	0.3	0.8	1.3	0.3	0.7	19.9	0.9	0.4	3.4	0.3	0.1	1.8	0.9	1.0	0.1	0.1	0.3	0.4	1.6	2.8	0.6	48.0	0.5	0.2	4.2	0.0	0.8	0.4	0.2	0.0	0.8	0.0	4.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	9.7	0.0	0.0	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	4.1	0.0	0.0	0.3	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.5	1.5	1.5	0.8	0.7	0.8	1.3	3.4	0.5	6.0	1.3	0.0	0.0	0.0	3.1	9.7	0.0	0.0	1.2	0.0	3.9	0.0	1.7	0.6	11.1	0.7	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	1.8	6.4	0.0	0.0	2.4	6.0	0.9	0.2	0.0	0.0	0.0	0.5	0.5	0.0	2.1	1.9	1.7	6.5	0.5	69.1	37.7	0.0	0.0	0.0	0.0	0.0
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 46.5"	"Cell type enhanced"	"Detected in many"	10	"Late spermatids: 48.0;Spermatocytes: 46.8;Spermatogonia: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.7	3.5	8.8	4.2	10.9	1.6	4.6	18.0	9.9	2.6	3.3	6.3	7.5	2.5	2.0	6.2	2.1	2.4	2.3	3.6	8.8	8.9	3.1	3.7	4.4	5.4	8.1	7.8	1.4	3.5	46.5	5.5	3.7	15.9	6.2	4.3	2.9	6.4	6.7	4.5	2.5	2.5	3.1	7.6	5.9	3.1	19.3	4.9	8.0	7.3	1.0	5.2	3.7	2.0	3.8	5.3	5.3	7.0	7.3	13.1	4.2	6.3	5.5	4.9	11.4	0.3	0.5	4.8	1.1	0.6	3.4	2.3	3.6	9.2	7.4	10.1	0.4	8.1	3.9	7.2	7.5	5.3	19.2	5.1	7.4	1.6	2.5	2.2	1.4	1.2	0.6	3.0	7.3	3.1	1.0	3.6	14.7	5.7	6.7	1.0	17.2	11.7	2.2	3.8	9.5	9.6	1.4	3.1	15.4	6.0	3.1	7.2	11.8	7.9	6.4	7.4	9.4	13.9	5.6	1.4	1.6	2.9	5.0	6.1	13.8	16.9	8.3	7.4	6.0	2.2	5.3	0.9	1.9	8.8	4.3	13.1	3.8	8.2	8.8	2.0	3.6	6.0	7.5	0.7	7.3	7.0	5.3	9.4	4.2	8.8	10.9	18.0	9.9	8.8	8.9	8.1	7.8	15.9	4.9	3.0	8.8	0.9	1.9	0.2	3.4	2.6	0.0	1.4	2.3	7.0	3.9	2.2	1.7	2.5	17.5	1.0	0.1	0.0	2.2	2.5	0.4	1.7	4.6	0.6	4.4	6.4	0.0	1.3	1.3	48.0	0.3	1.3	1.7	3.6	0.9	1.5	1.8	0.0	2.1	1.3	3.0	12.9	1.2	46.8	21.1	0.1	2.1	1.3	1.0	0.9
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053304-41064511	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 58.4;skeletal muscle: 163.0;tongue: 53.9"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 89.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 9.0;HSkMC: 3.1;SuSa: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014252, HPA017957"	Enhanced					NA	NA					"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	1.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	6.1	2.8	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	1.6	0.0	0.1	3.2	0.0	163.0	0.2	0.2	0.4	0.0	0.0	2.2	0.5	0.0	1.3	0.5	53.9	4.2	0.1	0.0	5.5	5.5	3.6	2.4	1.5	4.8	0.4	0.1	0.0	0.5	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.0	0.6	0.0	1.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	1.4	0.5	0.4	0.0	0.0	0.2	1.0	0.1	1.3	0.1	0.5	0.5	0.1	0.1	0.0	1.2	0.3	0.0	0.0	0.1	2.4	0.2	0.1	0.0	0.0	0.3	0.4	0.1	1.7	0.3	0.8	0.2	0.5	0.0	1.3	2.0	3.6	4.4	1.3	3.5	4.3	4.0	4.8	1.1	5.5	4.2	4.6	1.6	1.5	2.4	5.5	3.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	2.3	89.6	0.0	0.0	0.0	0.0	2.0	1.4	0.0	2.5	9.7	0.0	0.0	0.0	18.9	5.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	19.0	0.3	0.0	1.7	0.0	0.0	1.0	3.5	0.0	0.0	1.1	2.6	0.0	0.1	0.2	0.2	0.0	1.1	0.0	0.0	0.0
BNIP3	Nip3	ENSG00000176171	"BCL2 interacting protein 3"	Q12983	10	131966455-131982013	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 122.7"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 391.8;Proximal tubular cells: 579.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 72.0;hTERT-RPE1: 56.2;U-87 MG: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003015, CAB011676"	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"CAB011676: , HPA003015: AB_1078290"	"unprognostic (1.01e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-3)"	"unprognostic (6.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.98e-1)"	19.3	12.0	18.3	4.0	18.6	3.0	8.7	13.5	28.3	7.7	4.6	13.0	5.1	4.0	6.0	11.4	8.1	6.0	7.9	43.3	16.9	14.6	27.6	53.4	6.7	4.6	16.5	14.2	19.3	122.7	6.0	7.3	13.0	22.6	18.2	2.9	5.2	19.2	6.6	48.0	9.0	4.5	6.0	13.3	4.9	6.4	6.0	11.1	3.3	10.8	6.2	4.0	9.2	7.3	6.1	3.0	5.1	3.5	2.2	23.4	8.9	72.0	5.8	4.2	11.7	11.2	11.9	21.6	17.6	16.3	13.3	38.0	1.2	1.6	0.1	28.6	10.1	15.5	4.4	8.8	25.0	50.1	3.8	6.7	2.5	3.7	16.7	15.0	3.3	2.0	8.2	6.3	12.9	13.1	56.2	9.2	4.5	6.6	0.2	21.7	5.7	1.6	18.4	3.5	0.5	17.5	4.0	2.1	6.1	14.5	1.2	5.5	12.9	3.6	7.4	10.0	18.6	4.5	4.6	10.5	18.8	6.3	7.0	13.9	12.3	10.5	10.0	68.2	0.1	3.2	2.2	3.5	5.1	9.8	2.3	10.4	5.7	13.9	10.3	3.0	6.1	23.4	15.4	0.9	2.2	3.1	2.3	13.2	8.9	18.3	18.6	13.5	28.3	16.9	14.6	16.5	14.2	22.6	11.1	44.7	40.9	23.1	75.3	26.6	87.6	141.4	101.9	89.7	48.9	80.3	37.3	149.9	255.4	174.2	61.9	44.2	3.5	0.0	75.7	295.7	56.6	118.1	0.0	391.8	65.8	314.6	77.8	54.6	21.8	85.4	65.0	16.1	32.1	39.7	6.7	125.3	189.3	1.9	97.2	579.1	50.2	38.8	23.8	33.5	100.7	11.4	206.9	25.4	4.8	42.9
C1orf56	"FLJ20519, MENT"	ENSG00000143443	"Chromosome 1 open reading frame 56"	Q9BUN1	1	151047740-151051986	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 54.8;testis: 67.7"	"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 336.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037429, HPA037430"	Enhanced				"Secreted to blood"	NA	NA		90000000			"HPA037429: AB_10671755, HPA037430: AB_2675473"	"unprognostic (7.60e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.28e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.79e-2)"	3.3	6.4	2.9	2.0	3.6	0.9	3.1	3.8	3.5	3.7	2.7	5.2	5.1	2.9	3.4	5.6	3.1	4.3	4.6	5.6	3.1	2.1	4.0	6.4	2.6	2.8	3.3	2.0	4.8	7.0	3.9	6.3	3.0	3.4	4.7	1.2	4.3	6.5	6.4	4.0	3.3	2.0	3.8	2.3	2.7	3.1	67.7	3.8	0.7	7.1	1.2	1.7	3.3	3.0	16.3	7.8	54.8	15.4	15.5	28.4	1.0	4.0	8.1	2.8	1.3	4.8	4.7	2.6	2.3	3.4	1.5	1.2	3.5	5.8	0.9	3.7	2.5	3.2	5.5	1.6	0.3	0.8	5.2	1.8	1.0	6.4	4.3	3.3	1.1	0.8	3.4	1.8	2.3	0.8	2.9	2.2	1.8	2.1	2.1	1.3	15.8	1.5	2.8	4.7	3.2	4.6	1.3	2.8	2.9	1.2	2.3	3.8	7.4	7.4	3.8	5.3	5.6	7.5	3.0	2.3	2.0	3.6	5.3	2.0	5.0	3.9	12.7	3.8	0.6	2.5	54.8	7.3	13.7	27.8	15.4	20.8	14.2	24.2	24.2	5.5	16.3	20.6	28.4	20.2	15.5	12.7	7.8	13.7	1.0	2.9	3.6	3.8	3.5	3.1	2.1	3.3	2.0	3.4	3.8	6.0	8.5	68.1	31.4	57.5	18.6	7.0	48.4	6.7	10.3	40.1	19.6	38.8	33.2	18.8	336.7	30.8	8.0	46.7	12.8	26.9	47.4	29.5	39.1	34.7	28.3	17.5	14.3	63.3	73.4	44.3	26.4	65.6	84.4	83.0	12.5	13.8	26.2	17.5	24.1	24.8	24.2	25.8	37.6	148.7	13.6	72.8	74.8	126.9	12.0	45.1
GCNA	"ACRC, NAAR1"	ENSG00000147174	"Germ cell nuclear acidic peptidase"	Q96QF7	X	71578411-71613583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 29.4"	"Cell type enhanced"	"Detected in some"	20	"Collecting duct cells: 3.5;granulocytes: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA023476, HPA030870"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023476: AB_1844530, HPA030870: "	"unprognostic (6.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.07e-10)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.74e-1)"	"unprognostic (1.15e-5)"	1.4	6.9	1.2	1.7	1.7	1.6	1.2	3.7	1.7	1.2	1.2	1.2	1.2	1.0	1.2	1.4	1.2	0.9	1.2	1.2	1.3	2.5	1.2	1.8	1.4	2.6	1.2	1.2	1.5	1.7	0.4	1.2	1.2	1.7	1.2	1.0	1.2	1.2	1.2	3.1	1.7	1.5	1.2	1.2	3.9	0.9	29.4	1.2	1.2	1.6	1.2	1.4	1.2	1.2	1.4	0.6	1.1	0.6	1.4	3.3	0.5	0.6	1.1	2.2	2.0	4.5	4.2	1.3	3.6	1.9	1.2	2.1	2.0	1.3	5.5	2.7	1.9	1.2	2.6	4.3	0.2	1.8	0.9	2.9	1.1	4.9	0.5	1.2	1.0	5.1	1.6	6.9	1.0	1.0	4.6	0.8	4.3	1.5	3.5	2.5	0.7	0.4	3.9	2.2	2.5	2.6	1.0	0.1	4.0	2.8	1.6	1.3	0.2	1.2	0.6	3.0	2.4	0.4	3.5	1.4	1.3	2.6	1.8	1.0	1.0	2.5	2.2	2.5	2.1	2.2	0.6	0.6	0.1	0.7	0.3	1.3	1.4	1.7	3.3	0.3	0.5	1.0	1.1	1.1	1.4	0.1	0.6	3.0	0.5	1.2	1.7	3.7	1.7	1.3	2.5	1.2	1.2	1.7	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
OTUD4	"DUBA6, HSHIN1, KIAA1046"	ENSG00000164164	"OTU deubiquitinase 4"	Q01804	4	145110838-145180161	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036623	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA036623: AB_10696780"	"unprognostic (1.67e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-1)"	14.3	11.8	16.6	11.6	16.7	24.7	12.0	22.7	15.9	14.0	15.3	16.0	10.1	10.0	13.9	13.3	14.8	14.9	11.2	15.6	12.0	9.2	11.1	17.7	15.5	13.1	14.1	8.4	14.3	13.4	22.4	12.2	17.9	12.7	10.6	11.2	10.6	12.7	11.0	36.2	13.6	16.2	12.4	10.1	13.5	10.8	26.8	18.8	13.1	13.4	13.6	12.3	11.5	12.8	3.3	2.8	2.8	2.8	1.6	3.5	1.0	15.2	8.7	10.5	9.6	12.4	15.1	14.0	13.3	15.1	17.3	13.8	9.4	18.9	28.1	6.1	18.7	10.6	9.3	18.0	18.7	22.7	12.0	8.6	13.4	10.6	8.5	14.5	28.2	10.2	11.8	19.1	21.1	27.7	14.6	15.2	12.4	22.2	21.1	16.9	9.1	17.4	12.3	11.6	14.8	10.0	14.4	11.5	6.6	16.7	11.2	10.1	8.3	12.3	18.7	13.3	14.4	6.2	11.6	18.3	19.5	12.4	10.0	17.7	15.6	15.3	18.6	13.5	20.1	18.8	0.0	1.7	2.8	3.5	2.1	2.6	3.3	2.7	2.8	1.6	2.4	2.7	2.4	0.5	1.6	2.8	2.8	2.0	1.0	16.6	16.7	22.7	15.9	12.0	9.2	14.1	8.4	12.7	18.8	59.6	19.7	15.9	40.5	56.1	15.3	18.5	28.1	42.8	23.9	26.2	23.6	17.2	8.3	11.1	130.8	21.8	10.5	0.0	12.7	17.3	25.9	44.8	19.7	20.2	11.8	6.4	14.6	22.1	18.0	63.1	18.7	17.9	30.4	5.4	12.1	7.5	18.4	14.0	28.3	6.6	19.1	0.0	29.9	28.8	41.0	47.6	13.4	14.6	14.3	50.2
PPP1R3C	"PPP1R5, PTG"	ENSG00000119938	"Protein phosphatase 1 regulatory subunit 3C"	Q9UQK1	10	91628442-91633054	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 259.9"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 213.5;Hepatocytes: 61.4;Muller glia cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.4;HHSteC: 20.8;hTERT-RPE1: 33.7;LHCN-M2: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027041	Uncertain					NA	NA					"HPA027041: AB_1855649"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.44e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.61e-3)"	4.0	5.4	10.4	2.8	18.9	1.5	3.5	1.1	15.8	24.9	4.1	8.0	8.3	2.7	7.1	6.5	26.5	4.5	6.0	53.3	13.1	5.7	5.4	39.5	5.4	1.8	6.1	8.1	6.6	5.6	2.8	1.7	6.3	12.2	11.0	2.8	4.5	10.0	13.4	259.9	4.4	2.2	14.8	9.1	2.2	5.2	2.2	6.1	0.0	2.4	28.2	7.7	11.4	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.7	10.4	4.7	2.2	0.0	11.4	8.9	4.7	5.1	0.0	0.8	0.0	0.4	10.7	1.9	0.6	0.2	1.2	8.7	0.0	0.0	0.1	16.4	1.8	20.8	0.0	0.0	7.6	2.0	3.0	0.1	33.7	1.1	0.0	5.3	0.0	39.7	0.3	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.4	10.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.7	7.8	2.1	2.1	2.7	1.6	0.0	0.2	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	18.9	1.1	15.8	13.1	5.7	6.1	8.1	12.2	6.1	0.0	0.0	0.0	10.2	4.0	8.9	213.5	0.0	0.0	0.0	3.5	0.0	0.1	6.6	1.7	0.0	3.5	0.0	0.0	10.2	0.2	6.6	3.2	0.0	61.4	1.1	17.5	9.7	1.8	2.4	0.0	2.6	0.0	11.8	0.0	0.0	120.0	6.4	0.0	7.1	1.6	12.5	0.0	21.7	0.2	1.4	3.4	0.2	0.0	0.0	0.9
RASSF1	"123F2, NORE2A, RDA32, REH3P21"	ENSG00000068028	"Ras association domain family member 1"	Q9NS23	3	50329782-50340980	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 56.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040735	Approved					NA	Yes					"HPA040735: AB_10671692"	"unprognostic (5.02e-2)"	"prognostic favorable (2.64e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-3)"	"prognostic favorable (2.60e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (3.80e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (4.27e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.71e-2)"	21.5	9.9	8.5	21.3	13.0	50.3	23.3	12.4	13.8	17.9	17.1	12.3	15.7	11.2	15.7	13.7	13.6	13.4	25.2	17.7	10.4	7.5	12.2	10.6	25.9	24.5	17.6	8.6	14.7	23.2	5.2	10.3	18.4	12.9	13.5	8.7	15.0	23.7	12.8	18.8	17.8	17.2	16.0	12.5	32.3	13.3	24.6	12.9	9.7	13.6	15.2	21.4	19.7	16.9	12.7	6.9	56.8	15.1	16.7	23.1	10.0	14.2	5.9	4.4	7.3	10.2	14.0	6.5	24.6	16.3	21.2	17.0	13.5	10.8	6.9	3.8	26.3	9.5	7.7	9.3	10.2	11.5	17.1	6.0	23.8	18.4	7.0	11.8	23.3	26.3	10.7	7.3	20.9	7.5	6.2	9.4	8.6	9.9	16.2	9.5	5.0	8.8	31.4	5.9	12.0	17.8	7.3	4.6	15.9	6.2	4.2	5.2	9.6	21.9	14.8	16.4	4.7	8.9	23.0	8.9	14.7	11.0	20.8	12.1	6.6	4.3	15.0	8.2	29.2	26.2	56.8	6.6	21.2	23.1	11.1	14.5	12.7	7.5	16.3	6.9	9.7	4.8	11.4	5.1	16.7	15.1	5.2	7.5	10.0	8.5	13.0	12.4	13.8	10.4	7.5	17.6	8.6	12.9	12.9	14.9	7.2	27.0	30.7	65.6	12.0	9.5	10.2	5.3	13.6	1.8	13.7	23.5	5.0	21.6	1.7	46.0	9.2	0.0	22.9	22.0	28.3	20.6	56.5	4.2	32.7	3.2	16.0	26.4	22.3	7.2	17.5	21.8	86.0	16.2	14.1	7.8	29.1	14.4	13.8	6.3	9.1	25.8	58.7	31.7	9.3	43.8	13.8	61.7	12.0	18.2
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9, X-linked"	Q93008	X	41085635-41236579	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	18.0	21.8	17.7	14.0	15.9	15.5	16.8	16.6	16.7	18.4	20.6	11.4	25.4	13.2	19.6	19.0	17.3	17.0	17.1	20.9	14.2	14.2	18.5	34.2	16.7	23.1	15.2	15.4	15.7	16.5	45.8	17.0	41.1	12.9	13.4	14.4	13.9	14.2	25.2	42.8	14.8	22.0	17.3	14.0	16.7	16.9	16.9	14.0	21.1	20.3	17.6	16.5	20.3	19.9	6.4	5.5	13.0	5.0	4.9	7.8	3.1	18.2	21.6	19.2	19.6	16.1	16.9	4.4	10.5	14.1	12.0	13.9	9.9	8.5	12.3	5.9	23.9	35.9	12.4	32.9	19.1	20.1	15.4	23.6	14.2	20.9	8.9	13.6	12.3	10.4	14.6	8.6	28.7	27.2	17.2	18.5	8.3	17.2	10.0	18.5	13.3	8.8	4.9	20.3	6.5	11.9	9.7	26.2	7.9	11.4	15.1	10.9	10.2	44.2	12.2	12.0	36.0	11.8	6.9	19.7	18.3	14.2	17.3	11.3	9.2	10.7	15.7	13.1	5.5	9.1	3.3	4.7	6.0	5.6	4.2	7.8	6.4	6.6	6.2	5.5	4.7	6.7	6.0	13.0	4.9	5.0	4.2	5.6	3.1	17.7	15.9	16.6	16.7	14.2	14.2	15.2	15.4	12.9	14.0	38.7	32.0	23.8	26.8	42.8	35.0	73.6	43.3	30.8	36.4	26.2	35.3	31.0	6.6	26.8	13.0	39.8	39.2	70.0	22.8	21.8	35.1	30.2	24.4	55.5	29.3	35.0	25.8	52.8	43.4	13.1	30.8	38.0	32.1	33.3	42.5	32.0	27.0	35.7	46.3	20.3	29.3	32.3	39.6	31.4	69.2	48.3	39.0	26.1	36.7	34.3
